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Chronic inflammation is a persistent inflammatory condition ultimately leading 
to tissue destruction. The human lung is constantly exposed to foreign irritants 
and microbes thus effective immune regulation is essential to maintain lung 
homeostasis. The chronic infection of the cystic fibrosis (CF) lung with 
Pseudomonas aeruginosa strongly correlates with the decline of pulmonary 
function and mortality. Pseudomonas alkyl-quinolone signal (PQS), generated 
through the 2-alkyl-4-quinolones (AQs) system, is a diffusible signal for cell-
to-cell communication controlling the production of virulence factors in a 
population density dependent manner. PQS has been detected in the lung of CF 
patients and the amount was proportionate to P. aeruginosa colonisation. PQS 
molecules have also been demonstrated to inhibit pro-inflammatory signalling. 
However, how PQS influences the recognition of P. aeruginosa by the human 
lung is unknown. Towards this aim the contribution of PQS to the interaction 
of P. aeruginosa with human bronchial epithelial cells (HBECs) was 
characterised using a PQS-deficient mutant ǻSTV$L in comparison with its 
isogenic wild type (WT). ǻSTV$L did not produce AQs and pyocyanin; 
displayed reduced rhamnolipid synthesis and fragile biofilms suggesting an 
attenuated phenotype. However, the pathogenesis of WT and ǻSTV$L upon 
infection of HBEC did not differ in bacterial growth, actin degradation, 
junction protein disruption, and pro-inflammatory activation in HBECs. 
Further, despite PQS being highly secreted by a CF isolate LESB58, 
preliminary data showed that LESB58 was less cytotoxic than the laboratory 
  
WT strain. Our results suggest that PQS does not alter P. aeruginosa 
pathogenicity during infection of HBECs.  
Idiopathic pulmonary fibrosis (IPF) is a progressive pro-fibrotic disease 
characterised by heterogeneous pathological patterns caused by scarring that 
leads to destruction of lung architecture and high mortality. Despite the fact 
that inflammation is considered secondary to the IPF pathogenesis, emerging 
evidence suggests that dysregulated immunological events could cause the 
failure of tissue healing. Systemic immune responses of patients with IPF and 
age- and sex-matched healthy donors were determined by quantifying 
cytokines produced by peripheral blood mononuclear cells (PBMCs) upon an 
array of stimuli. Cytokine production in the cases was also correlated with their 
survival. The results showed that PBMCs in patients with IPF were less likely 
to produce IL-17A, IL-10 and IL-13 than healthy controls (IL-17A: OR 0.14, 
95% CI 0.003; IL-10: OR 0.3, 95% CI 0.03; IL-13: OR 0.27; 95% CI 0.018). 
Patients with lower levels of IFN-Ȗ,/-17A, IL-13 production by PBMCs had 
a four to six-fold increased risk of death (IFN-Ȗ+5&,,/-
17A: HR 4.60, 95% CI 0.0138; IL-13: HR 6.13, 95% CI 0.0052).   
This study contributes to a better understanding of the role of PQS in the 
pathogenesis of P. aeruginosa and identified cytokine production by immune 
cells as a novel prognosis marker in IPF. 
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1. GENERAL INTRODUCTION 
The lung is a dynamic organ that constitutes one of the largest interfaces 
between the body and the external environment and is constantly exposed to 
microorganisms and particulate irritants (Suzuki et al., 2008). In particular the 
lung epithelium acts as a key orchestrator of the pulmonary immune response. 
The aim of this study was to extend the understanding of the immune 
mechanisms of human pulmonary diseases by focusing on two chronic fibrotic 
diseases: cystic fibrosis (CF) and idiopathic pulmonary fibrosis (IPF). In order 
to contextualise and justify the present study, this general introduction briefly 
reviews the main features of the human respiratory system including anatomy, 
immunology and pathology, and introduces two fibrotic pulmonary diseases: (1) 
CF focusing on the innate response of airway epithelium upon bacterial 
infection and (2) IPF when the emphasis will be placed on systemic immune 
responses and their association with disease.  
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1.1. HUMAN RESPIRATORY SYSTEM 
1.1.1. Lung structure and function 
Humans have two lungs; a right lung consisting of three lobes and a left lung 
slightly smaller and consisting of two lobes. The primary function of the lung 
is gas exchange to obtain O2 for the use of body cells and to eliminate CO2 
(Sherwood, 2007). The air passes through the nasal, larynx and pharynx down 
into the conducting zone branching from trachea, bronchi to terminal 
bronchioles (see structure in Fig. 1.1) where the conditioning process takes 
place. This conditioning process involves warming and humidifying of 
incoming air and removal of particulate materials. The respiratory zone, also 
called lung parenchyma, comprises alveolar air spaces, alveolar epithelium and 
the pulmonary capillaries where gas exchange occurs (Berube et al., 2010, 
Ross et al., 2010). The human adult lung has approximately 200 million alveoli 
with an internal surface area of 75 m2 hence it is a tremendous platform easily 
accessed by foreign bodies. For this, the lung has evolved effective innate 
defense mechanisms that constantly protect airways against bacterial and other 
types of intrusions (Knowles and Boucher, 2002, Sherwood, 2007). 
The wall of bronchi contains five layers: (1) mucosa, which consists in a layer 
of pseudostratified epithelium that lies on the basement membrane lamina 
propria; (2) submucosa, a relatively loose connective tissue where glands and 
adipose tissue are present in the larger bronchi (Fig. 1.2B); (3) muscularis, a 
continuous layer of smooth muscle in the larger bronchi. Muscle contraction 
maintains the shape of the airway; (4) cartilage layer and (5) adventica, the 
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moderately dense connective tissue that connects with adjacent structures, such 
as pulmonary artery and lung parenchyma.  
 
 
 
 
 
 
 
 
 
 
 
 
 
The bronchial epithelium is approximately 25-40 ȝm thick and is made up of 
various differentiated epithelial cell types including ciliated cells, mucin-
Figure 1.1  Structure of the human lung. 
Schematic presentation of the respiratory branches in the human lung.  The conducting zone 
consists of the trachea, bronchi, and terminal bronchioles. In this area air passes through but 
no gaseous exchange takes place. The respiratory zone consists of respiratory bronchioles, the 
alveolar ducts and alveolar sacs where gas exchange occurs between the lung and pulmonary 
capillaries. From the larynx, the branching starts dividing from the trachea into two primary 
bronchi and up to 23 generations (Z) to the alveolar sacs. Figure adopted from (Berube et al., 
2010). 
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producing goblet cells, secretory club cells (Clara cells were renamed as club 
cells in 2013 (Irwin et al., 2013)) and basal cells that form a heterogeneous 
pseudostratified columnar epithelium (Fig. 1.2). The ciliated columnar cell is 
the most abundant cell type in the bronchial epithelium. It displays a 
characteristic pseudostratified columnar appearance with each cell carrying 
approximately 250 cilia at the apical surface, interspersed with microvilli that 
projects to the respiratory lumen. The motile cilia beat with the aid of mucus, 
traps noxious inhaled particles and propel them out of the lung (Shah et al., 
2009). This movement is termed the mucociliary clearance and protects the 
lung by facilitating the removal of small particles or infectious pathogens prior 
infection is established or further damage occurs (Mall, 2008, Ross et al., 2010). 
Goblet cells secrete mucins and are the second most numerous cell types in the 
bronchial epithelium. Like ciliated cells, goblet cells span the full depth of the 
epithelium and also project microvilli to increase surface area for mucus 
secretion. Their cytoplasm is occupied mostly by mucinogen granules that 
accumulate near the apical side. The mucins, secreted by goblet cells and from 
mucus glands, make up the mucus layer which covers the luminal surface and 
protects the epithelium from dehydration by saturation of inhaled air with 
water, and potential damage from inhaled particles (Ross et al., 2010, 
Boucherat et al., 2013). Club cells are cuboidal non-ciliated cells located in 
human terminal bronchioles and secrete glycosaminoglycans, club cell 
secretory protein uteroglobin, and surfactant by apocrine secretion to protect 
the bronchial lining (Reynolds and Malkinson, 2010). Club cells are also 
facultative progenitor cells and are capable of self-renewal and restoring 
terminally differentiated cells such as ciliated cells. Thus, this unique feature of 
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the maintenance and repair of lung epithelium suggests that an intervention that 
stabilises the club cell pool could be used for the treatment of chronic lung 
diseases (Reynolds and Malkinson, 2010). Basal cells are undifferentiated 
epithelial cells that extend into the respiratory lumen and are located adjacent 
to the basement membrane. They are able to differentiate and replenish ciliated 
and goblet cells (Ross et al., 2010). 
The alveolar epithelium is composed of type I (95% of the coverage) and type 
II alveolar cells (less than 5%) and occasional brush cells (Ross et al., 2010). 
The direct contact with air and continuous exposure to particles and microbial 
pathogens makes the alveolar surface vulnerable. Type I alveolar cells (also 
named type I pneumocytes) are squamous cells that line the alveolar surface by 
joining adjacent cells through occluding junctions. Type I alveolar cells are 
terminally differentiated. Type II alveolar cells (also named type II 
pneumocytes) are secretory cells rich in phospholipids, neutral lipids and able 
to produce surfactant. Type II alveolar cells are also the progenitor cells for 
type I alveolar cells (Barkauskas et al., 2013a). One proposed theory of 
idiopathic pulmonary fibrosis (IPF) aetiology is a defect of type II alveolar 
cells to differentiate into type I alveolar cells; aberrant epithelial cell function 
could result from continuous apoptosis of type I pneumocytes and proliferation 
of type II pneumocytes eventually leading to irreversible fibroblast foci  (Hoo 
and Whyte, 2012). 
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Figure 1.2  Cellular composition in the human lower and distal respiratory tract. 
A. The lower respiratory tract (RT) is comprised of trachea, bronchi (primary, secondary, 
tertiary and small which are defined by the number of dividing branches 1 to 4), bronchioles 
and terminal bronchioles. The lower RT is covered with bronchial/ bronchiolar epithelium 
comprised of ciliated cells, club (Clara) cells, basal cells, and goblet cells. Respiratory 
bronchioles and alveolar sacs, which belong to the distal RT, are composed by alveolar 
epithelium containing type I, II alveolar cells and alveolar macrophages. Figure adopted from 
(Berube et al., 2010). B. Cross-section of bronchial tissue strained with haematoxylin and 
eosin. Image taken from http://www.siumed.edu/.  
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1.1.2. The innate immunity in the lung 
1.1.2.1. Cells and their functions in the airway epithelium 
The airway epithelium plays an essential role in innate immunity to xenobiotics. 
In addition to gas exchange, airway epithelium participates in the regulation of 
immune defense encompassing the passive physical barrier, active mucociliary 
movement and immune modulation through the secretion of chemical 
mediators. The mucociliary escalator is powered by the cilia that is continually 
beating, pushing mucus up and out from the airway into the throat. Microbial 
pathogens or particles ranging from 2 to 10 ȝm in diameter are trapped in the 
sticky mucus blanket and moved up by the mucociliary escalator away from 
the respiratory tract (Ross et al., 2010, Widmaier et al., 2006). The mechanic 
movement able to expel pathogens and external irritants provides a major 
barrier against infection. The epithelial barrier is impermeable to foreign 
bodies because of the presence of the junctional complex consisting of tight 
junctions, anchoring junctions (desmosomes and adherens junctions), and gap 
junctions that tightly bind adjacent epithelial cells (Fig. 1.3) (Alberts et al., 
2002). Epithelial cells are capable of triggering immune responses and killing 
microbial pathogens through internalisation of pathogens, secretion of 
cytotoxic molecules (NO, O2- and H2O2), anti-microbial peptides and cytokines 
(described in section 1.1.2.3.) (Kowalski et al., 2007). Meanwhile, epithelial 
cells can be activated by bacterial components and cytokines such as tumour 
necrosis factor-alpha (TNF-Į) and interleukin 1beta (IL-1ȕ) to regulate the 
inflammatory response (Suzuki et al., 2008).  
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in the regulation of host defense. Like the epithelial barrier, the endothelial 
monolayer displays apical and basal surfaces that prevent passive movement of  
Upon microbial infection, endothelial cells reorganise their cytoskeleton to 
increase vascular permeability; the expression of surface proteins intercellular 
adhesion molecule-1 (ICAM-1) and platelet activating factor (PAF) on 
activated endothelial cells are also enhanced to increase the binding of 
neutrophils to facilitate the downstream inflammatory response (Sherwood, 
Figure 1.3  Epithelial cell junctions. 
Three specialised junctions support the cellular polarity and paracellular communication of 
differentiated epithelium. Tight junctions (TJs) are situated closest to the apical membrane and 
form a continuous intercellular barrier between adjacent epithelial cells. TJs which are 
composed of claudins, occludins and intracellular peripheral membrane proteins called zonula 
occludin (ZO) proteins form a restrictive barrier preventing the flux of fluid, ions and 
macromolecules between the apical and basolateral side (Godfrey, 1997). Beneath the TJs lie 
adherent junctions (AJs) which form a belt made up by cadherin-catenin complex around the 
circumference of cell membrane that linked to actin and myosin filaments (Baum and Georgiou, 
2011). AJs function to join adjoining cells in a calcium-dependent manner (Baum and Georgiou, 
2011). Gap junctions which sit near the basolateral side allow the exchange of intracellular 
cytoplasm, ions and other small molecules (Alberts et al., 2002). Figure adapted and modified 
from (Nature.com, 2014) 
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2007, Ross et al., 2010). In addition to their role as major constituents of the 
connective tissue structure, fibroblasts produce extracellular matrix, 
predominantly collagen type I and type III, to sustain the architecture of the 
lung (Suzuki et al., 2008). Fibroblasts are important in wound healing, and this 
activity is thought to be regulated by fibrocytes that reside in the tissue stroma. 
Following tissue injury, fibroblasts migrate to the site of damage and facilitate 
the healing process through the deposition of new collagen. At a healing 
wound, they change their actin gene expression and take on the contractile 
properties of smooth muscle cells that help to pull the wound margins together; 
these modified fibroblasts are termed myofibroblasts (Rubin and Strayer, 2008). 
Fibroblast secretion of matrix metalloproteases (MMPs) and cytokines induce 
leukocytes activation and also help shaping the inflammatory response 
(Andersson et al., 2008, Rubin and Strayer, 2008). 
1.1.2.2. Innate immune cells in the lung 
Macrophages are critical players in the initiation of inflammation and can 
promote chronic inflammation in some circumstances (Rubin and Strayer, 
2008). Alveolar macrophages are the major resident myeloid-derived cells in 
the lung. They are located on the luminal side of the lung and exert highly 
phagocytic function to facilitate protection of the host against infections. 
Alveolar macrophage activation is tightly controlled by soluble mediators in 
the lumen and the close cell-cell binding with bronchial/alveolar epithelial cells 
to limit unwanted inflammatory responses (Hussell and Bell, 2014). Current 
research indicated that the negative regulation of macrophage activation is 
controlled via the binding of IL-10 to IL-10R expressed by alveolar 
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macrophages that triggers Janus Kinase 1 (JAK1)-signal transducer and 
activator of transcription 3 (STAT3) resulting in the expression of suppressor 
of cytokine signalling 3 (SOCS3) and the microRNA miR-146b. The ligation 
of the ligand CD200 at type II alveolar epithelial cells with CD200 receptor 
(CD200R) in alveolar macrophage also inhibits the extracellular signal-
regulated kinase (ERK), p38 mitogen-activated protein kinase (MAPK) and 
JUN N-terminal kinase (JNK) inflammatory pathways. Binding of latent TGF-
ȕ by ĮȞȕ6 integrin on the bronchial or inflamed alveolar epithelial cells induces 
a conformational change in TGF-ȕ that facilitates access of the TGF-ȕ receptor 
(TGF-ȕR) resulting in inhibition of pro-inflammatory signalling (Hussell and 
Bell, 2014). A subset of alveolar macrophages was found to remain 
immunosuppressive upon endotoxin induced inflammation through the 
physical contact with alveolar epithelial cells at gap junctions. The connexion 
43 expressing gap junction protein knock-out alveolar macrophages in mice 
recruit higher amounts of neutrophils and secrete pro-inflammatory cytokines 
indicating that the activation of alveolar macrophages is tightly controlled 
through their intercommunication with alveolar epithelium to repress 
inflammation (Westphalen et al., 2014). Alveolar macrophages have a M2-like 
(alternatively activated macrophages), a phenotype associated with the 
resolution of many lung inflammatory conditions but that can also promote 
fibrotic disease through the production of TGF-ȕ, CCL18 and platelet-derived 
growth factor (PDGF). Despite that fact that alveolar macrophages produce 
higher levels of IL-13 in asthma patients and that the expression of CD163 is 
also higher on alveolar macrophages from patients with IPF, which activation 
pattern of alveolar macrophages promote healing or aggravate tissue damage 
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either transiently or chronically is still unclear and disputable (Alber et al., 
2012, Hussell and Bell, 2014).  
Neutrophils are phagocytes with potent anti-microbial capabilities. During 
pulmonary microbial infection, neutrophils migrate out of the pulmonary 
capillaries into the air spaces. The combination of degranulation through the 
release of proteases (neutrophil elastase, cathepsin G, lactoferrin, 
myeloperoxidase, etc.) and the oxidative response (the production of 
superoxide H2O2 by NADPH oxidase) result in efficient microbial killing in the 
phagolysosome. Neutrophils are not only the hallmark of acute inflammation 
but dysregulated function of neutrophils or neutropenia predispose patients to 
chronic pulmonary inflammation (Rubin and Strayer, 2008).  
Mast cells are ubiquitous in the airways and lung parenchyma (Suzuki et al., 
2008). Mast cells are involved in the response to parasitic infections and in 
mediating allergic responses. Aggregation of the IgE receptor FcİRI by binding 
to multivalent IgE-coated antigens causes rapid degranulation of mast cells, 
resulting in the release of various mediators such as histamine, prostaglandins 
and leukotrienes together with an array of proteases and cytokines/chemokines 
that cause immediate airway inflammation and the symptoms of asthma 
(Moiseeva and Bradding, 2011). Activated mast cells have been shown to 
produce inflammatory cytokines TNF-Į, IL-1ȕ, and IL-6 to promote acute 
inflammation in the rat lung after intratracheal instillation of P. aeruginosa 
LPS (Le et al., 2012). In addition, human cord blood-derived mast cells were 
also implicated in neutrophil recruitment via secretion of IL-1Į and IL-1ȕ upon 
activation with P. aeruginosa culture supernatants (Lin et al., 2002). 
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Eosinophils act to eliminate parasitic infections and are effector cells 
responsive to allergic responses (Suzuki et al., 2008). Eosinophil granules 
contain four different granule cationic proteins: eosinophil peroxidase, 
eosinophil cationic protein, eosinophil-derived neurotoxin and a major basic 
protein that is toxic to parasites and causes epithelial cell necrosis. Eosinophils 
secrete lipid mediators such as leukotriene C4 and platelet-activating factor in 
response to allergic inflammation that may result in dysfunction and injury to 
other cells (Rubin and Strayer, 2008). 
1.1.2.3. Soluble immune mediators in the lung 
Airway surface liquid and its anti-microbial properties  
Airway surface liquid (ASL) is composed mainly of mucin glycoproteins and 
anti-microbial molecules including ȕ-defensins, lactoferrin, and lysozyme. 
These anti-microbial molecules that can be secreted by neutrophils and 
macrophages in addition to epithelial cells ASL have anti-microbial properties 
and are effective at pH ranging from 6.5 to 7.3. Lysozyme hydrolyses 
peptidoglycan is the major component of Gram-positive bacterial membranes. 
Defensins are peptides containing 6 cysteines and 3 intramolecular disulphide 
bonds. Į and ȕ forms are expressed by humans. Epithelial cells mainly express 
6 ȕ-defensins (hBD-1 to 6) whereas Į defensins 1-4 are produced by 
neutrophils in the airways. Recruited neutrophils to the site of inflammation by 
microbial products secrete defensins and thereby induce airway epithelial cells 
to produce more IL-8, TNF-Į, and IL-1ȕ to recruit additional neutrophils (van 
Wetering et al., 2002). In addition to anti-microbial activities, defensins 
enhance airway epithelial cells bacterial binding, cytotoxicity, and cytokine 
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production. Lactoferrin is an iron-binding protein that directly damages 
bacterial membranes resulting in the release of lipopolysaccharides (LPS) and 
interferes with the binding of LPS to LPS binding protein. As a result, 
lactoferrin prevents host cells from activation by bacterial LPS. Cathelicidin 
LL-37 works synergistically with lysozyme and lactoferrin is secreted by 
airway epithelial cells and mast cells. LL-37 exerts chemotaxis for leukocytes, 
ligation of LPS, and induction of cytokine and chemokine expression by 
epithelial cells and promotion of epithelial wound healing (Suzuki et al., 2008). 
Complement components 
Complement proteins circulate in the blood in an inactive form in the absence 
of infection. In the presence of pulmonary infections, complement proteins 
extruding from the plasma to airways are involved in the inflammatory 
response against bacterial infection via opsonisation to facilitate leukocyte 
phagocytosis (Murphy, 2011). Complement activation can be triggered through 
three pathways: classical pathway that is initiated by the interaction of C1q (a 
component of C1 complex) with pathogen surface or with antibodies to the 
antigens bound bacterial surfaces; alternative pathway, the spontaneous 
hydrolysis of C3 binding to factor proteins triggered by microorganism-derived 
products, such as endotoxin, zymosan, polysaccharides; lectin pathway is 
triggered by the recognition and binding of mannose-binding lectin and ficolins 
to mannose groups on the pathogen surfaces. Complement C3a and C5a are 
anaphylatoxins that stimulate smooth muscle contraction and promote vascular 
permeability neutrophil recruitment into the lung and microbial killing (Rubin 
and Strayer, 2008, Suzuki et al., 2008).  
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Surfactant proteins 
Pulmonary surfactant is essential to reduce the air-liquid surface tension of the 
lung (Pattle, 1955) and functions in various aspects of pulmonary host defence 
(Wright, 2005). The majority of surfactant is composed of phospholipids and 
about 10% of surfactant consists of proteins with four surfactant proteins 
defined: surfactant protein A (SP-A), SP-B, SP-C and SP-D. SP-A and SP-D 
along with mannose-binding lectin (MBL) belong to the family of collectins 
which opsonise pathogens including a variety of bacteria, viruses, fungi, 
allergens and apoptotic cells and thereby enhance the uptake of these cells and 
particles by phagocytes (Crouch and Wright, 2001, Holmskov et al., 2003). 
Distinctive roles have been ascribed to surfactant proteins. SP-A inhibits the 
maturation of dendritic cells (DCs), whereas SP-D promotes the uptake and 
presentation of antigen by DCs (Lipscomb and Masten, 2002). Studies also 
indicated that the binding of SP-A and SP-D to T cells inhibits T-cell 
proliferation (Lambrecht et al., 1999, Wright, 2005). The above evidence 
suggests that surfactant proteins bridge innate and adaptive immunity. 
Surfactant proteins also negatively regulate alveolar macrophage activation. 
SP-A and SP-D prevent pro-inflammatory response through QXFOHDU IDFWRU ț
light-chain enhancer of activated B cells (NF-țB) activation in alveolar 
macrophages by blocking the interaction of TLR2, TLR4 and its co-receptors 
MD2 and CD14 with their correspondent ligands (Hussell and Bell, 2014). 
Binding of SP-A and SP-D to signal-regulatory protein-Į (SIRPĮ) on the 
surface of alveolar macrophages recruits SH2 domain-containing protein 
tyrosine phosphatase 1 (SHP1) that inhibits phagocytosis (Hussell and Bell, 
2014). 
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Induced inflammatory mediators 
Activation of receptors in the airway epithelial cells leads to the secretion of an 
array of cytokines/chemokines and growth factors that recruit leukocytes and 
lymphocytes to the site of infection (Parker and Prince, 2011). Cytokines can 
be categorised as pro-inflammatory and anti-inflammatory. ȉȃF-Į, IL-6, IL-1ȕ 
and the growth factor granulocyte macrophage colony-stimulating factor (GM-
CSF), chemokines IL-8, monocyte chemotactic protein-1 (MCP-1), T-cell-
specific CXC chemokines, IFN-induced protein of 10 kDa (IP-10) are among 
the well-known pro-inflammatory mediators produced by airway epithelial 
cells and haematopoietic cells that participate in acute inflammatory response 
(Parker and Prince, 2011). Major anti-inflammatory cytokines include IL-10, 
transforming growth factor-beta (TGF-ȕ), soluble cytokine receptors/receptor 
antagonist sIL-1ra. Secretion of IL-10 and TGF-ȕ by alveolar macrophages and 
epithelial cells down-regulates the inflammatory response by T cells, NK cells 
and monocytes (Stow et al., 2009).  
1.1.2.4. Pattern recognition receptors on the airway epithelium 
The innate immune response is the first line of host defence and is responsible 
for immediate recognition and control of a broad range of microbial infections. 
The sensing of infections relies on innate pattern recognition receptors (PRRs) 
which include surface transmembrane Toll-like receptors (TLRs) and cytosolic 
receptors retinoic acid-inducible gene I like (RIG-I-like) receptors, nucleotide-
binding oligomerisation domain-like (NOD-like) receptors and C-type lectin 
receptors that recognise highly conserved microbial structures (Takeuchi and 
Akira, 2010, Tam et al., 2011). Ligand-receptor binding triggers intracellular 
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signalling and a major component of mucosal immunity involves the activation 
of NF-țB, activator protein 1, IFN regulatory factors (IRFs), MAPKs leading 
to recruitment and activation of neutrophils and other immune cells in the 
airways (Parker and Prince, 2011). So far, human airway epithelial cells have 
been documented to express all ten TLRs mRNA but the predominant TLR 
genes expressed are TLR2 to TLR6 (Kato and Schleimer, 2007, Hallstrand et 
al., 2014). TLR2, which forms heterodimers with TLR1 or TLR6, recognises 
lipoprotein, peptidoglycan and lipoteichoic acid (LTA) in Gram-positive 
bacteria (Kato and Schleimer, 2007). Interaction of airway epithelium with P. 
aeruginosa involves TLR2, -4, and -5 (Zhang et al., 2005). P. aeruginosa 
infection induces the expression of TLR2 on airway epithelial cells and the 
binding of TLR2 regulates the function of gap junction through Ca2+ signalling 
(Martin and Prince, 2008). The flagellum of P. aeruginosa is recognised by 
TLR5 and asialoGM1 and induces mobilization of these receptors to the 
surface of the cell (McNamara et al., 2006, Zhang et al., 2005). TLR3 
recognises viral double-stranded RNA (dsRNA) and a synthetic analogue of 
dsRNA, polyinosine-polycytidylic acid. TLR4 recognizes LPS which is present 
in Gram-negative bacteria and a protein that mediates membrane fusion from 
respiratory syncytial virus, although TLR4 remains largely cytosolic thus less 
responsive, in airway epithelial cells (Gomez and Prince, 2008). Two 
cytoplasmic RNA helicases, melanoma differentiation-associated gene 5 
(MDA5) and (RIG-I) are expressed in airway epithelial cells that are 
responsive to viral dsRNA recognition independent of TLR3 (Kato and 
Schleimer, 2007). NOD-1 and NOD-2 which recognise peptidoglycan-derived 
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peptides, Ȗ-D-glutamyl-mesodiaminopimelic acid and muramyl dipeptide 
respectively, are also expressed in airway epithelial cells (Opitz et al., 2004). 
Figure 1.4  Schematic view of innate immunity in the respiratory epithelial cells. 
Airway epithelial cells express transmembrane surface receptors (TLR1-6) and intracellular 
receptors (endosomal receptors TLR3, 4, 7-9 and cytosolic receptors RIG-I, MDA5, NOD1,2, 
IL-1ȕ-converting enzyme protease activating factor (IRAF) and NOD-like receptor pyrin 
domain (NLRP3)). The secretion of anti-microbial peptides and cytokines after the activation of 
signalling results from the ligation of receptor-ligand. Figure adapted from (Parker and Prince, 
2011). 
 
18 
 
1.1.3. The adaptive immunity in the lung  
Soluble antigens have limited access to lung draining lymph nodes (dLN) 
through passive mechanisms (Hulbert et al., 1989) at early time points 
following intranasal challenge and it is unlikely that particulate antigens such 
as non-invasive bacteria gain free access to the pulmonary lymphatics. 
However, the adaptive immunity is developed in the lung dLN following 
transport of antigens, such as microbial pathogens and inhaled foreign irritants, 
by antigen presenting cells to this site (Kirby et al., 2009). CCR7-dependent 
migration of pulmonary dendritic cells is once thought to be the only 
mechanism in antigen presentation transported from the lungs to dLN (Legge 
and Braciale, 2003). In fact, in addition to the immunoregulatory function, 
alveolar macrophages also contribute to the antigen acquisition, patrol at 
alveolar spaces and constitutively migrate to the dLN to orchestrate immune 
responses (Kirby et al., 2009, Murphy, 2011). Effective and efficient immune 
defence follows the binding of antigen presented by antigen presenting cells to 
T-cell receptor on T lymphocytes and B-cell receptor on B lymphocytes at the 
site of inter cortex and subcapsular sinuses in the lymph nodes, respectively  
(Kirby et al., 2009). The secretion of antibodies by antibody-producing plasma 
cells which differentiated from B lymphocytes provides an additional layer of 
protection of the epithelial barrier against a wide range of different pathogens 
after pulmonary infection and inflammation. Antibodies bind to pathogens 
therefore facilitates antibody-dependent cell-mediated cytotoxicity in the lung 
parenchyma (Murphy, 2011). After encountering with antigens, T cells 
proliferate and differentiate into functional effector T lymphocytes. CD8+ 
cytotoxic T cells are responsible for clearance of intracellular pathogens such 
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as viruses. CD4+ helper T cells (Th cells) signal the function of antibody-
producing B cells and produce pro-inflammatory cytokines (IFN-Ȗ, TNF-Į) 
that influence the macrophage phagocytic capacity against bacteria, viruses, 
and intracellular parasites. Th2 T cells, another subset of CD4+ T cells which 
secrete IL-4, IL-5, IL-9 and IL-13, promote the activation of eosinophils, 
basophils, and mast cells to facilitate the control of parasite infections. Th1 and 
Th2 responses counteract each other to maintain a fine balance (Murphy, 2011). 
A dysregulated T-cell response could lead to chronic inflammatory diseases 
such as asthma and chronic bronchitis (described further in section 1.1.4.2.). 
IL-17-producing T cells such as Th17, ȖįT cells and natural killer cells (NK 
cells) are protective against some bacterial infections through the recruitment 
and activation of neutrophils (Nembrini et al., 2009). The airway epithelium 
bridges the innate and adaptive immune responses through the secretion of 
cytokines such as IL-25 (also known as IL-17E), IL-33 and thymic stromal 
lymphopoietin (TSLP) that are considered upstream of Th2 cytokines IL-4, IL-
5 and IL-13 in allergic inflammation such as asthma (Parker and Prince, 2011).  
1.1.4. Pathogenesis of pulmonary inflammatory diseases 
Respiratory tract diseases are diseases that affect the nasal passages, the 
bronchi and the distal alveoli of the lung. Regulation of lung inflammation is 
tightly controlled by cellular and molecular mechanisms for efficient 
orchestration of pro-inflammatory responses upon stimulation. These responses 
need to be proportionate to the type of stimulation and lead to the elimination 
of intruders/irritants. Balance is achieved through an anti-inflammatory 
inflammatory response characterised by the cytokines IL-10 and TGF-ȕ, 
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leading to airway remodelling and restoration of tissue homeostasis. Current 
concepts in the pathogenesis of acute inflammatory diseases are covered in the 
following sections and include infectious diseases such as bronchitis and 
pneumonia, and chronic inflammatory diseases such as asthma and chronic 
obstructive pulmonary disease (COPD). Two unconventional chronic 
inflammatory diseases in the lung: cystic fibrosis in which inflammation is 
propagated by chronic infections and idiopathic pulmonary fibrosis (IPF) in 
which the inflammatory response is considered secondary to disease 
progression was also discussed.   
1.1.4.1. Respiratory tract infections 
Upper respiratory tract is inhabited normal microbial flora but the lower 
respiratory tract remains sterile. Many microbial pathogens preferentially infect 
the peripheral airways, bronchi and bronchioles leading to bronchiolitis and 
bronchiectasis, such as in the case of adenovirus, respiratory syncytial virus 
(RSV) and measles infection. These infectious agents cause acute extensive 
inflammation of bronchioles caused by extravasation of inflammatory cells and 
congestion of the mucosa with subsequent healing by fibrosis. Non-obstructive 
bronchiectasis usually results from respiratory infections or defects in the 
defence mechanisms that protect the airways from infection. Bronchiectasis 
displays irreversible abnormal dilation of bronchi with thickening of the 
bronchial walls and fibrosis of the pulmonary parenchyma along with 
exaggerated inflammation that is vulnerable to infective exacerbations. 
Pneumonia is an acute lung inflammatory disease caused mainly by bacterial 
and viral infections in the lower respiratory tract that leads to alveolar filling 
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with exudate in the lung parenchyma. Nosocomial pneumonia is usually 
initiated by the infections at the upper airways of hospitalised patients. The 
transmission routs of pathogens leading to nosocomial pneumonia could be 
through 1) ventilator devices and feeding tubes termed mechanical injuries, 2) 
healthcare personnel that facilitate the transmission of Pseudomonas spp., and 
Acinetobacter spp. and 3) antibiotics resistant strains such as methicillin-
resistant Staphylococcus aureus (MRSA). Pseudomonas pneumonia is 
commonly seen in nosocomial infections and the chronic airway infection 
progressing to bronchiectasis, gas trapping, and hypoxaemia that lead to 
pulmonary insufficiency (O'Sullivan and Freedman, 2009). In this case, 
hospitalised patients with exposed wounds, immunosuppressed patients 
undergoing chemotherapies, patients treated with broad-spectrum of antibiotics 
and suffering from acquired immunodeficiency syndrome (AIDS) with T cell 
dysfunction are vulnerable to opportunistic pneumonia that could lead to 
systemic inflammation, shock or even sepsis (Rubin and Strayer, 2008).  
The acute inflammation induced by bacterial infection and successful 
resolution to restore tissue homeostasis involves multiple cellular components 
(non-haemopoietic and haemopoietic cells) and molecular mediators. Taking S. 
pneumoniae infection as example, the entry of S. pneumoniae to the distal 
alveoli is recognised by PRRs including TLRs on epithelial cells and alveolar 
macrophages, and macrophage receptor with collagenous structure (MARCO) 
expressed on alveolar macrophages. Low dose S. pneumoniae infection can be 
contained by epithelial cells, resident alveolar macrophages and the release of 
protective mediators such as IL-1, TNF-Į, SP-D and anti-microbial peptides 
without the infiltration of neutrophils. At high doses of infection, neutrophils 
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are recruited by chemoattractants to enhance the phagocytosis of the pathogen. 
In the transition phase of inflammation, neutrophils under the action of pro-
resolving signals start undergoing apoptosis followed by efferocytosis by 
alveolar macrophages. During efferocytosis, macrophage phenotypes switch 
from M1 to M2-like phenotype producing anti-inflammatory molecules (such 
as IL-10 and TGF-ȕ and pro-resolving mediators to promote tissue repair and 
resolution. M2 macrophages then further switch to M resolution (Mres) 
phenotype, which display reduced phagocytosis but produce anti-fibrotic and 
anti-oxidant proteins that limit tissue damage and fibrosis. Such events of 
increased production of pro-resolving mediators (such as lipoxin, resolvins, 
protectins), anti-inflammatory and anti-fibrotic agents by resolution 
macrophage (Mres), and lymph node drainage or apoptosis of macrophage 
close the inflammatory process and restore tissue homeostasis. Chronic 
infection is usually rare in immunocompetent individuals, but in cystic fibrosis 
patients which are immunocompromised in epithelial barrier function are 
predisposed to recurrent pulmonary infections (van der Poll and Opal, 2009, 
Alessandri et al., 2013). Section 1.2 describes in detail cystic fibrosis aetiology, 
pathology, and explores intrinsic and exogenous factors in chronic airway 
inflammation and respiratory infections. 
1.1.4.2. Chronic inflammatory lung diseases 
Different phases of acute inflammatory processes are meticulously on-check 
for successful resolution. A successful resolution is attributed to 1) abrogation 
of chemokine signalling that blocks continued neutrophil tissue influx; 2) 
neutrophil apoptosis that attracts monocytes and macrophages to induce their 
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clearance; 3) clearance of apoptotic neutrophils promoted by a transition of a 
pro-inflammatory to an anti-inflammatory macrophage phenotype which is also 
a prerequisite for macrophages to return to their  tissue homeostatic state; 4) 
migration of macrophages and dendritic cells from the site of inflammation 
after efferocytosis; 5) the aid of suppressive immune cells and the adaptive 
immune response; 6) induction of tissue repair to return to homeostasis without 
scarring (Michlewska et al., 2009, Ortega-Gomez et al., 2013). However, an 
extended or dysregulated inflammatory response may lead to chronic 
inflammation in which persistent injury prevents the restoration of tissue 
integrity and function (Ortega-Gomez et al., 2013). This section introduces the 
mechanisms of pathogenesis of two well-recognised chronic inflammatory lung 
diseases, asthma and chronic obstructive pulmonary disease (COPD). This led 
us to address the current view of how interstitial pulmonary fibrosis could also 
be propagated by inflammatory response which is regulated by macrophages 
(Lech and Anders, 2013, Hussell and Bell, 2014) and T lymphocytes (Wynn, 
2004, Kotsianidis et al., 2009, Gilani et al., 2010) and is distinct from the above 
conventional mechanisms.  
Asthma 
Asthma, a life-long disease that usually starts during childhood; it is 
characterised by recurrent, reversible bronchial obstruction and usually 
associated with bronchial hyper-responsiveness and chronic airway 
inflammation. Asthma is marked by a Th2-cell-dependent, IgE-mediated 
allergic disease and asthmatic patients are more likely to be sensitised to 
aeroallergens. The pathology of asthma is characterised by mucus-cell 
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hyperplasia. The secretion of CCL20 from epithelial cells recruits dendritic 
cells via binding to the receptor CCR6. The activated dendritic cells thereby 
induce naïve T cells to differentiate into Th2 cells. The infiltrated T cells 
further interact with B cells, eosinophils, and mast cells to promote allergic 
inflammation (Martinez and Vercelli, 2013). The Th2-centric paradigm of this 
disease is also related to the capacity of regulatory T cells to control Th2 
responses (van Oosterhout and Bloksma, 2005, Robinson, 2009). Airway 
remodelling contributes to the development and progression of the disease. In 
severe cases, airway obstruction attributed to mucus-cell hyperplasia, thickened 
subepithelial basement membrane, increased smooth-muscle mass and the 
undergoing airways fibrosis are in combination with increased deposition of 
fibroblast and myofibroblast proliferation. Asthma has a strong genetic 
component termed asthma-related loci, and the genes for CHI3L1, IL6R, IL-33, 
SMAD3, ORMDL3-GSDMB, and IL2RB, etc. have been identified in 
genome-wide association studies. However, only ORMDL3-GSDMB was 
repeatedly found between studies indicating that a polygenetic component is 
strongly involved in the genetics of asthma. The innate immune component is 
responsible for the initiation and promotion of this Th2-mediated disease. The 
release of IL-25, IL-33, TSLP by damaged airway epithelium upon allergens, 
pathogens, or pollutants activates natural-killer T cells, mast cells, eosinophils, 
and basophils (Mjosberg et al., 2011, Klein Wolterink et al., 2012). The newly 
identified innate immune lineage type II innate lymphoid cells (ILC2) found in 
human lung tissue and peripheral blood, secrete Th2 cytokines IL-13 and IL-5 
in response to airway epithelial damage that also promote adaptive Th2 
responses. Repetitive stimulation of epithelial cells, smooth muscle cells and 
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fibroblasts by Th2-derived and ILC2-derived cytokines would lead to airway 
hyper-responsiveness and remodelling. Inhaled corticosteroids remain to be the 
mainstream treatment of mild and moderate asthma (Martinez and Vercelli, 
2013). Schematic inflammatory cascade of asthma is illustrated in Fig. 1.5. 
Chronic obstructive pulmonary disease  
Severe end of asthma comorbidities can overlap with chronic obstructive 
pulmonary disease (COPD) (Martinez and Vercelli, 2013). However, COPD is 
defined as a preventable disease characterised by progressive airflow 
obstruction that is usually irreversible and the main cause is smoking tobacco 
(Decramer et al., 2012). Clinical manifestations of COPD include chronic 
bronchitis, a condition of large-airway inflammation and remodelling, and loss 
of elastic recoil by emphysema due to the destruction of parenchyma resulting 
in progressive decline of forced expiratory volume (FEV) and inadequate lung 
emptying on expiration (Tuder and Petrache, 2012, Decramer et al., 2012). 
Distinct from asthma, the cells that potentiate inflammatory response in COPD 
are neutrophils, macrophages, and CD8+ T cells. There is a major infiltration 
of neutrophils to the lung and neutrophilia is persistent throughout the 
progression of the disease. Increased proteinase production by neutrophils 
contributes to alveolar epithelial cell apoptosis leading to destruction of 
alveolar structures (emphysema). Proteinases also promote mucus 
hypersecretion resulting in increased goblet cell numbers and enlarged airway 
submucosal glands and narrow the small airway walls (obstructive 
bronchiolitis). In COPD, macrophages are increased in airway lumen, lung 
parenchyma and bronchoalveolar lavage fluid. Increasing evidence showed that 
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lung macrophages orchestrate the inflammation of COPD through the release 
of chemokines that attract neutrophils, monocytes and T cells and of proteases, 
particularly matrix metalloprotease 9 (MMP9) (Barnes, 2004). Despite the 
inflammation in COPD patients is aggressive, patients are refractory to 
corticosteroid treatment. Recent transcriptomic analysis investigating the 
pattern of macrophage activation demonstrated a distinct pattern in COPD 
patients from those in healthy smokers (Xue et al., 2014). Epigenetic regulation 
in COPD patients showed that glucocorticosteroid insensitivity is attributed to 
the nitrosylation at histone deacetylase 2 (HDAC2) in macrophages and the 
potential intervention to reverse the sensitivity has also been tested (Malhotra 
et al., 2011). A brief summary of the inflammatory cascade of COPD was also 
described in Fig. 1.5 in comparison with asthma.  
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Figure 1.5  Inflammatory cascade of asthma and COPD. 
The underlying disease mechanisms between asthma and COPD were illustrated. In asthma, 
inhaled allergens activate mast cells by crosslinking surface-bound IgE to release histamine, 
leucotrienes and prostaglandin D2 as bronchoconstriction mediators. Allergens are processed by 
dendritic cells which conditioned with TSLP released by epithelial cells and mast cells to 
release CCL17 and CCL22 to act CCR4 on Th2 cells. Th2 cells act a central role in 
orchestrating the inflammatory response in allergy via the release of IL-4 and IL-13 to stimulate 
B cells to synthesise IgG and IL-5 and IL-9 to induce eosinophilic inflammation (Barnes, 2008). 
The inflammation in COPD in the lung is perpetuated by neutrophilia. Inhaled cigarette smoke 
and other irritants activate epithelial cells and macrophages to release CCL2 with CCR2 on 
monocytes, CXCL1 and CXCL9 to act on CCR2 to attract neutrophils and monocytes 
differentiation in the lung. Release of proteinases from neutrophils (mainly), alveolar 
macrophages and epithelial cells together cause elastin degradation, emphysema and mucus 
hyper-secretion. Release of TGF-ȕ by macrophages and epithelial cells stimulates fibroblast 
proliferation leading to fibrosis in the distal airways. Figure adapted from (Roth, 2008). 
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Interstitial lung diseases  
Interstitium is the space between the alveolar epithelium and the capillary 
endothelium. The thin side of capillary consists of the fused basement 
membranes of the epithelial and endothelial layers where gas exchange occurs, 
whereas the thick side governs the fluid exchange across the endothelium and 
is composed of type I collagen fibrils. Interstitial lung diseases (ILDs; also 
known as pulmonary fibrosis) result from the development of excess fibrous 
connective tissue in the lung and are therefore termed µscarring of the lung.¶ 
The scarring in the lung parenchyma (alveolar tissue) or the pleura and chest 
wall cause the lungs to become stiffer and lose their elasticity to expand 
leading to dyspnoea. This is later followed by an impaired repair process of the 
epithelial barrier that results in extensive fibroblast proliferation, collagen 
deposition and destruction of lung architecture and function (Jakubzick et al., 
2004, Noble et al., 2012). Reduced lung vital capacity and small resting lung 
volume are the characteristics of these diseases, thus they are described as 
restrictive pulmonary diseases (Wardlaw and Hamid, 2002, West, 2003). ILDs 
can be categorised as known and unknown causes. In the case of 1) 
autoimmune conditions (lupus, rheumatoid arthritis and sarcoidosis); 2) 
environmental irritants (asbestos, silica, dust, etc.); 3) chemotherapeutic drugs 
(bleomycin, nitrofurantoin, sulfonamides, etc.) and 4) radiation therapies, 
diseases are triggered by an inflammatory response with infiltration of 
lymphocytes and plasma cells in the lung (Wardlaw and Hamid, 2002, Rubin 
and Strayer, 2008, Chen and Stubbe, 2005). Cigarette smoking may increase 
the risk of developing ILDs and may aggravate the disease progression. 
Idiopathic pulmonary fibrosis (IPF) for which no causative agent is known is 
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the most common form of ILDs and shares the histological characteristics of 
usual interstitial pneumonia (UIP). Patchy dense scarring with extensive 
regions of honeycomb cystic change is the pathologic pattern of this disease. 
Interstitial fibrosis is usually temporal and heterogeneous referring to the fact 
that the fibrosis changes over time in the lung tissue. Fibrosis is mostly 
pronounced beneath the pleura and adjacent to the interlobular septa. The dense 
scarring fibrosis leads to the remodelling of the lung architecture and dilation 
of proximal bronchioles and growth of the bronchiolar epithelium into the 
dilated air space that could ultimately result in collapse of alveolar walls, 
formation of cystic space and destruction of the distal airway. Wound repair is 
normally accomplished by four sequential steps: 1) clotting and coagulation; 2) 
infiltration of neutrophils at early stage of wound healing, soon replaced by 
macrophages after neutrophil degranulation; 3) fibroblast migration and 
proliferation of myofibroblasts via epithelial-mesenchymal transition, 
recruitment from fibrocytes or resident fibroblasts; 4) tissue remodelling. 
Although the cystic spaces contain mucus, macrophages or neutrophils, the 
interstitial chronic inflammation is usually mild or moderate and thus the 
contribution of inflammation to disease is considered secondary (Thannickal et 
al., 2004). In this regard, intrinsic defects in the wound healing process 
involving epithelial cells and fibroblasts have been proposed. The fact that an 
active inflammatory response is not a prerequisite would partially explain the 
failure of anti-inflammatory medications to treat pulmonary fibrosis (Demedts 
et al., 2005). Despite research being focused on the mechanisms on the 
proliferation, activation and regulation of collagen-secreting myofibroblasts, 
recent studies have identified different mechanisms that suggest macrophages 
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and Th2 cells playing active roles in propagating the disease (Wynn, 2011, 
Homer et al., 2011). A schematic representation of the proposed inflammatory 
regulation in pulmonary fibrosis is described in detail in Fig. 1.6. The 
introduction of the most severe form of pulmonary fibrosis, idiopathic 
pulmonary fibrosis was described in chapter 6.  
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Figure 1.6  Proposed pro-inflammatory and pro-fibrotic cascade in the initiation and 
maintenance of pulmonary fibrosis.  
(1) Irritants like silica, asbestos, and bleomycin can injure lung epithelial cells and can be 
detected by the Nalp3 inflammasome in macrophages. (2) These irritants stimulate the 
production of ROS, chemokines, and cytokines. (3) Subsequent recruitment and activation of 
leukocytes are induced by these inflammatory mediators could enhance the site of tissue injury, 
such as via ROS-expressing neutrophils that further damage epithelial cells. (4) IL-ȕ DOVR
promotes production of TGF-ȕ Dn important profibrotic cytokine that triggers fibroblast 
proliferation and activation. (5) TGF-ȕ DOVR WDUJHWV HSLWKHOLDO FHOOV LQGXFLQJ HSLWKHOLDO-
mesenchymal transition (EMT) and the formation of extracellular matrix (ECM)-producing 
myofibroblasts. (6) TGF-ȕIXUWKHUH[DFHUEDWHVWKHLQIODPPDWRU\UHVSRQVHE\VWLPXODWLQJWKH
differentiation of Th17 cells.  
Th2 cells and macrophages play distinct roles in pulmonary fibrosis. (A) After injury, epithelial 
cells release IL-25, IL-33, and TSLP, which facilitate the development of pro-fibrotic Th2 
responses. T cells also release IL-21 and IL-25 promoting Th2 differentiation. (B) Th2 cells 
release IL-4 and IL-13, which promote the development of a pro-fibrotic macrophage 
subpopulation that secretes TGF-ȕ&,/-13 can directly activate fibroblasts independently 
of TGF-ȕ 7K F\WRNLQHV DOVR WULJJHU VSHFLILF FKHPRNLQHV WKDW SURPRWH WKH UHFUXLWPHQW RI
collagen-secreting fibrocytes from the bone marrow, which amplify fibrotic responses. The 
resulting myofibroblasts release ECM components. (D) Th2 cytokines can also activate 
arginase-1 activity in M2 macrophages, which inhibit further IL-13 production and 
myofibroblast differentiation. IL-13 can also up-regulate the IL-13 decoy receptor in 
fibroblasts, which antagonizes ECM production via a negative feedback loop. Figure adapted 
and regenerated from (Wynn, 2011). 
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1.2. CYSTIC FIBROSIS  
1.2.1. Aetiology and pathophysiology of cystic fibrosis 
Cystic fibrosis (CF) is an autosomal recessive disorder caused by a mutation in 
the gene encoding cystic fibrosis transmembrane conductance regulator (CFTR) 
which encodes a chloride channel categorised in the family of adenosine 
triphosphate (ATP) binding cassette transporters (O'Sullivan and Freedman, 
2009, Patrick and Thomas, 2012). The abnormal chloride conductance caused 
by the defect in CFTR promotes extensive absorption of Na+ and water from 
the lumen of the respiratory, gastrointestinal, and reproductive epithelial tracts 
(Kreda et al., 2012). As a result, the decreased airway surface liquid (ASL) and 
mucociliary escalator malfunction create an unusual thick viscous mucosal 
layer. For the respiratory tract in particular, subsequent pulmonary lesions can 
be caused by obstruction of the bronchioles that blocks the airways and leads to 
thickening of the bronchiole walls (bronchiectasis) and the alveoli 
(bronchiolitis). The plugs of mucoid material trapped in the airways favours 
microbial colonisation resulting in a vicious circle of phlegm retention, 
pathogen infections and chronic inflammation. Chronic inflammation causes 
lung damage that ultimately advances to the stage of irreversible fibrosis 
(Hauser et al., 2011, Lavoie et al., 2011, Katkin, 2014).  
CFTR is a large chloride channel glycoprotein consisting of two membrane-
spanning regions and a cytoplasmic regulatory R domain and is expressed 
primarily in epithelial cells but can also be found in leukocytes (Cohen and 
Prince, 2012) (Fig. 1.8). In addition to chloride transportation, CFTR also 
regulates the functions of other ion channels such as Na+ and HCO3í  thus 
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coordinating the fluid and electrolyte absorption in the airway epithelium 
(Sheppard and Welsh, 1999, O'Sullivan and Freedman, 2009). Nearly 2000 
mutations in the CFTR gene have been identified and are classified into 5 types 
of mutations: class I, lack of CFTR production; class II, protein trafficking 
defect with ubiquitination and degradation in the endoplasmic reticulum and 
Golgi body; class III, defective CFTR activation; class IV, deficient ion 
transport at the apical membrane; class V, splicing defect with reduced 
production of normal CFTR, thus cause disease by impairing CFTR translation, 
cellular processing, and/or chloride channel gating (O'Sullivan and Freedman, 
2009, Rowe and Verkman, 2013). The most prevalent mutation ǻF508, which 
accounts for two-thirds of mutated alleles in northern European and North 
American populations (O'Sullivan and Freedman, 2009), belongs to the class II 
group of mutations and causes misfolding of the CFTR protein and degradation 
by endosome (Ratjen, 2009). Mutation G551D causes a partially functional 
channel whose activity can be potentiated by potentiators. The oral therapy 
Ivacaftor, a potentiator that restores CFTR cAMP-dependent chloride channel 
activity at the cell surface has recently been proved effective to treat CF 
patients with mutation at G551D (Derichs, 2013). 
1.2.2. Airway inflammation in cystic fibrosis 
In vitro studies showed that dysfunction of CFTR predisposes airway epithelial 
cells to constitutive activation of proinflammatory signallings even in the 
absence of microbial stimulation (Cohen and Prince, 2012). Elevated 
endogenous activation of NF-țB  leads to the induction of interleukin 8 (IL-8) 
and TNF-Į in the airways and the recruitment of neutrophils (Cohen-
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Cymberknoh et al., 2013). High levels of IL-8 correlated with the increased 
neutrophil count and free neutrophil elastase activity in the bronchoalveolar 
lavage (BAL) of most infants (Sagel et al., 2012). In addition, the accumulation 
of abnormally processed CFTR in the endoplasmic reticulum results in 
unfolded protein responses that trigger 'cell stress' and apoptosis leading to 
dysregulation of the epithelial cells and innate immune function in the lung, 
resulting in exaggerated and ineffective airway inflammation (Konstan et al., 
1994, Jacquot et al., 2008, Cohen-Cymberknoh et al., 2013). The following 
sections provide recent insights in the development of the airway inflammatory 
process in CF including aspects of endogenous effects in the airway epithelium 
and immune cell functions. 
1.2.2.1. Effects of epithelial cells in CF airway inflammation 
Inherent abnormal intracellular signalling pathways lead to abnormal apoptosis, 
cell stress and exaggerated cytokine production and propagating the 
inflammatory events in the CF airways. The activation of p38 and 
ERK/MAPKs pathways with high levels of NF-țB, p65 (RelA/RelB) and 
inhibition of IțB kinase, which is the primary inhibitor of NF-țǺ, was 
demonstrated in some CF epithelial cell lines and has been associated with 
altered CFTR function (Cohen-Cymberknoh et al., 2013). As mentioned above, 
another intrinsic proinflammatory feature in CF is the cytosolic accumulation 
of misfolded or unfolded CFTR proteins in the endoplasmic reticulum (ER) 
(Cohen-Cymberknoh et al., 2013). 
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Figure 1.7  Comparison of airway surface liquid topography between normal and CF 
bronchial epithelial cells. 
Mucus in airway surface liquid (ASL) is compact in CF airways due to excessive absorption of 
Na+ ion and fluid retention. A, Confocal microscopic images show thicknesses of fluid surface 
layers at time 0 and 24 h after covering cultured normal (left) and CF (right) bronchial 
epithelial cells with dextran (Green, Oregon green-dextran; red, 1 ȝm red fluorescent 
microsphere). 1 ȝm red-bead retention was observed in the ASL below 7 ȝm thick. B, Electron 
micrographs of tissues 24 h after applying the same fluid load above each culture of cells. The 
thin CF layer above and the apparently compressed cilia in the image below indicate excessive 
fluid absorption. C, Schematic illustration of the viscous mucus layer occupying the apical 
surface of the airway epithelium that causes ineffective mucociliary clearance in CF. Figure 
adapted from (Quinton, 2010, Matsui et al., 1998, Lyczak et al., 2002). 
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The production of antioxidants such as glutathione (GSH) and thiocyanate 
(SCN-) as well as their trafficking to the ASL are essential in response to the 
oxidative damage in the airway epithelium (Rahman and MacNee, 2000). 
Systemic GSH secretion to the epithelial surface is significantly reduced in CF 
patients and in the CF mouse model;  increased oxidative stress in turn leads to 
further induction of IL-8 gene expression (Roum et al., 1993, Bartling and 
Figure 1.8  Proposed model of CFTR structure. 
Theoretical CFTR is shown with a schematic presentation (black and white on the left (Sheppard 
and Welsh, 1999)) and a crystal structure simulation on the right (Serohijos et al., 2008). The 
CFTR primary structure contains two nucleotide-binding domains (NBD1 and NBD2) that 
control channel opening, two membrane-spanning domains (MSD1 and MSD2) each with six 
membrane-spanning Į-helix, and a regulatory region (R domain) that undergoes cAMP-
dependent phosphorylation by protein kinase A (PKA) and possibly other kinases results in 
channel activation. Each MSD contains two cytoplasmic loops that form interfaces with the 
NBDs. Homologous NBD and MSD structures have been modelled (Patrick and Thomas, 2012) 
whereas the R domain remains largely unstructured. Phenylalanine-508 (F508) is located at the 
N-terminal NBD1. PKA, protein kinase A. Figure reconstructed from (Sheppard and Welsh, 
1999, Serohijos et al., 2008). 
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Drumm, 2009). Bactericidal components hypothiocyanite (OSCN-) and SCN- 
generated by airway epithelial cells eliminate bacterial infections in the airway 
surface. Epithelial cells with mutations in CFTR fail to secrete SCN- and are 
compromised in their ability to kill bacteria (Moskwa et al., 2007). 
Intracellular alkalinisation and pH reduction in the ASL are also caused by 
CFTR deficiency. Reduced pH in the ASL resulting in impaired antimicrobial 
function was demonstrated in the porcine CF lung (Pezzulo et al., 2012). 
Mediators such as microRNA (miR) have also been studied in the regulation of 
airway inflammation in the CF lung (Tsuchiya et al., 2013). High levels of 
miR-155 and miR-215 in ex vivo CF epithelial cells were associated with 
increased production of IL-8 and pro-apoptotic pathway p53 (Tsuchiya et al., 
2013), suggesting miRNA also contributes to the differential regulation of 
inflammation in the CF airways. 
1.2.2.2. The function of immune cells in CF 
The influx of neutrophils is of importance for bacterial clearance during 
infection. However, the massive neutrophil accumulation in the CF lung does 
not correlate with bacterial eradication but rather causes extensive tissue 
damage and inflammation disproportionate to infection. This indicates that the 
function of neutrophils is dysregulated in CF (Cohen-Cymberknoh et al., 2013). 
Neutrophil elastase, shown to be present in the airway early in paediatric CF 
patients, induces a pro-inflammatory state of senescence in bronchial epithelial 
cells in vitro and correlate with the decline of lung functions (Gifford and 
Chalmers, 2014). Circulating neutrophils from CF patients display higher 
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CD64 (marker of neutrophil activation) and decreased level of TLR2 compared 
to neutrophils from healthy donors, and airways neutrophils from CF patients 
produce  high levels of IL-8, are unresponsive to lipopolysaccharide (LPS) and 
peptidoglycan stimulation, as well as resistant to the anti-inflammatory 
mediator IL-10 (Petit-Bertron et al., 2008). Thus, the differential expression 
patterns of circulating neutrophils and airway neutrophils in CF suggest a 
complex neutrophilic inflammation in CF.   
Alveolar macrophages in BAL were increased in paediatric CF patient (median 
age 3 yr) compared with non-CF in the absence of infection and were 
associated with elevated levels of CC chemokines including macrophage 
inflammatory protein (MIP-3Į, MIP-1Į and MIP-1ȕ), chemokine C-C motif 
ligand (CCL20), and monocyte chemotactic protein-1 (MCP-1) (Brennan et al., 
2009). The exaggerated pro-inflammatory response in CF might also derived 
from impaired function of peripheral macrophages where decreased expression 
of CD11b and TLR5, elevated production of inflammatory cytokines and 
deficient phagocytosis were demonstrated (Simonin-Le Jeune et al., 2013).  
Dysregulated adaptive immune response was also described  in CF. Studies 
have suggested that CFTR deficiency results in a Th2 cell bias upon P. 
aeruginosa infection (Hartl et al., 2006), although recent data showed that 
Th17 signalling plays a key role in response to extracellular pathogens in CF 
(Tan et al., 2011). IL-17 is a proinflammatory cytokine that has been 
implicated in mucosal neutrophil recruitment via regulating the local 
production of CXCR2 ligands CXCL1, CXCL6 and CXCL8 that are 
chemoattractants for neutrophils, together with neutrophil survival factors 
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granulocyte macrophage colony-stimulating factor (GM-CSF) and granulocyte 
colony-stimulating factor (G-CSF) from the airway epithelium (Traves and 
Donnelly, 2008). High levels of IL-17 and IL-23 were found in BAL of 
patients with CF during pulmonary exacerbations and increased numbers of IL-
17 secreting cells, including Th17, nature kiOOHU 1. 7 FHOOV DQG Ȗį 7FHOOV
were also found in paediatric patients in the absence of elevated IL-8. The 
above evidence indicates the importance of IL-17 secreting cells in the 
modulation of airway inflammation at early stage of CF.  
1.2.3. Respiratory infections in cystic fibrosis 
Infections in the upper airways predispose the lower respiratory tract of CF 
patients to a particular subset of microbial pathogens. Staphylococcus aureus 
and Haemophilus influenza are amongst the most commonly isolated 
pathogens in infants and paediatric patients in CF (Hauser et al., 2011). 
Although infections by these two pathogens are under control since antibiotic 
intervention was introduced, the breach of epithelial barrier by the above 
pathogens might therefore cultivate a colonisation niche for subsequent 
infections from nosocomial pathogens or even opportunistic pathogens. The 
prevalence of P. aeruginosa infection increases with age, and together with 
Burkholderia cepacia infection, is associated with rapid declines in the lung 
function of CF patients (Hauser et al., 2011). B. cepacia is highly transmissible 
and elicit robust inflammation in the host resulting in acute deterioration (Jones 
et al., 2004, Kalish et al., 2006). Around 15-20% of CF patients are colonised 
with Stenotrophomonas maltophilia, meticillin-resistant S. aureus (MRSA) and 
the colonisation is associated with the deterioration of pulmonary function 
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(Dasenbrook et al., 2008). Fungus Aspergillus fumigatus is also frequently 
isolated in CF patients. A. fumigatus usually does not cause invasive infection 
but rather induces intense allergic response which is known as allergic 
bronchopulmonary aspergillosis. This may affect up to 15% of patients with 
CF and the symptoms include wheezing, pulmonary infiltrates, and 
bronchiectasis (Stevens et al., 2003, O'Sullivan and Freedman, 2009).  
1.2.3.1. Pseudomonas aeruginosa 
P. aeruginosa is a Gram-negative aerobic rod-shaped motile bacterium with a 
single or two flagella categorised in the family Pseudomonadaceae. It is 
environmentally ubiquitous and thrives in a wide range of ecological niches 
from soil, water, plants to animal tissues. P. aeruginosa carries a large genome 
size of 6.3 million base pairs that is believed to provide it with metabolic 
versatility and environmental adaptability (Stevens et al., 2003, Stover et al., 
2000). The intrinsic low susceptibility to antibiotics of P. aeruginosa is 
attributable to the action of multidrug efflux pumps and P. aeruginosa is 
naturally resistant to penicillin and the majority of ȕ-lactam antibiotics. P. 
aeruginosa is also an opportunistic pathogen that preferentially infects 
susceptible individuals with compromised epithelial barrier that can be caused 
by tracheal intubation, urinary tract catheterisation, mechanical ventilation or 
burn wounds (Lavoie et al., 2011, Engel and Eran, 2011). The respiratory tract 
infection by P. aeruginosa is the leading cause of mortality in patients with CF.  
Consistent with the large genome size and versatile life pattern, P. aeruginosa 
exploits tightly regulatory mechanisms to control the expression of virulence 
determinants such as elastase, exotoxins, pyocyanin and biofilm formation. 
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Many of them are regulated in a cell density-dependent manner via cell-cell 
communication or so-called quorum-sensing (QS). Amongst the QS systems 
identified in P. aeruginosa, this thesis has focused on the investigation of the 
contribution of alkyl-quinolone (AQ) QS to P. aeruginosa pathogenesis and 
that will be further discussed in chapter 2. 
1.2.3.2. P. aeruginosa adaptation to the CF lung  
According to the cystic fibrosis foundation annual report, half of CF patients 
under 18 years of age are infected with P. aeruginosa and the prevalence rises 
up to 80% of patients age above 18 (Hauser et al., 2011). The mechanisms of 
how P. aeruginosa compete with other pathogens to adapt in the CF lung is 
still unclear, despite theories on the initial infections of the lung epithelium by 
S. aureus and H. influenza cultivating a niche suitable for P. aeruginosa 
persistence (Hauser et al., 2011). Here the evidence of phenotypic changes of P. 
aeruginosa that are considered superior for adaptation in the CF lung is listed. 
As mentioned above, in the CF airways, the function of the mucociliary 
clearance, cationic antimicrobial peptides and neutrophils and macrophages are 
impaired and inflammatory signal transduction pathways exaggerated. This 
results in the chronic airway colonisation with opportunistic pathogens and 
leads to life-threatening lung disease. Being a ubiquitous environmental strain, 
it is intriguing how P. aeruginosa shifts its lifestyle from an environmental 
unobtrusive planktonic life-pattern to a biofilm-forming phenotype during 
infection in the host. There are several virulence factors involved either in 
initial attachment and invasion or in the later chronic stage.  
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Early colonization 
Colonisation of CF airways is mediated by the adhesion of cell appendages 
such as flagellum and type IV pili to host epithelial cell surfaces. Studies have 
demonstrated that a type IV pili-associated protein (PilY1) is required for P. 
aeruginosa adherence to mucosal epithelium and preferentially binds to the 
exposed basolateral cell surfaces (Heiniger et al., 2010, Bucior et al., 2012). 
After attachment, P. aeruginosa is thought to inject type III secretion proteins 
ExoU, S, T, and Y into the host cells. These secreted proteins were identified to 
have a role in activating pro-apoptotic pathways, modulating small GTPases, 
enhancing P. aeruginosa invasive capabilities by interacting with multiple 
eukaryotic cytoskeletal components, such as tight junctions and causing cell 
death as a consequence (Soong et al., 2008, Kipnis et al., 2006, Engel and 
Balachandran, 2009, Angus et al., 2010). In addition, P. aeruginosa elastases, 
LasA and LasB, and alkaline protease are thought to modulate host 
immunoregulatory proteins and damage epithelia through mitogen-activated 
protein kinase (MAPK) pathways, increasing IL-8 expression (Azghani, 1996).  
Late stage adaptation 
The long-term persistence of P. aeruginosa in CF lung is characterised by the 
process of adaptive radiation, which causes the selection of a variety of 
genotype and phenotypes (Hogardt and Heesemann, 2010). The adaptability of 
P. aeruginosa confers a selective advantage to better thrive in the diverse 
niches and microenvironments of the inflamed and hostile CF lung. Loss-of-
function mutations in genes such as lasR, mucA and mexT lead to a general 
adaptation pattern of P. aeruginosa. More intriguingly, several cellular 
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virulence factors including type II secreted elastases and pyoverdines, 
exotoxins S/T/Y secreted via T3SS, pyocyanin and siderophores were 
attenuated. The most striking clinically important feature of P. aeruginosa 
infection is the tendency of this bacterium to adjust its life style from a single 
cell to mucoid phenotype. This phenotypic change probably initiates the 
chronic infection stage and therefore, enables P. aeruginosa to survive in the 
microaerobic or even anaerobic environment in CF lungs. P. aeruginosa 
mucoid exopolysaccharide, alginate has been shown to reduce chemotaxis of 
neutrophils into the CF lung and by itself to inhibit activation of the 
complement system. Mutated mucoid P. aeruginosa is inherently resistant to 
macrophage and neutrophil phagocytosis (Matsui et al., 2006). Clinical isolates 
of P. aeruginosa from a single CF sputum sample appear morphologically 
diverse and include mucoid variants, non-mucoid pyomelanin producing 
variants, non-pigmented LPS-rough variants and small-colony variants. This 
high mutation rate of variants that coexist with non-mutated variants is another 
evidence of how P. aeruginosa accelerates its ecological fitness in the CF lung 
(Hogardt and Heesemann, 2010, Hauser et al., 2011). 
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1.3. AIMS AND OBJECTIVES 
A type of QS in P. aeruginosa, the Pseudomonas alkyl-quinolone QS signal 
(PQS) which has been detected in the CF lung, regulates virulence and has 
been shown to have immunomodulatory properties. However, the contribution 
of PQS to P. aeruginosa infection of human bronchial epithelium needs better 
characterisation. Chapters 2 to 5 aimed to increase our understanding of 
inflammation in the CF airways by investigating the impact of the cell density-
dependent regulator of P. aeruginosa pathogenesis, PQS, in the interaction 
with human bronchial epithelial cells. The main aims of each chapter were 1) 
to generate a P. aeruginosa mutant deficient in PQS to identify the impact of 
PQS on the expression of virulence factors in vitro; 2) to develop an in vitro 
human bronchial epithelial infection model and 3) to use an in vitro airway 
epithelial model to investigate the role of PQS in the innate immune 
recognition of P. aeruginosa by airway epithelium; 4) to use a CF clinical 
isolate to assess the efficacy of the airway epithelial cell infection model 
retrospectively. 
The aim of Chapter 6 was to understand the systemic immune response in 
patients with idiopathic pulmonary fibrosis. This was achieved by an 
exploratory study measuring cytokine production by PBMCs, which was later 
correlated with clinical outcomes.  
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2. GENERATION AND CHARACTERISATION OF 
A PSEUDOMONAS AERUGINOSA MUTANT 
DEFICIENT IN ALKYL-QUINOLONE PRODUCTION 
2.1. INTRODUCTION 
P. aeruginosa is an opportunistic pathogen known for its metabolic plasticity 
to adapt a variety of environments such as that encountered in the CF lungs and 
where it has evolved the ability to form biofilms which are difficult to eradicate 
by antibiotics (Winsor et al., 2011, Heeb et al., 2011). Antibiotics work by 
inhibiting bacterial cellular processes that are essential for microbial survival, 
thus they pose a selective pressure which results in the emergence of drug 
resistant mutants. The population density-dependent regulatory systems called 
quorum sensing are used by many bacterial pathogens to regulate the 
expression of virulence factors, but they are not essential for survival under 
most conditions. Therefore, the disruption of TXRUXPVHQVLQJWHUPHGµTXRUXP
TXHQFKLQJ¶44LVFRQVLGHUHGDVDQDOWHUQDWLYHWRDWWHQXDWHYLUXOHQFHZLWKRXW
imposing the level of selective pressure posed by currently used antibiotics. 
(Galloway et al., 2011, Jimenez et al., 2012). P. aeruginosa employs a complex 
cell-cell communication network to coordinate the expression of a plethora of 
genes, many of which code for virulence determinants (Williams and Cámara, 
2009). Driven by the urgent need to develop alternative therapeutic strategies 
(LaSarre and Federle, 2013, Galloway et al., 2011), a comprehensive 
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understanding on the role of QS on the interactions between P. aeruginosa and 
the human airway epithelium is paramount.  
For the present chapter, the influence of QS on P. aeruginosa pathogenesis and 
its potential as a therapeutic target was further evaluated. In particular, the 
work focused on the alkyl-quinolone (AQ) QS system that is also known as the 
Pseudomonas quinolone signal (PQS) system. To achieve this, a mutant in 
blocking the AQs biosynthetic pathway for these signal molecules was 
constructed and its virulence was analysed. The following introduction sections 
will describe the QS networks in P. aeruginosa, their roles in virulence as well 
as the need for the generation of a new mutant in the PQS system. 
2.1.1. Quorum-sensing 
Quorum-sensing (QS) is an intercellular co-operative behaviour of bacteria 
used to coordinate the activities of individual cells (Miller and Bassler, 2001, 
Heeb et al., 2011, Williams and Cámara, 2009). This signalling mechanism is 
EDVHGRQWKHXVHRIGLIIXVLEOHVLJQDOPROHFXOHVDOVRNQRZQDVµDXWRLQGXFHUV¶
which, when they reach a threshold concentration, can coordinate multiple 
gene expression and a change in the behaviour of the bacterial population 
through the activation of sensor regulatory proteins. These activated regulators 
are also able to induce the transcription of the genes involved in the 
biosynthesis of the signal molecules triggering an autoinduction feed-back loop 
which results in more signal generation and changes in the whole bacterial 
population (illustrated in Fig. 2.1). QS is responsible for the regulation of a 
large number of genes,  for instance, around 10% of genes in the genome of P. 
aeruginosa are regulated by QS system (Williams and Cámara, 2009). The QS 
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signal synthase, QS signal receptor, and QS signal molecules are three essential 
elements of basic QS circuit machinery. The phenomena of QS was firstly 
described in the marine bioluminescence bacterium Vibrio fischeri that has 
been considered the paradigm of QS for the majority of Gram-negative bacteria 
(Nealson and Hastings, 1979). The bioluminescence was initiated with the 
luciferase operon (luxICDABE) where luxI encodes the autoinducer synthase 
that generates N-(3-oxo-hexanoyl)-L-homoserine lactone (3-oxo-C6 HSL) and 
luxCDABE codes for proteins responsible for bioluminescence production. 
This operon is regulated by the LuxR protein, also known as the QS 
transcriptional regulator/activator. Binding of 3-oxo-C6 HSL by LuxR 
activates the expression of the luxICDABE operon which in turns results in the 
production of more of this signal molecule, through an auto induction feedback 
loop, and bioluminescence (Engebrecht and Silverman, 1984). LuxI/LuxR 
homologues are widely spread in Gram-negative bacteria such as Yersinia 
enterocolitica (Atkinson et al., 2006), Burkholderia pseudomallei (Eberl, 2006), 
Salmonella enterica (Michael et al., 2001), Vibrio harveyi, Vibrio cholerae 
(LaSarre and Federle, 2013) and Pseudomonas aeruginosa (Galloway et al., 
2011, Waters and Bassler, 2005) amongst many other. QS in P. aeruginosa 
will be discussed further in this chapter. 
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Figure 2.1  General mechanism of quorum sensing autoinduction in Gram-negative 
bacteria.  
(A) At low population densities autoinducer signal concentration is low and cannot bind to the 
corresponding transcriptional activator protein due to unfavourable binding kinetics. (B) At 
higher population densities, signal concentration reaches the threshold at which it binds to the 
transcriptional regulatory protein inducing a conformational change. The bound complex 
subsequently regulates the expression of QS dependent phenotypes. R, QS transcriptional 
regulator (autoinducer receptor); I, autoinducer synthase. Figure adapted from (Fletcher, 
2007). 
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2.1.2. Quorum-sensing in Pseudomonas aeruginosa 
2.1.2.1. N-acylhomoserine lactone driven quorum-sensing in P. aeruginosa 
Two N-acylhomoserine lactones (AHL)-based QS systems named las and rhl 
circuits in P. aeruginosa have been widely studied (Heeb et al., 2011, Lee et al., 
2013, Diggle et al., 2006a). The las system is composed of an analogous of 
Lux-like synthase LasI and LuxR-like receptor, LasR. LasI mediates the 
synthesis of the autoinducer N-(3-oxododecanoyl)-L-homoserine lactone (3-
oxo-C12-HSL). This molecule is responsible for the activation of the 
transcriptional regulator LasR which in turns binds to the promoter region of 
lasI ultimately resulting in the production of more 3-oxo-C12-HSL. The LasR/I 
QS system controls the secretion of virulence factors such as elastase, the 
protease LasA, alkaline protease, exotoxin A and biofilm development (Diggle 
et al., 2003). Similarly, the rhl system is composed of another LuxI/LuxR-type 
system termed RhlI/RhlR. RhlI mediates the synthesis of N-butanoyl-L-
homoserine lactone (C4-HSL) which upon binding to RhlR activates the 
production of many virulence determinants including rhamnolipids, elastase, 
LasA protease, hydrogen cyanide, pyocyanin, and the cytotoxic lectins LecA 
and LecB (Williams, 2007, Cooley et al., 2008). The las and rhl systems 
control more than 6% of the P. aeruginosa genome (Schuster et al., 2003). 
Although it was originally thought that the LasR/I QS system work in a 
hierarchical way by controlling the expression of the RhlR/I system, it has now 
been shown that RhlR/I can function in the absence of the LasR being even 
able to activate lasI expression and a range of LasR/I controlled phenotypes 
(Dekimpe and Deziel, 2009) (Fig. 2.2).  
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Figure 2.2  Interactions between the two AHL QS systems in P. aeruginosa and their 
regulation in virulence.  
After a threshold concentration of 3-oxo-C12-HSL is reached the 3-oxo-C12-HSL±LasR 
complex binds the promoter regions of multiple genes, activating or repressing their 
transcription. Among the genes upregulated by this complex are lasI, which enhances the 
production of 3-oxo-C12-HSL (autoinduction effect), and rhlR, which increases the 
production of the rhl transcriptional regulator RhlR, activating the second AHL pathway. 
Virulence factors regulated by correspondent receptor-ligand complex are detailed on the left. 
Figure adapted from (Jimenez et al., 2012). 
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2.1.2.2. The alkyl-quinolones QS network in P. aeruginosa 
The study of the AQs from P. aeruginosa as signal molecules began from their 
intriguing structures similar to antimicrobial quinolones (Pesci et al., 1999). 
The role of PQS as a QS signal molecule was first described by Pesci et al., 
1999. Although PQS is not an antimicrobial, further studies unveiled that 
among more than 50 alkyl-quinolones found in P. aeruginosa, 2-heptyl-3-
hydroxy-4(1H)-quinolone (PQS) and its precursor molecular 2-heptyl-4(1H)-
quinolone (HHQ) can also work as QS signal that cooperates with the AHL-
dependent QS system in P. aeruginosa (Xiao et al., 2006a, Heeb et al., 2011).  
Synthesis of 2-heptyl-3-hydroxy-4(1H)-quinolone (PQS) depends on the 
pqsABCDE operon. PqsA, the anthranilate co-enzyme A ligase, catalyses 
anthranilate that produced by phnAB to anthraniloyl-coenzyme A. PqsD then 
mediates the synthesis of 2-aminobenzoylacetate (2-ABA) from anthraniloyl-
coenzyme A and malonyl-CoA, decarboxylating coupling of 2-ABA to an 
octanoate group of octanoic acid that linked to PqsC and PqsB to produce 
HHQ (Dulcey et al., 2013). HHQ can be transformed to 2-heptyl-3-hydroxy-
4(1H)-quinolone (PQS) by the mono-oxygenase PqsH (Fig. 2.3) (Diggle et al., 
2006a, Pesci et al., 1999). HHQ and PQS are the major AQ QS signalling 
molecules. PqsR, also known as MvfR, is a LysR-type transcriptional regulator, 
with a conserved N-terminal DNA-binding helix-turn-helix and a C-terminal 
co-inducer-binding domain. PqsR activates the transcription of pqsABCDE and 
possibly the phnAB operon when binding to PQS or HHQ and triggers the 
typical QS autoinducing response enhancing AQ biosynthesis (Maddocks and 
Oyston, 2008, Heeb et al., 2011). PQS has been shown to reach the maximal 
production at late logarithmic phase (Diggle et al., 2003) and its production is 
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also promoted by the availability of the substrate anthranilate and presence of 
the aromatic amino acids tryptophan, phenylalanine and tyrosine (Palmer et al., 
2005). The las QS circuit increases the expression of pqsR and pqsA as well as 
controlling the expression of pqsH indicating las acts as a positive regulator of 
PQS (Xiao et al., 2006b). However, the biosynthesis of PQS only partially 
relies on the las system since PQS is still produced during late stationary phase 
in the absence of lasR (Diggle et al., 2003). In contrast to the las QS system, 
the rhl system negatively regulates the PQS production (Heeb et al., 2011, 
Xiao et al., 2006b).  
PQS is regarded as a multifunctional molecular in addition to the regulatory 
role in quorum-sensing (Williams and Cámara, 2009). PQS has iron-chelating 
properties that contributes to iron transport and it is thought to facilitate 
siderophore-mediated iron delivery (Diggle et al., 2007). PQS is also involved 
in cell autolysis at high population densities in nutrient deprived conditions 
(Williams and Cámara, 2009). It has been demonstrated that there is far less 
DNA release in a pqsA mutants than its wild-type counterpart in both 
planktonic and biofilm cultures (Allesen-Holm et al., 2006). 
The control of virulence by the AQ systems remains a puzzle. Whilst PQS can 
have an impact on the expression of genes related to iron starvation, the control 
of most virulence factors is exerted by PqsE. Although this protein has been 
crystallised, this has not revealed any key information with regards to its 
mechanisms for controlling virulence gene expression. Virulence in a pqsA 
mutant has been shown to be restored by PqsE on its own to nearly wild-type 
levels. Furthermore, PqsE has been shown to negatively regulate the expression 
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of the pqs operon as a way to modulate virulence (Folch et al., 2013, Rampioni 
et al., 2010, Hazan et al., 2010). 
Recently, a new QS molecule, 2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde 
(IQS) encoded by the ambBCDE operon was discovered (Fig. 2.4). IQS is 
induced when P. aeruginosa is exposed to a phosphate deprived environment 
(Lee et al., 2013). Under an unfavourable environment, expression of IQS 
overcomes the las-led QS circuit and promotes the expression of virulence 
factors. This finding may also partially explain how P. aeruginosa clinical 
isolates persist in CF respiratory infection in the absence of a functional las 
system (Winstanley and Fothergill, 2009). 
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Figure 2.3  Biosynthesis, autoinduction, and virulence regulation by alkyl-quinolones 
in P. aeruginosa. 
Biosynthesis of PQS starts with the conversion (by the PqsABCD proteins) of anthranilate 
(originates from either the kynurenine pathway or the PhnAB anthranilate synthase) into 
HHQ, which is converted into PQS by the PqsH monooxygenase. Both HHQ and PQS bind 
the PqsR regulator, and the complex activates the transcription of the pqsABCDE and 
phnAB operons, increasing the levels of PQS (autoinduction) and pyocyanin production. 
Additionally, transcription of the PQS operon results in an increase in the levels of PqsE 
that increases the levels of pyocyanin, lectin, HCN, and rhamnolipids. Figure adapted from 
(Jimenez et al., 2012) 
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Figure 2.4  Integration of quorum-sensing networks in P. aeruginosa. 
The best described QS systems in P. aeruginosa are the AHL and AQ driven systems which 
are closely interlinked. The expression of the pqsABCDE operon is up-regulated by LasI/LasR 
but negatively controlled by RhlI/RhlR system. PQS enhances the production of RhlI/RhlR by 
activating the expression the autoinducer receptor, RhlR. The above three systems work 
reciprocally in an intertwined manner resulting in a fine control of virulence gene expression 
in P. aeruginosa. A newly uncovered cell-cell communication signal, IQS, functionally 
substitutes the central las system when P. aeruginosa in under phosphate-deprived 
environment. Disruption of IQS biosynthesis disabled the pqs and rhl QS systems and 
attenuated P. aeruginosa virulence in vitro. Green lines denote positive regulation; red lines 
denote negative regulation. This QS architecture diagram was expanded from (Williams and 
Cámara, 2009, Lee et al., 2013). 
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2.1.3. The impact of alkyl-quinolones on P. aeruginosa pathogenesis 
Despite the fact that the AHL-based QS systems of P aeruginosa have been 
shown to play a central role in the regulation of virulence and immune 
modulation in vitro, this situation could very much change in vivo. In the CF 
lung 50% of strains from late stage CF patients are deficient in lasR function 
(Winstanley and Fothergill, 2009). Moreover, abolishing the whole AHL QS 
by generating a quadruple mutation of rhlIR and lasIR exerted comparable 
infectivity to the wild-type strain in a mouse lung infection model (Lazenby et 
al., 2013), suggesting that the AHL-dependent QS might not be required for 
full pathogenesis in vivo and other regulatory mechanism might be involved. 
PQS has been identified in sputum, bronchoalveolar lavage fluid, and 
mucopurulent fluid from distal airways of end-stage CF lungs removed for 
transplant (Collier et al., 2002) and at different stages of the disease, from 
asymptotic early stage to late progression, implying a potential role of PQS in 
coordinating virulence factors during the course of infection (Collier et al., 
2002, Guina et al., 2003). An in vitro transcriptomic study investigating the 
physiology of P. aeruginosa grown in CF sputum revealed that expression of 
genes associated with PQS metabolism, such as these coding for the aromatic 
amino acid aminotransferase, 4-hydroxyphenylpyruvate dioxygenase (hpd) and 
pqsABCDE, was more than 10-fold induced compared to their expression in 
media containing glucose as carbon source (Palmer et al., 2005). In other 
words, the Pqs QS circuit, rather than the AHL-dependent QS may have a more 
dominant role in the control of virulence factors during infection of the CF 
lung. The above evidence suggests a pivotal role for the Pqs QS system in 
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orchestrating the production of virulence determinants and facilitating P. 
aeruginosa persistence in the human host. 
2.1.3.1. Virulence factors under the control of PQS  
P. aeruginosa produces a wide range of virulence determinants and many of 
them are regulated by QS. The virulence factors chosen for discussion below 
are those strongly controlled by the Pqs QS system. 
Elastase B 
Elastase B (LasB) is an elastolytic metalloproteinase encoded by the lasB gene. 
Over 75% of clinical isolates of P. aeruginosa secrete elastase B. Previous in 
vitro studies have shown that LasB degrades a number of components of the 
innate and adaptive immune systems, including surfactant proteins, 
antibacterial peptides, cytokines, chemokines and immunoglobulins (Kuang et 
al., 2011, Singh et al., 2010). PQS positively controls the expression of the 
lasB gene and this expression increases synergistically in the presence of both 
PQS and C4-HSL (McKnight et al., 2000). 
Pyocyanin 
Pyocyanin acts as a redox-active toxin required for full pathogenesis of P. 
aeruginosa in animal infection models (Lau et al., 2004). P. aeruginosa 
produces high levels of pyocyanin in the CF lungs and these levels are directly 
correlated with the deterioration of lung function (Winstanley and Fothergill, 
2009, Caldwell et al., 2009). Pyocyanin inhibits ciliary beat frequency in 
airway epithelial cells, induces cytotoxicity in A549 alveolar epithelial cells by 
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suppressing catalase activity and induces neutrophil extracellular trap (NET) 
formation (Rada et al., 2013, O'Malley et al., 2003). PqsE is essential for 
pyocyanin production via the control of phenazine biosynthetic operons. 
Interestingly, PqsE can control pyocyanin production in the absence of PQS 
(Rampioni et al., 2010, Jimenez et al., 2012). 
Rhamnolipids 
Rhamnolipids are biosurfactants that enhance bacterial surface translocation 
and mediate the uptake and degradation of hydrophobic compounds in the 
surrounding environment (Noordman and Janssen, 2002). Apart from being 
involved in adaptation to the environment, rhamnolipids also act as innate 
immune-modulators in the human host. Rhamnolipids purified from P. 
aeruginosa culture supernatants inhibited the production of IL-1ȕ and the 
antimicrobial peptide, human ȕ-defensin hBD-2 from keratinocytes by 
affecting protein kinase C signalling (Dossel et al., 2012, Gerstel et al., 2009). 
Rhamnolipids were also found to initiate bacterial biofilm dispersal from a 
mucoid clinical strain PA17 and induce necrotic death of neutrophils (Davey et 
al., 2003, Jensen et al., 2007). Rhamnolipids exerted cytotoxicity and acted as 
heat-stable extracellular hemolysins  controlled by QS during P. aeruginosa 
chronic infection (Noordman and Janssen, 2002, Johnson and Boese-Marrazzo, 
1980, Wang et al., 2013, Jensen et al., 2007).  
In P. aeruginosa, three genes linked to the rhl QS system, rhlAB and rhlC, 
code for the enzymes responsible for the last step of rhamnolipids synthesis 
(Abdel-Mawgoud et al., 2010, Reis et al., 2011). The Pqs QS system positively 
regulates the rhl QS system and hence promotes rhamnolipid biosynthesis in a 
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las QS independent manner. Additionally, due to the production of 
rhamnolipids occurs at late log phase which corresponds to the time point when 
PQS accumulates to the maximum (Reis et al., 2011), it is likely that the Pqs 
QS system exerts a key regulatory role over the expression of rhamnolipids.  
Biofilms 
P. aeruginosa undergoes a phenotypic transition from planktonic cells to a 
biofilm state to survive to environmental stress conditions. A biofilm is a 
complex dynamic mixture consisting of cells surrounded by an extracellular 
matrix made of exopolysaccharides, secreted proteins, nucleic acids and 
cellular debris (Mann and Wozniak, 2012). Biofilm attachment to the surface 
of biomedical devices such as urinary catheters and respiratory ventilators 
leads to severe nosocomial infections difficult to control. It has been 
recognised that P. aeruginosa chronic persistence in the CF lung might be 
driven by biofilm development as biofilms are 1,000 times more resistant to 
antibiotics than planktonic cells (Wagner and Iglewski, 2008). Interest in the 
development of methods for dispersing biofilms and improved coating of 
medical implants is rising in order to tackle biofilm-forming pathogens that can 
persist long-term in the host (Hook et al., 2012, Hansch, 2012). QS contributes 
to biofilm development in different ways. The psl (polysaccharide synthesis 
locus) operon is essential for the initiation and maintenance of biofilms and is 
tightly controlled by bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-
GMP) (Wei and Ma, 2013). LasR can bind to the psl promoter region, 
suggesting that QS can regulate biofilm formation (Wei and Ma, 2013).  
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A key component in biofilms is the presence of extracellular DNA (e-DNA). 
PQS has been shown to play a key role in the release of e-DNA enhancing 
biofilm formation this way (Yang et al., 2009). The QS regulated lectins LecA 
and LecB which bind sugars from the surface of P. aeruginosa have been 
shown to also play an important role in biofilm formation (Diggle et al., 2006b, 
Tielker et al., 2005). Furthermore, the QS controlled rhamnolipids are required 
for the formation of mature biofilms and their water channels also play an 
important role in biofilm dispersal (Boles et al., 2005, Davey et al., 2003).  
Type III secretion system and the transition from acute to chronic infection 
Toxins translocate into host cells via a transmembrane syringe-like apparatus 
constituted of around 25 proteins designated as type III secretion system 
(T3SS). Insertion of the T3SS of Gram-negative pathogens on eukaryotic cells 
results in pore formation and acute cell death (Shafikhani et al., 2008). The 
biochemical characteristics of at least five T3SS effector proteins in P. 
aeruginosa including ExoS, ExoT, ExoU, ExoY and FliC, have been 
extensively studied (Diaz et al., 2011). ExoS is essential and sufficient for the 
induction of caspase-3-dependent cell death but it is expressed only by 
approximately one-third of clinical isolates. ExoU, a phospholipase, induces 
necrotic cell death and ExoY is an adenylate cyclase that contributes to P. 
aeruginosa virulence in a mouse model of pneumonia (Soong et al., 2008). 
ExoT inhibits bacterial internalization into epithelial cells through its ADP-
ribosyltransferase domain activity and supresses cell migration by altering the 
actin cytoskeleton. Together, T3SS exotoxins enhance P. aeruginosa invasive 
capacities by interacting with eukaryotic cytoskeletal components, including 
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tight junction proteins zonula occludin 1 (ZO-1), occluding and ezrin (Angus et 
al., 2010). 
T3SS is considered to be responsible for acute infection but is lost during 
chronic persistence. Although there have been numerous studies trying to 
understand the mechanisms governing the switch between acute to chronic 
infection and in particular the regulation of T3SS in P. aeruginosa, there is still 
a significant gap in the knowledge of this transition. A study examined the 
profile of virulence factors associated with chronic infections using five 
sequential clinical samples isolated from a single patient who developed 
ventilator-acquired pneumonia. A reduction in pyoverdin production and 
increased secretion of ExoU and ExoT in the latter strains indicated that P. 
aeruginosa underwent a transition from a typical chronic to an acute phenotype 
in this clinical context. Moreover, the authors also found that PQS production 
and pqsA gene expression were higher in strains isolated during the chronic 
infection; addition of the PQS inhibitor farnesol to these strains, in turn 
promoted ExoU secretion. These findings supported the idea of PQS playing an 
important role in the modulation of T3SS and hence the transition between an 
acute to a chronic status (Singh et al., 2010). 
2.1.3.2. The impact of PQS on P. aeruginosa virulence  
The contribution of the Pqs QS system to virulence was firstly described by 
Cao, et al. using a pqsR knock-out mutant in P. aeruginosa PA14. PqsR 
positively regulates the expression of phnAB operon in this strain and the 
production of elastase, 3-oxo-C12, as well as PQS, thereby influencing the 
production of numerous virulence determinants. The pqsR mutant was 
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attenuated up to 320-fold in the Arabidopsis plant infection model caused a 
65% reduction in mortality in a burn wound mouse disease model (Cao et al., 
2001). The interaction of PqsR with the AHL QS circuit was investigated by 
another group showed that the effect of pqsR deficiency on pathogenesis was 
independent from LasRI/RhlRI (Deziel et al., 2005). This finding highlighted 
the importance of PQS on P. aeruginosa pathogenicity. Mutations in the 
multidrug efflux pump, such as mexI and opmD led to the inhibition of PQS 
production and the attenuation of P. aeruginosa in rat and plant infection 
models (Aendekerk et al., 2005). Additionally, provision of exogenous AQs to 
these mutants restored virulence on plants (Aendekerk et al., 2005). In 2010, 
Rampioni et al. found that both pqsA and pqsE mutants in PAO1 were 
attenuated in plant, nematode and mouse burn wound infection models 
(Rampioni et al., 2010). 
The QS signal molecules 3-oxo-C12-HSL, PQS and HHQ have been shown to 
have an important role not only in controlling the expression of virulence 
factors and biofilm formation in P. aeruginosa but also the interactions of this 
organism with the host (Williams and Cámara, 2009). In this chapter we will 
only focus on the AQs system. PQS was shown to inhibit T cell proliferation 
resulting in the inhibition of interleukin-2 (IL-2) production. However, PQS 
did not inhibit tumour necrosis factor alpha (TNF-Į) release from human 
monocytes treated with Escherichia coli lipopolysaccharide as 3-oxo-C12-HSL 
did, suggesting that PQS has very distinct immune modulatory properties from 
3-oxo-C12-HSL (Hooi et al., 2004). Both HHQ and PQS can inhibit the innate 
immune response in a murine model. Extracts from culture supernatants of a 
PA14 pqsA mutant elicited higher levels of TNF-Į and IL-6 production by a 
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mouse monocyte cell line than those extracted from wild-type PA14 that 
contains PQS. The addition of exogenous PQS to a pqsA mutant restored this 
inhibitory activity on mouse monocytes and primary bronchoalveolar cells via 
the suppression of the signalling mediated by the innate immune regulator 
nuclear factor-țB (NF-țB) (Kim et al., 2010b). Apart from the interference 
with the NF-țB activation cascade, PQS extracted from P. aeruginosa culture 
supernatant was found to suppress the HIP-1Į protein expression in human 
bronchial epithelial cells (IB3-1) (Schaible et al., 2013, Legendre et al., 2012). 
The hypoxia-inducible factor 1 (HIP-1) is a transcriptional factor required for 
adaptation to cellular stress caused by low-oxygen and has been recently 
associated with infection and inflammation. The upregulation of HIP-1 via NF-
țB pathway facilitates phagocytosis and enhances the innate immune activities 
of dendritic cell, mast cell and epithelial cells in response to microbial infection 
(Nizet and Johnson, 2009). These findings suggested AQs acts differently from 
AHLs in the inhibition of host innate immune responses. 
Despite the proposed contribution of the PQS molecules themselves to the 
interactions of P. aeruginosa with the host, there is still very little known on 
the role these molecules play on the interaction of this organism with the 
human airways. Our study was thereby initiated to address this question and 
expand our understanding of the role AQs have in the initial recognition of P. 
aeruginosa in the human lung. 
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2.1.4. Generation of a pqsA mutant in PAO1 Lausanne 
During the course of a study in our laboratory investigating the regulatory role 
of RsmA (a small RNA binding protein that acts as a post-transcriptional 
regulator controlling many phenotypes including swarming), it was discovered 
that a ǻrsmA mutant in the PAO1-subline Nottingham (PAO1-N) was unable 
to swarm, whereas swarming was maintained in a ǻUVP$ in PAO1-subline 
Lausanne (PAO1-L) (Mai-Prochnow, et al., manuscript in preparation). This 
led to the discovery of some key genomic differences between PAO1-N and 
PAO1-L which revealed that PAO1-L was closer to the original PAO1 ancestor 
strain as this organism has been shown to evolve very quickly (Klockgether et 
al., 2010). The main difference between these two strains was a 58,569 base 
pair chromosomal deletion in PAO1-N, between bases 724103 ± 780973, 
which was not present in PAO1-L. Amongst the genes present in this region is 
toxR (PA0707) which codes for a key regulator of exotoxin A (ETA), an 
important virulence factor in P. aeruginosa. ToxR was later shown to modulate 
swarming motility (Mai-Prochnow, et al., manuscript in preparation). 
Subsequently, genomic sequencing of PAO1-N and PAO1-L revealed the 
presence of a number of single nucleotide polymorphisms (SNPs) in the 
PAO1-N strain (Hardeep Naphra, on-going PhD thesis). Hence there was a risk 
that the attenuation observed in a ǻpqsA constructed in PAO1-N using a mouse 
burn wound model of infection could in part have been influenced by these 
strain differences (Rampioni et al., 2010). To gain a better understanding of 
how PQS impacts on P. aeruginosa pathogenesis, a new pqsA in-frame 
deletion mutant was constructed in the PAO1-L background. The generation 
and characterisation of this mutant would be described in this chapter. The 
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effect of PQS on the interaction of P. aeruginosa with human bronchial 
epithelium was subsequently investigated and described in chapter 4.  
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2.2. HYPOTHESIS 
Previous studies using P. aeruginosa PQS-deficient mutants indicated that 
interfering with AQ biosynthesis could reduce P. aeruginosa virulence in plant, 
nematode, and mouse burn wound models. Based on the high levels of PQS 
detected in bronchoalveolar lavage fluids from both early and late stage CF 
patients, we hypothesised that PQS could potentially influence the virulence of 
P. aeruginosa interaction with human bronchial epithelial cells.  
 
2.3. AIM 
To understand the impact of PQS in coordinating P. aeruginosa pathogenesis 
during the infection of the differentiated human bronchial epithelium, an AQs 
deficient mutant was generated by in-frame deletion of the pqsA gene in the 
PAO1-L background. This chapter includes the genotypic and phenotypic 
characterisation of this new mutant (termed ǻpqsAL) and a comparison with a 
pqsA mutant generated previously in PAO1-N. 
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2.4. MATERIALS AND METHODS 
2.4.1. Bacterial strains, plasmids and culture condition  
The strains and plasmids used in this study are listed in Table 3.1. Both E. coli 
and P. aeruginosa strains were routinely grown in Luria broth (LB) at 37oC 
with 200 rpm shaking. Antibiotics were added to culture media when required: 
DPSLFLOOLQDWWKHFRQFHQWUDWLRQRIȝJPOZDVDGGHGWR/%WRPDLQWDLQWKH
cloning plasmid pBluescript KS II (+) in E. coli '+Į WHWUDF\FOLQH DW WKH
FRQFHQWUDWLRQ RI  ȝJPO LQ /% ZDV XVHG WR VHOHFW IRU WKH VXLFLGH Yector 
pME3087 in E. coli S17- ȜSLU WHWUDF\FOLQH DW  ȝJPO ZDV XVHG IRU
pME6032mCherry in E. coli '+Į $QWLELRWLFV WHWUDF\FOLQH DW  ȝg/ml and 
carbenicillin at 2,000 ȝg/ml were used for the enrichment step during mutant 
generation to obtain tetracycline sensitive colonies. 
2.4.2. Generation of a pqsA in-frame deletion mutant in PAO1-L 
2.4.2.1. DNA manipulation 
Chromosomal DNA extracted from P. aeruginosa was prepared using a 
Wizard Genomic DNA purification kit (Promega, UK) following 
PDQXIDFWXUH¶V UHFommendations. Briefly, bacterial cells from 1 ml overnight 
culture were centrifuged for 2 min at 13,000 rpm; cell pellets underwent lysis, 
RNase treatment, protein precipitation and genomic DNA precipitation and 
rehydration. 
Plasmid DNA isolation was conducted using the Qiagen Miniprep kit (Qiagen, 
8.DFFRUGLQJWRWKHPDQXIDFWXUHU¶VSURWRFRO 
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 Table 2.1  Bacterial strains and plasmids used in this study 
 
To identify the size of DNA fragments, DNA samples were mixed with 6x 
DNA loading buffer  (Promega, UK) and loaded into 1% (w/v) agarose gel in 
1X TAE buffer (40 mM Tris, pH 8.0, 20 mM acetic acid, and 1 mM EDTA) 
supplemented with ethidium bromide (Sigma-Aldrich, UK) to a final 
FRQFHQWUDWLRQ RI  ȝJ PO 7KH JHOV ZHUH UXQ LQ ; 7$( EXIIHU LQ D '1$
electrophoresis tank at 100 volt for 20 min. DNA fragments were visualised 
using a UV trans-illuminator (UVP, USA). Restriction enzyme digestions and 
ligations were carried out by standard methods described in Molecular Cloning 
(Sambrook et al., 1989).  
2.4.2.2. Introduction of DNA to bacteria 
Electro-competent cells were prepared by using overnight E. coli or P. 
aeruginosa cultures to start a new culture in LB to OD600 0.6-0.8. Cells were 
harvested by centrifugation at 10,000 x g at 4oC for 5 min and washed with 
Strain/plasmid Relevant characteristics Reference or origin 
Strain   
E. coli   
'+Į Cloning strain; F- endA1 hsdR17 supE44 thi-1 recA1 gurA96 relA1 ǻ(lacZYA-
argF)U169 deoR Ȝ(ĳ80lacZǻM15) 
(Grant et al., 1990) 
S17-Ȝpir Conjugative strain for suicide plasmids (Simon et al., 1983) 
P. aeruginosa   
PAO1-L Wild-type P. aeruginosa from Université de Lausanne, Switzerland  
ǻSTV$L pqsA mutant in PAO1-L background This study 
PAO1-N P. aeruginosa PAO1 collection from University of Nottingham  
ǻSTV$1 pqsA mutant in PAO1-N background  
 
Plasmid 
  
pBluescript-II KS+ Cloning vector; ColE1 replicon; AmpR Agilent Technologies, US 
pME3087 Suicide vector, polylinker of pMMB67, ColE1-replicon; TcR (Voisard et al., 2007) 
  pYCL1 pME3087 derivative for pqsA in-frame deletion; TcR This study 
  pME6032mCherry pME6032 with mCherry fusion constitutively expresses red fluorescence protein (Heeb et al., 2002) 
  AmpR, ampicillin resistant; TcR, tetracyclin resistant 
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10% sterile ice-cold glycerol in H2O (Sigma-Aldrich, UK) four times. The 
wash volume was reduced by half each time. After the washes, the cell pellets 
were resuspended in 40-ȝORIJO\FHURODOLTXRWHGDQGVWRUHGDW -80oC 
for future use. Electroporation was conducted in 0.2 cm electrode gap Gene 
3XOVHU FXYHWWHV %LR5DG 8. XVLQJ  ȝO RI FRPSHWHQW FHOOV DQG 0 pg of 
DNA. A pulse of 2.5 kV (200 %) was delivered using the BioRad Gene Pulsar 
connected to a BioRad pulse controller (BioRad, UK). Cells were resuspended 
in 1 ml of LB broth, incubated at 37°C for 1 h, plated onto LB agar plates 
containing appropriate antibiotics and grown overnight at 137°C. 
2.4.2.3. Generation of plasmid pME3087mpqsA (designated as pYCL1)  
To construct the plasmid pYCL1, a pqsA deletion fragment that joined a 410-
bp fragment upstream of the pqsA gene and a 423-bp downstream fragment 
were generated and amplified by overlap extension PCR using P. aeruginosa 
PAO1-L chromosomal DNA as template. In the first PCR, the upstream 410-bp 
fragment was amplified using the forward primer pqsAf1 (Table 2.2) which 
carries a XbaI restriction site, and the reverse primer pqsAr1 with an 
overhanging end containing the last 12 nucleotides of the pqsA gene 
XQGHUOLQHGDQGH[WUDDUWLILFLDOQXFOHRWLGHVDWWKH¶HQGWRHQDEOHWKHSULPHU
to anneal to the DNA template (bold); the 423-bp fragment was amplified by 
the forward primer pqsAf2 containing 3 nucleotides upstream of pqsA and the 
first 12 nucleotides of pqsA; UHYHUVH SULPHU STV$U ZKLFK FDUULHV D +LQG,,,
UHVWULFWLRQVLWH7RSHUIRUPWKHRYHUODSH[WHQVLRQ3&5DVHFRQG3&5UHDFWLRQ
ZDV SHUIRUPHG XVLQJ WKH -ES DQG -ES IUDJPHQWV DV WHPSODWHV DQG WKH
SULPHUVSTV$UDQGSTV$I7DEOH 7KHILQDO3&5SURGXFWPSTV$ZDV
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FORQHG LQWRS%OXVFULSW ,,.6YHFWRUXVLQJ WKH;ED,DQG+LQG,,, UHVWULFWLRQ
VLWHV 7KH FRUUHFW FRQVWUXFWLRQ ZDV FRQILUPHG E\ QXFOHRWLGH VHTXHQFLQJ
6XEVHTXHQWO\ WKH GHOHWLRQ IUDJPHQW ZDV FORQHG LQWR WKH VXLFLGH YHFWRU
S0( UHVXOWLQJ WKH QHZ UHFRPELQDQW SODVPLG S<&/ IRU IXUWKHU PXWDQW
JHQHUDWLRQ  
2.4.2.4. Mutation of the P. aeruginosa pqsA gene 
The PAO1-Lausanne pqsA in-frame deletion was constructed by allelic 
exchange using the suicide vector pYCL1. The cloning strategy is illustrated in 
Fig. 2.5. Briefly, the first homologous recombination of mpqsA fragment with 
sequences on PAO1-L genome took place by conjugation of PAO1-L as 
recipient and E. coli S17-1Ȝpir/pME3087mpqsA as the donor cells on a LB 
agar plate containing tetracycline at 125 ȝg/ml and nalidixic acid  at 15 ȝg/ml 
(Heurlier et al., 2004). Next day, colonies on the selective plate were picked for 
purification on LB agar plate with the same antibiotic concentration, cultured at 
37oC overnight. The pqsA deletion mutants were firstly screened by colony 
PCR using primer pqsAf1 and pqsAr2. The desired PCR amplicon should be 
833 bp, but the amplicon could also be 2,367 bp LIUHFRPELQDWLRQGLGQ¶WRFFXU
Mutant candidates selected from colony PCR were subjected to enrichment 
with carbenicillin to excise plasmid pYCL1 from PAO1-L. The enrichment 
was carried out by culturing colonies in 5 ml of LB without antibiotics 
overnight at 37oC, 200 rpm. Next day, a new culture was prepared using the 
overnight culture as inoculum and an initial OD600 of 0.05-0.1.  Tetracycline 
was added to the culture to a final concentration of 20 ȝg/ml and the culture 
was incubated for 1 h at 37oC with shaking. Carbenicillin to a concentration of 
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2,000 ȝg/ml was added afterwards to kill dividing cells, leaving only cells that 
are tetracycline sensitive. This culture was thereafter cultured for another 6 
hours, centrifuged at 4,000 xg for 10 min, and the pellets were resuspended in 
1 ml of fresh LB to start a new overnight culture. The same procedure was 
performed again next day. At day 3, the overnight culture from day 2 was 
centrifuged, pellets resuspended in 1 ml LB and 100 Pl from serial dilutions in 
LB were plated on LB agar plates and incubated at 37oC overnight. Colonies 
were re-streaked both on LB agar with and without tetracycline at 100 ȝg/ml to 
confirm loss of tetracycline resistance and screened by colony PCR. The pqsA 
deletion in the recombinant strain was then verified by nucleotide sequencing. 
 Table 2.2  Primer sequences for ǻSTV$L mutant generation  
 
 
Primer 2OLJRQXFOHRWLGH6HTXHQFH¶Æ ¶ Description Tm (oC) 
pqsAf1 ATATCTAGACGCCTCGAACTGTGAGATTT With an underlined XbaI restriction site 60 
pqsAr1 TCAACATGCCCGTTCCAATGTGGACATGACAGAACG Underlined and bordered sequences are 
complementary therefore they join two 
DNA fragments during overlap extension 
PCR. Nucleotides ATG (CAT antisense) in 
bold indicate the start codon of pqsA  
66.5 
pqsAf2 GTCATGTCCACATTGGAACGGGCATGTTGATTCAGG 65.7 
pqsAr2 TATAAGCTTACTCGCTGTCCACTTCCAAT With an underlined HindIII restriction site 59.7 
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Table 2.3  pqsA gene nucleotide sequence along with its 800 bp upstream and downstream 
sequence  
pqsA gene nucleotides are in blue colour; the pqsA upstream region (410 bp) and downstream 
fragment (423 bp) used to generate mpqsA fragment are shaded. Primer pqsAf1 and primer 
pqsAr2 were designed to contain a restriction site for XbaI and HindIII respectively. 
>upstream 800 bp + pqsA 1,554 bp + downstream 800 bp 
AAATTCGGTACCTTGGAAGTCGAGCGGGAGTTCGAACCGGGAACGTTTGCCGGAAAAATATT
CCCGCAACTGGCGTTCGGTTTCCGCCAGGAGGGAGCTGTCCTCGGAGAGCCGCATCTCGTCC
AGCGGTACTCGGTTGGGACGCTCATGCTGCCAAAGAATCGCGACCAGAAAGGCATCGTCCCT
GGCTACCAGGGTCAGTGTCCCGACCGGCGATTCCATTTTCCTGTAGCTATGGGGCATGTAGG
TGTCCTCTTCGGCAGGCTCGCCCAGTGTACTACGCAATGGGATTTCAACAGGGAAGCCTGCA
AATGGCAGGCGAGGCGGGGCGGAGCGCTATCGGCCCGATG 
                                                                              primer pqsAf1 ATA TCTAGA 
GATGGCCGCCTGCTTCCAGGCATGCCGTCGCCCCCTTGGAGCCCAGGCCGAGCGCCTCGAAC
TGTGAGATTTGGGAGGCGATTTGCCGAGCAAAGTGGGTTGTCATTGGTTTGCCATCTCATGG
GTTCGGACGAGGCCTCGAGCAAGGGTTGTAACGGTTTTTGTCTGGCCAATGGGCTCTTGCGT
AAAAAGGCTGCCGCCCTTCTTGCTTGGTTGCCGTTCTCGGATCCCGCGCAGCCCGGTGGGTG
TGCCAAATTTCTCGCGGTTTGGATCGCGCCGATTGCCGCGGCCTACGAAGCCCGTGGTTCTT
CTCCCCGAAACTTTTTCGTTCGGACTCCGAATATCGCGCTTCGCCCAGCGCCGCTAGTTTCC
CGTTCCTGACAAAGCAAGCGCTCTGGCTCAGGTATCTCCTGATCCGGATGCATATCGCTGAA
GAGGGAACGTTCTGTCATGTCCACATTGGCCAACCTGACCGAGGTTCTGTTCCGCCTCGATT
TCGATCCCGATACCGCCGTTTATCACTATCGGGGCCAGACTCTCAGCCGGCTGCAATGCCGG
ACCTACATTCTCTCCCAGGCCAGCCAACTGGCCCGCCTGCTCAAGCCCGGCGATCGCGTGGT
GCTGGCGTTGAACGACTCGCCTTCGCTGGCCTGCCTGTTCCTGGCCTGCATCGCGGTCGGCG
CCATTCCCGCCGTGATCAATCCCAAGTCCCGCGAGCAGGCCCTGGCCGATATCGCTGCCGAC
TGCCAGGCCAGCCTGGTGGTGCGTGAAGCCGATGCACCGTCGCTGAGCGGTCCTTTGGCGCC
GTTGACCCTGCGTGCGGCCGCCGGACGCCCTTTGCTCGACGATTTCTCGCTGGACGCGCTGG
TCGGCCCTGCGGACCTCGATTGGAGTGCCTTCCATCGCCAGGACCCGGCGGCAGCCTGTTTC
CTGCAATACACCTCGGGTTCCACCGGGGCGCCCAAGGGGGTGATGCACAGCCTGCGCAACAC
GCTCGGTTTCTGCCGGGCGTTCGCTACGGAGTTGCTGGCATTGCAGGCGGGAGACCGGCTGT
ATTCGATTCCCAAGATGTTCTTCGGCTATGGCATGGGCAACAGCCTGTTCTTTCCCTGGTTC
AGCGGAGCCTCGGCGCTGCTCGACGATACCTGGCCGAGCCCGGAGCGGGTTCTGGAGAACCT
GGTCGCCTTCCGCCCCCGGGTCCTGTTTGGGGTGCCGGCCATCTATGCCTCGCTGCGTCCGC
AGGCCAGGGAGCTGTTGAGCAGCGTGCGCCTGGCGTTTTCCGCCGGCTCGCCGCTGCCGCGC
GGCGAGTTCGAATTCTGGGCCGCGCACGGGCTGGAGATCTGCGACGGCATCGGGGCTACCGA
GGTCGGCCATGTGTTCCTCGCCAACCGCCCGGGCCAGGCGCGTGCCGACAGCACCGGGCTGC
CGTTGCCTGGCTATGAGTGCCGGCTGGTGGACCGCGAAGGACACACTATCGAGGAAGCGGGC
CGGCAAGGCGTGCTGTTGGTGCGTGGCCCAGGGCTGAGTCCGGGTTACTGGCGGGCCAGCGA
AGAGCAGCAGGCGCGCTTCGCAGGTGGCTGGTACCGCACCGGCGACCTGTTCGAGCGCGACG
AGTCGGGTGCCTACCGTCACTGTGGGCGGGAAGACGATCTGTTCAAGGTGAATGGCCGCTGG
GTGGTGCCGACCCAGGTCGAGCAGGCGATCTGCCGTCATCTGCCGGAAGTGAGCGAGGCGGT
TCTGGTTCCTACCTGCCGGCTGCACGACGGCTTGCGTCCGACCCTGTTCGTCACCCTGGCCA
CTCCGCTGGACGACAACCAGATCCTGCTGGCGCAGCGCATCGACCAGCATCTCGCCGAACAG
ATTCCCTCGCACATGCTGCCCAGCCAATTGCATGTGCTGCCGGCCTTGCCGCGCAACGACAA
CGGCAAGTTGGCGCGCGCCGAGCTGCGCCACCTGGCCGACACCCTTTATCACGACAACCTTC
CGGAGGAACGGGCATGTTGATTCAGGCTGTGGGGGTGAACCTGCCCCCATCCTATGTGTGTC
TGGAGGGGCCGCTGGGAGGCGAACGCCCTCGCGCCCAGGGCGACGAGATGCTGATGCAGCGC
TTGCTGCCGGCGGTTCGCGAAGCCCTGGACGAGGCGGCGGTCAAGCCCGAGGAGATCGACCT
GATCGTCGGCCTCGCCCTGTCTCCCGACCATCTGATCGAGAACCGCGACATCATGGCGCCGA
AGATCGGCCATCCGTTGCAGAAGGTCCTCGGCGCGAATCGCGCGCATGTCTTCGACCTCACC
GACTCGAGCCTGGCCCGCGCCCTCTACGTGGTCGATACCCTCGCCAGCGACCAGGGCTATCG
CAACGTCCTGGTCGTGCGCGGCGAATCCAGCCAGGGATTGGAAGTGGACAGCGAGTCCGGCT
TCGCCCTTGCCGACGGCGCCCTGGCGCTGCTC 
                                AAGCTT ATA primer pqsAr2 
TGCCGGCCGACCGGCAAGGCCGCGTTCCGTCGCGGTGCGCTGGGCGGTGATCCGGCGCAGGA
ATGGCTGCCGCTGAGCATTCCGCTGAATACCGATATTCGCCAGGTAGGCGACGTCAAGGGAC
ACCTCAACCTGCCGGCCCAACCTGGATTGCCCGAAGCGGTACGCGCCGGATTCACCCGTCTG
GCCGGGGACTTCCCGCAACTGAACTGGGTGCGCGAGGAATGGTTCGGCCAGGGACGGCCCGA
TGGTCGTTGCCTGGGGCCGTTCGAACTGGCGTCGCAACTGCGCGCGGCACAGCGCGACCGTC
TGGATGAACTGCTGCTGATCAGCTTCGATCCGTTCGGCATGGTG 
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Figure 2.5  Strategy to generate a pqsA in-frame deletion in PAO1-L. 
To generate an in-frame deletion mutant, a suicide plasmid carrying a deleted fragment of 
pqsA gene was constructed. A. The deleted gene fragment was generated by overlapping PCR 
which joined the upstream and downstream sequence of pqsA gene (fragment mpqsA). B. The 
833 bp mpqsA fragment was cloned in the suicide vector pME3087 to become pYCL1 and 
was subsequently conjugated to PAO1-L. C. Homologous recombination between pYCL1 and 
PAO1-L chromosomal DNA was expected to occur as a result of pME3087 insertion into the 
chromosomal DNA. Conjugants were subjected to tetracycline and nalidixic acid selective 
medium plates. D. The second homologous recombination carried on and by tetracycline and 
carbenicillin enrichment, tetracycline resistant plasmids were eliminated out of the P. 
aeruginosa genomic DNA. The chromosomal DNA resulted in two genotypes; the desired 
mutation was expected to comprise 50% of total population. 
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2.4.3. Phenotypic characterisation of ǻSTV$L 
2.4.3.1. Determination of bacterial growth  
Bacterial growth was measured under aerated and static conditions. For aerated 
conditions P. aeruginosa was grown in 25 ml of LB or X-vivo in a 250 ml 
flask, 200 rpm 37oC and OD600 was measured using a spectrophotometer 
(BioMate 3s, Thermo Scientific, UK) every hour for 12 h and at 24 h. For static 
condition, cultures were growth in 96-well plates and OD600 was read every 30 
min for 24 hours using a microplate reader (Infinite® M1000 PRO, TECAN, 
UK). 
2.4.3.2. Detection of alkyl-quinolone using a biosensor assay 
P. aeruginosa PAO1-L, ǻSTV$L, PAO1-N, ǻSTV$N and the AQ biosensor strain 
PAO1 ǻSTV$&7;3STV$-lux (Fletcher et al., 2007) were cultured overnight 
at 37oC, 200 rpm in LB or X-vivo 15 (Lonza, UK). Five ml of each P. 
aeruginosa culture were harvested and spun at 10,000g at 4oC for 5 min to 
collect the supernatant. The AQ biosensor culture was adjusted with LB 
medium to OD600 1.0 and diluted 1 in 50 and 1 in 100 for the assay. Test 
bacterial supernatants were mixed with the same volume of the 1:50 diluted 
biosensor culture; 1:100 dilution of the AQ biosensor alone was added to 
negative control wells, positive control wells contained a 1:100 dilution of the 
biosensor with 4 serial dilutions of pure synthetic PQS or HHQ ranging from 
100 ȝ0WRȝ0%LROXPLQHVFHQFHSURGXFWLRQ2'495) and bacterial growth 
(OD600) were monitored at 37oC for 24 h using a microplate spectrophotometer 
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(Infinite® M1000 PRO, TECAN, UK). Luminescence was recorded as relative 
light units (RLU) per unit of OD600. 
2.4.3.3. Pyocyanin production assay 
The pyocyanin quantification is based on a colorimetric method by measuring 
the absorbance of pyocyanin in acidic solution. A 5 ml of fraction of overnight 
culture in LB was centrifuged in a 15 ml falcon tube at 10,000 rpm (Allegra X-
64R with C0650 fixed angle rotor, Beckman Coulter, UK) for 10 min at room 
temperature. The supernatant was transferred into a fresh tube and mixed with 
3 ml of chloroform. After thorough mixing the mixture was centrifuged and the 
chloroform organic layer was transferred to a fresh tube and mixed with 1 ml 
0.2 M HCl (Sigma-Aldrich, UK). After centrifugation at 10,000 rpm (Allegra 
X-64R with C0650 fixed angle rotor, Beckman Coulter, UK) at 4oC for 5 min, 
the top layer was collected to measure its absorbance at 520 nm. 
Concentrations of pyocyanin, presented as ȝg per ml, were determined by 
multiplying the value of OD520 after adjusting to growth using OD600 by 17.072 
(Essar et al., 1990). 
2.4.3.4. Swarming assay 
Overnight PA cultures in LB were adjusted to OD600 1.0 and 5 ȝl of the diluted 
cultures were drop dotted on the centre of a swarm agar plate. Swarm agar is 
composed of 0.5% of Bacto agar (Difco BD, USA), nutrient broth No.2 (Oxoid, 
USA) and 0.5% of D-Glucose (Sigma-Aldrich, UK). Swarm agar plates were 
then incubated at 38.7oC for 18 hours. Swarming images were obtained by 
placing plates on a black background with indirect illumination from below. 
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2.4.3.5. Quantification of rhamnolipids production by the orcinol method  
Quantification of rhamnolipids by the orcinol method was performed as 
described by Christova et al. (Christova et al., 2004) with the following 
modifications. Briefly, P. aeruginosa strains were cultured in 5 ml of CAA 
medium (1 g of casamino acid (Difco BD, USA), 4 g of glycerol (Sigma-
Aldrich, UK), 0.115 g of K2HPO4 (Sigma-Aldrich, UK) and 3 mM MgSO4 
(Sigma-Aldrich, UK) to a final volume of 200 ml in distilled water) at 37oC, 
200 rpm. After 18 h incubation, rhamnolipids were extracted twice from cell-
free culture supernatants with equal volume of diethyl ether (Sigma-Aldrich, 
UK). The organic fractions were vacuum dried using a centrifugal evaporator 
(Jouan RC10 series, Thermo Scientific, UK) for 40 min and resuspended in 1 
ml of orcinal solution (100 ȝl of ddH2O, 100 ȝl of 1.6% orcinol (MP 
Biomedicals, France) and 800 ȝl of 60% H2SO4). Sample solutions and serially 
diluted rhamnose standards were then incubated at 80oC for 7 min, cooled 
down to room temperature and OD421 was measured using a spectrophotometer. 
The amounts of rhamnolipids were calculated as mg per ml. Each sample was 
evaluated in triplicate. 
2.4.3.6. Biofilm formation, visualisation and analysis  
UV-sterilised glass slides were placed in petri-dishes inoculated P. aeruginosa 
cultures in RMPI-1640 (Sigma-Aldrich, UK) and started with an overnight 
culture in RPMI-1640 diluted to OD600 0.05 in RPMI-1640. Cultures were 
incubated at 37oC with shaking at 60 rpm for 72 hours. Glass slides were 
washed with PBS 3 times, rinsed with distilled water once and stained with 
SYTO9 and propidium iodine (FilmTracer Live/Dead Biofilm Viability Kit; 
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Life Technologies, USA). Images were acquired by confocal laser scanning 
microscope (Zeiss LSM 700). Green-channel images were acquired using 488 
nm excitation and 515 nm emission; red-channel images were collected using 
594 nm excitation and emission at 625 nm. Biofilm surface coverage 
percentage was analysed by software ImageJ and the means of surface 
coverage were taken from 7 images from different fields on a glass slide. 
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2.5. RESULTS 
2.5.1. Generation of the ǻSTV$L mutant 
The pqsABCDE operon is essential for PQS production. The pqsA gene for 
being the first gene from this operon in the AQ in P. aeruginosa, we decided to 
generate a pqsA knock-out mutant to block the biosynthesis of AQs.  
The P. aeruginosa laboratory strain PAO1-L was chosen as the background 
strain to generate this mutant for the reasons specified in Section 2.1.5. The 
mutant was constructed under the concept of allelic gene exchange. To knock-
out the target gene, we designed four primers pqsAf1, pqsAr1, pqsAf2 and 
pqsAr2 (Table 2.2). By using the primer pair pqsAf1/r1, pqsAf2/r2 and the 
PAO1-L genomic DNA as the template, a 410-bp long amplicon containing a 
Xba,UHVWULFWLRQVLWHDWLWV¶HQGDQGWKHRWKHU-bp amplicon with a HindIII 
UHVWULFWLRQ VLWH DW WKH ¶ HQG ZHUH JHQHUDWHG VHTXHQFHV GLVSOD\LQJ LQ JUH\
shades are shown in Table 2.3). For the second PCR the overlapping PCR was 
performed, where the above two PCR products were both used as templates 
and PCR was conducted with primers pqsAf1 and pqsAr2, resulting in an 833-
bp fragment made from joining two template fragments by the over-hanging 
nucleotides designed on the primers. The 833-bp fragment contains only 27-
nucleotide of the pqsA gene (the first 12 nucleotides and the last 15 nucleotides 
of pqsA) and was denoted as the mpqsA fragment (Fig. 2.5). The mpqsA 
fragment was digested with XbaI and HindIII and ligated into the cloning 
vector, pBluescript KS II (+) digested with the same enzymes. Subsequently, 
the mpqsA fragment was sub-cloned into the suicide vector, pME3087, 
resulting in pYCL1. Conjugation of E. coli s17- ȜSLU ZKLFK FDUULHV S<&/
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into P. aeruginosa PAO1-L, allowed homologous recombination to occur 
between the suicide vector and the PAO1-L genome (Fig. 2.5). After 
recombination, we screened the tetracycline sensitive mutant candidates using 
a three-day continuous enrichment method. The ǻSTV$ mutant sequence was 
verified by nucleotide sequencing showing that the first 12 nucleotides of pqsA 
were successfully linked to the last 15 nucleotides of pqsA (Fig. 2.6); the rest of 
nucleotides of the mpqsA fragment were aligned correctly with the gene 
PA0996 of P. aeruginosa PAO1-UW sequence obtained from Pseudomonas 
Genome Database (Winsor et al., 2011)  (data not shown). 
 
 
 
To determine if AQ production has been lost in the ǻSTV$L mutant, mutant no. 
m11-1 was selected to examine this function using an AQ biosensor assay. Fig. 
2.7 C shows a substantial reduction in PQS in ǻSTV$L mutant compared to 
PAO1-L. Collectively, these results indicate that a pqsA mutation that depleted 
1,527 bp out of 1,554 bp of the pqsA gene has obtained and that this mutation 
Figure 2.6  Nucleotide sequencing confirmed that an in-frame deletion was generated by 
joining first 12 nucleotides and the last 15 nucleotides of the pqsA gene. 
The first 12 nucleotides ATGTCCACATTG (underlined) and the last 15 nucleotides 
GAACFFFCATGTTGA (underlined) were linked, making a pqsA in-frame deletion by 
knocking out 1,527 nucleotides out of 1,554 nucleotides. 
80 
 
presented phenotypes of depleted pyocyanin biosynthesis and reduced 
secretion of alkyl-quinolones. 
Several mutants were selected and pyocyanin production was used as a 
surrogate marker to screen these potential PQS deficient mutants because its 
biosynthesis is controlled directly by the pqs operon. The green pigment 
appeared in the organic layer from the WT PAO1-L culture supernatant after 
chloroform extraction and it turned pink after acidification (Fig. 2.7 A). To 
determine the concentrations of pyocyanin, the values of OD520 after 
normalising to growth based on the OD600 were multiplied by 17.072 (Essar et 
al., 1990). The amount of pyocyanin in PAO1-L WT was 0.059 ȝg/ml. 
However, pyocyanin was barely detectable in the selected mutants no. m11-1, 
m11-4 and m17-7 with concentration of 0.007 ȝg/ml, 0.004 ȝg/ml and 0.004 
ȝg/ml respectively, indicating that there is a correlation between lack of pqsA 
function and pyocyanin biosynthesis (Fig. 2.7 B).  
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Figure 2.7  ǻSTV$L mutants were deficient in the production of pyocyanin and alkyl-
quinolones. 
Two phenotypes, pyocyanin and AQs production which are directly associated with PQS expression were 
used to screen for the potential ǻSTV$L mutants. A. Green pigment appeared in the chloroform layer of P. 
aeruginosa PAO1-L wild type (arrow) but this layer remained yellow in the case of ǻSTV$L mutants (left). 
The colour of the chloroform layer after 0.2 N HCl acidification became pink in WT (arrow), but not in 
ǻSTV$L mutants (right). B. Quantification of pyocyanin showed that ǻSTV$L mutants no. m11-1, m11-4 
and m17-7 produced low amounts of pyocyanin compared with WT PAO1-L. C. The presence of AQs in 
the supernatants of PAO1-L wild type and a selected ǻSTV$L mutant were examined using a AQs 
biosensor assay. AQ synthesis in ǻSTV$L mutant was highly decreased compared to the WT. Averages in 
(B) were from two independent experiments; Averages and standard deviations in (C) were from 3 
independent experiments.  
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2.5.2. Phenotypic characterisation of ǻSTV$L in comparison with ǻSTV$N 
2.5.2.1. Bacterial growth 
To examine whether the deletion of pqsA would alter fundamental metabolic 
processes, the growth of ǻSTV$L was compared to the growth of its isogenic 
WT strain PAO1-L. The two strains were cultured in LB and X-vivo 15 with 
aeration and OD600 readings were taken every hour for 12 h and at 24 h. X-vivo 
15 is a chemically defined, serum-free hematopoietic cell media that provides 
nutrient balanced environment for the growth of peripheral blood lymphocytes 
(PBL), tumour infiltrating lymphocytes (TIL) myeloid cells, human monocytes, 
macrophage cells and natural killer (NK) cells, etc. (Lonza, cell culture media 
reference (Wu et al., 2001, Jonuleit et al., 1997)). In our lab, X-vivo 15 has 
been used to growth human macrophages in the assay upon P. aeruginosa 
infection (Singh, 2012). As the original plan was to generate a multicellular 
epithelium system that includes human macrophages, it is essential to evaluate 
whether the growth of P. aeruginosa strain would differ in X-vivo 15 culture 
media. The growth rates of WT and ǻSTV$L, in LB and X-vivo 15 media were 
comparable as shown in Fig. 2.8. Additionally, the growth of the PAO1-L WT 
and ǻSTV$L were compared to that of PAO1-N and ǻSTV$N under static 
conditions. No distinguishable growth differences were observed among these 
4 strains when cultured in LB at static condition (Fig. 2.9). When the four 
strains were incubated in X-vivo 15 under static conditions, the cell densities 
were generally lower particularly in the case of PAO1-N and ǻSTV$N compared 
to PAO1-L and ǻSTV$L. These results suggest that the deletion of the pqsA 
gene does not affect P. aeruginosa growth.  
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Figure 2.8  Similar growth of P. aeruginosa PAO1-L (WT) and ǻSTV$L in LB and X-
vivo 15 media under aerated conditions. 
Growth of P. aeruginosa WT and ǻSTV$L cultures grown in LB and X-vivo 15 was 
investigated by measuring OD600 every hour for 12 h and at 24 h. PA cultures were grown in 
25 ml LB in 250 ml flasks at 37oC, 200 rpm. N=1; averages and error bars were from two 
preparations of each bacterial strain. 
Figure 2.9  Similar growth of P. aeruginosa PAO1-L, PAO1-N and their isogenic pqsA 
mutants in LB and X-vivo 15 under static conditions. 
Growth of P. aeruginosa WT and ǻSTV$L cultures grown in LB (A) and X-vivo 15 (B) was 
investigated by measuring OD600 every 30 min for 24h. PA cultures were grown in 96 well plates. 
The cell density of PAO1-N and ǻpqsAN was slightly lower than that of PAO1-L and ǻpqsAL in 
X-vivo 15. Overall, PA grew slower and reached lower density in X-vivo 15 under static 
conditions. N=1; each condition was conducted in triplicate. 
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2.5.2.2. Reduced alkyl-quinolones production in ǻSTV$L 
To determine the PQS production capacity of PAO1-L and its isogenic ǻSTV$L 
mutant, the secretion of alkyl quinolones to the extracellular milieu was 
measured. PAO1-N and ǻSTV$N were also compared. AQs production from 
PAO1-L was detected by the luminescence (RLU/OD600) emitted by the AQ 
biosensor strain PAO1 ǻSTV$ &7;3STV$-lux (Fletcher et al., 2007) as 
described in materials and methods. The bioluminescence levels detected from 
the PAO1-L supernatant was comparable to that obtained using 20 ȝg/ml of 
pure PQS compound as positive control (Fig. 2.10 C). The ǻSTV$L mutant 
secreted substantially lower amount of AQ compared to PAO1-L. Meanwhile, 
AQ production in PAO1-N was 85% higher to that of PAO1-L. AQ 
biosynthesis in the ǻSTV$N mutant was also highly reduced and comparable to 
that of ǻSTV$L (Fig. 2.10). In line with these results, the lack of pqsA gene 
function in PAO1-L causes a deficiency in PQS production that was also 
verified by liquid chromatography-mass spectrometry (LC-MS) (refer Fig. 
4.18). 
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Figure 2.10  Mutation in pqsA rendered PAO1-L AQ-negative. 
The two major AQs components, PQS and HHQ compounds were used as positive controls in 
the AQ biosensor (PAO1 ǻSTV$ &7;3STV$-lux) assay. The mean maximal light output 
from the AQ biosensor in response to serial dilutions of PQS (A) and HHQ (B) is shown. For 
the doses tested (0.8 to 100 ȝM) the AQ biosensor strain responded to PQS in a dose 
depended fashion, but this was not observed in the case of HHQ. (C) The maximal light 
output from the AQ biosensor in the presence of overnight cell-free culture supernatants from 
PAO1-L, ǻpqsAL, PAO1-N and ǻpqsAN respectively grown in LB. The biosensor strain 
emitted light in response to both WT PAO1 supernatants but not in response to the pqsA 
culture supernatant. Control represents the light emitted from biosensor in the presence of LB 
medium. The results were averaged from two independent experiments and each sample was 
done in triplicate. Averages and error bars were shown in the figures. 
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2.5.2.3. Reduced pyocyanin production in ǻSTV$L 
Pyocyanin is a redox-active exotoxin compound considered as a virulence 
factor of P. aeruginosa essential for full pathogenesis in animal models and its 
expression has been shown to be QS-dependent (Das et al., 2013, Lu et al., 
2012, Ran et al., 2003). In the absence of PQS there is no pyocyanin 
production. Therefore, the levels of pyocyanin are an indication of the presence 
of PQS. To determine whether pyocyanin production was affected by the lack 
of pqsA gene function, we examined the levels of pyocyanin extracted from 
culture supernatants of PAO1-L, ǻSTV$L, PAO1-N and ǻSTV$N. Pyocyanin 
production was reduced in ǻSTV$L to a barely detectable level as shown in Fig. 
2.11. Pyocyanin secretion by PAO1-N was 85% higher than in PAO1-L. This 
was in accordance with the differences in PQS production between PAO1-L 
and PAO1-N. Impaired pyocyanin production was also observed in ǻSTV$N 
(Fig. 2.11) which in consistent with the result conducted by Rampioni et al. 
(Rampioni et al., 2010). 
 
Figure 2.11  Lack of pyocyanin synthesis upon mutation of pqsA in PAO1-L and 
PAO1-N. 
Pyocyanin production could not be detected in the supernatants from the ǻpqsAL and 
ǻpqsAN mutants. PAO1-L produced 85% less pyocyanin than PAO1-N. The mean of the 
results were taken from two independent experiments and samples were prepared in 
duplicates 
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2.5.2.4. Production of surfactant rhamnolipids was significantly reduced in 
ǻSTV$L 
Rhamnolipids are considered as virulence factors in P. aeruginosa. It was 
suggested that rhamnolipids modulate the innate immune response by 
supressing pathogen-induced human ȕ-defensin-2 expression in keratinocytes 
(Dossel et al., 2012). Mutations in pqsR and pqsE result in the inability to 
produce PQS but also decrease rhamnolipids biosynthesis (Reis et al., 2011, 
Deziel et al., 2005). To determine whether the production of rhamnolipids was 
inhibited as a result of a PQS deficiency in the ǻSTV$L mutant, the semi-
quantitative orcinal method was used to compare rhamnolipid production in 
PAO1-L, ǻSTV$L, PAO-N and ǻSTV$L strains. By measuring the concentration 
of rhamnose, the amount of rhamnolipids could be calculated as two masses of 
rhamnolipids is equivalent of one mass of rhamnose (Christova et al., 2004). 
The concentrations of rhamnolipids produced by ǻSTV$L were about three 
times lower than those secreted by PAO1-L (Fig. 2.12), indicating that 
rhamnolipids biosynthesis was affected by the deletion of pqsA in PAO1-L. 
However, PAO1-N and the ǻpqsǹN mutant produced equivalent amounts of 
rhamnolipids at the levels produced by ǻSTV$L, suggesting the existence of a 
genetic element missing in PAO1-N which may be present in PAO1-L and 
responsible for these differences. As mentioned above, a study comparing the 
genome difference between PAO1-N and PAO1-L revealed that a 58,000 base 
pairs DNA deletion fragment has occurred in PAO1-N. We postulate that the 
genes located in this region could be associated with rhamnolipids synthesis.  
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2.5.2.5. Effect of the pqsA mutation on P. aeruginosa motility 
P. aeruginosa can colonise environmental niches by using three types of 
motility, swimming, twitching, and swarming (Heurlier et al., 2004). Swarming 
combines swimming and twitching motility and requires rhamnolipids 
production. The flagella and type IV pili are the two major components 
responsible for motility. To examine whether the pqsA mutation would affect 
bacterial motility, a swarming assay was performed in PAO1-L, ǻSTV$L, 
PAO1-N and ǻSTV$N. Both ǻSTV$L and ǻSTV$N swarmed slightly faster than 
their isogenic wild-type strain. PAO1-N strains (PAO1-N and ǻSTV$N) 
generally swarmed slower than the PAO1-L strains (PAO1-L and ǻSTV$L) (Fig. 
2.13).  
Figure 2.12  The pqsA mutation decreased rhamnolipids production in ǻSTV$L but not in 
PAO1-N.  
Rhamnolipid production in ǻSTV$L was substantially reduced compared with that of PAO1-L. 
However, there were no differences in rhamnolipids production between PAO1-N and ǻpqsAN. 
Data were analysed by un-paired t-test. PAO1-L produced more rhamnolipids than PAO1-N. 
The graph shows the average of the results from two independent experiments and samples in 
each experiment were conducted in triplicate. 
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2.5.2.6. ǻSTV$L and ǻSTV$N form fragile immature biofilms 
Biofilm formation is another characteristic controlled by QS signalling. Once P. 
aeruginosa starts to develop as a population during the course of infection, 
antibiotics fail to penetrate the biofilm because of the thick alginate 
surrounding the cells. This phenomena could even drive P. aeruginosa resistant 
to antibiotics (Hoiby et al., 2010). To test whether biofilm formation was 
influenced by the deletion of pqsA in PAO1-L as it has been shown for PAO1-
N, biofilms developed on glass slides for 72 h at 37oC with low speed shaking 
were visualised by confocal laser scanning microscopy and the surface 
coverage from each strain compared. Biofilm surface coverage of ǻSTV$L was 
3-fold lower than that of PAO1-L and this reduction was significant. ǻSTV$L 
formed microcolonies on the glass slide while PAO1-L developed evident and 
mature biofilms. The biofilm surface coverage of PAO1-N and ǻSTV$N were 
similar to those shown in PAO1-L and ǻSTV$L (Fig. 2.14). Collectively, the 
loss of pqsA function influences biofilm formation. 
Figure 2.13  Motility was increased in ǻpqsAL and ǻpqsAN mutants compared with their 
WT parental strains. 
Motility of PAO1-L, ǻpqsAL, PAO1-N and ǻpqsAN was examined on 0.5% swarming agar 
plates at 37oC for 18 hours. Both pqsA mutants displayed increased motility compared with the 
WT strains. Higher swarming motility was seen in PAO1-L WT compared to PAO1-N. These 
images are representative from three independent experiments showing similar trends in 
motility. 
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Figure 2.14  ǻpqsAL and ǻpqsAN formed fragile and immature biofilms compared with 
PAO1-L and PAO1-N. 
The percentages of biofilm surface coverage from each strain were plotted. Below the graph 
shows representative 3D confocal laser scanning microscope images of biofilms. ǻpqsAL 
formed less biofilm than PAO1-L and bacterial cells were sparsely distributed; ǻpqsAN, 
however, was the most deficient in biofilm formation amongst these 4 strains. The experiment 
was conducted twice and showed the same trend in biofilm formation. The means and the 
standards deviation presented in the graph were calculated from 7 different fields acquired 
from confocal laser scanning microscope in an experiment. 
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2.6. DISCUSSION 
2.6.1. ǻSTV$L mutant was compromised in the production of several 
virulence factors 
In this chapter, a pqsA in-frame deletion mutant, ǻSTV$L, was successfully 
generated in the PAO1-L background and verified by nucleotide sequencing. In 
comparison to the wild-type, ǻSTV$L exhibited a substantial reduction in PQS, 
pyocyanin and rhamnolipids production and formed fragile biofilms of reduced 
surface coverage. Pyocyanin, rhamnolipids are virulence factors and their 
presence positively correlate with deteriorated lung function in CF patients. 
Based on this we concluded that ǻSTV$L, might present an attenuated 
phenotype upon infection of host cells. To understand the influence of PQS on 
the pathogenesis of P. aeruginosa during pulmonary infections, an in vitro 
human bronchial epithelium infection model has been established (see Chapter 
3). Using this model we have investigated how the lack of pqsA affects the 
behaviour of P. aeruginosa upon infection of differentiated human bronchial 
epithelial cells (see Chapters 3 and 4). 
Swarming motility is a dynamic process that requires a functional flagellum 
and the production of rhamnolipid biosurfactants and is also influenced by the 
environment (Davey et al., 2003, Caiazza et al., 2005). Both PAO1-L and 
ǻSTV$L were motile in swarming, but pqsA mutants swarmed slightly faster in 
swarming agar than its correspondent wild-types PAO1-L and PAO1-N. 
Despite the fact that rhamnolipids are considered to facilitate P. aeruginosa 
swarming by lowering surface tension and thus supporting the flagella based 
propulsion of the bacteria (Kohler et al., 2000), swarming was not impaired in 
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spite of the reduced production of rhamnolipids in pqsA mutants compared to 
its AQs competent wild-type strains in our study. Rhamnolipids are 
synthesized by a rhamnosyltransferase, encoded by the rhlAB operon (Deziel et 
al., 2003). It has been shown that rhlB mutant (deficient in mono- and 
dirhamnolipid production) and rhlC mutant (deficient in dirhamnolipid 
production) altered swarming patterns, whereas rhlA gene was indicated to be 
required for swarming (Deziel et al., 2003, Caiazza et al., 2005). AQ QS might 
indirectly regulate the production of rhamnolipids via transcriptional regulation 
on rhl operon that influences the swarming ability, where the mechanism 
circuit is still unclear. A study indicated that HHQ suppressed swarming (Ha et 
al., 2011) partially explained a mild inhibition of motility in wild-type strains 
that are competent in AQs production. In addition, both PAO1-L WT and 
ǻSTV$L were observed under SEM to carry a single flagellum (refer to Fig. 4.1 
in Chapter 4) that is also one of the factors required for swarming. The above 
evidence suggests that the decreased production of rhamnolipids might reduce 
the motility or alter swarming patterns but cannot fully influence the swarming 
due to the counter effect of the lack of HHQ in pqsA mutants that increased the 
motility. 
According to our in vitro study, ǻSTV$L appeared attenuated based on the 
phenotypic assays. However, a study investigating the profile of virulence 
factors expressed in P. aeruginosa strains from infants with cystic fibrosis 
published recently demonstrated that persistent strains refractory to antibiotic 
intervention expressed lower pyoverdine, rhamnolipids, haemolysin, total 
protease, swimming and twitching motility than strains that could be readily 
cleared by antibiotics (Manos et al., 2013). This study suggested that the 
93 
 
persistent strains in the lung might not directly correlate with the expression of 
virulence determinants that are commonly defined to cause acute infections. 
Thus, to gain a greater understanding of the impact of PQS on P. aeruginosa 
pathogenesis, the use of a physiologically-relevant experimental model that 
allows P. aeruginosa to fully-adopt the phenotype required to establish 
infection in the human lung is required. Towards this aim we have established 
an infection model using differentiated human bronchial epithelial cells which 
will be described in chapters 3 and 4. 
2.6.2. Phenotype differences between PAO1-L and PAO1-N might due to 
the 58 kb deletion in PAO1-N and SNPs in PAO1-N subline 
Table 2.4  Phenotype summary of PAO1-L, PAO1-N and their correspondent pqsA 
mutants. 
Phenotype PAO1-L ǻSTV$L PAO1-N ǻSTV$N 
AQs production + - ++ - 
Pyocyanin 
production 
+ - ++ - 
Swarming ++ +++ + ++ 
Rhamnolipids 
production 
+++ + + + 
Biofilm 
formation 
+++ + +++ - 
+, positive response; -, negative response; PQS, Pseudomonas quinolone signal 
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Due to its ubiquitous and metabolically versatile characteristics being an 
opportunistic pathogen, P. aeruginosa PAO1 is one of the most commonly 
used strains for research. The QS circuits reciprocally coordinate the regulation 
of virulence determinants. Strain PAO1 is a derivative from the original 
Australian PAO isolate that has been distributed worldwide to laboratories and 
strain collections. Discordant phenotypes of PAO1 sublines have emerged 
since the sequence was firstly published in 2000 (Stover et al., 2000). It has 
been shown that the PAO1 sublines differed in their ability to cope with 
nutrient limitation and their virulence varied in an acute murine airway 
infection model (Klockgether et al., 2010). An ongoing microevolution of 
strain PAO1 thus was suggested. In this regard, high-throughput genome re-
sequencing will resolve more cases and could become a quality control for 
strain collections since  the differences between genotype and phenotype may 
produce inconsistent findings between laboratory to laboratory (Klockgether et 
al., 2010). To understand the contribution of the genome difference between 
the PAO1 sublines PAO1-N and PAO1-L to different phenotypes, the 
phenotypic characterisation of PAO1-N and ǻSTV$N was also performed along 
with that of the main focus strain of the present project, ǻSTV$L and PAO1-L. 
We identified phenotypic differences between PAO1-L and PAO1-N. PQS and 
pyocyanin production in PAO1-N were 85% higher than those in PAO1-L. 
PAO1-N displayed slightly reduced swarming motility compared with PAO1-L. 
The production of rhamnolipids in PAO1-N was equivalent to those in ǻSTV$/ 
that was 3-fold lower than PAO1-L. No rhamnolipid production difference 
between PAO1-N and ǻSTV$1. Surface coverage of biofilms was comparable 
between PAO1-L and PAO1-N. ǻSTV$L and ǻSTV$N both displayed highly 
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reduced PQS production, no detectable pyocyanin production and reduced 
rhamnolipids production compared with the phenotypes of their correspondent 
wild-type. The only phenotype difference between ǻSTV$L and ǻSTV$N was the 
biofilm surface coverage in ǻSTV$L was around 2-fold higher than ǻSTV$N, in 
both instances the biofilms were less-established compared with their 
respective isogenic WT strains (summarised in Table 2.4). 
As mentioned earlier in the introduction section 2.1.3, swarming motility 
appeared to be different in the RsmA deletion mutants constructed in PAO1-N 
and PAO1-L backgrounds.  Results from our laboratory showed that ToxR 
might enhance rhamnolipids production and swarming motility by positively 
regulating RsmA and activating the rhl QS system (Mai-Prochnow, et al., 
manuscript in preparation). Rhamnolipids production was suggested to be 
regulated via the rhl QS system (Rahim et al., 2001). In addition, whole 
genome high-throughput re-sequencing of PAO1-N and PAO1-L was 
conducted and SNPs were identified by comparison of the genetic difference 
between PAO1-L and PAO1-N that were aligned with the reference genome 
PAO1-UW (named after the University of Washington) (Klockgether et al., 
2010) (Hardeep Naphra, on-going PhD thesis). Preliminary data revealed that 
SNPs such as bifA (PA4367) and mexF (PA2494) were identified in PAO1-N 
other than the 5.8 kb missing fragment and genome of PAO1-L is closer to the 
reference PAO1-UW (personal communication with Hardeep Naphra, on-going 
PhD thesis). BifA is a cyclic-di-GMP phophadiesterase that localise at inner 
membrane of P. aeruginosa. It was demonstrated that a decreased swarming 
motility but an enhanced biofilm and polysaccharide production were 
presented in the bifA mutant in P. aeruginosa PA14 background (Kuchma et al., 
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2007). The bifA SNP in the genome of PAO1-N might partially explain the 
slightly reduced swarming motility found in PAO1-N compared with PAO1-L. 
MexF is a resistance-nodulation-cell division (RND) multidrug efflux 
transporter that acts as an efflux pump protein (Winsor et al., 2011). At least 
four broad-spectrum efflux pumps (Mex) were found involved in elevated 
intrinsic antibiotic resistance as well as in acquired multidrug resistance in P. 
aeruginosa (Aires et al., 2002, Kohler et al., 1999). Additionally, the absence 
of ETA was also found in the culture supernatants of PAO1-N suggesting the 
deletion of ToxR in the genome of PAO1-N might influence the expression of 
ETA (Farah Hussain, on-going PhD thesis). Studies are in progress to 
characterise the genes and their functions that differentially expressed in 
PAO1-L and PAO1-N (Hardeep Naphra and Farah Hussain, on-going PhD 
theses). The above evidence suggested the intrinsic genetic differences between 
PAO1-N and PAO1-L and the genome of PAO1-L is closer to the reference 
PAO1-UW. The pqsA mutant generated in PAO1-L background is presumably 
to be more reflective to a phenotype attributed solely to the lack of the pqsA 
gene function but not from other defects derived from the depletion of the 
genome. 
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2.7. SUMMARY 
An AQ deficient strain on PAO1-L background has been successfully 
generated using an in-frame deletion strategy that does not require antibiotic 
selection. Phenotypic characterisations of ǻSTV$L in comparison with PAO1-L, 
demonstrated barely detectable levels of AQs and pyocyanin, reduced 
rhamnolipid production, fragile biofilms and slightly increased motility, in 
spite of equivalent growth. Collectively, these data suggest that ǻSTV$L has an 
attenuated phenotype.  
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3. ESTABLISHMENT AND CHARACTERIZATION 
OF AN IN VITRO INFECTION MODEL TO STUDY 
THE INTERACTION OF PSEUDOMONAS 
AERUGINOSA WITH DIFFERENTIATED HUMAN 
BRONCHIAL EPITHELIAL CELLS 
3.1. INTRODUCTION 
Mammalian airway epithelium represents the first line of defence encountered 
by microbial pathogens including bacteria, viruses, fungi and parasites. Not 
only providing a physical barrier against foreign bodies, the role of airway 
epithelial cells as immune modulators is also increasingly appreciated. 
Disturbance of this efficient defence system as in the case of ventilator-
acquired respiratory injury or malfunction of the cystic fibrosis transmembrane 
conductance regulator (CFTR) in cystic fibrosis is a leading cause of mortality 
worldwide (El Solh et al., 2008, Campodonico et al., 2008, Eisele and 
Anderson, 2011). A comprehensive understanding of how AQs might impact 
on the initial encounter of P. aeruginosa with lung epithelium and the 
downstream immune response is still lacking. In addition, because in CF 
SDWLHQWV ZLWK µVWDEOH LQIHFWLRQV¶ WKH PDMRULW\ RI SVHXGRPRQDO ORDG LV LQ WKH
conducting airways but not in the alveolar spaces (Jelsbak et al., 2007), 
bronchial epithelium was considered as a suitable experimental model to study 
the initial recognition of P. aeruginosa in the human lung.  
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Thus, the aim of this project was to establish an airway epithelium infection 
model as a research platform applicable to the study of P. aeruginosa 
pathogenesis and particularly the impact of alkyl-quinolones. This work 
represents the first use of human airway epithelial cell cultures in our lab, thus 
it is important to demonstrate that the culture system consistently generates 
differentiated epithelial cells with physiological relevant features.  
Three categories of pulmonary infection models are currently used (i) animal 
models; (ii) ex vivo organo-typic cultures and (iii) in vitro cell culture. Mouse 
animal models were excluded initially due to concerns regarding intrinsic 
species differences between murine and human respiratory systems. 
Anatomically, the human lung diverges up to 54,000 branches whilst in the 
mouse lung, it only extends to 5,000. The distribution of different epithelial 
cell types also differs between human and mouse (Rackley and Stripp, 2012). 
Mouse epithelium has an extra transmembrane TLR11 that has not been 
identified in human epithelium (Greene and McElvaney, 2005). In addition, 
comparison of the human and mouse CFTR in a Chinese hamster ovary (CHO) 
cell overexpression system showed that murine CFTR has a reduced channel 
open probability and gating, as well as shorter duration of bursts of channel 
activity compared to human CFTR (Lansdell et al., 1998, Cai et al., 2004). 
CFTR is a chloride anion channel pumping Cl- ions out of the cell and it 
locates on the apical membrane of secretory epithelial cells. It is comprised of 
two six Į-helices spanning the plasma membrane region each connected to a 
nuclear binding domain which binds ATP called nuclear binding domain 
(NBD). The R-domain is located between the two NBDs and is involved in the 
regulation of CFTR by cAMP-dependent phosphorylation driven by protein 
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kinase A. (Denning et al., 1992a, Denning et al., 1992b, Linsdell, 2013, 
Randak et al., 2013). Patients with cystic fibrosis carry mutations in the CFTR 
gene with 70% of the patients bearing the mutation ǻF508 (List of CFTR 
mutations, 2013 version by US Cystic Fibrosis Foundation, National Institute 
of Health, US). The degradation of CFTR or CFTR protein misfolding at the 
apical membrane results in hyper-absorption of H2O and Na+ at the epithelium. 
As a consequence, thick and viscous mucus accumulates on the epithelium and 
it becomes a niche for the colonisation of opportunistic pathogens such as P. 
aeruginosa. Biofilm development facilitates P. aeruginosa long-term 
persistence because biofilms are difficult to eradicate by antibiotics 
(Campodonico et al., 2008, Quinton, 2010).  Studies have shown that not only 
the murine epithelial biology cannot fully recapitulate the properties of healthy 
human native epithelium, but the rising awareness of using in vitro tissue 
engineering as an alternative to animal experiments is also a current trend in 
UHVHDUFKIROORZLQJWKH5µ5HGXFWLRQ5HILQHPHQWDQG5HSODFHPHQW¶SULQFLSOH
(Berube et al., 2010). To elucidate the signalling mechanisms involved in the 
pulmonary infection at the cellular level, cell culture models have been shown 
to be rather useful in predicting in vivo conditions. Indeed, primary human 
bronchial epithelial cell (NHBE) cultures have shown to recapitulate the 
physiological properties observed in the human lung (Berube et al., 2010). 
However, previous work on primary NHBE culture in our lab had been 
frustrating. Experimental difficulties including NHBE passage limitation (no 
more than p4), generation of un-differentiated squamous multi-layers instead of 
a desired pseudostratified layer, non-reproducible and inconsistent 
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differentiation (Sonali Singh, PhD thesis) deterred us from using primary 
NHBE to establish an infection model system. 
With the support by our collaborator Dr. Cynthia Bosquillon (School of 
Pharmacy, University of Nottingham) and Dr. Victoria Hutter (School of 
Pharmacy, University of Nottingham), Calu-3 cell cultures were firstly 
introduced to our lab. The airway bronchial epithelial cell line Calu-3 was 
derived from a 25-year-old bronchial adenocarcinoma male and is 
commercially available (Fogh et al., 1977). The cells exhibited tight junctions, 
presented transepithelial resistance and increased short-circuit current (Isc) 
which are properties found in native serous airway epithelial cells (Shen et al., 
1994, Florea et al., 2003). Further, the contribution of the Isc to cAMP-
dependent Cl- secretion was in agreement with the expression of CFTR that 
was conducted by immunoprecipitation assays (Shen et al., 1994). Cultures of 
Calu-3 cells at air-liquid interface (ALI) were also compared with those in 
liquid covered culture (LCC) to evaluate the degree of differentiation in these 
two culture conditions. Calu-3 cells differentiated at ALI culture method 
displayed a thicker pseudostratified layer than Calu-3 cells in LCC. Tight 
junctions, microvilli and secretory granules were also more apparent in ALI 
culture than in LCC (Harcourt et al., 2011). 
Nevertheless, several other bronchial epithelial cell models are also available. 
BEAS-2B, derived from human normal bronchial epithelium, is a transformed 
immortalised bronchial epithelium transfected with an adenovirus 12-SV40 
virus hybrid (Lechner and LaVeck, 1985). However, no apparent 
differentiation capacities, mucin secretion or lack of tight junctions have been 
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reported in previous papers. (Berube et al., 2010); 16HBE14o- is also a 
transformed bronchial epithelial cell line that develops cilia, microvilli, and 
forms tight junctions but are defective in mucin secretion (Papi and Johnston, 
1999, Cozens et al., 1994, Wan et al., 2000). A comparison between the 
characteristics of commonly used bronchial epithelial cells was summarised in 
Table 3.1. 
Compared to in vivo studies, in vitro models have the advantage of flexibility 
and control of experimental conditions. They also allow the study of airway 
epithelial functions in the absence and in the presence of other cells such as 
macrophages, neutrophils, and fibroblasts, etc. (Stewart et al., 2012, Zhu et al., 
2010, Berube et al., 2010). We adapted the air-liquid interface culture system 
that has recently been recognised as one of the most physiologically relevant in 
vitro models for respiratory research (Berube et al., 2010). The schematic 
figure of our in vitro airway epithelial infection model shown in Fig. 3.1 
illustrated that Calu-3 cells seeding at the top of WUDQVZHOOLVGHVLJQDWHGµXSSHU
FRPSDUWPHQW¶ DQG WKH EDVDO FKDPEHU FRQWDLQLQJ FXOWXUH PHGLXP WKDW VXSSO\
WKH FHOOV ZLWK QXWULHQWV LV µORZHU FRPSDUWPHQW¶ 7KH FRQILJXUDWLRQ WKDW WKH
apical surface of the cells exposed to air mimics the conditions found in the 
human airway and drives differentiation towards a mucociliary phenotype. P. 
aeruginosa infection from the apical surface was conducted once the in vitro 
airway epithelium achieved polarity and integrity. A cost-effective, robust, 
reproducible, physiologically relevant human in vitro bronchial epithelium 
model for P. aeruginosa infection was established in this chapter. 
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Table 3.1  Summary of morphological characteristics and barrier function of commonly 
used in vitro human bronchial epithelial cell models. 
 
Cell Type NHBE Calu-3 BEAS-2B 16HBE14o- 
Origin Healthy tissue Lung 
adenocarcinoma 
Transformed 
healthy tissue 
Transformed 
healthy tissue 
Morphology 
and 
properties 
Mixed airway 
cell population 
Pseudostratified 
cilia-producing 
secretory cells  
Secrete 
cytokines and 
antioxidants  
Non-ciliated 
cuboidal cells 
Mucus 
producing YES YES NO NO 
Tight junction 
formation YES YES NO YES 
Maximum 
TEER at ALI 
(ȍ cm2) 
750 600 150 200 
Adapted from (Stewart et al., 2012, Berube et al., 2010, Sporty et al., 2008) 
 
Figure 3.1  Schematic of the in vitro respiratory epithelium model for P. aeruginosa 
infection.  
Calu-3 cells grown on 0.4 ȝM pore size membrane inserts at air-liquid interface drives 
differentiation of bronchial epithelial cells to a pseudostratified mucociliary epithelium. P. 
aeruginosa infection on the apical surface of the airway epithelium is to mimic bacterial 
infections occur in the human bronchial epithelium. 
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3.2. HYPOTHESIS 
Human lung epithelium represents the first barrier encountered by respiratory 
pathogens. Establishment of an in vitro infection model using differentiated 
human bronchial-epithelial cell line Calu-3 cells would provide a cost-effective 
and robust platform to investigate the initial interaction between pathogen and 
the host in the context of the lung. 
 
3.3. AIM 
The purpose of this study was to establish an airway epithelium platform to 
examine the impact of AQs on the pathogenicity of P. aeruginosa in the human 
lung. To achieve this, an in vitro infection assay using differentiated Calu-3 
cells and P. aeruginosa PAO1-subline Lausanne has been developed. 
Conditions optimised for this infection model included:  
(1) Establishment and characterisation of differentiated Calu-3 cells cultures 
(2) Establishment of condition to generate consistent P. aeruginosa inoculum 
for the infection on differentiated Calu-3 cells 
(3) The efficacy of the in vitro bronchial epithelial infection model 
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3.4. MATERIALS AND METHODS 
3.4.1. Calu-3 cell culture and differentiation 
Calu-3 cell culture handling and differentiation were described previously 
(Grainger et al., 2006). Calu-3 human bronchial epithelial cells (ATCC no. 
HTB-55) were purchased from the American Type Culture Collection 
(Rockville, USA) and used between passage 19 and 35. Newly thawed cell 
stocks were cultured initially in 75 cm2 flasks (Corning Life Sciences, the 
Netherlands) in 15 ml medium and maintained at 5% CO2, 37oC. Two culture 
media were evaluated in this study for their suitability for Calu-3 cell 
GLIIHUHQWLDWLRQ  'XOEHFFR¶V PRGLILHG (DJOH¶V PHGLXP '0(0 1XWULHQW
Mixture F-12 Hams (1:1) (Sigma-Aldrich, UK) containing 10% fetal calf 
serum (FCS) (Sigma-Aldrich, UK), 1x non-essential amino acid solution 
(Sigma-Aldrich, UK) and 1x L-glutamine (Sigma-Aldrich, UK) (thereafter 
GHVLJQDWHG µ'0(0¶  PLQLPXP HVVHQWLDO PHGLXP Į FRQWDLQLQJ
*OXWD0$; , /LIH 7HFKQRORJLHV 86$ FRQWDLQLQJ  )&6 GHVLJQDWHG
MEM onwards). 
For differentiation, cells cultured in T-75 were washed with PBS (Sigma-
Aldrich, UK) and trypsinised with 0.05% trypsin and 0.02% EDTA in 
phosphate buffered saline (PBS) solution (Sigma-Aldrich, UK) at 37oC for 15 
min and seeded on 0.4 ȝm pore size, 12-well transwell polyester inserts 
(Corning Life Sciences, the Netherlands). In some instances the polyester 
inserts were coated with rat tail type I collagen (BD Bioscience) or Matrigel 
(BD, Bioscience). Briefly, 100 ȝl of collagen solution at a concentration of 3 
ȝg/ml in PBS was added to each transwell insert and inserts were transferred to 
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the CO2 incubator, 37oC for 45 min. Collagen solution was aspirated, each 
insert washed once with 150 ȝl of PBS. To prepare Matrigel-coated inserts, 
100 ȝl of Matrigel diluted 1:4 in serum-free DMEM and MEM were added to 
each insert and incubated at 5% CO2, 37oC for 4 h to allow for self-assembly as 
a thin film. Calu-3 cells were seeded in the transwell polyester inserts at a 
density of 100,000 cells per well in 500 ȝl of complete culture medium with 1 
ml of medium in the basal chamber. After overnight culture at 37oC, 5% CO2, 
the medium in the insert was aspirated for the cells to differentiate at air-liquid 
interface (ALI). The medium in the bottom chamber was changed every other 
day up to 21 days.  
3.4.2. Assessment of Calu-3 cell differentiation  
3.4.2.1. Immunofluorescence staining and confocal fluorescence microscopy 
Antibodies  
The antibodies used for confocal imaging were of mouse origin and targeted 
the human cilia-associated tubulin IV (Life Technologies, USA), mucin 
MUC5AC (Life Technologies, USA), and zonula occludin-1 (ZO-1) protein 
(Life Technologies, USA). These primary antibodies were used at a dilution of 
1:1,000 for anti-tubulin IV and anti-MUC5AC antibodies and 5 ȝg/ml for anti-
ZO-1 antibody. A donkey anti-mouse antibody conjugated to Alexa Fluor 488 
(Life Technologies, USA) diluted 1:250 was used as secondary antibody.  
Phalloidin conjugated to Alexa Fluor 488 (Life Technologies, USA) was used 
to detect F-DFWLQ &HOO QXFOHL ZHUH YLVXDOLVHG ZLWK ¶ -diamidino-2-
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phenylindole hydrochloride (DAPI) (Sigma-Aldrich, UK) or Hoechst 33342 
(Cell Signalling Technology, UK). 
Fixation and staining 
Calu-3 cells cultured in transwell inserts were fixed with 4% paraformaldehyde 
(16% paraformaldehyde, EM grade, Electron Microscopy Sciences, USA) in 
PBS overnight at 4oC. The following day, the filters were removed from the 
inserts and placed in a 24-well plate (Corning Life Sciences, the Netherlands) 
for processing. Cells were washed with PBS for 5 min three times, 
permeabilized with 0.15% Triton X-100 (Sigma-Aldrich, UK) in PBS for 20 
min at room temperature. After 3 washes in PBS, non-specific binding sites 
were blocked with blocking solution (5% donkey serum, Sigma-Aldrich, in 
PBS) for 30 min. Cells were then incubated with the primary antibody diluted 
in blocking solution for 1 hr at room temperature. After rinsing three times 
with PBS, cells were incubated with the secondary antibody diluted in blocking 
solution for 30 min protected from light. Control samples were stained with the 
secondary antibody alone. For staining of the cytoskeleton, cells were 
incubated for 30 min with phalloidin-Alexa Fluor 488 at 1: 250 dilution. Cells 
were counter stained with DAPI or Hoechst 33342 at 1 ȝg/ml in PBS for 10 
min at room temperature and then washed three times with PBS. After staining, 
samples were mounted with Vectashield HardSet Mounting Medium (Vector 
Laboratories, UK). 
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Imaging 
Optical sections of the cells were obtained using a Zeiss LSM 700 laser 
scanning microscope equipped with detectors and filter sets for monitoring 
emissions of the selected fluorophores and oil-immersion plan-apochromat 
63x/1.4NA objective lens. Images were analysed using Zen 2009 (Zeiss, 
Germany) 
3.4.2.2. Histological staining 
Calu-3 cells cultured on transwell inserts uncoated or coated with collagen, 
type I solution (BD Biosciences, UK)from rat tail or Matrigel (BD Biosciences, 
UK) at ALI for 21 days in MEM or DMEM were fixed overnight with 4% 
paraformaldehyde (16% paraformaldehyde, EM grade, Electron Microscopy 
Sciences, USA) in PBS (Sigma-Aldrich, UK) at 4oC. After fixation, the filters 
were cut out, halved, and each half embedded in paraffin wax using a Leica 
TP1020 automated tissue processor. 5 ȝm thin cross-sections of wax-embedded 
inserts were obtained using a Leica RM2145 microtome. The air-dried cross-
sections were rehydrated using decreasing concentrations of ethanol and 
stained with haematoxylin and eosin (Raymond A Lamb Laboratory Supplies, 
8. DOFLDQ EOXH0D\HU¶V DFLG 6LJPD-Aldrich, UK), or alcian blue/fast acid 
stain (Sigma-Aldrich, UK). Following staining, sections were dehydrated by 
passing through increasing concentrations of ethanol, dried, and mounted using 
DPX mounting medium (Raymond A Lamb Laboratory Supplies, UK). 
Mounted sections were viewed using a Zeiss Axioplan light microscope and 
images were captured with a Q Imaging MicroPublisher 5.0 RTV camera along 
with Openlab software. 
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3.4.2.3. Scanning electron microscopy 
Calu-3 cells cultured on transwell inserts at ALI in MEM for 21 days were 
fixed with 3% glutaraldehyde (Agar Scientific, UK) in 0.1 M sodium 
cacodylate buffer  (Agar Scientific, UK)  at 4oC. Samples were then post-fixed 
in situ with 1% osmium tetraoxide (Agar Scientific, UK), dehydrated in serial 
concentrations of ethanol, and air-dried in a fume hood overnight. Once dry, 
inserts were cut out, mounted on inert supports and gold-sputter coated. 
Samples were visualised by using a Jeol JSM840 scanning electron microscope 
with an ISS Iscan digital frame grabber. 
3.4.2.4. Transepithelial electrical resistance 
The barrier function of Calu-3 cell cultures in ALI was determined by 
measuring transepithelial electrical resistance (TEER) using an epithelial 
voltohmmeter-EVOM (World Precision Instruments, UK). Prior to the 
measurement, the apical surface of Calu-3 cell culture was balanced by adding 
500 µl of culture medium for 30 min at 37oC, 5% CO2(IIHFWLYH7((5ȍ-cm2) 
was calibrated by subtracting the resistance of a cell-free transwell insert. 
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3.4.3. Pseudomonas aeruginosa culture 
3.4.3.1. Comparison of P. aeruginosa growth in LB, DMEM and MEM 
PAO1-L was streaked on a LB agar plate from a -80oC glycerol stock and 
cultured at 37oC overnight. The next day, a single colony was used to inoculate 
5 ml of LB, DMEM or MEM in a 50 ml falcon tube. Cultures were incubated 
at 37oC, 200 rpm overnight. The next day the overnight liquid culture was 
diluted (1:100) in 25 ml of the corresponding media in 250 ml flasks and 
incubated at 37oC, 200 rpm OD600 was measured every hour from 0 h to 12 h 
and at 24 h. 
3.4.4. PAO1-L infection of differentiated Calu-3 cells  
3.4.4.1. Preparation of PAO1-L inoculum for infection assay 
PAO1-L was streaked on a LB agar plate from a -80oC stock and cultured at 
37oC overnight. The next day, a single colony was used to establish a 5 ml 
overnight culture in LB (37oC, 200 rpm). The following day the OD 600 nm of 
the culture was measured using a spectrophotometer and the inoculum was 
adjusted to 1% to prepare a 25 ml culture in LB using a 250 ml conical flask. 
The new culture was incubated at 37oC, 200 rpm, for 4 hours. The culture was 
then transferred to a sterile 50 ml centrifuge tube and centrifuged at 10,000 rpm 
(Allegra X-64R with C0650 fixed angle rotor, Beckman Coulter, UK) at 4oC 
for 5 min. Bacterial pellets were washed twice with sterile tissue culture-grade 
PBS with CaCl2 and MgCl2 (Life Technologies, USA) using the same 
centrifugation conditions. After the second wash, bacterial cell pellets were 
resuspended in 5 ml PBS with CaCl2 and MgCl2. An aliquot was diluted 1:10 
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in PBS and mixed 1:1 with 4% paraformaldehyde (16% paraformaldehyde, EM 
JUDGH (OHFWURQ 0LFURVFRS\ 6FLHQFHV 86$ LQ 3%6  ȝO RI GLOXWHG IL[Hd 
PAO1-L were pipetted onto a Thoma counting chamber slide (Hawksley, UK). 
PAO1-L culture density was calculated using the following formula: 
 
Bacterial multiplicity of infection was adjusted accordingly using PBS with 
CalCl2 and MgCl2 based on the bacterial density determined by counting. 
3.4.4.2. Infection of differentiated bronchoepithelium with PAO1-L 
The number of Calu-3 cells present in a confluent monolayer on Day 21 in ALI 
was counted after trypsinisation and estimated as 700,000 cells per transwell 
insert. 21-day old differentiated Calu-3 cells on the inserts were thereafter 
infected with PAO1-L (see Section 3.4.4.1.) at MOI 50 (3.5x108 CFU/ml, 100 
Pl per well) in 5% CO2, 37oC incubator for 3 h and 6 h. 
3.4.4.3. Quantification of bacterial colonisation of the bottom chamber  
To assess whether P. aeruginosa breaches the epithelial barrier, bacterial CFU 
in the basal chamber were quantified at 3 h and 6 h post infection. Culture 
media in the basal chamber were collected, diluted in a 10-fold fashion in PBS. 
100 ȝl of neat and diluted media were plated on LB agar plates. The agar plates 
were subsequently incubated at 37oC for 18 h. Bacterial colonies were counted 
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and the actual number of bacteria across the barrier was calculated according to 
the dilution factor. 
3.4.5. Statistical analysis 
All statistical analyses were carried out using GraphPad Prism v. 6.0. When 
two sets of data were compared, significance was calculated by unpaired 
6WXGHQW¶V W WHVW GDWD REWDLQHG LQ WKLV VWXG\ ZHUH FRQVLGHUHG Qormally 
distributed). p-value  0.05 was regarded significant. 
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3.5. RESULTS 
3.5.1. Characterisation of Calu-3 cells differentiation at air-liquid interface 
3.5.1.1. Human bronchial epithelial cells displayed polarity on non-coated 
polyester transwell inserts in minimal essential culture medium (MEM) 
In the majority of published literature, DMEM was commonly used to grow 
and differentiate bronchial epithelial cells. Also, this culture medium was 
suggested by our collaborator Dr. Cynthia Bosquillon (Department of 
Pharmacy, University of Nottingham, U.K.) based on her experience in 
culturing Calu-3 cells (Stewart et al., 2012). However, as MEM is the medium 
recommended by ATCC for culturing Calu-3 cells (HTB-55), we decided to 
evaluate the effect of media on the differentiation of Calu-3 cells. Firstly, the 
morphology of undifferentiated Calu-3 cells in T-75 flask was compared using 
phase-contrast microscopy (Fig. 3.2). Calu-3 cells grew and displayed a spindle 
shape in both DMEM and MEM. Calu-3 cells grew slightly faster in DMEM 
than in MEM and appeared more vacuolated (Fig. 3.2). 
A previous study demonstrated that Calu-3 cells grown in ALI produced a 
columnar epithelium with a more heterogeneous apical topography and greater 
mucin proteins secretion than when grown in liquid-covered culture (Grainger 
et al., 2006). Thus, we decided to establish ALI cultures for this study in an 
attempt to recapitulate the physical properties of native human airway 
epithelium.  
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Calu-3 cells differentiation was firstly assessed using two cell markers: cilia 
associated type IV tubulin and the mucin protein, MUC5AC, the major 
component of airway mucus secreted exclusively by goblet cells (Ehre et al., 
2012, Hovenberg et al., 1996) using cells cultured in DMEM. At day 7, cilia-
like structure and secretion of mucin proteins were visualised in 
immunofluorescence images using anti-type IV tubulin and anti-MUC5AC 
antibody, respectively (Fig. 3.2). Individual cells were visualised with F-actin 
staining (Fig. 3.3). The specialised topology and mucin production showed that 
a considerable population of Calu-3 cells on the ALI inserts had differentiated 
into a heterogeneous epithelium containing ciliated cells and mucin-producing 
cells (goblet cells) only within 7 days.  
Native pulmonary epithelium is layered on extracellular collagen matrix 
comprised of lamina, collagen and fibronectin that not only provide epithelial 
cells with structural support, but influence cell differentiation, adhesion, 
migration, as well as survival (Tam et al., 2011). Some studies suggested that 
Figure 3.2  Morphology of undifferentiated Calu-3 cells at confluency in a T-75 flask.  
Spindle shaped Calu-3 cells were viewed under light microscopy in DMEM and MEM 
cultures. Magnification= 200x. 
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ciliated and secretory phenotypes in tracheal epithelial cells can only be 
achieved by culturing cells on collagen substratum (Kim, 1985, Wu et al., 
1997). We therefore examined the impact of two culture substrata, collagen 
and Matrigel, on the efficacy of Calu-3 cell differentiation. Rat tail type I 
collagen is a coating material used as a cell culture substratum to support 
adherent cells growth and differentiation. Matrigel is a gelatinous 
heterogeneous protein mixture secreted by mouse sarcoma cells. The protein 
mixture resembles the complex extracellular environment and thus has been 
commonly used as a basal membrane layer for metastasis studies. Cells were 
seeded on transwell inserts with or without coating and cultured in DMEM or 
MEM for 21 days. Cultures were subjected to histological analysis to 
determine the degree of differentiation. Calu-3 cells formed more regular 
pseudostratified columnar shapes in MEM culture compared with DMEM 
culture based on H and E staining (Fig. 3.4A). 
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Figure 3.3  Detection of cilia and mucin expression in one week-old Calu-3 cells cultured 
in DMEM at ALI. 
Immunofluorescence images of cilia-associated tubulin IV and mucin MUC5AC on one-week 
old Calu-3 cultures. Cells were stained with anti-tubulin IV and anti-MUC5AC antibody, 
respectively. F-actin was detected by phalloidin-conjugated with Alexa 488. Cell nuclei were 
stained with DAPI (blue). 
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Figure 3.4  Calu-3 cells grown on polyester inserts for up to 21 days differentiated into a 
pseudostratified monolayer and expressed mucins at the apical surface. 
Paraffin cross-sections of 3-week old Calu-3 cells cultures grown on 0.4 ȝm pore size, 
polyester transwell inserts at ALI were visualised by histological staining. A. Hematoxylin and 
eosin (H and E) staining demonstrated the presence of columnar like cells in DMEM and MEM 
cultures. B. $OFLDQ EOXH0D\HU¶V DFLG VWDLQLQJ LQGLFDWHG PXFXV SURGXFWLRQ DW WKH DSLFDO VLGH
(blue colour pointed by arrows) regardless of the presence of collagen. Mucin accumulation 
was more apparent in cells cultured in MEM. C. Alcian blue and fast acid staining indicated 
mucin accumulation (blue) at the apical surface when Calu-3 cells were cultured on uncoated 
inserts in MEM; Calu-3 cells seemed to display poor polarity on collagen-coated inserts as 
mucins were seen on both the apical and basolateral sides. Dark pink represents cell nuclei and 
light pink area is cytoplasm. Each condition was assessed as biological duplicates. Image 
shown are representative from 3 images taken from each sample. 
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Cell polarity refers to the asymmetric positioning of cell surface, intracellular 
organelles and the cytoskeleton. Polarity is extremely important in the correct 
functioning of cells, intracellular protein trafficking, and actin cytoskeleton 
arrangement (Bryant and Mostov, 2008). Epithelial cells classically exhibit 
apical specialised protruding structures and their nucleus locates near the 
basolateral region. By using alcian blue staining to identify mucin production, 
we observed that Calu-3 cells in MEM produced mucin at their apical side in 
the presence and absence of collagen coating. Calu-3 cells differentiated into 
an organised pseudostratified cellular layer on inserts coated with Matrigel 
both in DMEM or MEM, but no mucins appeared to be secreted by the cells on 
the Matrigel coated inserts (Fig. 3.4B). To further identify the optimal 
differentiation condition, alcian blue/ fast acid staining was introduced to 
distinguish mucins (blue), cytoplasm (pale pink) and nuclear localisation (dark 
pink). Tall columnar shaped Calu-3 cells that produce mucin were clearly seen 
in Fig. 3.4C. However, the polarity of Calu-3 cells grown in collagen coated 
inserts seemed affected by the coating as mucins were detected in the 
basolateral region (Fig. 3.4C). Additionally, immunofluorescence images also 
showed extensive mucin accumulation in cells cultured in uncoated inserts (Fig. 
3.5). Thus, ALI cultures of differentiated Calu-3 cells were supported by MEM 
in uncoated wells. Cilia-like apical protrusions were observed on the surface of 
Calu-3 cells at day 21 in ALI under scanning electronic microscopy (this part 
of work was supported by Dr. Lee Wheldon); again demonstrating cellular 
differentiation  (Fig. 3.6).  
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Figure 3.5  Calu-3 cells at ALI for 21 days exhibited microvilli at their apical surface. 
Scanning electron microscopy images of Calu-3 cells grown at ALI. Calu-3 cells displayed 
short and thick microvilli at their surface. Image shown on the left is at 5,000x 
magnifications and individual microvilli were clearly observed when image was zoomed in 
to 14,000x magnifications (right). N=1. 
 
Figure 3.6  Extensive mucin accumulation in Calu-3 cells when seeded on transwell 
inserts without coating. 
Immunofluorescence staining of mucins, MUC5AC (green), on 3-week old ALI cultures of 
Calu-3 cells. Cell nuclei were stained with DAPI (blue). N=1. 
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3.5.1.2. Barrier function of differentiated ALI cultures of Calu-3 cells  
The maintenance of cellular integrity is essential for epithelium to provide a 
functional physical barrier against constant foreign intruders (Eisele and 
Anderson, 2011). Tight junction (TJ) proteins block passage of molecules in 
extracellular fluid diffusion and prevent the movement of molecules between 
the cells. Zonula occludin 1 (ZO-1) is prominently expressed in intestinal and 
airway epithelial cells near the apical compartment to form an effective barrier. 
The movement of ions and fluid can be evaluated by measuring the resistance 
to flow provided by the cell monolayer, therefore denoted transepithelial 
electrical resistance (TEER). To determine whether differentiated Calu-3 cells 
at ALI culture acted as a barrier, TEER and the expression of ZO-1 were 
examined. TEER in Calu-3 cell cultures at ALI in DMEM and MEM were 
compared and tracked every 7 days for 3 weeks. TEER in the DMEM culture 
reached 939 ±  ȍ-cm2 DW GD\  DQG ZDV PDLQWDLQHG DERYH  ȍ-cm2 
throughout the 3 weeks. In MEM, TEER reached 721 ± ȍ-cm2 at day 7 but 
dropped at week two (457 ± ȍ-cm2) then increased to 767 ± 454 ȍ-cm2 at 
day 21 (Fig. 3.7). High TEER readings in both DMEM and MEM culture 
without significant difference at Day 21 indicated that ALI cultures of Calu-3 
cells attained barrier integrity in both media.  
Although both DMEM and MEM supported the expression of ZO-1 by Calu-3 
cells ZO-1 was predominantly enriched at the apical side in Calu-3 cells 
incubated in MEM (Fig. 3.8), which is he location expected in epithelial cells 
(Gonzalez-Mariscal et al., 2003). Thus, Calu-3 cells cultured in MEM appeared 
to resemble native epithelium closer than those cultured in DMEM.
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Figure 3.7  Transepithelial electrical resistance of Calu-3 cells ALI cultures in both in 
DMEM and MEM.  
The TEER measurements were taken every 7 days for 3 weeks. TEER measurements 
between 500 and 1,000 ȍ cm2 indicated that both DMEM and MEM supported Calu-3 cells 
ALI culture. TEER from DMEM cultures reached 1000 ȍFP2 at day 7 and was maintained 
for 3 weeks. In MEM cultures, TEER dropped at week two and increased to 800 ȍ cm2 at 
day 21. TEER of 3 week old Calu-3 cells cultured in DMEM and MEM were comparable 
(NS). Measurements were from 3 independent experiments and each experiment was done 
in duplicate. TEER of Calu-3 cells in DMEM and MEM were compared by unpaired t-test. 
NS, no significant difference. 
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Figure 3.8  Localisation of the tight junction protein ZO-1 in Calu-3 cells cultured in ALI for 21 days.  
Calu-3 cells cultured in DMEM (A) and MEM (B) expressed ZO-1. ZO-1 was enriched at the apical region of MEM cultures. ZO-1 protein was detected 
using mouse anti-ZO-1 antibody as described in materials and methods. The image is the representative from three independent experiments. 
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3.5.2. Optimisation of P. aeruginosa inoculum 
3.5.2.1. Determination of PAO1-L culture condition for the infection of 
bronchial epithelium  
Pathogen associated molecular patterns (PAMPs) such as lipopolysaccharide 
(LPS), lipopeptides, RNA and DNA trigger innate immune responses via 
recognition by pathogen associated molecular receptors (PRRs) on host cells, 
including toll-like receptors (TLRs), retinoid acid-inducible gene I (RIG-I)-like 
receptors (RLRs) and other cytosolic nucleic acid sensors, and nucleotide-
binding and oligomerisation domain (NOD)-like receptors (NLRs) (Baccala et 
al., 2009). The non-defined medium Luria-Bertani (LB) medium, commonly 
used to culture P. aeruginosa, consists of yeast extract and tryptone which can 
be a reservoir of nucleic acids and endotoxins. To eliminate potential PAMPs 
and damage-associated molecular patterns (DAMPs) in the LB medium that 
could elicit an immune response even without the presence of the target of 
interest (P. aeruginosa in this study) on differentiated Calu-3 cells, two defined 
media, DMEM and MEM were tested for their ability to support growth of 
PAO1-L. In all instances the stationary phase was reached at 8 h (Fig. 3.9). 
Compared to LB, PAO1-L displayed an equivalent growth rate and reached the 
same cell density when cultured in DMEM (Fig. 3.9A). In contrast, lower cell 
density was seen when PAO1-L was cultured in MEM compared to LB 
medium (Fig. 3.9B). This might be due to the fact that the glucose content in 
MEM is 3-fold lower than in DMEM. Because MEM was found most suitable 
for the generation of differentiated Calu-3 cultures in ALI, using MEM to grow 
P. aeruginosa to infect Calu-3 cells seemed to be the sensible choice. However, 
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it remained a concern whether the phenotype of P. aeruginosa would change in 
this nutrient-deprived medium. Furthermore, the phenotypic characterisation of 
P. aeruginosa has been mostly performed in LB medium, including this study 
(Chapter 2). Thus, to minimise the phenotypic changes that might occur when 
P. aeruginosa is cultured in nutrient deficient medium, LB medium was chosen 
to grow P. aeruginosa to ensure optimal viability prior the infection assay but 
extensive washes in PBS were performed to minimise carryover of LB-derived 
products. For this P. aeruginosa cultures were centrifuged, culture supernatants 
were discarded, cell pellets were thoroughly washed twice with PBS. P. 
aeruginosa inocula were finally resuspended in PBS with CaCl2 and MgCl2.
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Figure 3.9  P. aeruginosa PAO1-L growth rate was comparable in LB, DMEM and 
MEM but the final cell density was lower in MEM. 
OD600 of P. aeruginosa PAO1-L culture was measured every hour for 12 h and at 24 h. 
Bacteria were cultured in LB, DMEM or MEM at 37oC, 200 rpm. No lag phase was observed 
in any conditions and stationary phase was reached after 8 h incubation. PAO1-L growth 
pattern was similar in both DMEM and MEM. However, the cell density was lower in MEM 
(B) compared with DMEM (A). N=2. 
 126 
 
3.5.2.2. Optimisation of bacterial inoculum  
Initially, the inoculum used for the infection was prepared from 8h cultures in 
LB as PQS is largely expressed during stationary phase. To determine which 
multiplicity of infection was most suitable for studying the interaction of P. 
aeruginosa with differentiated Calu-3 cells, we examined bacterial 
dissemination using multiplicity of infection (MOI) 1 (means one cell is 
infected with one bacterium) and 10. In contrast to macrophages that are highly 
susceptible to PAO1-L infection with 50% killed even at MOI 1 at 4 hour post 
infection (hpi) (Singh, 2012), Calu-3 cells were more refractory to PAO1-L at 
MOI 1 and MOI 10 as only a few bacteria were observed on the epithelium in 
confocal images even at 6 hpi (data not shown). In an attempt to track the P. 
aeruginosa dissemination on the epithelium, we evaluated different MOI 
including MOI 1,000.  
An important aspect of the optimisation of the infection assay was to ensure 
that the inoculum was accurate. We firstly evaluated whether the actual 
inoculum was equivalent to the expected CFU from inocula prepared to obtain 
a MOI of 1,000, 250, 50 and 10 upon infection. High variation was found 
among experiments and the actual CFU at high MOI failed to correspond the 
expected CFU (Fig. 3.10). Differences between expected and actual CFU 
might due to the loss of bacterial viability at 8 h culture when there might be 
bacterial lysis. Thus, a 6 h cultures were tested for their suitability as a reliable 
source of bacteria for infection. Using 6 h cultures we observed good 
correlation between expected and actual CFU for Wt PAO1-L. In this assay we 
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also included ǻpqsAL and we observed higher CFU than expected at MOI of 
250 but lower CFU at MOI of 50 and 10 (Fig. 3.11A). 
  
 
 
 
 
 
 
 
 
We found that ǻSTV$L formed clumps at MOI 200 (1.4x1010 CFU/ml) 
compared to Wt PAO1-L (Fig. 3.11B). Therefore, the high variability might be 
caused by bacteria aggregation at high MOI. To overcome this problem, 
inocula were prepared from 4 h cultures in an attempt to avoid potential cell 
aggregates. CFU counting was again assessed in comparison with the expected 
CFU. However, the variation appeared again at the high density of MOI 200 
Figure 3.10  Lack of correlation between experimental and expected CFU in high density 
inocula. 
High density inocula (MOI 250 and 1000) were prepared from 8 hour Wt PAO1-L cultures 
based on cell counting in the Thoma chamber (expected CFU) and serial dilutions were 
prepared and plated in LB to obtain the actual CFU. A and B correspond to two independent 
experiments.  
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both in WT and ǻSTV$L culture (Fig. 3.11C). Because the bacterial counting 
could be highly variable at high density, a MOI 50 was therefore chosen. 
Consistent and reproducible counting was achieved in 5 independent 
experiments when Wt PAO1-L was cultured in LB for 4 h and the inoculum 
was prepared to achieve MOI 50 (range from 27 to MOI 50) (Fig. 3.12). When 
ǻSTV$L cultures were prepared alongside WT cultures, the inocula from WT 
and ǻSTV$L were comparable and reproducible and ranged between MOI 27 
and MOI 50 (Fig. 3.13). Thus, P. aeruginosa incubated in LB for 4 h and 
adjusted an inoculum to obtain a MOI of 50 were the conditions selected for 
the infection assays on differentiated Calu-3 cells. 
 
Figure 3.11  Lack of correlation between actual and expected CFU in high density inocula 
for WT PAO1-L and ǻpqsAL. 
CFU variation occurred in ǻpqsAL inoculum prepared from 6 h culture (A) which might due to 
the formation of cell aggregates in the culture broth (B). P. aeruginosa PAO1-L and ǻpqsAL 
were detected with rabbit polyclonal anti-Pseudomonas antibody and images were obtained by 
confocal laser scanning microscope. CFU counting variations between experiments still 
occurred at a MOI of 200 for both Wt PAO1-L and ǻpqsAL. (A), N=1; (B), representative 
images from three independent experiments; (C) and (D), results from two independent 
experiments. 
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Figure 3.12  Reliable bacterial counting was achieved when inocula for MOI 50 were 
prepared. 
Consistent PAO1-L inocula were achieved in 5 assays (MOI varied from 27 to 50; IA 1 to 
IA 5). The black bar represents the number of expected CFU at MOI of 50 (3.5x108/ml) 
and the white bars are actual CFU obtained from 5 independent assays. Standard errors 
were shown from each experiment when bacterial cultures were prepared in two individual 
flasks. 
Figure 3.13  WT and ǻpqsAL inocula were comparable and achieved consistency at MOI 
50. 
Reliable counting was achieved at MOI of 50 from 4 hour bacterial cultures. The actual inocula 
were determined by CFU counting after plating the bacterial inoculum on LB agar plate.  
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3.5.3. Assessment of the suitability of differentiated Calu-3 monolayers to 
model PAO1-L infection  
P. aeruginosa infection on epithelium can be divided into three major events 
bacterial adherence, penetration/invasion, and barrier disruption/tissue 
dissemination (Heiniger et al., 2010). To assess the suitability of differentiated 
Calu-3 cell monolayer for modelling this series of events upon P. aeruginosa 
infection, the appropriate time windows that would provide information 
regarding (1) early recognition events with sustained epithelial barrier and (2) 
bacterial invasion and compromised epithelium need to be established. 
Following apical inoculation on the differentiated Calu-3 culture, barrier 
function was assessed by determining the number of bacteria in the basal 
chamber. By 2 and 3 hpi, no bacteria were found in the basal chamber (data not 
shown) suggesting the barrier function was maintained at this time point. At 6 
hpi, bacteria were detectable in the basal chamber. The number of bacteria 
across the differentiated Calu-3 culture barrier consistently ranged between 
3,000 and 6,000 from 4 independent experiments and duplicates in each 
experiment (Fig. 3.14). Thus, the differentiated Calu-3 cell monolayer can be 
used to study early and late events during the interaction with P. aeruginosa 
(Chapter 4 and 5). 
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Figure 3.14  Detection of PAO1-L at the bottom chamber of differentiated Calu-3 
cultures at 6 hpi. 
Calu-3 cell barrier integrity was compromised at 6 hpi during PAO1-L infection when 
bacteria appeared in the basal chamber. The bacterial numbers found in the basal chamber 
were consistent (CFU between 3,000 and 6,000). Four independent infection assays were 
conducted and each had biological duplicates. 
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3.6. DISCUSSION 
3.6.1. Successful generation of differentiated human bronchial epithelium 
cultures at air-liquid interface 
The lower airway epithelium is a pseudostratified layer lined up with columnar 
shaped ciliated cells, basal cells interspersed with goblet cells and club (Clara) 
cells (Berube et al., 2010). Culture of Calu-3 cells at ALI has been shown 
morphologically and functionally more relevant to in vivo airway epithelium 
compared to liquid submerged culture (Grainger et al., 2006). In particular, 
cells at ALI have been shown to possess a more columnar morphology and 
form a 20-45 ȝM pseudostratified layer thicker than submerged cultures 
(Grainger et al., 2006). The present study was the first in our group to establish 
a differentiated human bronchial epithelial culture in an attempt to generate an 
in vitro model for P. aeruginosa respiratory infection. The first stage of the 
study involved the establishment of a robust culture condition for the in vitro 
differentiation of human bronchial epithelial cells, Calu-3. The 21-day old 
differentiated Calu-3 cells in this study consistently featured (1) cilia-
expression and mucus production at the apical surface visualised by 
histological staining, confocal and scanning electronic microscopic images; (2) 
tight junctions and transepithelial resistance verified by the expression of ZO-1 
tight junction protein and relatively high TEER.  
Calu-3 cells grew faster in DMEM than in MEM and this might be caused by 
the fact that the glucose content in DMEM is 3.15-fold higher than in MEM. 
The fast growth of Calu-3 cells in DMEM might contribute to the high 
numbers of vesicle-like organelles observed in phase-contrast images. It is 
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likely the vesicle-like organelles were secretory vesicles that are produced by 
VHFUHWRU\FOXEµ&ODUDFHOOV¶ZHUHUHQDPHGDVµFOXEFHOOV¶LQ(Irwin et al., 
2013)) cells. Club (Clara) cells are cuboidal non-ciliated cells involved in 
multiple functions including barrier maintenance, secretion and metabolism in 
the bronchioles (Stripp and Reynolds, 2008). Evidence showed that club (Clara) 
cells are progenitor cells capable of differentiate to other cell type in normal 
bronchial epithelium and also act as cancer stem cells (Reynolds and 
Malkinson, 2010). An over-differentiation of club (Clara) cells in Calu-3 cells 
might partially explain the fast-growing morphology phenotype in DMEM 
culture.  
Despite the fact that Kim and Wu, et al. (Kim, 1985, Wu et al., 1997) 
suggested that collagen substratum is required for the differentiation of tracheal 
epithelial cultures, Calu-3 cells in this study were able to differentiate into cilia 
and mucin producing cells on the permeable polyester inserts without 
substratum. This result was in agreement with the study conducted by Stewart, 
et al. showing that Calu-3 cells possess a ciliated phenotype and produce 
mucins in the absence of collagen substratum (Stewart et al., 2012). Calu-3 
cells on Matrigel coated inserts differentiated into columnar shaped cells and 
apical protrusions and mucin producing were also detected. Matrigel is an un-
defined mixture of extracellular matrix proteins, predominantly comprised of 
laminin, collagen IV, and enactin extracted from Englebreth-Holm-Swarm 
tumours in mice (Hughes et al., 2010). The composition might be different 
from batch-to-batch which could cause undesired experimental variations. 
Regarding the cells cultured on collagen coating inserts, although mucin 
production was observed both by histological and immunofluorescence 
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staining, some mucin labelling appeared at the basolateral compartment 
indicating that Calu-3 cells might lack polarity under these culture conditions.  
Contrary to the study by Stewart et al. (Stewart et al., 2012) showing that Calu-
3 cells expressed low levels of ZO-1 junction proteins at the mRNA and 
protein levels, our results showed that ZO-1 proteins were present near the 
apical side of polarised Calu-3 cells, particularly those in the MEM culture. It 
could be possible that the immunofluorescence images in this publication 
(Stewart et al., 2012) were misleading as the images might have been acquired 
at the interphase (cross-section) where ZO-1 proteins are not supposed to be 
present.  
Collectively, the morphology, polarity and barrier characteristics of the 
differentiated Calu-3 cell culture in our lab corresponded to the phenotype 
reported in the literature. Importantly, Calu-3 cells not only expressed CFTR 
channels but also were efficient in mediating Cl- anion conductance and 
secretion of bicarbonate (HCO3-) in response to cyclic adenosine 
monophosphate (cAMP)-stimulating agents (Shan et al., 2011, Devor et al., 
1999, Haws et al., 1994). Thus, Calu-3 cells represent a relatively healthy 
airway that exhibits functional CFTR that would provide a baseline to study the 
molecular changes that occur in human epithelium in response to P. aeruginosa 
infection. In our lab, the CFTR mRNA transcripts were detectable in both 
undifferentiated and differentiated Calu-3 cells and the presence of CFTR 
protein at the molecular weight of 168 kDa was also validated by 
immunoblotting (Faraidon Qader, MSc dissertation). 
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Although differentiated Calu-3 cell cultures at ALI featured the properties of 
cultures derived from primary NHBE (Berube et al., 2010), we have to 
acknowledge that this lung adenocarcinoma cell line is hypotriploid. Therefore, 
some properties in Calu-3 cells may not fully reflect those in healthy native 
epithelium. For instance, Calu-3 monolayers secrete mostly bicarbonate flux 
that carry the short-circuit current when stimulated with forskolin in alkaline 
condition, whereas chloride ion is the main anion transported by primary 
epithelial cells under this condition (Shan et al., 2011).   
3.6.2. Variation of P. aeruginosa inoculum occurred at high cell density 
The aim of this project was to investigate the impact of PQS on the interaction 
of P. aeruginosa with human bronchial epithelium. Therefore, for the infection 
assays it would be desirable to use bacterial cultures where maximum PQS 
production occurs. Because PQS production reached maximum at the late 
logarithmic phase (Diggle et al., 2003), cultures incubated for 8 h in LB were 
used to prepare the inocula in the first instance. In addition, as the immune-
competent airway epithelium is usually not susceptible to P. aeruginosa 
infection, a considerable amount of P. aeruginosa inoculum would be required 
in this acute respiratory infection model. Difficulties in obtaining consistent 
bacterial counting with high bacterial density cultures (MOI 1,000 is 7x109/ml 
in our study) and the large variation in actual CFU obliged us to modify the 
experimental approach. P. aeruginosa genome harbours a prophage Pf4 that 
influence biofilm formation and virulence by inducing cell death (Rice et al., 
2009). The filamentous phage played a role in shaping the biofilm structure 
from the formation of microcolonies to biofilm dispersal as it causes cell lysis 
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and release of DNA (Whitchurch et al., 2002, Rice et al., 2009). We postulate 
that prophage-PHGLDWHG µP. aeruginosa DXWRO\VLV¶ PLJKW RFFXU DW KLJK FHOO
density after 8 h incubation. Since nutrients become limited in cultures, 
surviving bacterial cells would benefit from the molecules released from lysed 
cells, such as DNA. Extracellular DNA is a source of carbon, phosphate and 
nitrogen that can be used by P. aeruginosa through the action of an 
extracellular deoxyribonuclease (PA3909) (Mulcahy et al., 2010, D'Argenio et 
al., 2002). At stationary phase, bacterial cultures are a complex mixture 
composed of viable cells and cells undergoing autolysis which might cause 
counting of viable bacterial inconsistent. The P. aeruginosa culture time was 
thereby adjusted from 8 h to 6 h, and then to 4 h when the majority of the cells 
are viable. In addition, inconsistent bacterial counting and variations between 
experiments still occurred with wild-type PAO1-L and ǻSTV$L at MOI of 250 
and 200. Based on the immunofluorescence images, both wild-type PAO1-L 
and ǻSTV$L formed clumps and aggregates which could be the cause for high 
CFU variability. Aggregates appeared to be larger in the case of ǻSTV$L. A 
VWXG\ FRQGXFWHG E\ '¶$UJHQLR HW DO GHPRQVWUDWHG WKDW 346 RYHUSURGXFWLRQ
could promote cellular autolysis in P. aeruginosa strain PAO1 (D'Argenio et 
al., 2002). In a transposon mutant library screening, a pqsL mutation displayed 
autolysis phenotype that secreted pronounced PQS 4 times higher than the 
wild-type (D'Argenio et al., 2002). The gene pqsL is predicted to encode an 
enzyme involved in PQS degradation (McKnight et al., 2000). The pqsL 
mutation (PQS overproduction) resulted in substantial cell lysis in bacterial 
colonies; in contrast to pqsA and pqsR mutants (no PQS production) that 
presented no lysis (D'Argenio et al., 2002). It was suggested that extracellular 
 137 
 
PQS could have a role in regulating cell survival as a means to adapt to the 
environmental change. In order to keep both PAO1-L WT and ǻSTV$L viable 
during inoculum preparation and avoid the potential problems with autolysis, 4 
h (mid-logarithmic phase) P. aeruginosa cultures diluted to a MOI of 50 
(3.5x108/ml) were selected for the study.  
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3.7. SUMMARY 
A robust method to generate an in vitro human differentiated bronchial-
epithelial infection model using Calu-3 cells was established. This 
pseudostratified bronchial epithelium displayed cilia-like microvilli, mucus 
production, tight junction integrity as well as cellular polarity that resembled 
the in vivo phenotype. The preparation of P. aeruginosa inocula suitable for the 
infection on differentiated epithelium was also optimised. 
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4. THE IMPACT OF ALKYL-QUINOLONE 
QUORUM SENSING ON THE INTERACTION OF 
PSEUDOMONAS AERGUINOSA WITH 
BRONCHIAL EPITHELIUM AND PHAGOCYTES 
4.1. INTRODUCTION 
P. aeruginosa alkyl-quinolone signal (PQS) molecules have been implicated in 
the immuno-modulation on host cells. PQS has been shown to modulate cell 
proliferation, the production of interleukin-2 (IL-2) and tumour necrosis factor 
(TNF-Į LQ PLWRJHQ-stimulated human peripheral blood mononuclear cells 
(PBMCs) (Hooi et al., 2004). AQs inhibited the production of IL-12 by LPS-
stimulated bone marrow-derived dendritic cells which led to reduced T-cell 
proliferation (Skindersoe et al., 2009). In addition, AQ extracts derived from P. 
aeruginosa strain PA14 supernatant down-regulated host innate immune 
response via inhibition of the NF-ț% DQG +,3-1Į pathways in murine cells 
from bronchoalveolar lavage fluid and macrophages (Kim et al., 2010a, Kim et 
al., 2010b, Legendre et al., 2012). However, the role of PQS on P. aeruginosa 
pathogenesis during the initial interaction of P. aeruginosa with human 
bronchial epithelium remains unknown. The aim of this chapter was to 
investigate the contribution of PQS to the pathogenesis of P. aeruginosa upon 
infection of human bronchial epithelium by comparing the infectivity of viable 
PAO1-L WT to that of its isogenic PQS deficient mutant. The 
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immunomodulatory properties of PQS in the context of P. aeruginosa infection 
of diffCalu-3 cells were also evaluated. 
Numerous P. aeruginosa virulence factors interfere with the properties of 
epithelial cells including barrier function, cell viability and modulation of 
innate immune signalling. The presence of flagella was shown required for 
transmigration across polarized airway epithelial cells. Flagella elicited Toll-
like receptor 5 (TLR5) dependent signalling that led to the induction of 
proinflammatory cytokines as well as neutrophil (CXCL1, CXCL2, CCL3) and 
macrophage (CCL20) attracting chemokines in 16HBE epithelial cells (Parker 
and Prince, 2013). Elastase B degraded two tight junction proteins, ZO-1 and 
ZO-2 in type II alveolar epithelial cells and Madin-Darby canine kidney 
(MDCK) cell monolayers (Azghani, 1996). P. aeruginosa exotoxin A (ETA) 
induced 16HBE14o- cell death via an early mitochondrial dysfunction and 
superoxide anion production (Plotkowski et al., 2002, Kipnis et al., 2006). 
Purified P. aeruginosa rhamnolipids disrupted intercellular tight junctions, 
inhibited ciliary beating, released mucus glyco-conjugates from trachea/ 
bronchial epithelial cells (Read et al., 1985, Graham et al., 1993). In addition, 
rhamnolipids in P. aeruginosa supernatants inhibited the expression of human 
ȕ-defensin-DQGLQWHUOHXNLQȕ,/-ȕLQNHUDWLQRF\WHVYLDFDOFLXP-regulated 
pathways and protein kinase C activation (Dossel et al., 2012). Pyocyanin 
inhibits ciliary beat frequency that impedes the subsequent clearance of P. 
aeruginosa in the airway epithelium. Inhibition of vacuolar ATPase and 
catalase activity in airway epithelial cells by pyocyanin alters the localization 
and function of CFTR (O'Malley et al., 2003, Lau et al., 2004, Rada and Leto, 
2013). Quorum-sensing circuits including the alkyl-quinolone dependent 
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system, positively regulates the expression of the majority of factors described 
above, we were intrigued to investigate whether the deficiency in PQS would 
affect the interaction of P. aeruginosa with human airway epithelium. 
On the aspect of how host cells respond to infection, the following signalling 
pathways have also been investigated in the context of P. aeruginosa infection 
on airway epithelial cells. Both Toll-like receptor 4 (TLR4) which recognises 
lipopolysaccharide (LPS) and TLR5 that, as mentioned above, binds to 
flagellin are sufficient to induce the expression of interleukin 6 (IL-6) and 
tumour necrosis factor-Į 7)1-Į DQG WKH FKHPRNLQHV NHUDWinocyte-derived 
chemokine (KC, also known as CXCL1) in murine alveolar macrophages and 
epithelial cells (Raoust et al., 2009). In view of the hyper-inflammatory state 
caused by recurrent infection in the CF lung, TLR5 could be a potential anti-
inflammatory target. Indeed, a reduced response flagellin caused by a 
polymorphism in the TLR5 gene correlated with improved lung function 
((Blohmke et al., 2010) et al., 2008, Blohmke et al., 2010). Epithelial cells also 
secrete anti-microbial mediators to promote an innate immune response. A 
significant decrease in P. aeruginosa strain PAK clearance in mice deficient in 
surfactant protein (SP)-A and SP-D were observed at 6 hpi (Giannoni et al., 
2006). Epilysin, a matrix metalloprotease secreted by Club (Clara) cells (Irwin 
et al., 2013), acts as a negative regulator that restrains a rapid macrophage 
recruitment to the lung in a P. aeruginosa pneumonia infection model 
indicating that bronchial epithelial cells and macrophages collaborate to reduce 
the bacterial burden at early time points (Manicone et al., 2009). In cultured 
airway epithelial cells and in a mouse model of P. aeruginosa infection, TLR2 
was shown not only to induce chemokine expression to recruit PMNs, but also 
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to initiate cleavage of junction proteins occludin and E-cadherin to 
accommodate transmigration of the recruited PMNs without breaching the 
epithelial integrity (Martin and Prince, 2008, Chun and Prince, 2009a, Chun 
and Prince, 2009b). The studies above illustrate numerous strategies employed 
by airway epithelial cells to protect against P. aeruginosa infection. Airway 
epithelium is also an important mediator for downstream activation of effector 
cells, such as macrophages and neutrophils. 
In this chapter, we aimed to determine the contribution of PQS to the 
interaction of P. aeruginosa with human bronchial epithelial cells by using a 
PQS deficient mutant ǻSTV$L in comparison with its isogenic wild-type strain.  
Apart from the original plan of evaluating the impact of PQS on the initial 
recognition of P. aeruginosa by diffCalu-3 cells in an acute infection setting, 
an infection model attempting to recapitulate P. aeruginosa airway chronic 
infection was also assessed. We investigated whether PQS affects the barrier 
function of airway epithelia, the ability of P. aeruginosa to exert cytotoxicity, 
expression of proinflammatory cytokines and chemokines as well as the 
signaling pathways associated with TLR recognition and inflammation. 
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4.2. HYPOTHESIS 
Pqs QS regulates a host of virulence factors in P. aeruginosa by orchestrating 
the quorum sensing circuits. AQs were detectable in the sputum and 
bronchoalveolar lavage fluids of CF patients throughout all stages of infection, 
from undetectable bacterial infection to late stage in spite of the fact that lasR 
mutants appeared in 70% of CF isolates. These results suggest that PQS plays 
an important role during P. aeruginosa infection in the lung. 
We hypothesised that PQS might contribute to P. aeruginosa pathogenesis by 
affecting bacterial innate immune recognition by human airway epithelium. 
 
4.3. AIM 
Due to the lack of a comprehensive understanding of how PQS operates during 
the course of infection, an in vitro human bronchial epithelial infection model 
was used (see Chapter 3) to investigate the barrier competence, cytotoxicity, 
innate immune activation and the induction of signalling pathways in response 
to viable wild-type PQS competent P. aeruginosa PAO1-L and a ǻSTV$L 
mutant deficient in PQS production.  
A preliminary investigation of the impact of PQS on phagocytes including 
neutrophils and M-CSF primed macrophages was also performed.
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4.4. MATERIALS AND METHODS 
4.4.1. Bacterial strains and culture conditions 
Bacterial strains and culture conditions were described previously in Chapters 
2 and 3.  
4.4.2. Infection of differentiated Calu-3 cells with P. aeruginosa 
4.4.2.1. Infection assay with PAO1-L wild-type and ǻSTV$L  
Calu-3 cells were plated on permeable Transwell insert (Corning, the 
Netherlands) and grown at an air-liquid interface for 21 days to form 
differentiated, polarised pseudostratified epithelium as previously described 
(Chapter 3, Section 3.4.1.). In the case of differentiated Calu-3 cells (diffCalu-3 
cultures), two types of infections were performed during the course of this 
study.  
1) P. aeruginosa PAO1-L wild-W\SHKHQFHIRUWKGHVLJQDWHGµ:7¶DQGǻSTV$L 
were grown to early-exponential growth phase for 4 h in LB broth, washed 
twice with sterile PBS containing CaCl2 and MgCl2 (Sigma-Aldrich, UK) and 
suspended in PBS at a concentration of 3.5x108 CFU/ml. For each strain, 100 
ȝl of bacterial suspension (equivalent to MOI 50) was added to the apical 
surface of the diffCalu-3 cultures. Infected cultures were incubated at 37oC, 5% 
CO2 for 2, 3 and 6 h. 
2) P. aeruginosa PAO1-L WT and ǻSTV$L were grown overnight for 16 h in 
LB broth, washed twice with sterile PBS containing CaCl2 and MgCl2 (Sigma-
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Aldrich, UK) and suspended in PBS at a concentration of 3.5x106 CFU/ml. For 
each strain, 100 ȝl of bacterial suspension (equivalent to MOI of 0.5) was 
added to the apical surface of the diffCalu-3 cultures. Infected cultures were 
incubated at 37oC, 5% CO2 for 6, 9, 12 and 24 h. 
4.4.2.2. Quantification of bacterial growth post infection of diffCalu-3 cultures 
P. aeruginosa growth on diffCalu-3 cultures was quantified by determining 
bacterial CFU. In the case of bacteria grown on and within the epithelium 
(thereby designated as cell-associated bacteria), diffCalu-3 cells were lysed 
with 250 ȝl of 0.1% Triton X-100 (Sigma-Aldrich, UK), homogenised with a 1 
ml syringe plunge. Lysates were collected, subjected to serial dilutions in 
sterile PBS containing CaCl2 and MgCl2 (Sigma-Aldrich, UK) and plated on 
LB agar plates. After incubation at 37oC for 16 to 18 h CFU was calculated by 
multiplying the number of colonies on the plate by their dilution factors and 
adjusting the counts to the volume of the original lysate. For the bacteria that 
gained access to the basal chamber (designated transmigrated bacteria), the 
basal culture media were collected and CFU were calculated as described 
above. The number of bacteria grown in MEM alone during the infection assay 
was used as control (designated PA only). 
4.4.3. Assessment of the expression of proinflammatory cytokines and 
chemokines by diffCalu-3 cells in response to P. aeruginosa infection 
4.4.3.1. Relative quantification of gene expression 
RNA isolation 
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RNAs were extracted from diffCalu-3 using the Absolutely RNA Miniprep Kit 
6WUDWHJHQH8.DFFRUGLQJ WRPDQXIDFWXUHU¶V LQVWUXction. In brief, cells were 
O\VHG LQ UHFRQVWLWXWHG /\VLV %XIIHU FRQWDLQLQJ ȕ-mercaptoethanol and 
homogenised by pipetting. Homogenates were then transferred to a Prefilter 
Spin and centrifuged. Filtrates were mixed with an equal volume of 70% 
ethanol and vortexed. The mixtures were transferred to the RNA Binding Spin 
Cup and centrifuged as before. Following a salt-gradient extraction from low 
salt to high salt washes, RNA was eluted and resuspended in DNase/RNase-
free water (Life Technologies, UK). The quantity and quality of RNA were 
determined using a Nanodrop 2000 spectrophotometer (Thermo Scientific, 
UK). The purity of RNA measured by the A260/A280 ratio ranging between 
1.9 and 2.1 is acceptable. 
Reverse transcription to cDNA 
The quantity of RNA from multiple samples was adjusted to 3 µg before 
reverse transcription. First strand cDNA strand was synthesized using random 
hexamers and Moloney Murine Leukemia Virus (M-MLV) reverse 
WUDQVFULSWDVH/LIH7HFKQRORJLHV8.DFFRUGLQJWRPDQXIDFWXUHU¶V LQVWUXFWLRQ
with minor modifications. Generally, RNAs were mixed with random 
hexamers (Life Technologies, UK) and placed at 70oC for 5 minutes to 
eliminate any secondary structures that may have formed. The mixtures were 
then transferred to ice for 5 min to prevent reformation of secondary structures. 
Bulk mix composed of 5x first strand buffer (250 mM Tris-HCl, [pH 8.3]. 375 
mM KCl, 15 mM MgCl2) and 0.1 M of dithiothreitol was added to the template 
and primer mixture. Reverse transcriptase was added to the whole mixture right 
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before starting the reaction. Samples were incubated at 37oC for 1 hour. cDNA 
was then incubated at 95oC for 10 minutes to inactivate the reverse 
transcriptase. Reverse transcript negative controls were also performed. cDNA 
were stored at -20oC until quantitative real-time PCR analysis. 
Quantitative real-time PCR 
Quantitative real-WLPH3&5T3&5DPSOLILFDWLRQPL[WXUHV ȝOFRQWDLQLQJ
template cDNA (2 µg to 3 µg), 2x SYBR green I qPCR master mix with 2.5 
mM MgCl2 (Stratagene, UK) were used along with ROX as the reference dye 
to correct for pipetting error. Reactions were run on an Agilent Mx3005P 
qPCR system. The cycling conditions were 10 min at 95°C and 40 cycles as 
follows: 95°C for 30 sec, and 72oC for 60 sec. Each sample was performed in 
triplicate. Primer efficiencies were evaluated by a standard curve performed 
with templates in 4-log serial dilutions and efficiencies between 99-110% are 
considered appropriate. A validation experiment was conducted in the input 
cDNA concentration for 4-log serial dilutions to assess whether the efficiency 
of the target gene amplification and the efficiency of the reference gene 
amplification is approximately equal.  The relative gene expression between P. 
aeruginosa infected diffCalu-3 cells and non-infected diffCalu-3 cells 
(comparative Cq method that compares the Cq value of the gene of target to the 
control (2-ǻǻCq); the Cq of target and the control were normalised with 
reference gene (ǻCq) ) was analysed by program MxPro PCR software 
Mx3005P (provided by Stratagene, UK).  
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Table 4.1  Primers used for qPCR 
Primer 
(Accession number) 
Primer Sequences  Position 
Amplicon length 
(nucleotides) 
NM_000194.2    
HPRT_f GTAATGATCAGTCAACGGGGGAC 484-660 177 
HPRT_r CCAGCAAGCTTGCAACCTTAACCA   
NM_006098.4    
GNB2L1S TCTGCGGGGTCACTCCCACT 280-300 118 
GNC2L1AS TGGCCCACAAATCGCCTCGT 398-417  
NM_002180    
IGHMBP2S CCCACCACAGTCTCTCACAA 1318-1338 111 
IGHMBP2AS GTACTGCACCGTCAGTGTCC 1409-1428  
NM_000758.3    
GM-CSF_f TCTVAGAAATGTTTGACCTCC 211-231 98 
GM-CSF_r GCCCTTGAGCTTGGTGAG 291-308  
NM_000600.3    
IL-6_f GATGAGTACAAAAGTCCTGATCCA 548 - 571 130 
IL-6_r CTGCAGCCACTGGTTCTGT 659 - 677  
NC_018922.2    
IL-18_f CAGAGTCAAGGACTGCCAACT 10311 - 10331 60 
IL-18_r TAGGCCCTGGGTTCCTGT 10353 - 10370  
NM_000594.3    
TNFaH_f GACAAGCCTGTAGCCCATGT 28 - 47 105 
TNFaH_r TCTCAGCTCCACGCCATT 115 - 132  
NM_000576.2    
IL-ȕBI TACCTGTCCTGCGTGTTGAA 637 - 656 76 
IL-ȕBU TCTTTGGGTAATTTTTGGGATCT 690 - 712  
NM_000584.3    
IL-8_h_f AGACAGCAGAGCACACAAGC 76-95 62 
IL-8_h_r ATGGTTCCTTCCGGTGGT 120-137  
NM_002982.3    
MCP-1_f AGTCTCTGCCGCCCTTCT 79-96 93 
MCP-1_r GTGACTGGGGCATTGATTG 153-171  
NM_013278.3    
IL-17c_f CCCTCAGCTACGACCCAGT 293 - 311 126 
IL-17c_r CTTCTGTGGATAGCGGTCCT 399 - 418  
NM_022789.3    
IL-17e_f GTGAAGATGGACCCCTCAAC 488 - 507 73 
IL-17e_r AGCCGGTTCAAGTCTCTGTC 541 - 560  
 
4.4.3.2. Cytokine protein quantification 
Enzyme-linked immunosorbent assay (ELISA) 
The levels of GM-CSF in the supernatants of diffCalu-3 cultures were 
TXDQWLILHG IROORZLQJ PDQXIDFWXUH¶V LQVWUXFWLRQ 5	' 8. &XOWXUH
supernatants were centrifuged to remove cell debris and bacteria. Between each 
step, solutions were aspirated and the wells were washed three times with wash 
buffer (0.05% Tween-20 (Sigma-Aldrich, UK) in PBS, pH 7.2-7.4). Wells of 
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96-well MaxiSorp surface microplates (Thermo Scientific, UK) were coated 
with 100 ȝl of mouse anti-human GM-CSF capture antibody at the 
concentration of 20 ȝg/ml in PBS (Sigma-Aldrich, UK) and incubated at room 
temperature overnight. The solution was aspirated and wells were washed three 
times with 300 ȝl of wash buffer. Each well was blocked with 300 ȝl of 
Reagent Diluent (1% bovine serum albumin of protease free/ fraction V grade 
(Millipore, US) in PBS, pH 7.2-7.4, 0.2 ȝl filtered) for 1 h at room temperature. 
100 ȝl of samples and recombinant human GM-CSF standards (2-fold serial 
dilutions diluted from 1,000 pg/ml to 15.625 pg/ml) and then incubated for 2 h 
at room temperature. Wells were aspirated, washed and 100 ȝl of the Detection 
Antibody (biotinylated anti-rhGM-CSF) at a concentration of 0.5 ȝl/ml was 
added and incubated for 2 h. After washes, 100 ȝl of horseradish peroxidase 
conjugated (HRP)-streptavidin at working concentration (1:200) was added to 
each well and incubated for 20 min. 100 ȝl of substrate solution containing 1:1 
mixture of tetramethylbenzidine (TMB) and H2O2 was then added and the plate 
was incubated in dark for 20 min. 50 ȝl of 2N H2SO4 was added to each well to 
stop the reaction and optical density (OD) incubation at room temperature for 
20 min and read at 450 nm. The concentrations of GM-CSF in samples were 
calculated according to the equation obtained from the standard curve readings. 
Bead-based immunoassay 
Simultaneous quantification of the levels of interleukin-6, interleukine-8, 
tumour necrosis factor-Į, interleukin-1ȕ, and monocyte chemoattractant 
protein- 1 in diffCalu-3 culture supernatants was done using the bead-based 
immunoassay FlowCytomix Simplex kit in combination with FlowCytomix 
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human Basic kit (eBioscience, UK) according to the manual. Samples were 
analysed by flow cytometry using the software FlowCytomix Pro provided by 
eBioscience. 
Polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting  
Protein separation based on their electrophoretic mobility was derived from 
Laemmli method and described previously by (Towbin et al., 1979). Briefly, 
difCalu-3 cultures were lysed with RIPA buffer (Thermo Scientific Pierce, UK) 
supplemented with protease and phosphatase inhibitors (Thermo Scientific, 
UK). Total lysate proteins were suspended in 1x SDS loading buffer (50 mM 
Tris-HCl pH 6.8, 1% SDS, 7.5% glycerol, and ,0.02 % bromophenol blue) 
containing 1% ȕ-mercaptoethanol and heated at 95oC for 5 min. Equal volume 
of each sample was loaded on a 12% polyacrylamide gel, electrophoresis ran at 
30 mV for 90 min in Tris-glycine electrophoresis buffer (25 mM Tris base, 192 
mM glycine, 0.1% SDS, pH 8.3) (BioRad, UK). After electrophoresis, proteins 
were transferred to an Immobilon-P PVDF membrane (Millipore, US) in a wet 
transfer system (transfer buffer: 25 mM Tris base, 192 mM glycine, 20% 
methanol, pH 8.3) overnight, and the membrane was then incubated overnight 
again in blocking solution comprised of PBS containing 0.1% Tween-20 
(Sigma-Aldrich, UK) and 5% skimmed milk. Incubation with mouse anti-
hGM-CSF (1 ȝg/ml, R&D, UK) and mouse monoclonal anti-ȕ-actin (1 ȝg/ml, 
Sigma-Aldrich, UK) as loading control was followed by secondary antibody 
HRP-conjugated goat anti-mouse antibody (1:10,000 dilution, Sigma-Aldrich, 
UK). Antibody binding was detected using Enhanced Chemiluminescence 
(ECL) Detection Reagent (GE Healthcare, UK). 
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4.4.4. Immunofluorescence staining and confocal laser scanning 
microscopy 
To visualise the distribution of P. aeruginosa on Calu-3 cells, 
immunofluorescence labelling was performed using similar steps as described 
in Chapter 3. In short, after fixation, permeabilization and blocking, primary 
antibody rabbit polyclonal anti-Pseudomonas antibody (Abcam) at 4.5 µg/ml in 
blocking buffer was added for 1 hour, followed by three times washes. Donkey 
anti-rabbit antibody conjugated to Alexa Fluor 674 was used as secondary 
antibody (diluted 1:250 in blocking solution) together with Phalloidin Alexa 
488 that labels F-actin (diluted 1:40 in blocking solution) after 30 min and 3 
washes, glass slides were stored at -20oC before visualisation using a Zeiss 
LSM 700 laser scanning microscope. Images were processed using Zen 2009 
(Zeiss. Germany).  
4.4.5. Microarray analysis of signalling pathways activation 
This part of the study was performed by Dr. Ola Negm at the Post-Genomic 
7HFKQRORJLHV )DFLOLW\ 4XHHQ¶V 0HGLFDO &HQWUH 8QLYHUVLW\ RI 1RWWLQJKDP 
Briefly, difCalu-3 cultures infected with PAO1-L and ǻSTV$L at 3 and 6 hpi 
were lysed with 70 ȝl of RPPA (Reverse Phase Protein Microarray) buffer 
(Thermo Scientific Pierce, UK) supplemented with protease and phosphatase 
inhibitors (Thermo Scientific Pierce, UK). Reverse phase protein microarray 
was carried out on the protein lysates in order to determine expression of the 
IROORZLQJ VLJQDOLQJ PROHFXOHV DQG WUDQVFULSWLRQ IDFWRUV WKH SUHIL[ µS¶
represents phosphorylated forms of these molecules): pp38, pNF-țB (p65), 
pERK1/2, pIRF7, pAKT-Serine and pAKT-Threonine. Data were analysed 
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using RPPAnalyzer software that is written in R. Expression of all proteins was 
normalised against ȕ-actin. The expression of tight junction proteins ZO-1 and 
E-cadherin, mucin MUC5AC, cilia-associated ȕ-type IV tubulin, heat-shock 
protein 90 (HSP90) and nuclear pore complex protein 98-kDa (NUP98) was 
also examined. 
4.4.6. Cytotoxicity 
4.4.6.1. Assessment of cytotoxicity based on the loss of fluorescence signal 
from ȕ-actin using microarray. 
During the course of the microarray signalling study a decrease in the 
fluorescence signal corresponding to the endogenous control protein ȕ-actin 
was observed in the infected diffCalu-3 samples at 3 and 6 hpi. Based on 
confocal images suggesting substantial cellular damage during infection, it was 
considered that the reduction in ȕ-actin could be used as a surrogate marker of 
cytotoxity. For this the degree of actin degradation was quantified based on the 
decrease in arbitrary fluorescence units (AFU) from infected cells compared 
with the AFU obtained from untreated cells. 
4.4.6.2. LDH cytotoxicity detection assay 
Cytotoxicity was assessed using the lactate dehydrogenase (LDH) colorimetric 
assay according to the protocol provided by the manufacturers (Roche Applied 
Sciences, UK). Briefly, undifferentiated Calu-3 cells were seeded in a 24-well 
tissue culture plate (Corning Life Sciences, the Netherlands) at a cell density of 
100,000 cells per well and cultured for three days to reach confluency. On the 
day of infection, culture medium was replaced with MEM without fetal bovine 
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serum. Cells were infected with PAO1-L WT or ǻSTV$L in PBS at MOI 50 for 
3 and 6 h. Cells incubated with PBS were used as negative controls. Cell 
supernatants were collected and centrifuged to remove cell debris and bacteria. 
50 ȝl of supernatant was mixed with equal volume of reaction solution 
(diaphorase / NAD+ mixture, iodotetrazolium chloride, and sodium lactate) in a 
96-well microtitre plate (Corning Life Sciences, the Netherlands) and 
incubated at room temperature for 20 min protected from light. Supernatants 
from uninfected cells were used as negative controls and those collected from 
Calu-3 cells lysed with 2% of Triton X-100 represented the 100% cell death 
positive control. The absorbance of sample and control wells was measured at 
492 nm and 650 nm (reference wavelength used to correct for differences in 
absorbance between wells due to imperfections in the material of the microtitre 
plate) using a Labsystems Multiskan EX plate reader. The OD readings of the 
samples were firstly subtracted from the OD readings of negative controls, and 
the percentage of cell death was calculated by comparison with the OD 
readings from 100% cell death. 
4.4.7. Measurement of reactive oxygen species (ROS) production by 
neutrophils in response to PAO1-L  
Neutrophils isolation 
Neutrophil isolation procedure and characterisation was previously optimised 
in our lab (Sonali Singh, PhD thesis). Healthy donors were recruited from 
DPRQJVW VWXGHQWV DQG VWDII DW WKH 4XHHQ¶V 0HGLFDO &HQWUH DQG &HQWUH IRU
Biomolecular Sciences, Nottingham. Ethical approval and informed consent 
was obtained for all individuals prior to sample collection. 12 ml of venous 
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blood was collected from each healthy donor in EDTA vacutainers (BD 
Diagnostics-Preanalytical Systems, UK) and neutrophil isolation begun no later 
than 1 h post-collection. To isolate neutrophils from fresh whole blood, 12 ml 
of Histopaque-1077 (Sigma-Aldrich, UK) was added to a 50 ml falcon tube 
(BD Biosciences, UK). 12 ml of Histopaque-1119 (Sigma-Aldrich, UK) was 
then carefully laid beneath the Histopaque-1077 layer such that both types of 
Histopaque formed two sharply separated layers. 12 ml fresh whole blood 
diluted with 12 ml RPMI-1640 (Sigma-Aldrich, UK) was layered over the 
Histopaque-1077 layer and the tube centrifuged at 700 x g, acceleration slow, 
brake off for 30 min at room temperature. The neutrophil layer was harvested 
using a Pasteur pipette after removal of the upper layers. Isolated neutrophils 
were washed once with RPMI-1640 to remove any Histopaque. 0.2% saline 
(Sigma-Aldrich, UK) was then added to the washed neutrophils and incubated 
at room temperature for 1 min in order to lyse contaminating red blood cells 
(RBCs). An equal volume of 1.6% saline was added to the cells to equilibrate 
the solution, and cells were washed once with RPMI-1640. Two more washes 
were carried out in buffer A in preparation for the subsequent ROS 
measurement assay (see below). Neutrophils were used immediately after 
purification to avoid loss of cell viability / function over time. 
ROS production of neutrophils in response to P. aeruginosa 
Production of ROS by neutrophils was assessed by the luminol 
chemiluminescence assay as described previously (Pleass et al., 2007). Briefly, 
100 ȝl of luminol solution (67 ȝg/ml luminol (Sigma-Aldrich, UK) in buffer A; 
buffer A comprises 20 mM HEPES (Invitrogen, UK) and 0.1% BSA (Sigma-
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$OGULFK 8. LQ +DQN¶V EXIIHUHG VDOLQH VROXWLRQ FRQWDLQLQJ &D2+ and Mg2+ 
without phenol red (Invitrogen, UK)) was added to the wells of a 96-well 
chemiluminescence microtitre plate (BD Biosciences, UK). The stimuli 
Zymosan A (Life Technologies, UK) or live PAO1-L diluted in buffer A were 
then added to the wells.  Viable PAO1-L was prepared from 3 h cultures in X-
Vivo 15 (Lonza, UK) as described previously in Chapter 3 (Section 3.4.4.1.) 
and resuspended in buffer A to achieve an MOI of 20. Unstimulated controls 
contained only Buffer A. All conditions were carried out in triplicate. In some 
instances PQS pure compound was added at a concentration of 1,000 nM to 1 
nM.  Diluent (HPLC-grade ethanol, Sigma-Aldrich, UK) was used as negative 
control. Finally neutrophils resuspended in buffer A were added to the 
microtitre plate at a density of 50,000 cells per well immediately prior to 
measurement. Chemiluminescence was measured at 2 min intervals for 2 h at 
37oC using a Fluorostar Optima plate reader.   
4.4.8. Extraction of quorum-sensing signaling molecules and LC-MS 
analysis 
 ȝO FXOWXUH VXSHUQDWDQWV FROOHFWHG IURP GLII&DOX-3 cultures infected with 
PAO1-L and ǻSTV$L DVZHOODVȝORI0(0FXOWXUHGZLWK:7DQd ǻSTV$L 
were centrifuged and cell-free supernatants were retained for subsequent 
H[WUDFWLRQ(TXDOYROXPHRIDFLGLILHGHWK\ODFHWDWHȝORIJODFLDODFHWLFDFLG
(Sigma-Aldrich, UK) in 1 L of ethyl acetate (Sigma-Aldrich, UK)) was added 
to the cell-free VXSHUQDWDQWDQGYRUWH[HGIRUVHF$YROXPHRIȝORIȝ0
d9 C5-HSL was added to the culture supernatant as internal standard. The 
organic phase was taken up to a 2 ml microcentrifuge tube and the extraction 
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was repeated twice more. The total extracted solutions were subjected to speed 
vacuum (Jouan RC10 series, Thermo Scientific, UK) to dry the solvents at 
45o&IRUPLQ7KHGULHGFUXGHH[WUDFWVZHUHUHFRYHUHGE\DGGLQJȝORI
methanol (Sigma-Aldrich, UK), transferred to LC-MS glass vial and subjected 
to LC-MS analysis. 
4.4.9. In vitro infection of macrophages with PAO1-L WT and ǻSTV$L 
4.4.9.1. Preparation of M-CSF primed macrophages from peripheral blood 
mononuclear cells 
Peripheral blood mononuclear cells (PBMCs) were isolated from leukocyte 
cones (Blood Transfusion Service, Sheffield, UK) by Histopaque-1077 (Sigma-
Aldrich, UK) density gradient centrifugation. Briefly, the leukocyte cone was 
diluted with 35 ml of RPMI-1640 (Sigma-Aldrich, UK) to make the final 
volume around 50 ml. 25 ml of diluted blood was then layered over 12 ml of 
Histopaque-1077 in each of two 50 ml falcon tubes (BD Biosciences, UK) and 
centrifuged at 800 x g, acceleration slow, brake off at room temperature for 30 
min. The buffy layer consisting of PBMCs was collected and washed three 
WLPHV ZLWK +DQNV¶ EDODQFHG VDOW VROXWLRQ PRGLILHG ZLWK 1D+&23, without 
CaCl2 and MgSO4) (Sigma-Aldrich, UK) to remove contaminating platelets. 
CD14+ cells were then purified from the PBMC fraction by positive selection 
using human CD14 MicroBeads (human) and LS MACS columns (Miltenyi 
%LRWHF8.DFFRUGLQJWRPDQXIDFWXUHU¶VLQVWUXFWLRQV3XULILHGPRQRF\WHVZHUH
resuspended at a density of 2 x 106 monocytes/ml in RPMI-1640 (Sigma-
Aldrich, UK) containing 15% human AB serum (PAA Laboratories Ltd, UK), 
2 mM L-glutamine (Sigma-Aldrich, UK), 100 U/ml penicillin and 100 ȝg/ml 
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streptomycin (Sigma-Aldrich, UK), and 10 mM HEPES (Invitrogen,  UK)  ±  
UHIHUUHGWRLQWKLVVWXG\DVµ530,FRPSOHWHPHGLXP¶QJPOUHFRPELQDQW
human monocyte-colony stimulating factor (rhM-CSF) (R&D Systems, UK) 
was added to the monocyte cultures. 107 monocytes in 5 ml RPIMI complete 
medium were seeded per Teflon bottle (Nalgene, UK) (total capacity of each 
Teflon bottle = 125 ml) and incubated at 37oC, 5% CO2 for 6 days. Culture 
cells were fed with 1.5 ml per bottle of fresh RPMI complete medium 
containing M-CSF on day 3. (Method derived and modified from Sonali 
Singh¶s PhD thesis µ,QQDWHLPPXQHUHFRJQLWLRQRIPseudomonas aeruginosa) 
4.4.9.2. Quantification of P. aeruginosa growth during infection 
M-CSF monocyte macrophages were harvested on day 7 and plated in 24-well 
tissue culture plates at a density of 250,000 cells per well in X-Vivo 15 and 
incubated overnight. The next day, cells were washed three times with cold 
PBS (Sigma-Aldrich, UK) to remove dead or non-adherent cells. PAO1-L mid-
log phase (4 h) inoculum (350 ȝl at a density of 7.14 x 105 cfu/ml in X-Vivo 15 
containing M-CSF) was added to the wells and cultures were incubated at 37oC, 
5% CO2 for 2, 4 and 6 h. Controls were Mock-infected macrophages and 
bacteria only controls.  To assess whether M-CSF primed macrophages were 
able to restrict the growth of PAO1-L and ǻSTV$L during infection, the amount 
of extracellular and macrophage-associated P. aeruginosa were quantified at 2, 
4, and 6 hpi. The amount of extracellular and macrophage-associated P. 
aeruginosa was compared to bacteria only controls. CFU were determined as 
described above but to measure macrophage-associated bacteria in the samples, 
250 ȝl of cold, sterile, ultra-pure distilled water (Invitrogen, UK) was added to 
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each well containing infected macrophages, the plates were placed on ice, and 
the bottom of the wells scraped with the plunger of a 1 ml syringe in order to 
lyse all the macrophages and release any associated bacteria.  
4.4.10. Statistical analysis 
All statistical analyses were carried out using GraphPad Prism v. 6.0. In this 
chapter, three data sets including untreated, WT-infected and ǻSTV$L infected 
conditions were compared at the same time; one-way analysis of variance with 
non-parametric Kruskal-Wallis test was executed to calculate significance. P-
value  0.05 is regarded significant. 
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4.5. RESULTS 
4.5.1. Effect of PQS on P. aeruginosa colonisation, invasion and growth on 
differentiated Calu-3 cells 
4.5.1.1. P. aeruginosa invades differentiated Calu-3 cells at 2 hpi and 3 hpi 
with the epithelial integrity largely maintained  
To investigate whether PQS affects the colonisation, invasion and growth of P. 
aeruginosa on differentiated bronchial epithelial Calu-3 cells, Calu-3 cells 
were infected with P. aeruginosa PAO1-L WT and ǻSTV$L at an MOI 50 for 2 
h, 3 h and 6 h. In the first instance infected and uninfected Calu-3 cells were 
fixed with 3% glutaraldehyde at 2 hpi and subjected to scanning electronic 
microscopy to visualise the initial stages of the infection process. Surprisingly, 
given the MOI used, few bacteria were seen at the cell surface implying a low 
frequency of P. aeruginosa binding to the epithelial apical surface. The 
majority of the attached bacteria were found close to cell junctions that could 
correspond to areas where the tight junctions were being degraded (Fig. 4.1). 
These results are in agreement with previous observations by Lee et al. using 
FITC-labelled P. aeruginosa. According to these, approximately less than one 
per cent of the bacteria bound at the apical membrane of airway epithelial cells 
(Lee et al., 1999). Polarised Calu-3 cells displayed apical protrusions like 
prolonged microvilli that attached to WT and ǻSTV$L (Fig. 4.1C), although the 
real function of apical protrusion requires further characterisation.  
Motility and attachment are major functions attributed to P. aeruginosa flagella 
(Parker and Prince, 2013). In our study, both WT and ǻSTV$L carried a single 
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flagellum based on the images obtained by scanning electron microscopy (Fig. 
4.1D). This observation is consistent with the fact that both WT and ǻSTV$L 
displayed swarming motility (Chapter 2, Section 2.5.2.5.). The capability of 
transmigration across epithelial cells by WT and ǻSTV$L was compared by 
enumerating the bacteria in the basal chamber at different time post- infection. 
At 2 hpi, neither WT nor ǻSTV$L was found in the basal compartment 
indicating the barrier integrity was maintained for up to 2 hpi (data not shown). 
Few to none bacteria were recovered randomly in the basal chamber at 3 hpi 
suggesting some of the cells on the diffCalu-3 monolayer started to 
compromise (data not shown).  
To further examine the impact of PQS on the interaction of P. aeruginosa with 
bronchial epithelium, infected cells were labelled using an anti-Pseudomonas 
antibody and analysed by confocal laser scanning microscope. Although WT 
and ǻSTV$L were randomly detected across polarised Calu-3 cells at 3 hpi, 
bacterial invasion was observed (Fig. 4.2). Z-stacks of infected differentiated 
Calu-3 cells were obtained. The WT mainly accumulated at the apical surface 
forming small patches (Fig 4.2). White arrows indicated the bacteria inside 
Calu-3 cells while the integrity of the monolayer was maintained. 
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Figure 4.1  Visualisation of differentiated Calu-3 cells infected with PAO1-L WT and 
ǻSTV$L by scanning electron microscopy.  
Uninfected Calu-3 cells presented short microvilli and formed cilia-like structures. Relatively 
long surface protrusions scarcely appeared on few cells. A and B. Both WT (arrows 1, 2 and 3) 
and ǻSTV$L (arrows 4 and 5) were seen at cellular boundaries and appear to induce disruption 
of the junctions. (Next page)  
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It was clearly seen in the confocal image in Fig. 4.2 that the cell membrane 
remained mostly intact and surrounded by F-actin staining, suggesting that the 
plasma membrane was still linked to the actin filaments. ǻSTV$L also formed 
cell aggregates and could be detected inside the cells. However, ǻSTV$L 
seemed to cause cell misplacement in polarised Calu-3 cell as some cells were 
found climbing on each other (Fig. 4.2 ǻSTV$L infection on Calu-3 cells at 3 
C. Protruding microvilli at the surface of Calu-3 cells appear responsive to WT and ǻSTV$L. 
D. Arrow 6, 7 and 8 indicate that both WT and ǻSTV$L carried a flagellum as their motile 
organelle. 
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hpi shown in Y-axis). Previous studies indicated the type III secreted effectors 
ExoS, ExoT and ExoY enabled P. aeruginosa to invade and disrupt the actin 
cytoskeleton without compromising cell viability at early stage of infection 
(Cowell et al., 2005, Angus et al., 2010). This observation is compatible with 
our findings regarding the disturbance of the epithelial monolayer induced by 
ǻSTV$L.  
4.5.1.2. P. aeruginosa growth and colonisation of the epithelial layer at 6 hpi 
At 6 hpi the epithelial layer was damaged and there was accumulation of 
bacteria forming a biofilm-like structure. In some instances bacteria were 
found tightly associated to extracellular DNA if this was present. In 
comparison with the cells infected with WT where the epithelial monolayer 
was largely maintained, Calu-3 cells infected with ǻSTV$L seemed to round up 
(Fig. 4.3).  
The capability of growth on the respiratory epithelium is the first step in the 
establishment of infection (Heiniger et al., 2010). We assessed the virulence of 
P. aeruginosa PAO1-L WT and ǻSTV$L by quantifying bacterial growth on the 
epithelium and bacteria transmigrated to the basal chamber at 6 hpi. Bacteria 
cultured in complete MEM were used as controls, and the bacterial inocula 
were validated for each infection assay (see Chapter 3 Section 3.5.2.2). The 
results showed that the inocula from both WT and ǻSTV$L were within the 
optimal range and the bacterial counts for WT and ǻSTV$L from each 
experiment were also consistent. Bacterial numbers in the control wells were 
21 times and 18 times higher at 6 hpi compared to the initial inocula for WT 
and ǻSTV$L respectively. This was consistent with previous observations 
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(Section 2.5.2.1.). A wide range of values, between 2-logs and 4-logs, were 
obtained for the bacteria present in the basal chamber and these differed among 
experiments (Table 4.2; Fig. 4.3). In fact, the majority of bacteria remained 
cell-associated with numbers up to 8-logs at 6 hpi. Given the fact that the 
numbers of randomly transmigrated bacteria were 4-logs to 6-logs lower than 
the numbers of cell-associated bacteria, the transmigration events were 
negligible compared to numbers of cell-associated bacteria. In addition, we 
found the ratLRµFHOODVVRFLDWHG-EDFWHULD¶WRµ0(0RQO\EDFWHULD¶ZDVDQG
0.32 for WT and ǻSTV$L, respectively. This suggested that the growth of P. 
aeruginosa was reduced by approximately 64-68% in differentiated Calu-3 cell 
monolayers compared to MEM-only controls.  
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Figure 4.2  Invasion of WT and ǻSTV$L in differentiated Calu-3 cells occurred at 3 hpi whilst 
epithelium maintained its integrity. 
P. aeruginosa adherence and invasion in differentiated Calu-3 cells was visualised by confocal fluorescent 
microscope. Cell nuclei were detected by Hoechst (blue), F-actin was detected with Phalloidin-Alexa488 
(green) and P. aeruginosa was detected with rabbit poly-clonal anti-Pseudomonas antibody (red). 
Uninfected Calu-3 cells formed pseudostratified structure with healthy shaped nuclei seen on the picture. 
However, in some cases, floating DNA was found at the surface (see results and discussion). Both WT 
and ǻSTV$L invaded Calu-3 cells at 3 hpi without disrupting cell integrity (white arrows). These findings 
were supported by the fact that no CFU could be found in the basal medium at 3 hpi. 
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Figure 4.3  Substantial accumulation of WT and ǻSTV$L associated to extracellular DNA in infected Calu-3 cells cultures. 
3D representation of uninfected, WT-infected and ǻSTV$L infected cells at 6 hpi are shown on the left. Correspondent z-stack 
images from the apical side to the bottom are also shown (see right panels). The integrity of Calu-3 cells was compromised at 6 hpi 
in response to WT and ǻSTV$L infection at MOI 50. 
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Table 4.2  Summary of the averages of bacterial colony forming units of inocula, PA    
 only controls, transmigrated and cell-associated bacteria at 6 hpi. 
Total CFU 
(Average, n=3) WT ± SD ǻpqsAL  ± SD 
Inoculum (107) 2.1 ± 1.1 2.4 ± 1.1  
PA* only in MEM (108)  4.5 ± 2.3  4.4 ± 2.0  
Transmigrated bacteria (104)  4.7 ± 7.2 5.8 ± 9.2 
Cell-associated bacteria (108)  1.6 ± 0.7 1.4 ± 0.2 
Cell-associated bacteria/ PA 
only in MEM 
0.36 0.32 
*PA, P. aeruginosa  
  
Figure 4.4  The majority of PAO1-L WT and ǻpqsAL remained cell-associated at 6 hpi 
during infection of diffCalu-3. 
Bacterial growth after infection of diffCalu-3 cells was assessed by counting bacterial CFU in 
the cell-associated fraction and in the basal chamber. CFU values for the inocula and MEM 
only-controls are also shown.  The experiment was conducted for three times (n=3). Each dot 
shown in the figure represents the mean from one single experiment. 
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4.5.2. Induction of pro-inflammatory cytokines in diffCalu-3 cells in 
response to PAO1-L WT and ǻSTV$L 
4.5.2.1. Validation of endogenous control genes for gene expression studies on 
Calu-3 cells 
In this part of the study, quantitative real-time PCR was introduced to evaluate 
the relative levels of mRNA in diffCalu-3 cells upon WT and ǻSTV$L infection. 
When performing relative quantification of the expression of a target gene, the 
choice of a suitable gene for use as an endogenous control is important. An 
endogenous control gene is a gene whose expression level should not differ 
between samples, such as a housekeeping that is constitutively expressed. 
Comparison of the Cq value of a target gene with that of the endogenous 
control gene allows the expression level of the target gene to be normalized to 
the amount of input cDNA. The use of an endogenous control gene corrects for 
variation in RNA content, reverse-transcription efficiency, nucleic acid 
recovery, possible RNA degradation or presence of inhibitors in the RNA 
sample and differences in sample handling (Huggett et al., 2005). The stability 
of the endogenous gene is another critical issue when performing real-time 
quantitative PCR. The expression of a good internal control should not change 
upon treatment among samples (He et al., 2008, Kulkarni et al., 2011). To 
perform an endogenous gene validation test that is suitable for our study, the 
expression of the gene should be maintained in Calu-3 cells after P. aeruginosa 
infection. Three reference genes commonly used in bronchial epithelial cells 
were compared for consistency and efficiency between samples: hypoxanthine 
phosphoribosyltransferase 1 (HPRT), guanine nucleotide-ELQGLQJ SURWHLQ ȕ-
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peptide 2-like- *1%/ DQG LPPXQRJOREXOLQ ȝ ELQGLQJ SURWHLQ 
(IGHMBP2) (Table 4.3). The expression of HPRT, GNB2L1 and IGHMBP2 
were firstly investigated in uninfected diffCalu-3 cells. Their Cq (quantification 
cycle) values were 23.40 ± 0.01, 19.35 ± 0.25 and 27.28 ± 0.27 (Fig. 4.5) 
respectively. The averages and standard deviations were obtained from two 
independent experiments, with each experiment containing two samples 
analysed in triplicate. The suggested Cq value of HKG to use is around 25. The 
relatively higher Cq value for IGHMBP2 compared to the other two HKGs 
suggested a lower gene expression than the other two. Despite the fact that 
HPRT and GNB2L1 were both constitutively expressed at relatively high 
levels in diffCalu-3 cells HPRT appeared to perform more consistently based 
on the smaller standard deviations between experiments. Furthermore, to verify 
whether the HPRT is consistently expressed in polarised Calu-3 cells upon P. 
aeruginosa infection, Cq values of HPRT from Calu-3 cells infected with WT 
and ǻSTV$L were also examined. Based on the Cq values obtained, HPRT was 
shown to be consistently expressed in uninfected and infected diffCalu-3. 
HPRT was therefore selected as the endogenous control for normalisation of 
the expression levels of target genes in samples. 
Table 4.3  Brief description of references genes tested using qPCR 
Abbreviation Gene name Gene function 
HPRT* Hypoxanthine phosphoribosyltransferase 1 
A transferase in the generation of 
purine nucleotides through the 
purine salvage pathway 
GNB2L1* Guanine nucleotide-binding SURWHLQȕ-peptide 2-like-1 
Binding and anchorage of protein 
kinase C 
IGHMBP2* Immunoglobulin ȝ binding protein 2 
A 5' to 3' helicase that unwinds 
RNA and DNA duplices in an 
ATP-dependent reaction  
*(He et al., 2008) 
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4.5.2.2 Similar induction of pro-inflammatory cytokines gene expression in 
response to WT and ǻSTV$L infection of diffCalu-3 cells. 
In addition to producing broad-spectrum antimicrobial agents in the mucus, 
such as defensins and surfactant proteins, airway epithelial cells secrete 
chemokines and cytokines in response to pathogens that lead to the recruitment 
Table 4.4  HPRT CT values in diffCalu-3 cells collected after exposure to P. aeruginosa 
infection at MOI 50 for 2 hpi and uninfected control 
 
Treatment 
HPRT Cq value 
(triplicate) Average ± SD 
Uninfected 23.02 22.96 22.29 22.99 ± 0.031 
Infected with WT 23.38 23.59 23.51 23.49 ± 0.106 
Infected with  ǻSTV$L  23.54 23.56 23.38 23.49 ± 0.099 
Figure 4.5  Consistent Cq values of reference genes in uninfected diffCalu-3 cells in two 
independent experiments. 
All three references genes HPRT, GNB2L1 and IGHMBP2 showed consistent Cq values 
between two independent experiments. However, HPRT was chosen as endogenous control in 
this study because its relatively lower variation compared with the other two. 
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of inflammatory cells to the site of infection (Martin et al., 1997, Polito and 
Proud, 1998, Tam et al., 2011). To understand whether proinflammatory genes 
cells were differentially induced in diffCalu-3 upon WT and ǻSTV$L infection, 
levels of mRNA encoding for several proinflammatory cytokines and 
chemokines were examined by qPCR. The products investigated included GM-
CSF, IL-8, TNF-Į, IL-6, IL-1ȕ, IL-18, IL-17C and IL-17E. Our results show 
that transcription of GM-CSF, IL-8, TNF-Į and IL-6 was significantly induced 
in diffCalu-3 cells upon WT and ǻSTV$L infection (Fig. 4.6). The levels of IL-
17C transcripts were also highly upregulated in diffCalu-3 cells after exposure 
to WT and ǻSTV$L, whereas the expression of IL-17E was not increased. No 
induction of the expression of IL-1ȕ and IL-18 in Calu-3 cells upon PAO1-L 
WT and ǻSTV$L infection was observed in our study (Fig. 4.6). 
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Figure 4.6  Induction of pro-inflammatory cytokines, GM-CSF, IL-8, TNF-Į, IL-17c, and 
IL-6 in Calu-3 cells in response to WT and ǻpqsAL. 
Expression of transcripts encoding for GM-CSF, IL-8, TNF-Į and IL-17c was increased by the 
infection with WT (black dots) and ǻpqsAL (white dots) compared to uninfected controls (grey 
dots). IL-6 expression was also induced by P. aeruginosa infection but levels varied among 
experiments (n=2-4). Each dot represents the result from an independent experiment 
performed in duplicate. QPCR assay was done in triplicate. *ND, not detectable in one single 
experiment. P-values were calculated by one-way ANOVA and non-parametric Kruskal-
Wallis test. *p <0.05 
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4.5.2.3. Similar induction of pro-inflammatory cytokines at protein level in 
response to WT and ǻSTV$L infection of diffCalu-3 cells. 
While qRT-PCR quantifies the relative expression of mRNA transcripts, levels 
of mRNA do not always correlate with protein expression. In addition, whether 
cytokines are transported to the extracellular milieu to play their roles as 
immune mediators also remains unknown. To address this question, we 
quantified the levels of the proinflammatory cytokines IL-6, TNF-Į, GM-CSF, 
IL-1ȕ, and chemokines IL-8 and monocyte chemotactic protein-1 (MCP-1, also 
known as CCL2) either by a high-throughput bead-based immunoassay or the 
enzyme-linked immunosorbent assay (ELISA). At 2 hpi, the levels of IL-6, IL-
8, TNF-Į and GM-CSF were slightly increased in response to WT and ǻSTV$L 
but this was not significantly different. The levels of MCP-1 in the supernatant 
at 2 hpi remained unchanged compared to untreated cells. The productions of 
IL-6 (819 ± 458 in WT infection; 947 ± 621 in ǻSTV$L infection) and TNF-Į
(434 ± 204 in WT infection; 436±186 in ǻSTV$L infection) were dramatically 
increased at 6 hpi, whilst the secretion of MCP-1 (386 ± 303 in WT infection; 
155 ± 33 in ǻSTV$L infection) and GM-CSF (63 ± 32 in WT infection; 71 ± 30 
in ǻSTV$L infection) were also enhanced to levels significantly different from 
the uninfected cells. IL-8 seemed to be intrinsically secreted by both untreated 
and infected Calu-3 cells at relatively high levels. No consistent production of 
IL-1ȕ was detected. 
Providing the high induction of GM-CSF and TNF-Į of mRNA in Calu-3 cells 
upon both WT and ǻSTV$L infection, the levels of GM-CSF production in the 
supernatant did not seem to correlate with its high mRNA expression. We 
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speculated that the production of GM-CSF might be retained in the cytoplasm 
of infected cells. To test this hypothesis, lysates of uninfected and infected 
Calu-3 cells were collected at 3 and 6 hpi and subjected to Western blotting 
against anti-rhGM-CSF antibody. The positive control was purified 
recombinant human GM-&6)DWDFRQFHQWUDWLRQRIȝJDQGȝJȕ-actin 
was used as the endogenous control for each condition. The results showed that 
GM-CSF was not detectable in any of the lysates (Fig. 4.8). Thus, low levels of 
GM-CSF secretion were not attributed to cytosolic accumulation. However, we 
noticed that ȕ-actin disappeared in cells infected with WT and ǻSTV$L at 6 hpi. 
GM-CSF production might be inhibited due to severe cell damage leading to a 
halt of metabolism and protein trafficking. 
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Figure 4.7  Infection on Calu-3 cells with WT and ǻpqsAL induced the secretion of 
proinflammatory cytokines at 2 and 6 hpi. 
Differentiated Calu-3 cell basal media were collected after infection with WT, ǻpqsAL and 
PBS only as negative control. Media were centrifuged and were subjected to cytokine 
quantification. Production of pro-inflammatory cytokines IL-6, TNF-Į, MCP-1 and GM-CSF 
was induced by P. aeruginosa infection but the levels did not differ between the WT and 
ǻpqsAL. Each dot represents the mean from one single experiment. (n=2-5). *p <0.05 
**p<0.005. Unt, untreated. P-values were calculated by one-way ANOVA with non-
parametric Kruskal-Wallis test. 
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4.5.3. Similar activation of innate signalling pathways in diffCalu-3 cells 
upon P. aeruginosa PAO1-L WT and ǻSTV$L infection 
In spite of the similar levels of cytokines and chemokines (mRNA and protein) 
in Calu-3 cells when exposed to WT and ǻSTV$L infection, how these 
downstream consequences were initiated has not been clarified. The binding of 
bacteria and shed bacterial components to pattern recognition receptors (PRRs) 
leads to the activation of signalling pathways that can result in the secretion of 
cytokine and chemokines. Changes in cytokines and chemokines gene 
expression are coordinated by latent transcription factors of the nuclear factor-
kB (NF-țB) and interferon regulatory factor (IRF) families. Also, mitogen-
activated protein kinase (MAPK) p38, c-Jun N-terminal kinase (JNK), and 
extracellular-signal-regulated kinases (ERK1/2), the serine±threonine kinase 
Figure 4.8  Low levels of GM-CSF secretion was not due to the accumulation in the 
cytoplasmic compartment. 
Differentiated Calu-3 cells were infected with WT and ǻpqsAL at a MOI of 50. Cells were 
lysed with RPPA cell lysis buffer at 3 and 6 hpi. Lysate proteins were resuspended in SDS-
PAGE sample buffer, electrophoresed on 12% SDS-PAGE, transferred to a PDVF membrane 
and incubated with mouse anti-rhGM-CSF and mouse anti-ȕ-actin antibody as endogenous 
control. Goat anti-mouse IgG-horseradish peroxidase conjugate was used as a secondary 
antibody. Two concentrations of recombinant hGM-CSF, 0.45 ȝg and 0.2 ȝg, were used as 
positive control. GM-CSF was not detectable in the cytoplasm. Unt, untreated. Noted that 
actin was significantly degraded at 6 hpi in this experiment (Representative image from n=2).  
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Akt (AKT Ser and Thr) are often involved in the proinflammatory signalling. 
The signalling pathways need to be tightly regulated to ensure the induction of 
cytokines and chemokines is appropriate in magnitude and duration (Ryu et al., 
2010, Takeuchi and Akira, 2010). To further establish the potential 
consequences of PQS on skewing the activation of Calu-3 cells upon P. 
aeruginosa infection, activation of a series of signalling kinases and 
transcriptional factors associated with proinflammatory activation were 
measured by reverse phase protein microarray and normalised against actin. As 
the ability to accurately discriminate between small changes in protein 
expression is limited in a Western-blot based technique such as this one, only 
changes greater than 2-fold were considered true results. (The microarray work 
was conducted by Dr. Ola Negm).  
The results showed that infection of differentiated Calu-3 cells with WT and 
ǻSTV$L led to a mild activation of mitogen protein kinase (p38 and ERK1/2), 
transcriptional factor NF-țǺ (p65 subunit), IRF7, and AKT Threonine to 
comparable levels at 3 hpi (Fig. 4.9). An increase to 1.4 fold was seen on the 
activation of p38, NF-țB and AKT Threonine signaling pathways and to 1.2 
fold in the case of ERK1/2 and AKT Serine compared to uninfected cells. 
These changes cannot be considered as a real induction. Dr. Ola Negm 
mentioned a concern about the loss of fluorescence signals due to actin in the 
cells infected with P. aeruginosa (refer section 4.5.4. Fig. 4.12A). Due to the 
concern that the arbitrary intensity of signal transduction proteins might be 
concealed by the normalisation with actin, we recalculated the activation level 
of signalling proteins based on absolute values without normalisation. However, 
the results showed none to even less signal induction in P. aeruginosa infected 
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cells compared to the signal from untreated cell control (Fig. 4.10). This 
suggested actin normalisation is essential to calibrate the levels of activation. 
The activation of signalling cascades detected in Calu-3 cells upon WT and 
ǻSTV$L infection was too weak to be regarded as a true induction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9  A small induction of mitogen activated protein kinase, NF-țB, 
serine/threonine AKT and IRF7 signaling pathways in Calu-3 cells in response to WT 
and ǻpqsAL infection. 
Several canonical signaling pathways associated with proinflammatory response and 
respiratory inflammation were investigated including MAP kinase, NF-țB, serine/threonine 
AKT and IRF7 in differentiated Calu3 cells upon WT and ǻpqsAL infection at 3 hpi. WT and 
ǻpqsAL induced comparable activation of signaling in Calu-3 cells. However, the signaling 
induction by P. aeruginosa infection was not significant enough to discern from the untreated. 
Significance was assessed by one-way ANOVA and non-parametric Kruskal-Wallis test. (n=3) 
 
Figure 4.10  Actin normalisation is essential for interpretation of signaling data. 
Absolute fluorescence signals for each phosphorylated signalling proteins were plotted (n=3) 
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4.5.4. Assessment of P. aeruginosa-mediated cytotoxicity in response to 
WT and ǻpqsAL infection.   
Actins are highly conserved proteins involved in the maintenance of cell 
structure and integrity. ȕ-actin was used as an endogenous control to normalise 
the signals for signalling proteins in the microarray-based signalling study. 
Unexpectedly, we found that WT and ǻSTV$L infection induced the loss of 
actin fluorescence signal at 3 hpi and 6 hpi. It is well-established that actin 
depolymerisation takes place when cells are exposed to either drugs, chemicals 
or pathogen infection and cell survival is compromised. Thus, actin 
degradation can be used as an indication of cytotoxicity through apoptosis or 
necrosis (Geijtenbeek, 2012). The absolute intensity of actin fluorescent signals 
from lysates obtained at 3 hpi and 6 hpi were therefore taken as a means to 
evaluate cytotoxicity. Loss of actin signals on the microarray chip is showed in 
Fig. 4.11A. Signals due to actin from untreated Calu-3 cells were 9667.8 ± 
1851 arbitrary fluorescence unit (AFU) and they dropped to 6403 ± 1638, 6978 
± 1118 AFU at 3 hpi upon WT and ǻSTV$L infection, respectively. At 6 hpi, the 
actin signals from uninfected cells was 10,984 ± 612 and those from cells 
infected with WT and ǻSTV$/ dropped dramatically to 475 ± 210 and 602 ± 
360, respectively (Fig. 4.11B). No significant differences were observed 
between Calu-3 cells infected with WT and ǻSTV$/. The loss of actin during P. 
aeruginosa infection of diffCalu-3 is in an agreement with the lack of ȕ-actin 
in cell lysates of diffCalu-3 infected with P. aeruginosa at 6 hpi observed by 
Western blotting (Fig. 4.8) and suggest that both WT and ǻSTV$L infection 
caused actin degradation in diffCalu-3 cells. 
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Furthermore, to understand whether ȕ-actin was an exclusive target during WT 
and ǻSTV$L infection in bronchial epithelial cells, the expression of two other 
commonly used endogenous control proteins, heat-shock protein 90 (HSP90) 
and nucleoporin 98 kDa (NUP98), was also examined by reverse phase protein 
microarray (Fig. 4.12). HSP90 is an abundant ATP-dependent molecular 
chaperone essential for activating many signaling proteins in the eukaryotic 
cell (Retzlaff et al., 2009). Similarly, the 98 kDa NUP98 is constitutively 
generated from a cleavage of a 186 kDa precursor protein resulting in its 
localisation on the nucleoplasmic side of nuclear pore complex (NPC). NPC 
proteins are critical in regulating nucleocytoplasmic traffic of macromolecules 
across the nuclear envelope (Franks and Hetzer, 2013, Xu and Powers, 2013). 
Levels of NUP98 are constant under non-pathological situations. As shown for 
actin, levels of HSP90 were significantly reduced in both WT and ǻpqsAL-
infected cells at 6 hpi. In contrast the levels of NUP98 on infected cells 
remained intact compared with the untreated cells. These results suggest that 
both WT and ǻSTV$L cause cytotoxicity in Calu-3 cells by inducing 
degradation of cytoskeleton components and chaperon proteins which might 
lead to the downregulation of downstream signalling proteins. 
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Figure 4.11  WT and ǻpqsAL induced actin degradation on differentiated Calu-3 cells. 
White rectangles indicated the dots where actin red fluorescent signals were missing on the 
array slide (A). Absolute fluorescence values from untreated cells and cells infected with WT 
and ǻpqsAL for 3h and 6 h were plotted in (B). Significant actin degradation in response to 
WT and ǻpqsAL infection compared with untreated cells started at early at 3 hpi; substantial 
actin degradation was observed at 6 hpi. The amount of actin in uninfected cells at 3 and 6 
hpi remained constant. Data were obtained from three independent experiments each 
performed in duplicate. P-value was calculated by one-way ANOVA. ** p< 0.005 and **** 
p< 0.0001. 
 
Figure 4.12  P. aeruginosa PAO1-L WT and ǻSTV$L induced actin and HSP90 
degradation, but did not affect NUP98 levels. 
Degradation of actin (left panel) and HSP90 (middle panel) on Calu-3 cells was induced by WT 
and ǻpqsAL infection. Each bar is the mean from 3 independent experiments. At 6 hpi, the 
reduction was significant with p-value <0.0001 calculated by one-way ANOVA. Nucleoporin 
98-kDa (NUP98) remained intact during the course of P. aeruginosa infection (right panel). 
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Cytotoxicity is a general term that encompasses cell death by apoptosis or 
necrosis. Lactate dehydrogenase (LDH) is a stable cytoplasmic enzyme 
presents in all cell types. It is readily released to the cell culture supernatant 
when the plasma membrane integrity is compromised upon damage. The LDH 
activity is determined in an enzymatic test; firstly, LDH reduces NAD+ to 
NADH+ and H+ by the conversion of lactate to pyruvate; secondly, 2H are 
transferred from NADH+ H+ to the yellow tetrazolium salt by a catalyst turning 
pale yellow colour to a red colour formazan salt. Quantification of cell death is 
based on a reliable correlation of the amount of LDH in the supernatant with 
the amount of cell death. Initially, the LDH assay was performed using culture 
supernatants from the basal chamber of infected diffCalu-3 cultures. However, 
a significant background caused by the presence of 10% FBS which interfered 
with the colorimetric reaction was observed. To overcome this problem, WT 
and ǻSTV$L were used to infect on undifferentiated Calu-3 cells grown to 
confluency in a 24-well plate. In this setting, culture media were replaced with 
serum-free medium prior to infection assay. By comparing with cell 
supernatants obtained from cells lysed with 1% Triton-X100 that represented 
100% cytotoxicity, it was estimated that WT and ǻSTV$L induced 7% cell death 
at 3 hpi and 22% at 6 hpi (Fig 4.13). Intrinsic cell death of uninfected cells was 
3-4% at 3 and 6 hpi. Thus, WT and ǻSTV$L induced similar cytotoxicity at 3 
and 6 hpi and this is in agreement with the degradation of actin and HSP90 
previously described. 
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4.5.5. WT and ǻSTV$L disrupted tight junctions and abrogated barrier 
function 
P. aeruginosa causes disruption of tight junctions, resulting in decreased 
epithelial barrier function and increased access to the basolateral surface 
(Rejman et al., 2007). It has been shown that P. aeruginosa is cytotoxic to 
human airway epithelia only when the bacteria have direct access to the 
basolateral membrane where the P. aeruginosa adhesins flagella and type IV 
pili mediate the initial adherence (Lee et al., 1999, Bucior et al., 2010, Bucior 
et al., 2012). Using protein microarray, in comparison to the readings from 
uninfected Calu-3 cells, AFU readings of tight junction proteins ZO-1 and E-
cadherin, mucin protein MUC5AC and cilia-associated ȕ-tubulin IV dropped 
slightly at 3 hpi, and were significantly reduced at 6 hpi on the cells infected 
Figure 4.13  Calu-3 cell death during the course of infection with WT and ǻSTV$L. 
Cell death caused by WT and ǻSTV$L infection increased from 7.7± 1.1% and 7.7 ± 1.6% at 3 
hpi to 22.6 ± 2.6% and 21.7 ± 1.9% at 6 hpi, respectively. Cytotoxicity was assessed in 
comparison with LDH content released from 100% cell death prepared from cells lysed with 
1% Triton X-100. Data presented were mean ± SD from 3 independent experiments. 
Significance was calculated by one-way ANOVA and Kruskal-Wallis test. *p<0.05. 
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with WT and ǻSTV$L. Thus it appears that WT and ǻSTV$L induce the loss of 
junction proteins, mucin and cilia in Calu-3 cells at equivalent levels 
suggesting that PQS production during P. aeruginosa LQIHFWLRQGLGQ¶WDIIHFWWKH
breaching of the epithelial cell barrier.  
 
 
 
 
Figure 4.14  PQS was not essential for PAO1-L on epithelial barrier destruction and 
tight junction disruption. 
Calu-3 cells surface glycoprotein MUC5AC, cilia associated Į-tubulin IV and tight junction 
proteins ZO-1 and E-cadherin were compromised to WT and ǻSTV$L infection at comparable 
levels. Significant protein reductions happened at 6 hpi. Each bar is the mean from three 
independent experiments. P-values were evaluated by one-way ANOVA. 
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4.5.6. Analysis of the interaction of WT and ǻSTV$L with differentiated 
Calu-3 cells at low MOI 
Based on the above experiments, WT and ǻSTV$L displayed similar phenotypes 
during their interaction with bronchial epithelial cells regarding bacterial 
growth, cytotoxicity, induction of proinflammatory response and signalling. 
However, the capability of P. aeruginosa to exploit the amino acid tryptophan 
for PQS biosynthesis but not for AHLs QS molecules suggests a predominant 
role for PQS in coordinating P. aeruginosa metabolism during long-term host 
colonisation (Collier et al., 2002, Heeb et al., 2011). In addition, the fact that 
mutations in lasR are commonly found in chronic CF isolates imply PQS QS 
might override the effect from AHL-dependent QS in modulating P. 
aeruginosa pathogenesis during chronic infection (Winstanley and Fothergill, 
2009). To test this hypothesis, we adapted the diffCalu-3 infection model in an 
attempt to better recapitulate the long-term persistence of P. aeruginosa in 
native lung. For this low inocula (MOI 0.5) were used to infect polarised Calu-
3 cells. In this assay, the growth of cell-associated bacteria and the bacteria 
transmigrated to the basal chambers were assessed at 6, 9, 12 and 24 hpi. 
Bacteria cultured in MEM was again used as the PA only control. The ability 
of Calu-3 cells to restrict P. aeruginosa growth was presented as the ratio of 
the cell-associated bacteria to PA only control and the ratio of transmigrated 
bacteria to PA only control. Surprisingly, at low MOI the integrity of the 
polarised Calu-3 cells barrier was compromised at 6 hpi upon infection with 
both WT and ǻSTV$L as bacteria was detected in the basal chamber (Fig. 4.15) 
despite the fact that the MOI was 0.5 which is 100-fold less than the MOI used 
in the previous assays (see Section 4.5.1). Although the barrier function of 
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diffCalu-3 cells culture was compromised at 6 hpi, bacterial growth was 
restricted until 12 hpi. For instance at 12 hpi, the growth of WT and ǻSTV$L 
within the epithelial cells was reduced up to 70% compared with the number of 
bacteria in the PA only controls. However, the infectivity and bacterial growth 
of ǻSTV$L in bronchial epithelial cells were comparable to those observed for 
WT even in this long-term infection setting. Thus, PQS might not contribute to 
P. aeruginosa pathogenesis during the infection of human bronchial epithelial 
cells even by using low MOI. 
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Figure 4.15  Both WT and ǻSTV$L breached the epithelial barrier at 6 hpi at MOI 0.5 
but the epithelium restrained PA growth till 12 hpi.  
Infections on Calu-3 cells with PAO1-L WT and ǻSTV$L at MOI 0.5 were performed three 
times independently (Exp. 1, 2 and 3). Cell-associated bacterial growths (circle, on the left of 
the graph) and transmigrated bacteria (triangle, on the right of the graph) at 6, 9, 12 and 24 h 
were compared with growth in MEM only and presented as percentage. The epithelium 
consistently restrained PA growth until 12 hpi. P. aeruginosa grew mainly associated to Calu-
3 cells therefore the bacteria transmigrated to the basal chamber were relatively low. 
Surprisingly, P. aeruginosa at MOI 0.5 breached the epithelial barrier starting at 6 hpi as at 
MOI 50. No significant differences between WT and ǻSTV$L could be discerned at this MOI. 
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4.5.7. Analysis of the potential role of PQS in modulating ROS production 
by human neutrophils in response to PAO1-L 
So far, despite in vitro phenotypic characterisation demonstrated the ǻSTV$L 
mutant has lost the expression of numerous virulence factors, PQS deficiency 
in P. aeruginosa does not seem to affect the interaction with human bronchial 
epithelial cells. We wondered whether the lack of professional immune cells in 
this single cell model was intrinsically inert to P. aeruginosa infection and 
could not provide an appropriate model to discriminate the impact of PQS on P. 
aeruginosa virulence. Neutrophils are key players in the innate immune 
response to microbial infections. During infection, following the phagocytosis 
of pathogens and their delivery to phagolysosomes, a reaction called 
respiratory burst releases high concentrations of super oxide into the 
phagosome and a cascade of reactions occur resulting in the generation of 
additional reactive oxygen species (ROS) finalise the destruction of pathogens 
(Robinson, 2008). ROS production is used as an approach to assess the ability 
of neutrophils to respond to stimuli and can be quantified by a robust 
chemiluminescence assay. To determine whether PQS would alter the 
production of ROS by neutrophils in response of P. aeruginosa, PAO1-L at 
MOI 20 were administered to neutrophils in the presence or absence of 
exogenous AQs using zymosan (20 particles per cell) as the positive control. 
Because AQs (PQS (2-heptyl-3-hydorxy-4(1H)-quinolone) and Me-PQS) were 
initially reconstituted in methanol, methanol diluted to the same concentrations 
as those used for PQS compounds was used as control. Unexpectedly, 
methanol affected ROS production by neutrophils in response to zymosan 
and/or PAO1-L (Fig. 4.16A and 4.16D) and there was variability regarding the 
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ability of P. aeruginosa to elicit ROS production in human neutrophils (see 
below). The preliminary data obtained from only two donors are inconclusive 
and the analysis of the ability of PQS to modulate ROS production by 
neutrophils requires further investigation.   
In addition, donor dependent variability in ROS production by neutrophils in 
response to PAO1-L was observed. As shown in Fig. 4.17, ROS production 
elicited by PAO1-L exhibited two major patterns. A weak response to PAO1-L 
results in continuous low to intermediate production of ROS throughout the 
assay (Fig.4.17 A, B and C from donor 1, 2 and 5). The other pattern showed a 
rapid high production of ROS to levels equivalent to or higher than those 
elicited by zymosan followed by a sharp decrease (Fig.4.17 D and E from 
donor 3 and 4). 
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Figure 4.16 Effect of PQS on ROS production by human neutrophils. 
ROS production by neutrophils (PMNs) in response to zymosan and PAO1-L were examined. In 
donor 2, in spite of a background induction of ROS productionby the diluents, addition of PQS 
inhibited ROS production by PMNs in response to zymosan (A and B) and PAO1-L (D and E) 
in a dose-dependent manner. Maximum chemiluminescence peaks in response to zymosan (C) 
and PAO1-L (F) in the presense of diluents and different doses of PQS. Continuted next page 
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(Continued from Fig. 4.16) In donor 4, the influence of the diluent in the generation of PQS 
was negligible but still no major effects of PQS were observed (G, H, J, K, L). Maximum 
chemiluminescence peaks in response to zymosan (I) in the presence of different doses of 
diluents and PQS; Maximum chemiluminescence peaks in response to PAO1-L (M) in the 
presence of different doses of diluent, PQS and methylated PQS (Me-PQS). 
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Figure 4.17  Donor dependent variability in ROS production by human neutrophils. 
Viable PAO1-L elicited two patterns of ROS production by neutrophils (PMNs). A B and C 
represent pattern I in which low level ROS was persistently produced by PMNs in response to 
PAO1-L throughout the assay; D and E represent another pattern in which there was a high 
peak of ROS production that dropped gradually afterwards. F, maximum luminescence peaks in 
response to zymosan and PAO1-L in 5 donors. Black symbols denote PMNs treated with 
zymosan, white circles denote PMNs treated with PAO1-L and grey dots are PMNs alone. 
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4.6. DISCUSSION 
The presence of PQS in CF lungs and the fact that CF sputum has been shown 
to induce high PQS biosynthesis in P. aeruginosa suggested that PQS might 
play a role in promoting P. aeruginosa persistence in the CF lung (Collier et al., 
2002, Guina et al., 2003, Palmer et al., 2005). Regarding the role of PQS in 
immune modulation, PQS has been implicated in down-regulating the 
inflammatory response via inhibition of NF-țǺ and hypoxia-inducible factor 1 
(HIP-1) signalling in human and mouse airway epithelial cells (Kim et al., 
2010b, Legendre et al., 2012). P. aeruginosa pqsA knock-out mutant (PAO1 
Nottingham background) was attenuated in a mouse burned wound model 
(Rampioni et al., 2010). The above studies suggested that PQS support P. 
aeruginosa persistence by inhibition of inflammatory signalling. We thus 
postulated that Pqs QS might be positioned at a higher hierarchy to coordinate 
the expression of a range of virulent factors in P. aeruginosa. Understanding 
the effect of PQS in the host response in human bronchial epithelial cells could 
provide us with a potential intervention target for immune modulation. 
However, here we demonstrated that PQS does not play a role in the initial 
recognition of P. aeruginosa PAO1-L by differentiated human bronchial 
epithelial cells. This conclusion is based on the analysis of bacterial 
colonisation/growth, cellular cytotoxicity, barrier integrity, induction of pro-
inflammatory cytokines and activation of inflammation and upstream kinase 
signalling pathways. Furthermore, a preliminary investigation of the influence 
of AQs on the respiratory burst by human neutrophils was also performed. The 
addition of exogenous PQS on PAO1-L WT-treated neutrophils seemed to 
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inhibit the generation of ROS by neutrophils, although the results were not 
conclusive and further repeats are required to address the donor variation effect. 
The diluent methanol itself might disturb host cell membrane permeability 
resulting in altered ROS production which makes data interpretation difficult 
(Hancock et al., 2001, Burch and Heintz, 2005).  
Despite the in vitro phenotypic characterisation showing that ǻSTV$L mutant 
was deficient in the production of various virulence factors compared to 
PAO1-L WT (Chapter 2), the conditions during the infection of differentiated 
bronchial epithelial monolayer might profoundly impact the physiology of WT 
and ǻSTV$L as well as their capability to secrete AQs to the extracellular milieu. 
To address this concern we tested whether AQs were produced and secreted to 
the extracellular compartment by WT but not by ǻSTV$L in the context of 
differentiated human airway.  Basal media from infected diffCalu-3 cells were 
collected, centrifuged to remove cell debris, and subjected to liquid 
chromatography-mass spectrometry (LC/MS) for the quantification and 
identification of QS molecules. Supernatants from WT and ǻSTV$L cultures in 
MEM were used as controls.  (LC-MS analysis was supported by Dr. Catharine 
Ortori and data interpretation was assisted by Dr. Jean Dubern.) AQ molecules 
2-heptyl-3-hydroxy-4(H)-quinolone (PQS), 2-heptyl-4H-quinolone (HHQ) and 
2-heptyl-4(H)-quinolone N-oxide (QNO) were all detectable in the 
supernatants of WT MEM cultures at 6 hpi but only a minimal amount of AQ 
molecules was detected in the ǻSTV$L infected culture (Fig. 4.18A). PQS, HHQ 
and QNO were detected in the basal chamber from WT-infected diffCalu-3 
cells but much less to none were identified in ǻSTV$L infected cultures (Fig. 
4.18B). In addition, the AHL-QS molecules C4-HSL and 3-oxo-C12 were also 
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included in the LC/MS study. No major differences in the levels of C4-HSL 
and 3-oxo-C12-HSL secreted by WT and ǻSTV$L in MEM only (Fig. 4.19A) 
and in the Calu-3 cell basal chambers (Fig. 4.19B) were observed, although the 
large error bars due to lack of repeats rendered the results inconclusive. 
The QS molecule identification supported our initial assumption that minimal 
to none PQS, HHQ and QNO were secreted by ǻSTV$L during the infection 
with diffCalu-3 cells. Thus, comparable cytotoxicity and infectivity of WT and 
ǻSTV$L were unlikely attributed to the lack of PQS production by WT or the 
complementation of PQS production in ǻSTV$L. However, since the initial plan 
of this project was to establish a robust co-culture model including epithelial 
cells and phagocytes to study the innate immune response upon microbial 
infections, infections of M-CSF primed macrophages (a model for resident 
tissue macrophages (Hamilton, 2008) derived from CD14+ monocytes purified 
from PBMCs) with WT and ǻSTV$L was also performed. The results showed 
that the growth of WT and ǻSTV$L on macrophages was comparable at 2, 4 and 
6 hpi. M-CSF primed human macrophages inhibited WT and ǻSTV$L growth to 
an equivalent level and no significant differences were identified (Fig. 4.20). 
The differences between experiments might be due to donor to donor variation. 
Thus, no infectivity difference was identified between the PQS-competent 
strain and PQS-deficient strain in macrophages.  
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Figure 4.19  WT and ǻSTV$L produced comparable amounts of C4-HSLand 3-oxo-C12-
HSL in MEM and in the basal medium of diff Calu-3 cells after infection. 
Concentrations of C4-HSL and 3-oxo-C12-HSL were determined by LC-mass spectrometry in 
the cell-free supernatants from WT and ǻSTV$L in MEM (A) or supernatants from WT and 
ǻSTV$L infected diffCalu-3 cells (B). Graphs present the mean of duplicates from one 
experiment and the standard error from the mean. 
Figure 4.18  PQS, HHQ and QNO were detectable in MEM only and the basal medium 
from Calu-3 cells infected with WT, but not ǻSTV$L. 
Concentration RI346SUHVHQWHGLQPLFURDEVRUEDQFHXQLWP$8++4ȝ0DQG412ȝ0
were determined by LC-mass spectrometry. PQS, HHQ and QNO were detectable in MEM 
culture supernatants of Wt (A) and the basal medium of differentiated Calu-3 cells infected with 
WT (B). None to small amounts of PQS, HHQ and QNO were detected in samples from ǻSTV$L 
infection either in MEM medium only or in the basal medium after infection of differentiated 
Calu-3 cells. No PQS, HHQ and QNO were detectable in MEM medium or basal medium from 
uninfected Calu-3 cells used as negative controls (data not shown). The results were obtained 
from one experiment with duplicates and the standard errors from the mean. ND, not detectable.  
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Thus, we wondered why WT and ǻSTV$L did not differ in pathogenicity when 
infecting on the diffCalu-3 cells despite the different phenotypes identified in 
vitro.  
During early infection, apical protrusions of diffCalu-3 cells were observed in 
contact with WT and ǻSTV$L and both displayed a single flagellum based on 
SEM images at 2 hpi. WT and ǻSTV$L were also seen attached near cellular 
junctions. P. aeruginosa binding to adjacent host cell junctions has been shown 
to activate and recruit phosphatidylinositol 3-kinase (PI3K) to the apical 
Figure 4.20  Equivalent growth of WT and ǻSTV$L on M-CSF primed macrophages. 
The impact of PQS on the infection of P. aeruginosa at MOI 1 of M-CSF primed macrophages 
was analysed at 2, 4 and 6 h. In experiment A, macrophages restrained the WT and ǻSTV$L 
infection at 4 hpi (80% bacteria reduction); at 6 hpi, WT overgrew than the control but ǻSTV$L 
growth was still under control by macrophages to 30% inhibition. In experiment B, macrophages 
elicited approximately 50% of killing of both WT and ǻSTV$L and the killing effect continued till 
6 hpi to 70%. 
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surface (Kierbel et al., 2005, Kierbel et al., 2007). PI3K, localised to the 
epithelial cell basolateral surface, is required for the synthesis of 
phosphatidylinositol 3,4,5-triphosphate (PIP3) leading to the activation of a 
downstream serine/threonine kinases Akt. The enrichment of PIP3 and actin at 
the apical surface of bacteria binding site via the activation of PI3K/PIP3/AKT 
pathway was shown to be necessary and sufficient for P. aeruginosa 
internalisation in polarised epithelial cells (Kierbel et al., 2005). In addition, it 
has been shown that P. aeruginosa type IV pili bound to apical receptors N-
glycans whereas flagella preferentially bound to heparan sulfate proteoglycans 
which are enriched at basolateral region in either injured or polarised MDCK 
and Calu-3 cells (Bucior et al., 2010, Bucior et al., 2012). These studies 
suggested P. aeruginosa is subverting host cell polarity to transform apical into 
basolateral membrane with the aid of pili and flagellum at early stages of 
infection thus generating a niche for colonisation of the local host cell 
environment. Subsequently, the formation of bacterial aggregates as 
microcolonies takes place (Engel and Eran, 2011). As both WT and ǻSTV$L 
had comparable swarming ability which is a phenotype dependent on type-IV 
pili (TFP) and flagella, their colonisation capacity on host cells was expected to 
be equivalent. Meanwhile, WT and ǻSTV$L induced comparable levels of 
mRNA of pro-inflammatory cytokines including GM-CSF, TNF-Į, IL-8 and 
IL-17C in diffCalu-3 cells at 2 hpi. The results above suggest that PQS might 
not influence P. aeruginosa infectivity and immune modulation at early times 
post-infection.  
P. aeruginosa has been shown to form aggregates rapidly upon the interaction 
with epithelial cells and the internalisation of bacterial microcolonies taking 
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place at PIP3-enriched protrusions in a Lyn-mediated manner (Lepanto et al., 
2011). Lyn is a member of Src family tyrosine kinases. Consistent with this 
finding, internalisation of WT and ǻSTV$L by diffCalu-3 cells and small 
patches of microcolonies cells were observed in our confocal microscopy 
images at 3 hpi. Type III secretion system (T3SS) of P. aeruginosa is a 
syringe-like apparatus that translocates cytotoxic effector proteins from the 
bacteria, across the bacterial membranes and into the eukaryotic cytoplasm by 
forming a pore in the eukaryotic membrane. Previous studies demonstrated that 
T3SS effector proteins ExoS and ExoT, which possess GTPase activity at the 
N-terminal region and ADP ribosylates activity at the C-terminal region, could 
disrupt tight junctions, actin cytoskeleton and result in caspase 1-dependent 
apoptosis (Engel and Balachandran, 2009). Angus et al. further provided 
evidence that the ADP-ribosylation domain of ExoS is required for P. 
aeruginosa to reside in membrane blebs thereby promoting bacterial survival 
by inducing apoptosis rather than acute necrotic cell death (Angus et al., 2010). 
In agreement with these observations our data showed small amounts of actin 
degradation, tight junction protein disruption and cytotoxicity in WT and 
ǻSTV$L infected diffCalu-3 cells at 3 hpi.  
At 6 h of WT and ǻSTV$L infection on diffCalu-3 cells, substantial actin 
degradation, loss of tight junction proteins and transmigrated bacteria were 
consequently identified. The release of elastase B (LasB) and exotoxin A (ETA) 
by P. aeruginosa might aid this effect. LasB has been shown to disrupt tight 
junction proteins ZO-1 and ZO-2 as well as release mucins from rabbit trachea 
epithelial cells, whereas ETA inhibits protein synthesis via blockade of 
elongation factor-2 and therefore abrogates the restoration of tight junction 
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proteins once cells are injured (Klinger et al., 1984, Kipnis et al., 2006). P. 
aeruginosa PAO1-L has been shown to secrete ETA to the supernatant 
whereas PAO1-N subline was found deficient in ETA production (Farah 
Hussain, on-going PhD thesis). The production of ETA by ǻSTV$L can also be 
tested if required. Collectively, our data suggest that type IV pili, flagellum, 
T3SS toxins and extracellular proteases could be the predominant virulence 
factors that cause the infectivity of P. aeruginosa in an acute epithelial 
infection model rather than the role of PQS in regulating the expression of 
virulence factors. To prove the hypothesis, T3SS and PQS double mutant 
ExoS/pqsA, ExoT/pqsA or triple mutant ExoS/ExoT/pqsA could be generated to 
investigate the pathogenicity of P. aeruginosa in a similar infection setting.  
A recent study demonstrated an inverse association between the secreted levels 
of T3SS exotoxin ExoU and PQS, and their association with the disease 
progression of a patient with ventilator-acquired pneumonia (Singh et al., 
2010). High levels of PQS reversely correlated with ExoU secretion, whereas 
the expression of elastase and pyoverdin are positively controlled by PQS. 
Decreased PQS shifted the virulence profile from a chronic infection state to an 
acute phenotype that promotes the secretion of T3SS exotoxins. The 
phenotypic change paralleled the transition of a ventilator-acquired pneumonia 
clinical isolate to an acute T3SS secreting phenotype within a short period of 
time. Based on the above results the PQS deficient mutant ǻSTV$L was 
expected to have a more cytotoxic phenotype as the secretion of T3SS toxins 
would not be inhibited by extracellular AQs. However, due to the lack of ExoU 
in the genome of WT and ǻSTV$L (Winsor et al., 2011), the phenotype 
transition according to the axis of PQS and T3SS toxin cannot fully apply to 
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the strain PAO1-L, at least ExoS and ExoT do not seem to elicit a similar effect 
in the AQs deficient strain. 
Nasal airway epithelial cells and lung epithelial cells were shown to secrete the 
proinflammatory cytokines GM-CSF, IL-8, and IL-6 when exposed to P. 
aeruginosa rhamnolipids, autoinducer 3-oxo-C12 HSL and mucoid 
exopolysaccharides (Bédard et al., 1993, Smith et al., 2001). IL-8, also known 
as neutrophil chemotactic factor, readily recruits neutrophils and binding at the 
site of inflammation. GM-CSF not only stimulates myeloid cells survival, 
proliferation, and differentiation but is essential for normal pulmonary 
surfactant homeostasis and alveolar macrophage function (Trapnell and 
Whitsett, 2002). For instance, mice deficient in GM-CSF showed decreased 
survival to P. aeruginosa lung infection as a consequence of impaired killing 
and phagocytosis by alveolar macrophages (Ballinger et al., 2006). The 
cytokine TNF-Į participates in multiple biological effects and has been 
implicated in chronic inflammatory diseases such as asthma and pulmonary 
fibrosis. TNF-Į secreted by epithelial cells also stimulates IL-6, IL-8 and GM-
CSF production as a positive feedback loop and alters tight junction integrity 
(Ye et al., 2006, Martin et al., 1997). The IL-17 family of cytokines consists of 
at least six members IL-17A to IL-17F. To date, IL-17A which secreted mostly 
by Th17 cell subset has been best studied and it is essential in maintaining the 
mucosal homeostasis and mice deficient in IL-17A are more susceptible to 
respiratory infections. Attention to IL-17C has been drawn in recent studies as 
it is exclusively expressed in epithelial cells. Human bronchial epithelial cells 
(HBECs) have been shown to express IL-17C in response to P. aeruginosa, 
Haemophilus influenza, and TLR-3 as well as TLR-5 agonist stimulation. In 
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addition, IL-17C, acts as an autocrine cytokine; by binding to the receptors IL-
17RA and IL-17RE expressed in epithelial cells, promotes the expression of 
proinflammatory cytokines, chemokines and antimicrobial peptides in a skin-
inflammation model (Pappu et al., 2012, Pfeifer et al., 2012, Reynolds et al., 
2012). In accordance with a previous study, IL-1ȕ was not detectable in 
16HBE cells upon P. aeruginosa PAK flagella stimulation following 2 h to 24 
h given the presence of a Nlrc4 transcript was readily detected (Parker and 
Prince, 2013). The results of the cytokine profiling demonstrated that in vitro 
differentiated human bronchial epithelial cells mount a robust proinflammatory 
response upon viable PAO1-L WT and ǻSTV$L infection. High levels of the 
transcripts encoding for the proinflammatory cytokines GM-CSF, TNF-Į, IL-6 
and IL-17C and the chemokine IL-8 were detected at 2 hpi. Secretion of 
cytokines and chemokines was also evaluated. Abundant TNF-Į and IL-6 were 
detected at levels comparable with the high mRNA expression; however, the 
production of GM-CSF was relatively low given the high expression detected 
at mRNA level. Cytosolic GM-CSF accumulation was not detected. Whether 
the amount of GM-CSF protein is relatively low compared to TNF-Į due to 
translational inhibition or protein degradation in the cytoplasm requires further 
study. Chemokine IL-8 seemed constitutively produced at high levels by 
diffCalu-3 cell even in the absence of P. aeruginosa infection. In fact, the low 
CT values of IL-8 mRNA transcripts obtained from untreated Calu-3 cells 
might explain why the high levels of IL-8 secretion in uninfected cells were 
similar to those produced by P. aeruginosa-infected cells. It should be taken 
into consideration that IL-8 and IL-6 are more abundantly secreted apically 
than at the basal chamber shown in reproductive tract epithelial cells (Fahey et 
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al., 2005). Asymmetrical cytokine secretion could be a confounding factor as 
apical secretion has not been quantified in our study. 
 
To date, TLRs 1-10 have been found in airway epithelial cells, both in CF and 
non-CF tracheal and bronchial epithelial cell lines (Muir et al., 2004). TLR2 
and TLR5 are amongst the mostly studied and have been frequently associated 
with cellular activation in response to P. aeruginosa. The activation of 
intracellular signal pathways is initiated via the binding of flagellum and pili to 
asialoGM1 and TLR5. Further adherence is conferred by interactions between 
LPS and asialoGM1, CD14 and/or CFTR. Both flagellar interaction with TLR5 
and LPS binding to TLR4/MD2 activates myeloid differentiation primary 
response 88 (MyD88) adaptor protein-dependent NF-ț% SDWKZD\V leading to 
increased IL-8 transcription. TLR signaling also leads to activation of AP1 and 
the MAP kinases JNK, p38 and ERK1/2. TLR3, TLR4 and TLR5 in epithelial 
cells were found to reside mainly intracellularly (Greene and McElvaney, 
2005). TLR4 has also been shown expressed at low levels at the apical surface 
Figure 4.21  TLR protein expression in bronchial airway epithelial cells. 
TLR2 is the predominant TLR expressed on the apical surface of airway epithelial cells. 
TLR3 and TLR4 reside intracellularly and TLR5 is located at the basolateral surface. Black 
TLR, confocal data; grey TLR, flow cytometry or slide-based fluorescent cell counting data. 
Figure was adopted from (Greene and McElvaney, 2005). 
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in type II alveolar cell line A549 (Guillot et al., 2004). Additionally, studies in 
human bronchial epithelial cells including BEAS-2B, 16HBE, HAEo- and 
MM-39 showed that TLR4 resided intracellularly and that TLR in bronchial 
epithelial cells were hyporesponsive to Gram negative bacteria. Relatively low 
expression of TLR on the airway epithelium is suggested to avoid uncontrolled 
activation by inhaled bacteria. In our study, we found that the high levels of 
pro-inflammatory activation seen at 2 hpi do not correlate with a less than 2-
fold induction of upstream signalling at 3 hpi. This can be partly explained by 
the protein degradation taking place at 3 hpi that could have underestimated the 
overall signalling events. This problem can be solved by moving the time-
frame prior to 2 hpi or by monitoring an early time course. Moreover, the 
signalling pathways in this study including MAPK, NF-țǺ, IRF and AKT do 
not inclusively respond to bacterial infection but are also involved in the 
regulation of a variety of events, such as cell apoptosis, inflammation and 
metabolism. For instance, serine/threonine AKT pathway, in close cooperation 
with PI3K pathways, promotes cell growth through protein synthesis driven by 
mTOR signalling and inhibits apoptosis by blocking FoxO1 activity in cancer 
cells (Engelman, 2009, Weichhart and Saemann, 2008). Calu-3 cells used in 
this study were derived from lung adenocarcinoma that might inherently 
express high levels of PI3K/AKT signalling in which could mask the induction 
from P. aeruginosa infection.  
Because no differences in pathogenicity could be identified between a PQS-
competent and PQS deficient strain of P. aeruginosa using diffCalu-3 cells, the 
highly virulent CF clinical isolate Liverpool epidemic strain B58 (LESB58) 
was introduced in our study in order to verify the efficacy of this in vitro 
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human bronchial epithelial model. This investigation will be discussed in next 
chapter. 
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4.7. SUMMARY 
PQS is not required for the pathogenesis of P. aeruginosa PAO1-L during the 
initial innate immune recognition by bronchial epithelial cells based on 
bacterial colonisation, cytotoxicity, barrier breakage, and activation of 
proinflammatory response. Also, ǻSTV$L was not attenuated in the infection of 
M-CSF primed macrophages suggesting a marginal effect of PQS on P. 
aeruginosa pathogenesis even in the interaction with phagocytes.
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5. THE INTERACTION BETWEEN 
PSEUDOMONAS AERUGINOSA STRAIN LESB58 
AND HUMAN BRONCHIAL EPITHELIUM 
5.1. INTRODUCTION 
In the previous chapter, a AQs deficient mutant ǻSTV$L, displayed similar 
cytotoxic properties and infectivity to its isogenic wild type strain upon 
infection of diffCalu-3 cells (Chapter 4) in spite of its attenuated phenotype in 
vitro (Chapter 2). These results suggest that AQs might not be required during 
the infection of human bronchial epithelial cells by P. aeruginosa PAO1-L. 
However, we also wondered whether this infection model was capable of 
discerning between virulent and non-virulent strains of P. aeruginosa. To 
further examine the efficacy of this in vitro differentiated human bronchial 
epithelial infection model in differentiating between virulent and non-virulent 
P. aeruginosa strains, the Liverpool epidemic strain subtype B58 (LESB58), a 
CF clinical isolate, was studied. The ability of LESB58 to growth, disrupt the 
cellular cytoskeleton and induce the expression of pro-inflammatory cytokines 
was compared with those of PAO1-L.  
The Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa is a ȕ-
lactam-UHVLVWDQWLVRODWHILUVWO\LGHQWLILHGDWDFKLOGUHQ¶V&)FHQWUHLQ/LYHUSRRO
United Kingdom (Cheng et al., 1996). LES is transmissible and is the clone 
most frequently isolated from CF patients in England, Wales, Scotland and 
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Australia (Edenborough et al., 2004, Lewis et al., 2005, Armstrong et al.). In 
2002, a case report described the transmission of a super virulent LES strain 
from a CF patient to both her non-CF parents leading to significant morbidity 
and recurrent infections (McCallum et al., 2002). LESB58 is one of the LES 
CF isolates; it exhibits an unusual upregulation of the quorum sensing regulon 
that results in the overexpression of virulence-related exo-products LasA, 
elastase and pyocyanin and hyper production of biofilms (Salunkhe et al., 2005, 
Fothergill et al., 2007, Kukavica-Ibrulj et al., 2008). In addition to its resistance 
to ceftazidine which is how this widespread strain was identified during an 
anti-microbial screening of multiple LES isolates, it is known that the LES 
strains can acquire resistance to several antibiotics such as meropenem, 
aztreonam, tobramycin, and ciprofloxacin (Fothergill et al., 2007). Hence, the 
LES isolates are considered aggressive strains capable of adapting to the CF 
lung, because of their ability to mutate and resistance to the antibiotics 
commonly used for therapy. The P. aeruginosa strains PAO1 and PA14 were 
previously compared with LESB58 to assess in vivo growth, bacterial 
persistence, and localization within tissues in a rat model of chronic lung 
infection (Kukavica-Ibrulj et al., 2008). The three P. aeruginosa strains 
demonstrated similar growth in vivo and lung colonisation but were 
differentially distributed in lung tissues. Different infectivity profiles based on 
the bacterial CFU in mouse lung tissues 7 days post-infection were identified 
when the results were presented as competitive index (CI) values: 0.02 for 
PAO1-PA14, 0.002 for PAO1-LES and 0.14 for LES-PA14. The results 
indicated a 1,000-fold reduction in PA14 CFU when compared with PAO1, 
LESB58 showed 10,000-fold attenuation when compared with PAO1, whereas 
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PA14 was 10-fold attenuated when compared with LESB58 (Kukavica-Ibrulj 
et al., 2008). The LESB58 strain remained in the agarose beads used to deliver 
bacteria to the lung lumen, whereas PAO1 and PA14 strains disseminated into 
the alveolar regions and grew as macrocolonies at 14 days post-infection. 
These observations were consistent with the fact that LESB58 was less motile 
than PAO1 and PA14 but produced more biofilm in vitro. 
LESB58 is the earliest LES isolate archived and its whole genome has been 
sequenced (Winstanley et al., 2009). Compared to the genome of PAO1-L that 
harbours two tendon-defective prophages pyocin R2 and F2 (Stover et al., 
2000), five prophage clusters, one defective (pyocin) prophage and five non-
phage genomic islands were identified in the sequence of LESB58 (Winstanley 
et al., 2009). Because LESB58 appeared to be highly adapted to the human 
lung and behaved so differently to PAO1 and PA14 during chronic lung 
infection, we questioned whether AQs production could contribute to LESB58 
virulence by promoting persistence in the lung lumen and if this could be 
modelled using diffCalu-3 cells. The use of the virulent clinical strain LESB58 
would pave the road towards a better understanding of how virulent clinical 
isolates interact with bronchial human epithelium and the inflammatory 
response triggered upon infection with clinical strains. 
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5.2. HYPOTHESIS 
A clinical virulent CF strain LESB58 would differ from PAO1-L regarding its 
ability to cause cytotoxicity, grow and induce a pro-inflammatory response 
upon infection of diffCalu-3 cells. 
 
5.3. AIM 
To evaluate the suitability of the differentiated human bronchial epithelial cells, 
diffCalu-3 cells, as an in vitro infection model for the examination of the 
pathogenesis of P. aeruginosa, a transmissible virulent CF clinical isolate 
LESB58 was used to infect diffCalu-3. The phenotypic characterisation of 
LESB58 infection was performed in comparison with the laboratory strain P. 
aeruginosa PAO1-L. The parameters analysed were: bacterial growth on the 
epithelium, expression of pro-inflammatory cytokines and chemokines, cellular 
cytotoxicity and alterations in barrier function. 
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5.4. MATERIALS AND METHODS 
5.4.1. Phenotypic characterisation of LESB58 
The methodology used for the phenotypic characterisation of LESB58 was 
described previously in the materials and methods section in Chapter 4.  
5.4.2. Infection of diffCalu-3 cells with PAO1-L and LESB58 
Differentiated Calu-3 cell cultures were prepared as described in Chapter 3, 
section 3.4.1. For infection, P. aeruginosa PAO1-L and LESB58 were grown 
overnight for 16 h in LB broth at 37oC, 200 rpm, washed twice and suspended 
in sterile PBS containing CaCl2 and MgCl2 (Sigma-Aldrich, UK) at a 
concentration of 3.5x108 &)8PO )RU HDFK VWUDLQ  ȝO RI EDFWHULDO
suspension (equivalent to moi of 50) was added to the apical surface of 
diffCalu-3 cell cultures. Infected cultures were incubated at 37oC, 5% CO2 for 
3 and 6 h. 
5.4.3. Assessment of pathogenesis of LESB58 on diffCalu-3 cells in 
comparison with PAO1-L 
The methodology for the assessment of bacterial pathogenesis including 
bacterial growth, induction of pro-inflammatory response at mRNA and protein 
levels, and the cytotoxicity have been described previously in Chapter 4. 
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5.5. RESULTS 
5.5.1. Phenotypic characterisation of LESB58 in comparison with PAO1 
laboratory strains 
5.5.1.1. Growth characteristics, PQS and pyocyanin production by LESB58  
Initially, the bacterial growth and features associated with PQS QS regulation 
including the secretion of PQS molecules and the production of pyocyanin 
were examined in LESB58. LESB58 grew following a kinetics similar to that 
of the laboratory strain PAO1 (PAO1-L, PAO1-N, ǻSTV$L and ǻSTV$N) but 
reached a lower density at stationary phase when cultured in LB medium (Fig. 
5.1A, LB). However, in X-vivo 15 medium all P. aeruginosa strains displayed 
similar growth kinetics and reached comparable cell density (Fig. 5.1A, X-vivo 
15). Overnight cultures (16 h) of LESB58, PAO1-L and its isogenic ǻSTV$L 
mutant, PAO1-N and its isogenic mutant pqsA-N were collected, centrifuged 
and supernatants were retained for the analysis of PQS and pyocyanin 
production. The results showed that LESB58 produced 4-fold more PQS (Fig. 
5.1B) and pyocyanin (Fig. 5.1C) than PAO1-L in LB cultures; a 9-fold increase 
in PQS production by LESB58 compared to PAO1-L in X-vixo 15 cultures. 
Thus, although LESB58 reached lower cell density than PAO1-L at stationary 
phase, the productions of PQS and pyocyanin by LESB58 were higher than in 
PAO1-L. The results were consistent with the finding that most of the P. 
aeruginosa Liverpool CF epidemic strains of are characterized by over-
production of quorum sensing-regulated virulence factors including pyocyanin 
and LasA protease (Fothergill et al., 2007, Salunkhe et al., 2005). 
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Figure 5.1  LESB58 produced high amounts of PQS and pyocyanin compared to PAO1 
strains, despite reaching lower cell density in culture. 
Bacterial growth of LESB58 and PAO1 lab strains were monitored for 24 h in a static system 
(Tecan) in LB and X-vivo 15 medium. LESB58 reached stationary phase at the same time as 
PAO1 strains in LB, whilst in X-vivo 15 medium the growth between all strains was 
comparable (A). LESB58 produced 5-fold PQS more than PAO1-L (B) in agreement with 
pyocyanin production (C). A, n=1; B and C, averages were from two independent experiments 
and each sample was done in triplicate. (Each experiment was conducted with LESB58 and 4 
PAO1 strains simultaneously for comparison. The data for PAO1 strains have been shown 
previously in chapter 2.) 
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5.5.1.2. LESB58 is non-motile and produces less rhamnolipids than PAO1-L 
As described in Chapter 2, the production of surfactant rhamnolipids and 
motility are two of the factors associated with virulence in P. aeruginosa. 
Analysis of the capability of LESB58 to swarm and to produce rhamnolipids in 
vitro demonstrated that LESB58 displayed reduced rhamnolipid production and 
motility (Fig. 5.2). The reduced motility of LESB58 observed in this study is in 
agreement with its persistence in the bronchial lumen in a rat model  of chronic 
lung infection (Kukavica-Ibrulj et al., 2008). Additionally, neither flagella nor 
pili were detected on the surface of LESB58 (Winstanley et al., 2009).  
 
Figure 5.2  LESB58 produces low levels of rhamnolipids and is non-motile.  
Rhamnolipids production and motility of LESB58 were compared with PAO laboratory strains. 
LESB58 produced no detectable rhamnolipids and appeared non-motile in a swarming plate. 
Two independent experiments were conducted for rhamnolipid production assay. Images for 
biofilm formation are representative from three independent experiments showing similar trends 
in motility. (Each experiment was conducted with LESB58 and 4 PAO1 strains simultaneously 
for comparison. The data for PAO1 strains have been shown previously in chapter 2.) 
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5.5.2. Reduced translocation of LESB58 upon infection of diffCalu-3 cells  
Among the strategies employed by live pathogens to infect their hosts, the most 
common is the ability to grow in their host upon infection (Vance et al., 2009). 
Thus, the growth of LESB58 on differentiated diffCalu-3 cells in comparison 
with Wt was evaluated in the first instance to assess its correlation with 
virulence. Due to LESB58 achieved low cell density at mid log-phase culture 
(4 h, 3.5x108/ml) overnight cultures (16 h) of PAO1-L and LESB58 were used 
for the infection of diffCalu-3 cells (MOI 50) instead. Using 21-day old 
differentiated Calu-3 cells, we quantified: 1) the bacteria growth in the cellular 
fraction (cell-associated bacteria), 2) bacteria able to cross the epithelial barrier 
to the basal chamber (transmigrated bacteria) and 3) bacteria grown in MEM 
only wells (PA only). The mean values for the Wt inocula were 1.7-fold higher 
than for the LESB58 inocula but these differences were not significant. The 
bacteria grown in MEM only reached 108 for both strains and the mean values 
for Wt were 1.8-fold higher than for LESB58 (Fig. 5.3). The majority of 
bacteria remained cell-associated and the mean for PAO1-L was 2.6-fold 
higher than for LESB58. Although this difference was statistically significant, 
its biological relevance is questionable because it represented less than 1 log 
change. The reduced growth of LESB58 on Calu-3 cells might be caused by 
the inherent low growth rate of LESB58 compared to PAO1-L based on the 
growth curve. Despite the fact that the number of cell associated bacteria and 
the bacteria in MEM cultures were non-significantly different between Wt and 
LESB58, the amount of transmigrated bacteria for LESB58 were 4-logs lower 
than for Wt infected cultures (summarised in Table 5.1). This indicated that 
LESB58 mainly accumulated within the epithelium and was less invasive than  
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PAO1-L. 
Table 5.1  Summary of the average number of bacteria ± standard deviation for Wt and 
LESB58 in each compartment at 6 hpi of diffCalu-3 
Total CFU 
 (Average, n=3)  PAO1-L LESB58 
Inoculum (x107)  4.2 ± 0.6 2.5 ± 0.2 
PA* only in MEM (x107)  30.4 ± 4.2 16.8 ± 9.3 
Transmigrated bacteria  14,228 ± 20,566 1.7 ± 2.9 
Cell-associated bacteria (x107)  12.7 ± 3.1 4.9 ± 1.8 
PA* only in MEM/ inoculum 7.3 6.8 
Ratio cell -associated bacteria/  
PA only in MEM 0.42 0.29 
*PA, P. aeruginosa  
  
Figure 5.3  LESB58 remained mainly cell-associated upon infection of diffCalu-3 cells. 
The numbers of bacteria in the inocula and PA only controls were comparable between 
PAO1-L and LESB58. Although the numbers of cell-associated bacteria for WT were 
significantly higher than for LESB58, the 2.6-fold change represented less than one-log 
difference. Few to none LESB58 crossed the polarised diffCalu-3 cells barrier. Three 
independent experiments were conducted. 
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5.5.3. LESB58 induced a lower pro-inflammatory response upon infection 
of diffCalu-3 cells compared to PAO1-L 
To understand whether Wt and LESB58 cause differential induction of pro-
inflammatory cytokines by diffCalu-3 cells, levels of mRNA coding for 
selected pro-inflammatory cytokines and chemokines including IL-6, TNF-Į
GM-CSF, and IL-8 were examined. Transcripts encoding for IL-6, IL-8, TNF-
Į, and GM-CSF were all induced in diffCalu-3 cells upon LESB58 infection 
and levels ranged from 25-fold to 150-fold compared to uninfected cells. 
However, the expression was differentially induced compared to the levels of 
expression when diffCalu-3 cells were infected with PAO1-L. LESB58 
induced 1.3-fold higher IL-6 expression than PAO1-L but this difference was 
not significant. In contrast the levels of TNF-Į and GM-CSF transcripts after 
LESB58 infection were 3-fold and 3.8-fold lower than after PAO1-L infection 
(Fig. 5.4A). Similarly, the levels of pro-inflammatory cytokine protein 
production displayed the same trend and were consistent with the mRNA 
analysis (Fig. 5.4B). This was a preliminary observation and more repeats (IL-
6, IL-8, TNF-Į, n=2; GM-CSF, n=3) need to be performed to achieve statistical 
significance. However, these results suggest LESB58 might exert a relatively 
lower activation of a pro-inflammatory response compared with PAO1-L upon 
infection of airway epithelial cells.  
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Figure 5.4  Induction of pro-inflammatory cytokines and chemokines by diffCalu-3 cells 
upon Wt and LESB58 infection. 
A, Expression of IL-6, TNF-Į, GM-CSF and IL-8 was investigated in diffCalu-3 cells infected 
with PAO1-L and LESB58 at a moi 50 for 3 h by qPCR.  LESB58 induced 1.3-fold higher 
expression in IL-6 than PAO1-L but significance was not achieved. The levels of TNF-Į and 
GM-CSF induced by PAO1-L infection was 3-fold and 3.8-fold respectively higher than the 
expression elicited by LESB58. B, Cytokines were quantified in the culture supernatants at 3 
hpi and 6 hpi. The trend in cytokine production correlated with the mRNA quantification 
shown in A. Each symbol represents one experiment. Each sample in each experiment was 
prepared in duplicate. Significance was calculated by one-way ANOVA. * p <0.05 is 
considered significantly different. 
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5.5.4. LESB58 was less cytotoxic than PAO1-L upon infection of diffCalu-
3 cells 
Hijacking and disrupting normal host cytoskeleton function is a pattern of 
pathogenesis employed by a variety of intracellular bacterial pathogens. This 
strategy facilitates intracellular pathogens to gain access to the cell for 
subsequent replication (Vance et al., 2009). In spite of the fact that P. 
aeruginosa is commonly considered as an extracellular pathogen, PAO1-L Wt 
and its isogeneic mutant ǻSTV$L were seen previously to invade diffCalu-3 
cells and disrupted the barrier functions via degradation of actin and tight 
junction proteins ZO-1 and E-cadherin. To investigate the pathogenicity of 
LESB58 on the diffCalu-3 infection model, the amount of actin and other two 
endogenous proteins HSP90 and NUP98 as well as proteins associated with 
barrier integrity were examined by reverse protein array. Actin and HSP90 
remained intact in diffCalu-3 after LESB58 infection. However, substantial 
degradation of actin and HSP90 on diffCalu-3 cells infected with Wt was 
observed at 6 hpi. This result was consistent to previous findings described in 
Chapter 4.  
In Chapter 4, airway epithelial barrier function including the anti-microbial 
glycoprotein MUC5AC, ȕ-tubulin-associated cilia that propel intruding 
pathogens away from the epithelium, and tight junction proteins that control 
the molecular passage to the basal compartment from the airway lumen were 
all readily disrupted by both PAO1-L Wt and its isogenic mutant ǻSTV$L as 
these effects could be detected at 3 hpi and a substantial degradation seen at 6 
hpi (refer Fig. 4.14). These results suggested that AQs might not directly 
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influence the loss of epithelial cell integrity. To understand whether LESB58, a 
strain that overproduces AQs, could disturb the barrier function of diffCalu-3 
cells, the levels of MUC5AC, ȕ-tubulin, ZO-1 and E-cadherin were measured 
in LESB58 and PAO1-L infected cells. Surprisingly, compared to the 
substantial degradation of MUC5AC, ȕ-tubulin, ZO-1 and E-cadherin in 
diffCalu-3 cells infected with PAO1-L, these proteins were largely maintained 
in diffCalu-3 cells upon LESB58 infection for 6 hpi (Fig. 5.6). In summary, 
LESB58 did not elicit actin degradation in diffCalu-3 cells until 6 hpi and only 
minimal degradation of mucin, tubulin and junctional proteins were observed. 
 
 
 
Figure 5.5  Calu-3 cells actin, HSP90 and NUP98 remained intact upon LESB58 
infection at 6 hpi. 
Protein expression of endogenous proteins actin, HSP90 and NUP98 was analysed by protein 
microarray. At 6 hpi levels of actin and HSP90 were reduced in Wt-infected cells but not in 
LESB58-infected cells. NUP98 was maintained during the course of infection with Wt and 
LESB58. Each bar is the mean and SD from three independent experiments. Significance was 
assessed by un-paired t-test and *p-value < 0.05 is considered significantly different. NS, not 
significant. 
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Figure 5.6  The barrier function of Calu-3 cells was maintained after LESB58 infection 
compared to PAO1-L infection  
Whole cell lysates collected from Calu-3 cells infected with PAO1-L and LESB58 at 3 and 6 
hpi were subjected to protein microarray analysis to examine the levels of tight junction 
proteins, mucins and cilia-associated tubulin. The above proteins remained intact after 
LESB58 infection. Each bar is the mean and SD from three independent experiments. 
Significance was assessed by un-paired t-test and *p-value < 0.05 is considered significantly 
different. NS, not significant.  
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5.6. DISCUSSION 
The establishment of an in vitro bronchial epithelial infection model aimed to 
generate a robust platform which can readily discern between virulent and non-
virulent strains of P. aeruginosa. In this study, parameters including bacterial 
translocation, induction of inflammatory mediators, cytotoxicity and epithelial 
barrier integrity were used to evaluate the efficacy of the infection model, 
diffCalu-3 cell culture to determine differences in pathogenesis between a 
clinical CF isolate LESB58 and P. aeruginosa laboratory strain PAO1-L. We 
found that swarming motility and rhamnolipids production were reduced but 
PQS and pyocyanin were over-produced in LESB58 cultures in vitro. LESB58 
was capable of growing on diffCalu-3 cells, barely crossed the epithelial barrier 
and caused relatively mild inflammation and no apparent cytotoxicity on 
diffCalu-3 cells compared to PAO1-L. 
The cell density of LESB58 was lower in LB medium, although the growth 
kinetics was equivalent to that of P. aeruginosa strain PAO1-L and both strains 
reached stationary phase at the same time. However, the growth of PAO1-L 
and LESB58 was similar when cultured in X-vivo 15. This was in agreement 
with the finding that the growth of LESB58 in vivo was similar to that of PAO1 
and PA14 in a rat chronic lung infection model (Kukavica-Ibrulj et al., 2008). 
This implies the growth of P. aeruginosa in X-vivo 15 medium might reflect 
more closely the growth in the host environment than LB medium. The growth 
of LESB58 on diffCalu-3 cells was always slightly less than the growth of 
PAO1-L although the change was within one-log difference. However, the 
capacity of LESB58 to attain less cell density compared with laboratory P. 
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aeruginosa strains correlated with a study demonstrated that the planktonic 
growth rates of P. aeruginosa CF isolates were significantly lower than non-CF 
strains (Salunkhe et al., 2005). LESB58 over-expressed PQS and pyocyanin 
compared to PAO1-L. The maximum amount of PQS and pyocyanin produced 
by LESB58 was 4 times higher than the amount produced by PAO1-L in LB 
cultures. We also noticed that the accumulation of PQS in the extracellular 
milieu in vitro was independent of the lower cell density in LESB58 strain. It 
has been demonstrated that AQs are substantially produced at late-logarithmic 
phase that overcomes the cell-dependent AHL-QS hierarchy (Diggle et al., 
2003). In addition, AQs can also be produced in the absence of lasR and has 
been isolated in the bronchoalveolar lavage fluid and sputum in CF patients 
infected with P. aeruginosa. This supports the hypothesis that the continuous 
production of PQS might contribute to the persistence of P. aeruginosa in the 
CF lung (Collier et al., 2002, Guina et al., 2003). In addition, the prevalence of 
AQs in vivo also suggests that AQs promotes P. aeruginosa long-term 
colonisation in the CF lungs in a  LasR QS-independent manner (Diggle et al., 
2003). AQs controls the synthesis of phenazine, including pyocyanin and 
iodonin which perform diverse roles in P. aeruginosa physiology and act as 
virulence factors in CF. The genome of LESB58 contains two gene clusters 
encoding putative phenazine biosynthesis pathways orthologs of PAO1 PhzA2-
G2 and phzB, which probably have redundant roles (Winstanley et al., 2009). A 
recent study proposed that the redundancy in phenazine production can be 
considered an advantage for environmental adaptation. Production of 
phenazine mediated by Phz1 or Phz2 depended on the culture conditions 
(planktonic liquid culture vs biofilm aggregates) (Recinos et al., 2012). This 
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evidence again suggests that AQs may contribute to the environmental fitness 
and virulence of P. aeruginosa. The reduced motility on swarming agar plates 
of LESB58 was consistent with the observation that LESB58 remained tightly 
associated with the agar beads rather than invading the lung (Kukavica-Ibrulj et 
al., 2008). The lack of any form of motility can also be explained by the lack of 
flagella or pili at the surface of LESB58 based on electron microscopy analysis 
(Kukavica-Ibrulj et al., 2008, Winstanley et al., 2009). The redox-active 
exotoxin pyocyanin has been shown to induce mucin MUC2/MUC5AC 
secretion, lymphocytes infiltration, release of inflammatory cytokines and 
growth factors via the epidermal growth factor receptor (EGFR) pathway in 
mouse airways (Hao et al., 2012). CF clinical isolates display a pyocyanin 
over-production phenotype in vitro and the overproduction of pyocyanin 
correlated with pulmonary exacerbations (Fothergill et al., 2007, Caldwell et al., 
2009). Therefore, we postulate that LESB58 could be more virulent than 
PAO1-L by producing 4 times higher levels of pyocyanin in vitro. Surprisingly, 
LESB58 exerted no significant cell damage and relatively lower activation of 
pro-inflammatory cytokines on diffCalu-3 cells compared to PAO1-L. Since 
pyocyanin is a secondary metabolite of P. aeruginosa produced at maximum 
amounts during late-logarithmic phase and has been recovered from chronic 
infected CF patients, it is possible that PAO1-L and LESB58 have not started 
producing pyocyanin within the 6 h infection time on diffCalu-3 cells. 
Moreover, the fact that AQs can be detected in culture supernatants (refer 
Chapter 4 Fig. 4.18) argues that the lack of AQs expression might not be 
responsible for these observations. The effect of pyocyanin on pathogenesis of 
strain PAO1-L and LESB58 in the acute infection model needs to be re-
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evaluated. Previous studies to investigate the impact of pyocyanin on bronchial 
epithelial cells and animal models were conducted using purified pyocyanin 
rather than the whole viable bacteria; whether the effects identified reflect 
events that occur during infection with viable bacteria needs to be taken into 
consideration.  
Infection of LESB58 on diffCalu-3 cells revealed an attenuated pattern of 
pathogenesis demonstrated by few to none bacterial transmigration, no actin 
and tight junction protein degradation up to 6 hpi, and relatively mild induction 
of inflammation compared to PAO1-L. Particularly, given the pleiotropic 
feature of IL-6, the preliminary data showed an enhanced IL-6 in the context of 
low TNF-Į induced by LESB58 in bronchial epithelial cells might imply a 
different pattern of activation in human epithelium by CF isolates. These 
results were consistent with the data demonstrated by Carter et al. (Carter et al., 
2010) in assessing the virulence of the CF LES subtypes in an acute murine 
infection model. Compared with the three other LES subtypes, LESB58 (QS-
overproduction) was less virulent than subtype LES400 (QS-deficient) 96 h 
post respiratory acute infection in mice. However, LESB58 was shown rather 
to persist in the lung epithelium than cause drastic cell damage in a chronic rat 
infection model (Kukavica-Ibrulj et al., 2008). In the case report describing the 
infection of non-CF parents with an epidemic P. aeruginosa strain from their 
CF child, the mother who carries single allele ǻF508 was referred to a 
microbiological screening of her sputum after 5-month of flu-like symptoms, 
chest pain, dramatic weight loss and production of 30 ml sputum per day. But 
no evident bronchiectasis was identified by computed tomography (CT) scan. 
A P. aeruginosa strain resistant to ceftazidine was identified in her sputum 
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later on. Although she was given intravenous antibiotics and discharged when 
her lung function was back to normal, the symptoms resumed in one month 
time and antibiotic resistant P. aeruginosa was continuously isolated from her 
sputum. The father with genotype G551D, however, was initially admitted to 
hospital because of pneumonia. He had a past history of right upper lobectomy 
and thoracoplasty because of bronchiectasis and no tuberculosis or 
Pseudomonas was isolated in the sputum in the past. This admission found 
lingula consolation in the thoracoplasty part and two Pseudomonas strains 
resistant to ceftazidine were identified in the sputum. Despite receiving 
intravenous antibiotics and discharged when sputum was negative with 
microorganisms, resistant Pseudomonas was constantly isolated from his 
sputum afterwards and the patient seemed to develop chronic infections with 
mild bronchiectasis in his right lung (McCallum et al., 2002). Whilst the 
symptoms in the father could be explained by the lung susceptibility due to the 
disease in the past, more studies are required to understand how and why did 
the physically healthy mother also receive LES infection. 
The LESB58 genome carries all the reported virulence genes of P. aeruginosa 
strain PAO1 located LQWKHµFRUHJHQRPH¶ZKLFKFRPSULVHGRIWKHJHQRPH
such as type II and III secretion systems and iron transport as well as gene 
clusters involved in determining O-serotype, flagellin, type IV pili, siderophore 
production, genomic/ pathogenicity islands and prophages that compose the 
µDFFHVVRU\ JHQRPH¶ (Winstanley et al., 2009) 7KH µDFFHVVDU\ FOXVWHUV¶ WKDW
compose 10% of the genome may provide clinical isolates with the capability 
to adapt environmental changes that leads to strain diversity (Shen et al., 2006). 
Excluding the prophage shared between PAO1 and the other one commonly 
 227 
 
appeared in P. aeruginosa epidemic strains, the rest of the four prophages have 
been studied for their potential to provide plasticity for environmental 
adaptation that makes LES the dominant transmissible CF strain. It has also 
been suggested that the horizontal transfer of prophages and the integrase/ 
transposase-driven plasticity contribute to the bacterial genomic evolution. 
The introduction of a clinical CF isolate to the diffCalu-3 epithelial culture 
provided us with a new understanding of the patterns of pathogenesis 
employed by P. aeruginosa. Loss of motility organelles flagellum and type IV 
pili restrict LESB58 colonisation of the airway epithelium but in turn, LESB58 
might evade the recognition of flagellin by TLR5 in the epithelial cells leading 
to no subsequent NF-ț% VLJQDOOLQJ DQG QR SURGXFWLRQ DQG UHOHDVH RI
proinflammatory cytokines that could recruit neutrophils to the infected area. 
LESB58 shows mild infectivity which in turn could represent its strength by 
favouring the establishment of biofilms for long-term persistence in the lung. 
The results were based on the experiments conducted on a CFTR competent 
epithelial cell line Calu-3 cells. CFTR deficient epithelium has been shown to 
be hyper-inflammatory although the claim remains controversial (Machen, 
2006). It needs to be clarified how the innate immune system responds to 
LESB58 infection in the absence of a functional CFTR. Tissue models such as 
CFTR knock-out cell lines, primary or immortalised CF bronchial epithelial 
cells or CF animal models are available (porcine CF lung (Stoltz et al., 2010, 
Pezzulo et al., 2012) for instance is the closest to a human CF model) and can 
be applied for studying the mechanism of LESB58 pathogenicity. In addition, 
the culture condition for LESB58 may also be adjusted to resemble the 
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environment in CF lung by using artificial sputum medium (Sriramulu et al., 
2005, Kirchner et al., 2012). P. aeruginosa in the form of microcolonies or 
biofilm is an important element to consider in the infection of CF lung. Studies 
to target biofilms by inducing biofilm dispersal or blocking biofilm formation 
suggest that this is a plausible therapeutic target (Majik and Parvatkar, 2013, 
Sharma et al., 2013, Wei and Ma, 2013). Inoculation of biofilm matrix 
developed by embedding P. aeruginosa in homogeneous agarose beads (50-
500 ȝm diameter) or porous beads containing pores (260 ȝm diameter) 
(Strathmann et al., 2000) can be an alternative to study the virulence in the 
form of bacterial aggregates shown in CF lung; meanwhile, this method may 
overcome the issue of low cell density of LESB58 in the planktonic liquid 
culture. 
In the present study, diffCalu-3 cells stand as a robust bronchial epithelial 
model by demonstrating the expression of tight junction proteins, exhibition of 
polarity with apical cilia-like protrusions and the induction of an inflammatory 
response upon P. aeruginosa infection. DiffCalu-3 culture is a suitable model 
demonstrated for a reliable and consistent preliminary evaluation of P. 
aeruginosa pathogenicity. However, due to the plasticity and complex 
phenotype of P. aeruginosa, more complex models containing professional 
immune cells, animal models or 3-dimensional multiple cell culture systems 
(Barrila et al., 2010) can be developed to address this research question. 
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5.7. SUMMARY 
The clinical CF isolate P. aeruginosa LESB58 displayed reduced motility but 
over-produced AQs and pyocyanin compared with P. aeruginosa PAO1-L. 
LESB58 elicited minor cell damage and mild activation of pro-inflammatory 
response in diffCalu-3 cells in comparison with PAO1-L. 
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6. SYSTEMIC IMMUNE RESPONSES IN 
IDIOPATHIC PULMONARY FIBROSIS 
6.1. INTRODUCTION 
This chapter on the systemic immune responses in patients with idiopathic 
pulmonary fibrosis (IPF) was initiated as a side project to a study on the 
analysis of the association between thrombophilia and the tendency to develop 
IPF. This study identified a strong association between the presence of a 
prothrombotic state and clinical disease in IPF (Navaratnam et al., 2013). The 
pathogenesis of IPF is widely considered to be caused by the inability of type II 
alveolar epithelial cells to restore pulmonary tissue after continuous 
microinjuries rather than an inflammation-driven disease. However 
macrophage polarization has been also shown to be critical in disease 
progression (Homer et al., 2011, Wynn and Barron, 2010). We postulated that 
inherent differences in immune status between diseased and healthy donors 
might contribute to the progressive pulmonary fibrosis whereas the role of 
chronic inflammation in IPF remains elusive.  
In this exploratory study, we aimed to determine the cytokine profiles of 
peripheral blood mononuclear cells (PBMCs) from healthy individuals and 
patients with IPF. PBMCs were isolated from the blood pellets once sera had 
been preserved for the thrombophilia study. PBMCs were stimulated with a 
panel of stimuli including a mitogen, a superantigen, canonical Th1 and Th2 
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primers and a crude extract of P. aeruginosa in an attempt to obtain an immune 
response profile in an unbiased but comprehensive manner. Additionally, 
access to a large population cohort was one of the strengths of this study as 
correlations with clinical outcomes could be established in an attempt to 
identify potential prognostic biomarkers. 
The following introduction addresses the conceptual molecular mechanisms in 
pathogenesis together with current hypotheses on the role of inflammation and 
potential biomarkers in IPF that constituted the basis for the rationale of our 
study.  
6.1.1. Pathogenesis and molecular mechanisms of IPF 
Interstitial lung diseases (ILDs), categorised as known and unknown causes, 
are initially trigger by an inflammatory response but followed by an impaired 
repair process of epithelial cells that result in fibroblast proliferation, collagen 
deposition and destruction of lung architecture and function (Jakubzick et al., 
2004, Noble et al., 2012). Idiopathic pulmonary fibrosis (IPF) is the most 
common form of idiopathic interstitial pneumonia that characterised by 
heterogeneously thickened, stiff, and scarring tissue in the lung. IPF is a 
devastating fatal disease, medium survival is merely 2 to 3 years following 
diagnosis in populations above 40 years and the mean age is 66 (Meltzer and 
Noble, 2008). People with IPF usually suffer from chronic dyspnoea and cough 
due to the limited lung capacity for gas-exchange. IPF prevalence estimated in 
Europe has risen to 23.4 cases per 100,000 populations according to reliable 
data from 2005 till 2011. The annual incidence in Europe ranged between 0.22 
and 7.4 per 100,000 population  and the incidence of IPF clinical symptom in 
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primary care is from 5.10 to 7.44 per 100,000 person-years in United 
Kingdoms (Navaratnam et al., 2011, Nalysnyk et al., 2012). The prevalence in 
men is 1.5 fold higher than women (Hoo and Whyte, 2012). Difficult to 
diagnose, aggressive progression with random exacerbations, and poor 
prognosis are the problems underlying the disease waiting to be solved. No 
effective treatment is available and the aetiology remains unclear (King et al., 
2011).  
Currently IPF pathogenesis is thought to be initiated by the aberrant activation 
of alveolar epithelial cells caused by recurrent environmental microinjuries in 
the ageing, susceptible lung. Upon activation resident epithelial cells and 
fibroblasts differentiate into mesenchymal cells. Exaggerated activation of 
epithelial-mesenchymal transition (EMT) thereby induces the migration of 
resident fibroblasts and bone marrow-derived progenitor cells fibrocytes and 
the production of extracellular matrix at the sites of microinjuries (King et al., 
2011, Meltzer and Noble, 2008). IPF patients eventually succumb to 
respiratory failure due to the accumulation of extracellular matrix in the gas-
exchanging region. The deregulated regeneration, proliferation and migration 
of epithelial cells exhaust the airway remodelling process and develop 
fibroblast foci heterogeneously distributed in the so-called honeycomb-like 
lung (Hoo and Whyte, 2012). Recent evidence indicates that environmental 
insults and genetic predisposition contribute to the pathogenesis of IPF. 
Cigarette smoking, viral infection or occupational exposure to microaspiration 
such as metal dust, wood dust, farming, hairdressing, and stone cutting are 
associated to the development of IPF (Odds ratio ranges from 1.7 to 4.4) 
(Steele and Schwartz, 2013). 
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The continuous apoptosis of progenitor cells AECII (Barkauskas et al., 2013b) 
failing to regenerate type I alveolar epithelial cells upon injury may ultimately 
lead to persistent pulmonary fibrosis (Noble et al., 2012, Steele and Schwartz, 
2013).Mutations in telomerase (gene TERT/hTR) have been identified in 
familial IPF and shorten telomeres have been identified in sporadic cases of 
IPF. Single nucleotide polymorphisms (SNPs) in mucin 5B (gene MUC5B) 
result in over-expression of mucin by bronchial epithelial cells has also been 
found common to both familial and sporadic IPF. However, the underlying 
mechanisms need to be determined of how the genetic variants and 
overproduction of mucin 5B lead to pulmonary fibrosis. 
Mediators involved in the regulation of epithelial-mesenchymal crosstalk such 
as activin, bone morphogenetic protein 4 (BMP4) and BMP7, TGF-ȕ:QWȕ-
catenin and sonic hedgehog (Shh) belong to TGF-ȕ PRUSKRJHQLF F\WRNLQH
family. Activation of TGF-ȕ E\ DOYHRODU PDFURSKDJHV KDV EHHQ LPSOLFDWHG D
critical promoter for fibrogenesis; the up-UHJXODWLRQ RI LQWHJULQ ĮȞȕ RQ WKH
epithelium is required for the activation of latent TGF-ȕ (Bringardner et al., 
2008, Noble et al., 2012).  
Figure 6.1  Dysregulation in wound healing contributes to pulmonary fibrosis. 
The four stages of wound healing: (1) clotting, (2) infiltration of inflammatory cells, (3) 
fibroblast migration, proliferation and activation to myofibroblast and (4) tissue remodelling 
(Wynn, 2011). 
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6.1.2. The immunology of IPF  
Inflammation is considered the secondary feature in IPF. The fact that (a) no 
substantial infiltration of immune cells occurs in the IPF lung, (b) no 
histological differences have been found between early and late stage IPF lungs, 
and (c) failure of conventional immunosuppression treatments, suggest that 
inflammation may not be critical for disease progression (Bringardner et al., 
2008, Homer et al., 2011). However, a novel hypothesis suggests that  
macrophage interference in the wound-healing process might account for the 
atypical inflammation in the IPF lung (Homer et al., 2011).  
Difficulties in diagnosis due to the heterogeneity of the IPF lung prompted the 
study of biomarkers. An ideal biomarker should be able to distinguish IPF from 
other interstitial lung diseases to provide early diagnosis and predict disease 
prognosis (Bargagli et al., 2011, Richards et al., 2012, Vij and Noth, 2012). SP-
A is a lipoprotein secreted by club (Clara) cells and type II alveolar epithelial 
cells. The levels of SP-A in the BAL fluid of IPF patients were significantly 
lower compared with healthy controls, whereas the effect was inverse when 
SP-A was identified in serum. Glycoprotein Krebs von den lungen-6 antigen 
(KL-6) expressed by type II alveolar epithelial and bronchial epithelial cells 
acts as a chemotactic factor that promotes migration and proliferation of lung 
fibroblast is at significantly higher levels in serum and BAL fluid of IPF 
patients compared to healthy populations. Levels of macrophage-derived 
chemoattractant proteins such as CCL18, IL-8, CCL2, S100A9; matrix 
metalloprotease 1 and 7, and the proinflammatory cytokine osteoponitin, 
correlated with lung functions in IPF patients. These molecules were identified 
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in serum and/or BAL and are considered as potential biomarkers (van den 
Blink et al., 2010, Bargagli et al., 2011, Vij and Noth, 2012). However, all 
above biomarkers have their limitations; some of the biomarkers cannot 
differentiate IPF from other interstitial lung diseases; patients in some studies 
were immunosuppressed as a result of corticosteroid treatment which might 
bias the study. The present study was initiated with the aim to identify a 
potential cytokine profile that could distinguish between IPF patients and 
healthy controls. 
6.1.3. Rationale of experimental design 
Agents such as bleomycin, silica asbestos, and irradiation using different 
administration methods have generated numerous animal models of pulmonary 
fibrosis with different inflammatory profiles. Despite the animal models 
SURYLGH D SOHWKRUD RI LQIRUPDWLRQ WR µNQRZQ FDXVH¶ SXOPRQDU\ ILEURVLV IRU
humans including bleomycin induced lung fibrosis models, growth factor gene 
overexpression (TGF-ȕ, IL-1ȕ, IL-13, etc.), irradiation and particle irritation 
models such as asbestos, silica, etc. (Gharaee-Kermani et al., 2005, Degryse 
and Lawson, 2011, B et al., 2013), none of them can fully recapitulate the 
phenotype of patients with IPF. Human PBMCs which contain 70% T 
lymphocyte, up to 25% monocyte/macrophage and dendritic cells are widely 
used to assess the individual immune condition in health and disease. The 
availability of a large clinical cohort to investigate the response of PBMCs to 
stimulation is one of the strengths of this study. The strategy we employed was 
to assess the systemic immune status in IPF patients compared with normal 
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superantigen, Th1, Th2 primers as well as P. aeruginosa-crude extract. 
Phytohaemagglutinin (PHA) is a plant lectin that induces polyclonal 
proliferation of T lymphocytes and monocytes (Mire-Sluis et al., 1987, 
Christmas et al., 2006). The preparation of PHA used in this study was a crude 
sodium chloride extract of the red kidney bean Phaseolus vulgaris. The 
efficacy of this crude extract was tested prior to our study and was found to 
induce proliferation of more than 90% of CD4+ T cells in healthy control 
PBMCs (Singh, 2012). Both monocytes/macrophages and T cells in PBMCs 
upon PHA stimulation would contribute to cytokine production. Superantigens 
(SAgs) such as Streptococcal exotoxin B (SEB) are immuno-stimulatory 
molecules that cross-link host MHC class II and the T cell receptor that 
activate up to 25-40% of T cells in the body. The trimolecular complex triggers 
the protein kinase C pathway and the protein tyrosine kinase pathways 
resulting in profound non-specific T-cell proliferation and release of pro-
inflammatory cytokines (Baker and Acharya, 2004, Sriskandan et al., 2007, 
Balaban and Rasooly, 2000). Mycobacterium tuberculosis purified protein 
derivative (PPD) induces the secretion of IFN-Ȗ by PBMCs (Dockrell et al., 
1996) and house dust mite (HDM) induces allergen-specific CD4+ Th2 cells 
that orchestrate the allergic response via induction of IgE (Wang, 2013). In 
addition to extend our general interest in the recognition of P. aeruginosa by 
immune cells, P. aeruginosa PAO1-L crude extract (PA extract) was also 
included as one of the stimuli. 12-O-phorbol-myristic-13-acetate (PMA), a 
mitogen that strongly activates protein kinase C, was added at day 6 to promote 
the overall cytokine production by PBMCs (Blumberg, 1988, Han et al., 1998, 
Chang et al., 2005). PBMC supernatants harvested on Day 7 were assayed for 
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the presence of a panel of cytokines which would reflect the action of activated 
T cells and monocytes/ macrophages. 
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6.2. HYPOTHESIS 
The fibrotic process in the lung of IPF patients is associated with a skewed 
immune response and presence of type 2 alternatively activated macrophages. 
 
6.3. AIM 
The purpose of this study was to examine systematically the immunological 
status of IPF patients in attempt of discovering potential prognostic biomarkers. 
To achieve this, the levels of selected cytokines representing Th1 (IFN-Ȗ7K
(IL-13), anti-inflammatory (IL-10) and Th17 (IL-17A) responses produced by 
PBMCs from IPF patients and healthy populations in response to mitogen, 
super antigen, Th1 and Th2 inducers and P. aeruginosa crude extract were 
quantified. We then conducted a case-control study using this cytokine profile 
to investigate the association between cytokine production and IPF disease, and 
whether the levels of cytokine production related to mortality in IPF patients.    
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6.4. MATERIALS AND METHODS 
6.4.1. Study design 
The study was initiated as a side study from a project of assessing the risk of 
the presence of thrombophilia in the development of IPF in the East-midlands 
region in UK (funded by Medical Research Council) to identify potential 
biomarkers. Blood sources and ethics were obtained before starting this study. 
6.4.2. Study populations 
In the first cohort, blood pellets (plasma removed) were collected from 38 
healthy donors (9 females and 29 males) and 34 diseased (9 females and 25 
males) with clinical data available; the second cohort made it total populations 
of 66 healthy subjects (15 females and 51 males) and 66 cases (19 females and 
47 males). The age of subjects in both populations were grouped in 6 
categories: those less than 65 years old; 65-69 years old; 70-74 years old; 75-
79 years old; 80-84 years old and those more than 85 years old (Table 6.2 and 
Table 6.7). Clinical data including lung functions and survival were available. 
6.4.3. Determination the levels of IFN-Ȗ,/-17A, IL-10, and IL-13 in 
peripheral blood mononuclear cells (PBMCs) supernatant by multiplex 
immunoassays 
6.4.3.1. Isolation of PBMCs from IPF patients and healthy controls 
Whole blood samples were obtained from the cohort of IPF patients and 
healthy controls in the Trent Lung Fibrosis Study. Blood cell pellets from four 
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to seven anti-coagulant 10-ml EDTA vacutainers (BD Diagnostics-
Preanalytical Systems, UK) collected either from IPF patients or healthy 
controls were pooled in a 50-POIDOFRQWXEHGLOXWHGZLWK+DQNV¶EDODQFHGVDOW
solution (modified with NaHCO3, without CaCl2 and MgSO4) (Sigma-Aldrich, 
UK) up to 35 ml. Diluted blood was layered on 12 ml of Histopaque-1077 
(Sigma-Aldrich, UK) and centrifuged at 800xg for 30 min at room temperature 
with low acceleration and deceleration. The PBMCs layer appeared as a yellow 
LQWHUIDFHDIWHUGHQVLW\JUDGLHQWVHSDUDWLRQZDVFROOHFWHGDQGZDVKHGLQ+DQNV¶
balanced salt solution and re-suspended in RPMI (Sigma-Aldrich, UK) 
containing 10% of human AB serum (Sigma-Aldrich, UK) and antibiotics 100 
U/ml Penicillin/100 ȝg/ml Streptomycin (Sigma-Aldrich, UK).  
6.4.3.2. PBMCs stimulation 
PBMCs were plated on 96 round bottom plates at a density of 200,000 cells per 
well in 100 µl RPMI-10% AB serum and stimulated in duplicate with 2 µl of 
phytohaemoagglutinin (PHA) (Invitrogen, UK), 10 ng/ml of Staphylococcus 
enterotoxin B  (SEB) (Sigma-Aldrich, UK), 2 µg/ml of the Th1 primer, 
Mycobacterium tuberculosis purified protein derivative (PPD) (Statens Serum 
Institut, DK) and 10 µg/ ml of the Th2 primer house dust mite extract (HDM) 
(Greer allergy immunotherapy, US). In order to compare the cytokine 
expression with those from cystic fibrosis patients, two independent 
preparation of P. aeruginosa PAO1-L (6,250 ng/ml) crude extract from 3-hour 
cultures (PA extract) were also included in this assay (PAO1-L lysates were 
provided by Sonali Singh). High concentrations of PA extracts 6,250 ng/ml and 
1,562 ng/ml, and low concentrations 97.7 ng/ml and 24.4 ng/ml were initially 
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tested (Fig. 6.1, marked as PA11-PA14, representing PA extract preparation 1 
at four concentrations from high to low; likewise, PA21-PA24 represented PA 
extract preparations 2 at four concentrations). At day 6, PBMCs cultures were 
re-stimulated with phorbol 12-myristic 13-acetate (PMA) (Sigma-Aldrich, UK) 
at a concentration of 15 ng/ml and incubated at 37oC, CO2 for another 24 h. At 
day 7, PBMCs supernatants were collected and stored at -80oC until to 
cytokine analysis. 
6.4.3.3. Cytokine quantification 
Simultaneous quantification of the level of cytokines in PBMCs supernatants 
was done using the bead-based immunoassay FlowCytomix Simplex kit in 
combination with FlowCytomix human Basic kit (eBioscience, UK) according 
to the manual. Samples were analysed by flow cytometry using the software 
FlowCytomix Pro provided by eBioscience. 
6.4.4. Statistical analysis 
Before conducting logistic regression to generate odds ratio (ORs) for 
evaluating the association between IPF and a particular cytokine response, the 
levels of cytokine were grouped into composite binary variables low response 
and high response. Logistic regression was used to generate ORs for the 
association between the levels of cytokine and IPF adjusted for age and sex. 
7KH DVVRFLDWLRQ EHWZHHQ FDWHJRULFDO GDWD ZHUH DVVHVVHG E\ Ȥ2 test.  Cox 
regression modelling was used to investigate whether the levels of cytokines 
were associated with mortality in IPF patients. The date participants gave 
FRQVHQW WR HQWHU WKH VWXG\ ZDV FRQVLGHUHG DV WKH µVWDUW GDWH¶ DQG WKH GDWH RI
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GHDWK RU ODVW GDWD FROOHFWLRQ DV WKH µVWRS GDWH¶ 3ULVP 9HUVLRQ  *UDSK3DG
Software) and Stata version 11.0 (Texas) were used for statistical analyses and 
hypothesis testing.  
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6.5. RESULTS 
6.5.1. Optimisation of PBMCs stimulation 
To understand the systemic immune status of IPF patients PBMCs isolated 
from IPF patients and healthy controls (age and sex matched) were treated with 
a panel of stimuli including PHA, SEB, Mycobacteria tuberculosis purified 
protein derivative (PPD), a Th1 response primer (Dockrell et al., 1996), house 
dust mite (HDM) that promotes a Th2-biased allergic response (Wang, 2013) 
and PA extract. Th1 Th2, Th17 responses were evaluated by quantifying the 
levels of IFN-Ȗ7K1 response), IL-17 (Th17 response), IL-13 (Th2 response) 
and IL-10 (anti-inflammatory response). Meanwhile, to investigate if PBMCs 
from IPF patients and age-matched healthy control are responsive to P. 
aeruginosa, PBMCs treated with P. aeruginosa whole cell crude extracts (PA 
extracts) were also included in the cytokine profile study. To determine the 
concentration of PPD and HDM required for stimulating PBMCs, 5-fold serial 
dilutions from 10 ȝJPO WR  ȝJPO ZHUH WHVWHG )LJ  +LJK
concentrations of PA extracts 6,250 ng/ ml and 1,562 ng/ ml, and low 
concentrations 97.7 ng/ ml and 24.4 ng/ml were also included (marked as 
PA11-PA14, representing the first prep of PA extract at four concentrations 
from high to low; likewise, PA21-PA24 represented the second prep of PA 
extract at four concentrations). PBMCs isolated from two healthy subjects and 
two IPF patients and the cytokines IFN-Ȗ, IL-10, IL-13 and IL-17A were 
included in the quantification. The results indicated the levels of IFN-Ȗ LQ
PBMCs upon PPD and HDM stimulation were dose-dependent (Fig. 6.1 IFN-Ȗ). 
Considering that readings needed to be within the linear scale of the assay, 
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concentrations of 2 µg/ml for PPD and 10 µg/ ml for HDM were chosen to 
stimulate PBMCs in the following assays. Likewise, in order to obtain readable 
values of cytokine production, the concentration of 6,250 ng/ml of PA extracts 
was used for stimulation.  
6.5.2. Comparison of the cytokine profile between IPF patients and 
healthy donors 
To investigate the cytokine profile of patients with IPF, levels of IFN-Ȗ, IL-
17A, IL-10 and IL-13 in the supernatants of PBMCs from 39 healthy donors 
(HD) and 38 IPF patients (IPF) stimulated with mitogen, superantigen, Th1 and 
Th2 primers and PA extract were quantified and plotted. Fig. 6.3 shows that the 
levels of IFN-Ȗ were significantly higher in PBMCs treated with PPD (Th1 
primer) than in cultures treated with the Th2 primer HDM (p<0.0001); same 
effect was observed in the supernatant of PBMCs in IPF patients (p=0.0053). 
This indicated that PPD indeed induced the release of higher amounts of IFN-Ȗ 
than HDM which is a Th2 inducer. Levels of IL-10 in PBMCs upon HDM 
stimulation were significantly higher (p=0.0209 in HD samples) than in those 
treated with PPD (Fig. 6.3).  
Secretion of IFN-Ȗ by both IPF patients and healthy controls PBMCs was 
substantially induced upon non-specific stimulation with PHA and SEB with 
half of the participants producing IFN-Ȗ levels above the detection limit of the 
assay (20,000 pg/ml). No significant differences in the levels of IFN-Ȗ between 
HD and IPF were identified. The levels of IL-17A in PBMCs treated with PHA 
were marginally significantly (p=0.0461) higher in IPF patients than in healthy 
individuals. On the contrary, the levels of IL-10 in PBMCs treated with PMA 
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were significantly lower (p=0.0003) in IPF patients than healthy controls (Fig. 
6.3). Levels of IL-17A in PBMCs treated with PA extract were also 
significantly lower (p=0.0246) in IPF patients than in healthy controls. 
However, the levels of IFN-Ȗ, IL-17A, IL-10 and IL-13 in PBMCs of IPF 
patients and healthy donors in response to the other stimuli were comparable. 
Thus, no pattern of immune response could be identified when differences in 
cytokine production between patients with IPF and healthy controls were 
assessed by comparing the mean of cytokine levels from all participants using 
an un-paired t-test.  
 
 
 
Table 6.1  Significant cytokine production difference between treatments or between 
the cases and healthy donors 
Cytokine Stimulus Comparison between the Th1 and Th2 stimulation P-value 
IFN-Ȗ PPD versus HDM Production upon PPD > production upon 
HDM 
0.0001 (HD) 
0.0053 (IPF) 
Cytokine Stimulus Comparison between IPF and HD P-value 
IL-17A PHA IPF > HD 0.0481 
IL-17A PA IPF < HD 0.0246 
Cytokine Stimulus Comparison between IPF and HD P-value 
IL-10 PHA IPF < HD 0.0003 
Cytokine Stimulus Comparison between the Th1 and Th2 stimulation P-value 
IL-10 PPD versus HDM Production upon PPD < production upon HDM 0.0209 (HD) 
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Figure 6.2  The levels of cytokines, IFN-Ȗ, IL-17A, IL-10 and IL-13 secreted by PBMCs 
in response to PPD, HDM and PAO1-L lysates were mostly dose dependent. 
PBMCs from two healthy controls (C118 and C233) and two IPF patients (D181 and D204) 
were stimulated with serial 5-fold dilutions of PPD, HDM from 10 µg/ml to 0.08 µg/ml and 
PA extracts at high concentrations 6250 ng/ml and 1562 ng/ ml (PA11 and PA12; PA21 and 
PA22), and low concentrations 97.7 and 24.4 ng/ml (PA13 and PA14; PA23 and PA24). 
PBMCs supernatants from above treatments were subjected to cytokine quantification.  
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 Figure 6.3  Levels of IFN-Ȗ, IL-17A, IL-10 
and IL-13 in PBMCs from healthy donors 
(HD) and IPF patients (IPF) in response to 
a panel of stimuli.  
The levels of cytokines IFN-Ȗ, IL-17A, IL-10 
and IL-13 in PBMCs isolated from IPF 
patients (white circles) and healthy donors 
(black circles) in response to a panel of 
stimuli, including mitogen PMA, PHA, super 
antigen SEB, PPD and HDM as Th1 and Th2 
inducers respectively and PA crude extract. 
PBMCs treated with PPD secreted 
significantly higher levels of IFN-Ȗ than when 
treated with HDM as expected. This occurred 
in healthy controls and IPF patients, implying 
that this assay was working as expected in 
both populations. PBMCS from IPF patients 
produced more IL-17A than HD in response 
to PHA stimulation, whilst PBMCs from IPF 
patients produced less IL-10 under the same 
stimulation. However, no significant 
differences were achieved between IPF 
patients and HD in PBMCs IL-13 production 
upon any stimulation. The dashed line at 
20,000 pg/ml in IFN-Ȗ graph indicated that 
those readings above 20,000 pg/ml were 
beyond the linear detection range (20 - 20,000 
pg/ml) when samples were not yet diluted. 
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6.5.3. Case-control study: the association between IPF and the cytokine 
production 
In this section, a case-control study method was introduced to investigate 
whether there is any association between cytokine profile and IPF. For this end, 
demographic features between the healthy donors and IPF patients should have 
been taken into consideration as matching factors before recruiting the study 
cohort. Demographic features from the first half participants (in Section 6.5.2.) 
including 38 controls (one clinical data set was missing) and 34 patients with 
IPF (5 missing clinical data) are listed in Table 6.2. Due to the collection of 
clinical data were attributed to the efforts made by research nurses and clinical 
scientists in the city hospital, University of Nottingham, the missing data could 
be the volunteers dropped out from the clinic for unforeseen reasons or the 
inevitable generic data handling error given this was a collaborative study. 
However, the majority of data were kept synchronised in both sides (clinical 
and laboratory). The mean age was 70.7 ± 10.3 years for the cases, 69.3 ± 9.8 
years for the controls and the cases were predominantly male (9 females and 25 
males). Men were therefore predominantly recruited in healthy donors (9 
females and 29 males) to match with cases. The numbers in each smoking habit 
groupings between cases and controls also matched. The levels of highly 
sensitive C-reactive protein (hsCRP) were grouped as low (less than 1 mg/ml), 
intermediate (between 1-3 mg/ml) and high (more than 3 mg/ml). hsCRP is 
commonly used in clinic to assess the risk of developing cardiovascular disease. 
Numbers of cases with high levels of hsCRP were more than in healthy 
controls. The cases were 3 times (odds ratio (OR) 2.97, 95% CI 0.51-17.28) 
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more likely to have intermediate levels of hsCRP than the controls; 16 times 
(OR 16.04, 94% CI 2.75-93.57, p<0.002) more likely to have high levels 
hsCRP than the controls after adjusting for age category and sex.  
In a case-control study, logistic regression is the method to generate odds ratio 
(OR). OR works as an indicator that describes the association between the 
response and the exposure. The response in this study was the disease outcome, 
IPF; the exposure was one of the cytokines measured in this assay. Cytokines 
including IFN-Ȗ,/-17A, IL-10 and IL-13 produced by PBMCs in response to 
different stimuli were assessed individually. For OR above 1 means an 
increased tendency of disease associated with exposure (cytokine production) 
and OR less than 1 indicates a decreased tendency of disease associated with 
exposure. The levels of cytokine production were divided into two groups: high 
UHVSRQVHDQG ORZUHVSRQVHXVLQJµELQDU\TXDQWL]HPHWKRG¶ LQ6WDWD1XPEHUV
of patients and healthy donors corresponded to high levels or low levels of 
cytokine were segregated in comparable numbers using the same method (refer 
to Table 6.3 ± Table 6.6 for detail).  
Table 6.3 showed that cases (IPF patients) were 1.5 times more likely to 
produce IFN-ȖLQWKDQWKHFRQWUROVZKHQ3%0&VZHUHWUHDWHGZLWK30$25
1.55, 95% confidence interval (CI) 0.61-3.97) and SEB (OR 1.53, 95% CI 
0.60-3.90). When PBMCs were treated with PPD and PA extract, IPF patients 
were 60% less likely to produce IFN-Ȗ WKDQ WKH FRQWrols (OR 0.42, 95% CI 
0.15-1.16; OR 0.34, 95% CI 0.12-0.96), whereas secretions of IFN-Ȗ LQ ,3)
patients and controls were comparable when PBMCs were treated with PHA 
(OR 0.99, 95% CI 0.39-2.51) and HDM (OR 1.08, 95% CI 0.40-2.93) 
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stimulation. ORs were adjusted for sex and age category. Fig. 6.3 summarised 
the ORs and 95% CI. However, none of the associations between IFN-Ȗ
production by PBMCs in response to any stimuli and IPF were significant. 
Table 6.2  Demographic characteristics of controls and IPF patients from the first 
part of the population in this study 
Characteristic  Controls Cases Total OR (95% CI) 
Number (% total)  38 (52.78%) 34 (47.22%) 72 (100%)  
Sex Female 9 9 18 (25.97%)  
 Male 29 25 54 (74.03%)  
Age category (years) <65 17 9 26  
 65-69 2 8 10  
 70-74 8 7 15  
 75-79 4 4 8  
 80-84 4 2 6  
 >85 3 4 7  
Mean age ± SD  69.3 ± 9.8 70.7 ± 10.3   
Smoking habit Never smoked 17 (45%) 11 (32%) 28 (39%) 1.00 
 Ex-smoker 19 (50%) 20 (59%) 39 (54%) 1.77 (0.63 to 4.94) 
 Current smoker 2 (5%) 3 (9%) 5 (7%) 3.05 (0.40 to 23.34) 
*hsCRP category (mg/ 
ml) 
<1 11 2 13 (18.06%) 1.00 
 1-3 17 8 25 (34.72%) 2.97 (0.51-17.28) 
 >3 10 23 33 (45.83%) 16.04 (2.75-93.57), 
p=0.002 
*hsCRP, highly-sensitive C-reactive protein. ORs are adjusted for age category and sex. 
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Table 6.3  The association between IFN-Ȗ secretion and IPF 
IFN-ȖSURGXFWLRQ 
Stimuli Binary 
Controls 
(n=38) 
Cases 
(n=34) 
Unadjusted OR 
(95% CI) 
OR adjusted for 
age_cat and sex  
(95% CI) 
PMA    
1.56 
(0.62-3.97) 
1.55 
(0.61-3.97) 
 Low 21 15   
 High 17 19   
PHA    
1.00 
(0.40-2.52) 
0.99 
(0.39-2.51) 
 Low 19 17   
 High 19 17   
SEB    
1.56 
(0.62-3.97) 
1.53 
(0.60-3.90) 
 Low 21 15   
 High 17 19   
PPD    
0.51 
(0.20-1.30) 
0.42 
(0.15-1.16) 
 Low 16 20   
 High 22 14   
HDM    
1.25 
(0.49-3.16) 
1.08 
(0.40-2.93) 
 Low 20 16   
 High 18 18   
PA    
0.32 
(0.12-0.83) 
0.34 
(0.12-0.96) 
 Low 14 22   
 High 24 12   
Figure 6.4  Summary of OR assessing the association between IPF and IFN-Ȗ production 
in PBMCs in response to a panel of stimuli. 
IPF patients had no evident tendency to have more IFN-Ȗ production than controls in PBMCs 
upon PMA, PHA, SEB and HDM stimulation.  IPF patients PBMCs were 58% and 66% less 
likely to produce IFN-Ȗ in response to PPD and PA respectively. 
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PBMCs in cases were 86% (OR 0.14, 95% CI 0.04-0.50, p=0.003), 70% (OR 
0.31, 95% CI 00.11-0.86, p=0.025) and 83% (OR 0.17, 95% CI 0.02-0.55, 
p=0.003) less likely to produce IL-17A than the controls in response to SEB, 
PPD and PA extract respectively and the effects were significant (Table 6.3). 
PBMCs upon PMA, PHA and HDM stimulation in IPF patients were also less 
likely (64%, 38% and 50% respectively) to produce IL-17A than the healthy 
donors, although no significance was obtained (Table 6.3). ORs summarised in 
Fig. 6.4 indicated that PBMCs in IPF patients were generally less likely to 
produce IL-17A than the controls in response to all stimuli. This result suggests 
the production of IL-17A (Th17 differentiation) in PBMCs from patients with 
IPF might be down-regulated or dysfunctional compared to the healthy controls.   
Regarding the association between the production of IL-10, the anti-
inflammatory cytokine, and IPF, PBMCs of IPF patients upon PHA and PA 
were 80% (OR 0.20, 95% CI 0.06-0.61, p=0.005) and 70% (OR 0.30, 95% CI 
0.10-0.89, p=0.03) less likely to produce IL-10 than healthy donors (Table 6.4). 
PBMCs in IPF patients treated with PMA, SEB, PPD and PDM were also less 
likely (60%, 40%, 26%, and 32% respectively) to produce IL-10 than the 
healthy individuals, although no significance was achieved (Table 6.4). Fig. 6.5 
highlighted not only PBMCs in IPF patients stimulated with PHA had a 
tendency to produce less IL-10 than the healthy controls when the levels of IL-
10 were grouped in binary, but the mean of IL-10 production in PBMCs in IPF 
patients was also significantly less (Un-paired t-test, p=0.0003) than the mean 
in healthy donors. 
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Table 6.4  The association between the production of IL-17A and IPF 
IL-17A  production 
Stimuli Binary 
Controls 
(n=38) 
Cases 
(n=34/32) 
Unadjusted OR 
 (95% CI) 
OR adjusted for 
age_cat and sex  
(95% CI) 
PMA    
0.36 (0.14-0.93) 
p=0.034 
0.36 (0.13-1.00) 
 
 Low 15 22   
 High 23 12   
PHA    0.80 (0.32-2.02) 0.62 (0.22-1.80) 
 Low 18 18   
 High 20 16   
SEB    
0.25 (0.063-0.66) 
p=0.006 
0.14 (0.04-0.50) 
p=0.003 
 Low 13 23   
 High 25 11   
PPD    
0.32 (0.12-0.83) 
p=0.02 
0.31 (0.11-0.86) 
p=0.025 
 Low 14 22   
 High 24 12   
HDM    0.51 (0.20-1.30) 0.50 (0.18-1.36) 
 Low 16 20   
 High 22 14   
PA   32 
0.24 (0.09-0.65) 
p=0.005 
0.17 (0.02-0.55) 
p=0.003 
 Low 13 22   
 High 25 10   
Figure 6.5  Summary of OR assessing the association between IPF and IL-17A 
production in PBMCs in response to a panel of stimuli. 
IL-17A production in people with IPF was lower than healthy controls when PBMCs were 
treated with a variety of stimulants. Moreover, PBMCs from IPF patients were up to 86% and 
83% significantly less likely to produce IL-17A in response to SEB and PA respectively than 
healthy subjects 
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Table 6.5  The association between the production of IL-10 and IPF 
IL-10 production 
Stimuli Binary 
Controls 
(n=38) 
Cases 
(n=33/32) 
Unadjusted OR 
(95% CI) 
OR adjusted for 
age_cat and sex  
(95% CI) 
PMA    0.47 (0.18-1.22) 0.41 (0.15-1.15) 
 Low 16 20   
 High 22 13   
PHA    
0.23 (0.083-0.61) 
p=0.004 
0.20 (0.06-0.61) 
p=0.005 
 Low 13 23   
 High 25 10   
SEB    0.50 (0.19-1.29) 0.49 (0.17-1.38) 
 Low 16 19   
 High 22 13   
PPD    0.63 (0.24-1.62) 0.74 (0.26-2.12) 
 Low 17 18   
 High 21 14   
HDM    0.63 (0.24-1.62) 0.68 (0.24-1.90) 
 Low 17 18   
 High 21 14   
PA    
0.31 (0.11-0.82) 
p=0.018 
0.30 (0.10-0.89) 
p=0.03 
 Low 14 21   
 High 24 11   
Figure 6.6  Summary of OR assessing the association between IPF and IL-10 production 
by PBMCs in response to a panel of stimuli. 
IPF patients PBMCs were less likely to produce IL-10 in response of a panel of stimuli. OR 
indicated that PBMCs stimulated with PHA from people with IPF were 80% less likely to 
produce IL-10 than the healthy donors (OR 0.20; 95% CI 0.06-0.61) (red box). The association 
identified by calculating OR corresponded to the result obtained when the levels of IL-10 were 
assumed to have a normal distribution. 
 
 256 
 
Th2-associated cytokines IL-4, IL-5, and IL-13 have been linked to the 
development of fibrosis in a variety of chronic inflammatory diseases. IL-13 
signalling pathway is considered as one of the dominant inducers of Th2-
dependent fibrosis in several chronic lung diseases (Wynn, 2011). High 
expression of IL-13 receptors IL-4RĮ and IL-13RĮ2 were identified in surgical 
lung biopsies and fibroblasts from patients with IIP compared with normal 
patients without pulmonary fibrosis (Jakubzick et al., 2004). In addition, levels 
of IL-13 and IL-13RĮ1 in the BAL fluids in patients with IPF were inversely 
correlated with lung function (Park et al., 2009, Wynn, 2011). Extensive 
collagen deposition secreted by fibroblasts upon IL-13 and TGF-ȕ1 stimulation 
also support the role of IL-13 as a profibrotic mediator (Murray et al., 2008).   
In the present study, PBMCs from IPF patients upon HDM and PA stimulation 
were 71% (OR 0.29, 95% CI 0.10-0384, p=0.022) and 73% (OR 0.27, 95% CI 
0.09-0.80, p=0.018) less likely to produce IL-13 than healthy subjects (Table 
6.5). PBMCs in IPF patients were also less likely to secret IL-13 in response to 
PMA, PHA, SEB and PPD (from 46% to 18%) than healthy controls, although 
the effects were less potent and not significant (Table 6.5; Fig. 6.7). Contrary 
to the high expression of IL-13 in the local pulmonary environment, PBMCs in 
IPF patients seemed to produce less IL-13 than the matched controls upon the 
stimulation of HDM and PA extract.  
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Table 6.6  The association between induced production of IL-13 and IPF 
IL-13 production 
Stimuli Binary 
Controls 
(n=37/38) 
Cases 
(n=32) 
Unadjusted OR 
(95% CI) 
OR adjusted for 
age_cat and sex  
(95% CI) 
PMA    0.66 (0.26-1.71) 0.57 (0.20-1.66) 
 Low 17 18   
 High 20 14   
PHA    0.52 (0.20-1.36) 0.54 (0.19-1.56) 
 
Low 16 21 
  
 
High 19 13 
  
SEB    0.50 (0.19-1.29) 0.63 (0.21-1.89) 
 Low 16 19   
 High 22 13   
PPD 
   
1.00 (0.39-2.56) 0.82 (0.29-2.31) 
 Low 19 16   
 High 19 16   
HDM 
   0.31 (0.11-0.82) 
p=0.018 
0.29 (0.10-0.84) 
 p=0.022 
 Low 14 21   
 High 24 11   
PA 
   0.31 (0.11-0.82) 
p=0.018 
0.27 (0.09-0.80) 
 p=0.018 
 Low 14 21   
 High 24 11   
Figure 6.7  Summary of OR assessing the association between IPF and IL-13 production 
in PBMCs in response to a panel of stimuli. 
IPF patients PBMCs were less likely to produce IL-13 in response of the panel of stimuli in 
this study.  
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6.5.4. Assessing the association between IPF and the production of IL-10 
and IL-13 in PBMCs upon PMA and PHA stimulation in the total 
population (66 patients and 66 healthy controls) 
Next it was decided to focus on IL13 and IL10 for the following reasons: (1) 
the mean of IL-10 production in PBMCs of IPF patients upon PHA stimulation 
was significantly lower than the controls (refer Table 6.5), which suggested 
that patients with IPF seemed prone to a pro-inflammatory systemic immune 
status; (2) PBMCs from 7 random patients produced substantial amounts of IL-
13 in response to PMA than the rest of the patients and the controls. We 
hypothesised that in a subgroup of patients with IPF their PBMCs were 
particularly hyper-responsive to PMA and produced higher levels of IL-13. To 
test the two hypotheses above, quantification of the levels of IL-10 and IL-13 
in PBMCs upon PMA and PHA stimulation in the other half population was 
performed. In addition, supernatants of PBMCs in response to PMA were 
diluted in 1:5 to obtain readings retain in the linear range due to the levels of 
IL-13 production from PBMCs in the first half population (14 of 39 controls; 
21 of 38 patients) were higher than the detection limit (above 20,000 pg/ml) by 
using immuno multiplex assay.  
The results showed that the mean IL-10 production in PBMCs from 68 IPF 
patients in response to PMA was significantly higher than the mean from 66 
healthy controls (Fig. 6.8B). The significance of the mean IL-10 production in 
PBMCs upon PHA stimulation between HD and IPF was lost when the whole 
population was considered but the trend towards reduced levels of IL-10 in IPF 
PBMCs remained (Fig. 6.8). The mean of IL-13 in PBMCs from 68 IPF in 
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response to PMA were also significantly higher than the mean from the healthy 
donors (Fig. 6.8B).  
 
 
 
Demographic features of the whole population listed in Table 6.7 showed that 
the controls (66 HD) and cases (66 IPF available due to 2 missing clinical data) 
were matched in age and sex. Patients with IPF were 2 times (OR 2.16, 95% CI 
1.08-4.31, p=0.05) more likely to have been ex-smokers than the controls. IPF 
patients in general secrete higher hsCRP than the general population. The 
results summarised in Table 6.8 showed that PBMCs from patients with IPF 
Figure 6.8  Mean of the IL-10 and IL-13 production in PBMCs from 68 IPF patients 
(IPF) upon PMA stimulation was higher than that of 66 healthy donors (HD) and the 
trend of lower IL-10 production in PBMCs of IPF patients. 
A, levels of IL-10 and IL-13 in PBMCs in response to PMA and PHA from the first half 
population (39 HD and 38 IPF) were shown in dot plots. B, levels of IL-10 and IL-13 in 
PBMCs in response to PMA and PHA from the whole population (66 HD and 68 IPF) were 
shown in dot plots. 
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upon PMA stimulation were 57% (OR 0.43, 95% CI 0.21-0.89) less likely to 
produce IL-10 than the healthy controls when levels of IL-10 were binary 
grouped; PBMCs in IPF patients were 26% (OR 0.74, 95% CI 0.49-1.11) less 
likely to produce IL-10 than the general population when levels of IL-10 were 
categorised in 3 groups: low, medium and high response. Whilst PBMCs from 
patients with IPF upon PHA stimulation were 38% (OR 0.62, 95% CI 0.30-
1.28) less likely to produce IL-10 than the healthy controls when levels of IL-
10 were binary grouped; PBMCs in IPF patients were 28% (OR 0.72, 95% CI 
0.46-1.11) less likely to produce IL-10 than the general population when levels 
of IL-10 were categorised in 3 groups: low, medium and high response. 
However, none of the above associations were significant (summarised in Fig. 
6.9).  
Results in Table 6.9 showed that no apparent association exists between IL-13 
production in response to PMA and IPF (OR 1.01, 95% CI 0.53-2.23). PBMCs 
from patients with IPF upon PHA stimulation were 70% (OR 0.31, 95% CI 
0.14-0.66, p=0.003) less likely to produce IL-13 than the healthy controls when 
levels of IL-13 were grouped in binary categories; when levels of IL-13 were 
categorised in 3 groups, PBMCs in IPF patients also appeared 50% (OR 0.50, 
95% CI 0.32-0.80, p=0.004) less likely to produce IL-13 than the general 
population (summarised in Fig. 6.10).   
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Table 6.7  Demographics containing the whole population of incident cases of IPF and 
healthy controls in this study 
Characteristic  Controls Cases Total OR (95% CI)* 
Number (% total)  66 (50%) 66 (50%) 132 (100%)  
Sex Female 15 19 34 (26%)  
 Male 51 47 98 (74%)  
Age category (years) <65 26 17 43  
 65-69 4 12 16  
 70-74 14 16 30  
 75-79 9 10 19  
 80-84 6 4 10  
 >85 7 7 14  
Mean age  69.6 (9.9) 71.5 (9.8)   
Smoking habit Never smoked 30 17 47 (35.6%) 1.00 
 Ex-smoker 32 45 77 (58.3%) 
2.16 (1.08 to 4.31), 
p<0.05 
 Current smoker 4 5 9  (6.8%) 2.60 (0.60 to 11.22) 
hsCRP category 
(mg/ml) 
<1 23 6 29 (21.9%) 1.00 
 1-3 29 18 47 (35.6%) 2.40 (0.87 to 6.57) 
 >3 14 41 56 (42.4%) 
7.77 (2.86 to 21.09), 
p<0.0001 
*OR adjusted for age category and sex.   
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Table 6.8  The association between PMA and PHA induced production of IL-10 and 
IPF in the whole population in this study 
IL-10 production 
Stimuli  
Controls 
(n=66) 
Cases 
(n=66) 
Unadjusted OR 
(95% CI) 
OR adjusted for 
age_cat and sex (95% CI) 
PMA Binary   0.48 (0.24-0.96) 0.43 (0.21-0.89) 
 Low 27 39   
 High 39 27   
PMA Category   0.78 (0.53-1.15) 0.74 (0.49-1.11) 
 Low 36 39   
 Medium 18 5   
 High 22 22   
PHA Binary   0.61 (0.31-1.22) 0.62 (0.30-1.28) 
 Low 29 37   
 High 37 29   
PHA Category   0.76 (0.48-1.10) 0.72 (0.46-1.11) 
 Low 17 27 1.00 1.00 
 Medium 25 19 0.48 (0.20-1.12) 0.48 (0.19-1.16) 
 High 24 20 0.52 (0.22-1.22) 0.51 (0.21-1.23) 
Figure 6.9  A summary plot illustrates the association between IPF and the induced 
production of IL-10 in response to PMA and PHA from the whole population in this 
study. 
OR consistently less than 1 indicates that IPF patients were less likely to produce IL-10 when 
PBMCs were stimulated with PMA and PHA although no significance was achieved. 
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Table 6.9  The association between PMA and PHA induced production of IL-13 and 
IPF in the whole population in this study 
IL-13 response 
Stimuli  
Controls 
(n=66) 
Cases 
(n=66) 
Unadjusted OR 
(95% CI) 
OR adjusted for 
age_cat and sex 
(95% CI) 
PMA Binary   1.00 (0.56-1.97) 1.01 (0.53-2.23) 
 Low 33 33   
 High 33 33   
PHA Binary   
0.36 (0.18-0.74) 
p=0.0006 
0.31 (0.14-0.66) 
p=0.003 
 Low 25 41   
 High 41 25   
PHA Categorical   
0.52 (0.33-0.80) 
p=0.003 
0.50 (0.32-0.80) 
p=0.004 
 
Low 
(490.69-13963.21) 15 29 1.0 1.0 
 
Medium  
(14,063.49- 31,319) 22 22 0.52 (0.22-1.22) 0.47 (0.19-1.16) 
 
High  
(32,068-348,679.3) 29 15 
0.27 (0.11-0.65) 
p=0.003 
0.25 (0.10-0.64) 
p=0.004 
The concentration of cytokine was measured in pg/ml. 
Figure 6.10  A summary of odds ratios quantifying the association between IPF and 
IL-13 production in response to a panel of stimulation. 
PBMCs from IPF patients were 69% less likely to produced IL-13 upon PHA stimulation 
than the healthy controls (OR 0.31; 95% CI 0.14-0.66). IPF patients were 75% less likely 
than healthy controls to produce IL-13 at high levels (PHA cat High). 
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6.5.5. Correlation between the levels of cytokine production and survival 
in the IPF cohort 
To determine whether the levels of cytokine production by PBMCs correlated 
with the clinical outcome in the IPF cohort, Cox regression modelling of 
individual cytokine production and survival performed. In Cox regression 
modelling, hazard is the slope of the survival curve indicating how rapidly 
subjects are dying. The hazard ratio (HR) is defined as the hazard in the 
exposed groups divided by the hazard in the unexposed groups (Hernan, 2010). 
For instance, HR 2.0 means a patient in group one who has not died has twice 
the probability of having died in group two. The groups used in this analysis, 
high levels and low levels of IFN-Ȗ, IL-17A, IL-10 and IL-13, were the same 
used in the logistic regression analysis. Group one in our analysis default 
VHWWLQJZDVµORZOHYHOVRIF\WRNLQHSURGXFWLRQ¶DQGJURXSWZRZDVµKLJKOHYHOV
of cytokine. 
The results showed that the survival of patients with lower levels of IL-17A 
production in PBMCs upon PMA, PHA, HDM and PA extract stimulation had 
increased risk of mortality than those with high levels of IL-17A (Fig. 6.9). 
Lower production of IL-17A increased mortality by 4 times in average (see 
Table 6.10 for detail). Similarly, lower levels of IL-13 in PBMCs upon HDM 
and PA stimulation increased mortality by 6 and 4 times respectively compared 
with those IPF patients with higher levels of IL-13 (See Table 6.10 for detail; 
Fig. 6.10). Lower levels of IFN-Ȗ in PBMCs upon HDM and PA stimulation 
also increased mortality by 4 times compared with those with higher levels of  
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IFN-Ȗ (Table 6.10 for detail; Fig. 6.11). However, lower levels of IFN-Ȗ in 
PBMCs upon SEB stimulation correlated with decreased mortality (0.3 times) 
compared with higher levels of IFN-Ȗ (Table 6.10). Levels of IL-10 in PBMCs 
in response to any of the stimuli used in the study cohort did not correlate with 
mortality. 
 Overall, this preliminary analysis suggests that in general lower levels of 
cytokines in PBMCs of IPF patients correlate with higher risk of mortality.   
 
Table 6.10  Significant Cox regression correlations between individual 
cytokine production and survival in the IPF cohort 
Variable Hazard ratio 95% CI P-value 
IFN-ȖSEB) 0.29 0.085 to 0.99 0.0487 
IFN-Ȗ (HDM) 3.94 1.17 to 13.31 0.0271 
IFN-Ȗ (PA) 4.31 1.29 to 14.41 0.0176 
Variable Hazard ratio 95% CI P-value 
IL-17A (PMA) 4.10 1.23 to 13.69 0.0219 
IL-17A (SEB) 3.65 1.08 to 12.35 0.0377 
IL-17A (HDM) 4.45 1.34 to 14.80 0.0148 
IL-17A (PA) 4.60 1.37 to 15.50 0.0138 
Variable Hazard ratio 95% CI P-value 
IL-13 (HDM) 6.13 1.72 to 21.84 0.0052 
IL-13 (PA) 4.02 1.13 to 14.34 0.0318 
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Figure 6.11  Survival plot of IPF patients with high and low levels of IL-17A in PBMCs 
upon PMA, SEB, HDM and PA extract stimulation. 
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Figure 6.12  Survival of IPF patients with high and low levels of IL-13 in PBMCs upon 
HDM and PA extract stimulation. 
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Figure 6.13  Survival of IPF patients with high and low levels of IFN-Ȗ in PBMCs 
upon SEB, HDM and PA extract stimulation. 
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6.6. DISCUSSION 
Repetitive apoptosis of alveolar epithelial cells leading to epithelial 
mesenchymal transition and massive accumulation of extracellular matrix is 
considered the primary factor that causes impaired tissue remodelling in 
patients with IPF. However, numerous cytokines derived from T cells, 
monocytes/macrophages and other myeloid cells are also important regulators 
of myofibroblast differentiation (Duffield et al., 2013). In this study, the 
systemic immune status in patients with IPF was investigated by analysing the 
cytokine profile in PBMCs upon unbiased stimulation in comparison with age- 
and sex-matched healthy individuals. We demonstrated that the production of 
IL-17A was 90%, IL-10 80% and IL-13 70% more likely at lower levels in 
PBMCs of patients with IPF than in the general population controls. 
Additionally, lower levels of IL-17A, IL-13 and IFN-Ȗ were associated with 
disease severity, with IPF patients in the low production group being 4 to 6 
times more likely to die. Our study showed that circulating immune cells in 
patients with IPF were generally less responsive to both non-specific and 
specific antigens than healthy donor cells.  
Numerous studies have suggested the involvement of the cytokine milieu in 
regulating disease progression caused by aberrant epithelial damage can lead to 
exaggerated deposition of extracellular matrix in the lung (Duffield et al., 2013, 
Hams et al., 2014). Th2 response cytokine IL-13 has been widely considered a 
profibrotic mediator in tissue remodelling, including chronic asthma, IPF and 
lung fibrosis models (Murray et al., 2008, Duffield et al., 2013). The 
bleomycin-induced mouse pulmonary fibrosis model demonstrated that 
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increased levels of IL-13 induced fibrosis via up-regulating the production of 
TGF-ȕ (Lee et al., 2001). Concentrations of IL-13 in the serum, the BAL, 
smooth muscle, bronchial epithelium and alveolar macrophages of patients 
with IPF were higher than healthy controls and the levels were inversely 
correlated with lung function (Xiao et al., 2003, Park et al., 2009). Increased 
production of IL-13 by innate lymphoid cells in pulmonary fibrosis has also 
been shown. In addition to T-cell -mediated antigen-specific immune responses, 
a recent study described elevated IL-25 production by type 2 innate lymphoid 
cells (ILC2) in which also express IL-13 in a Schistosoma mansoni egg-
induced pulmonary granuloma model. This finding of increased IL-25, IL-13 
and TFG-ȕ production correlated with a population of ILC2 in the BAL and 
lung biopsy in patients with IPF suggested an innate mechanism was also 
involved in the generation of pulmonary fibrosis (Hams et al., 2014). 
IL-17A is a proinflammatory cytokine involved in autoimmune disease and 
chronic airway remodeling (Tan and Rosenthal, 2013, Nembrini et al., 2009). 
Recently, enhanced IL-17A production was identified in murine pulmonary 
fibrosis models and in the lungs of patients with IPF. The bleomycin-induced 
mouse fibrosis model indicated that IL-ȕ DQG ,/-23 promote pulmonary 
fibrosis by inducing IL-17A which causes significant neutrophilia (Wilson et 
al., 2010, Gasse et al., 2011). Early IL-17A and IL-)H[SUHVVLRQE\525ȖW
Ȗį 7 FHOOV ZDV VKRZQ WR EH UHTXLUHG IRU SXOPRQDU\ ILEURVLV and this was 
enhanced by TGF-ȕSURGXction; inversely, blocking of IL-17A promoted the 
resolution of pulmonary inflammation via TGF-ȕ1 dependent and independent 
pathways (Gasse et al., 2011, Mi et al., 2011). In addition, elevated IL-17 
expressed by macrophages, CD3+ T cells and epithelial cells has also been 
 271 
 
detected in the aggressively fibrotic region in the lungs of patients with IPF 
(Nuovo et al., 2012). The above studies suggest that fibrogenesis in IPF could 
be predominantly regulated by enhanced local production of IL-13 and IL-17 
in the interstitial lung. 
 
However, our data contradicts to previous studies by showing that peripheral 
blood from IPF patients are more likely to secret lower levels of cytokines than 
healthy controls. This might due to the fact that we investigated the production 
of cytokines by PBMCs in response to a panel of stimuli whereas in other 
studies, the levels of cytokine were quantified in serum and BAL. Secondly, 
WKH JHQHUDOO\ ORZHU F\WRNLQH SURGXFWLRQ LQ SDWLHQWV¶ 3%0&V FRPSDUHG WR
Table 6.11  Summary of ORs with significance differences 
Stimuli Cytokine Unadjusted OR 
 (95% CI) 
OR adjusted for 
age_cat and sex  
(95% CI) 
PMA IL-17A 0.36 (0.14-0.93) 
p=0.034 
0.36 (0.13-1.00) 
 
SEB IL-17A 0.25 (0.063-0.66) 
p=0.006 
0.14 (0.04-0.50) 
p=0.003 
PPD IL-17A 0.32 (0.12-0.83) 
p=0.02 
0.31 (0.11-0.86) 
p=0.025 
PA IL-17A 0.24 (0.09-0.65) 
p=0.005 
0.17 (0.02-0.55) 
p=0.003 
PA IL-10 0.31 (0.11-0.82) 
p=0.018 
0.30 (0.10-0.80) 
p=0.03 
HDM IL-13 0.31 (0.11-0.82) 
p=0.018 
0.31 (0.10-0.8204) 
p=0.022 
PA IL-13 0.31 (0.11-0.82) 
p=0.0018 
0.27 (0.09-0.80) 
p=0.018 
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healthy controls could be partially explained by the lack of potency of 
peripheral blood cells, either T-cell differentiation is skewed or the function of 
antigen-presenting cells was impaired, in response to stimuli. We postulated 
that the enhanced cytokine production, including IL-13 and IL-17A, in the 
serum and BAL in patients with IPF might have exhausted the immune cells 
therefore cannot respond further stimulation. The exhausted immune system 
thus causes IPF patients more susceptible to exacerbations. The regulation of 
systemic T cell differentiation upon stimulation might also be deteriorated. A 
recent transcriptomic study showed that reduced expression of genes that 
participate in T-cell co-stimulatory signalling including CD28, ICOS 
(inducible T-cell costimulator, also known as CD278), LCK (lymphocyte-
specific protein tyrosine kinase) and ITK (interleukin-2-inducible T cell kinase) 
were identified in PBMCs from patients with IPF compared with healthy 
donors (Herazo-Maya et al., 2013). Further, CD4+CD28+ cells were identified 
to be the cellular compartments with reduced CD28, ICOS, LCK and ITK 
expression in the replication cohort. ITK expressed in T cells, NKT cells and 
mast cells is a non-receptor tyrosine kinase which regulates the T cell receptor 
(TCR), CD28, CD2, chemokine receptor CXCR4, and FcİR-mediated 
signaling pathways. In T cells, ITK mediates TCR activation via Src and Lck 
NLQDVH SKRVSKRU\ODWLRQ RI 3/&Ȗ WKDW OHDGV WR DFFXPXODWLRQ RI LQWUDFHOOXODU
calcium and activation of MAP, ERK, JNK kinases and the transcription 
factors NFAT (nuclear factor of activated T-cells) and AP-1 (activating protein 
1) (Sahu and August, 2009). ITK in association with CD28, ICOS, and LCK 
has a pivotal role in the secretion of Th2 cytokines IL-4, IL-5 and IL-13 and 
regulation of the development of effective Th2 response in allergic asthma and 
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worm infections that involves in Th2-mediated inflammation. This study 
partially explains our results that the generally lower levels of cytokines in 
PBMCs of patients in IPF upon a broad range of antigen stimulations compared 
with healthy individuals could be attributed to the decreased expression of T 
cell co-stimulatory signalling. In another study, down-regulation of CD28 in 
circulating CD4 T cells was implicated with an association with disease 
severity in patients with IPF (Gilani et al., 2010). T cells develop functional 
and phenotypic changes upon repetitive chronic antigen stimulations that could 
have included the loss of co-stimulatory surface protein CD28. Not only the 
impaired co-stimulatory signalling in CD4+CD28+ T cells might result in 
insufficient cytokine production upon antigen stimulation, reduced cytokine 
production in the PBMCs cultures might also attribute to an activation-induced 
T cell death in circulating cells (Gilani et al., 2010, Herazo-Maya et al., 2013). 
IPF has been considered as an autoimmune disease. The study conducted by 
Kotsianidis et al. demonstrated that Tregs in peripheral blood and BAL from 
patients with IPF exhibited defective inhibition of Th1 and Th2 cytokine 
production by T effector cells (CD4+CD25-) (Kotsianidis et al., 2009). Locally 
and systemically reduced Tregs displayed a compromised suppressor role in 
maintaining the balance of Th1 and Th2 response. The theory of globally 
skewed regulatory role of Tregs in patients with IPF supported our findings 
that PBMCs from people with IPF have the tendency of lower levels of both 
Th1 and Th2 cytokine secretion and correlated with mortality. In this regard, 
IPF patients might suffer an impaired immunity thus are vulnerable to acute 
exacerbations usually induced by virus infections (Hoo and Whyte, 2012, 
Wuyts et al., 2012). 
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In addition to T cells population, we suspect that the antigen-presenting cells 
(APCs) also play a role in mediating the production of cytokines in the 
peripheral blood. Macrophages regulate fibrogenesis by secreting chemokines 
that recruit fibroblasts and other inflammatory cells. Although collagen-
secreting myofibroblasts were considered the cellular origin of extracellular 
matrix components that lead to fibrosis, macrophages in vivo were found co-
localise with collagen-producing myofibroblasts and produce profibrotic 
mediators that directly activate fibroblasts, including TGF-ȕ DQG SODWHOHW-
derived growth factor (PDGF and TFG-ȕ are the master regulators in fibrosis 
progression and resolution) (Wynn and Barron, 2010, Duffield et al., 2013). 
Macrophages can be induced by TLR signalling and IFN-Ȗ that turn into M1-
type (classically activated) macrophages and M2-type macrophages 
(alternatively activated) that induced by IL-4 and IL-13, although more 
subtypes of M2 macrophages have also been described (Hussell and Bell, 
2014). A positive correlation between the levels of M2-type macrophages in 
peripheral blood and lung functions was demonstrated in patients with IPF 
(Prasse and Muller-Quernheim, 2009). A systematic study in order to elucidate 
the compartmentalization of cell activation showed that the secretion of IL-2 
by T cells in PBMCs and BAL of patients with IPF was decreased after steroid 
treatment whereas BAL macrophages remained activated. It was suggested that 
macrophages in IPF failed to respond to the surrounding cytokine milieu 
(Homolka et al., 2003). This result also implicated why anti-inflammatory 
treatments fail to relieve the symptoms in patients with IPF. 
In the present study, the univariate Cox proportional model was used to define 
a hazard ratio for a cytokine (biomarker) in relation to mortality and 
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demonstrated a significant correlation between lower levels of cytokine with 
poor survival (Prasse and Muller-Quernheim, 2009). However, multivariate 
Cox proportional models are required to adjust for baseline parameters, such as 
sex, age, smoking habit, etc. Heterogeneity of pulmonary fibrosis in each IPF 
patient and no consistent patterns could be found between individuals has been 
a challenge to identify the immunological parameters to predict disease 
prognosis. Further investigations including cell compositions in PBMCs, cell 
population in correlation with cytokine production, and the grouping of 
multiple cytokines using multivariate model are also needed. A signature 
pathway generated by multivariate model will further our understanding of the 
underlying mechanism in IPF.  
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6.7. SUMMARY 
This study suggests that PBMCs in patients with IPF were in general less 
responsive to a variety of stimulations based on the lower production of IL-
17A, IL-10 and IL-13 observed. 
Lower levels of IL-17A secreted by PBMCs in response to SEB, PPD, HDM 
and PA correlated with increased mortality (4 fold); lower levels of IL-13 and 
IFN-Ȗ in PBMCs upon HDM and PA extract stimulation also increased the risk 
of death by 6 and 4 fold respectively. One exception was higher levels of IFN-Ȗ 
in PBMCs stimulated with SEB were associated with poor survival. These 
results indicate that the ability of circulating immune cells to produce cytokines 
in response to stimulation could be used as a prognosis marker in IPF. 
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7. GENERAL DISCUSSION AND FUTURE 
PERSPECTIVES 
The first project 
Pseudomonas quinolone signal (PQS) coordinates the expression of virulence 
factors of P. aeruginosa, promotes the formation of biofilms and has been 
detected in the CF lung (Collier et al., 2002). In parallel with the fact that the 
PQS QS system is not essential for bacterial survival (Galloway et al., 2011), it 
is proposed that disruption of PQS can be a promising treatment to replace 
antibiotics in the attenuation of pathogenesis of P. aeruginosa in the CF. 
However, little was known about how PQS contributes to P. aeruginosa 
pathogenesis during the initial innate recognition by the human airway 
epithelium. The purpose of the present study was to investigate whether PQS 
deficiency affects the interaction of P. aeruginosa with differentiated human 
airway epithelium. This was achieved by infecting human differentiated 
bronchial-epithelial cells (chapter 3) with wild-type P. aeruginosa PAO1 
Lausanne (PAO1-L) and its isogenic PQS-deficient mutant ǻpqsAL. Due to an 
intrinsic loss of a 5.8 kb genomic fragment in PAO1-N that might mask the 
impact of our target of interest AQs, we re-generated an AQs deficient mutant 
by depletion of gene pqsA in the PAO1-L background with a genomic 
sequence closer to the original PAO1 strain (Chapter 2). The phenotype of 
ǻpqsAL was characterised in vitro and showed highly reduced production of 
AQs, decreased secretion of exotoxins pyocyanin and rhamnolipids, and fragile 
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biofilms; thus ǻpqsAL displayed a phenotype associated with attenuation 
(Chapter 2). Bacterial pathogenesis and innate immune recognition by 
diffCalu-3 cells of PQS-competent and PQS-deficient strains were 
subsequently assessed be determining bacterial growth within cultures, 
induction of proinflammatory cytokines (mRNA and protein), activation of 
TLR-mediated signalling pathways and cytotoxicity (Chapter 4). Further, the 
efficacy of the in vitro differentiated human epithelial infection model was 
evaluated using a highly virulent CF isolate LESB58 (Chapter 5). The results 
indicated that AQs do not contribute to the initial immune recognition of P. 
aeruginosa by human airway epithelium. CF clinical isolate LESB58 displayed 
slower growth and caused less damage to the airway epithelium compared to 
PAO1-L.  
Our results show that P. aeruginosa infection in airway epithelium initiates 
through the attachment of bacteria to apical protrusions, bacterial accumulation 
close to cell junctions and a robust activation of pro-inflammatory mediators 
(mRNA). Degradation of actin and tight junction proteins was detected at 3 hpi 
whilst no bacteria could be detected across the epithelial layer. Substantial 
disruption of actin and tight junction proteins along breach of barrier integrity, 
as suggested by the detection of bacteria translocation, occurs at 6 hpi.  
In the CF lung, the accumulation of abnormally processed CFTR proteins in 
WKHHQGRSODVPLFUHWLFXOXP(5UHVXOWVLQµ(5VWUHVV¶DQGLPSDLUHGPXFRFLOLDU\
clearance leading to dysregulation of the innate immune function and persisted 
and ineffective airway inflammation (Cohen-Cymberknoh et al., 2013). Our 
findings are in agreement with previous literature describing secretion by 
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airway epithelial cells of pro-inflammatory mediators able to recruit and 
activate phagocytic cells in response to bacterial infection (Gomez and Prince, 
2008, Pfeifer et al., 2012). The expression of mRNA encoding for GM-CSF, 
IL-8, TNF-Į and IL-17C in diffCalu-3 cells was highly induced by P. 
aeruginosa PAO1-L infection. TNF-Į and the recently identified cytokine IL-
17C, are of great interest because of their predominant roles in regulating 
airway inflammation. TNF-Į is considered a pleiotropic cytokine. It confers 
protection against P. aeruginosa in mice as depletion of TNF-Į in DBA/2 mice 
and BALB/c mice using anti-ȉȃF-Į antibodies increased susceptibility to P. 
aeruginosa lung infection (Morissette et al., 1996, Gosselin et al., 1995, 
Sadikot et al., 2005). On the other side it was also found to promote 
inflammation in CF airways (Mukhopadhyay et al., 2006, Maille et al., 2011). 
IL-17C, produced by epithelial cells and keratinocytes in an autocrine manner, 
acts as a pro-inflammatory mediator in the mucosal epithelium upon bacterial 
and viral infections (Bordon, 2011, Ramirez-Carrozzi et al., 2011, Pfeifer et al., 
2012). Although the downstream signaling pathways remain mostly unknown, 
IL-17C has been shown to promote Th17 cell differentiation via the binding of 
its receptor IL-17RE on Th17 cells (Chang et al., 2011). The binding of IL-
17C/IL-5( LQGXFHG WKH H[SUHVVLRQ RI ,ț%ȟ to potentiate the Th17 cell 
response in a mouse model of autoimmune disease: experimental autoimmune 
encephalomyelitis (EAE) (Chang et al., 2011, Ramirez-Carrozzi et al., 2011). 
Of note, IL-17C can work synergistically with TNF-Į to promote skin 
inflammation in psoriasis using a IL-17C transgenic mouse model (Johnston et 
al., 2012). Recent VWXGLHVGHILQHG&)DVDµ7KGLVHDVH¶7KFHOOVDQGWKH
cytokines IL-17A/F, IL-22 and IL-23, which would promote neutrophil 
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recruitment to the airways, are increased in CF and might lead to a neutrophil-
mediated tissue damage in the CF airways (McAllister et al., 2005, Tan et al., 
2011, Brodlie et al., 2011, Decraene et al., 2010). We postulate that IL-17C 
production by airway epithelial cells upon P. aeruginosa infection not only 
synergistically enhances the induction of TNF-Į which could perpetuate the 
airway inflammation, but also plays a role in shaping the subsequent Th17 
response in the adaptive immunity. In combination with our preliminary data, 
we propose several questions that would be of great importance to further our 
knowledge on IL-17C and its contribution to the modulation of the Th17 
response in the CF: (1) which is the underlying signalling mechanism leading 
to the production of IL-17C alone or in conjunction with TNF-Į in airway 
epithelial cells upon P. aeruginosa infection and the contribution of CFTR 
expression; (2) would an early inhibition of IL-17C in the airways (or CF 
airways which is still unknown) dampen a Th17 response and protect from 
perpetuating inflammation? In the scope of designed immunomodulatory 
therapy, anti-TNF-Į therapy has been tested in CF and showed abrupt 
stabilization with improved forced expiratory volume (FEV1) (Chmiel and 
Konstan, 2007, Casserly and Donat, 2009). To promote resolution of chronic 
inflammation in the CF lung, manipulation of the signalling pathways triggered 
by pro-inflammatory cytokines (TNF-Į and IL-17C for instance) could have 
beneficial consequences for the host response as it might be possible to 
stimulate sufficient phagocytic cells for bacterial clearance without 
overwhelming the lung with inflammation that leads to tissue damage.  
The signalling pathways induced during P. aeruginosa infection in diffCalu-3 
cells were investigated. TLR2, TLR5 and asialoGM1 expressed on the apical 
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surface of airway epithelial cells have been shown essential for the pro-
inflammatory activation upon P. aeruginosa infection (Zhang et al., 2005, 
Tseng et al., 2006, Adamo et al., 2004). The binding of flagellin to TLR5, 
lipoproteins to TLR2 that together with asioloGM1 trigger the downstream 
signalling activation cascade through the adaptor protein MyD88/TIRAP, and 
the subsequent MAPK, ERK-1/2, and AKT-dependent translocation of 
transcription factors NF-țǺ, p38 and IRFs resulting in the production of pro-
inflammatory cytokines (Adamo et al., 2004, Zhang et al., 2005, McNamara et 
al., 2006, Tseng et al., 2006, Gomez and Prince, 2008). However, the levels of 
activation of TLR-associated signalling examined in our study including p38, 
ERK1/2, NF-țǺ, IRF7, AKT serine/threonine at 3 hpi were less than 2-fold, 
and thus cannot be considered biologically significant. This could be 
attributable to the cytotoxic effects of P. aeruginosa as actin degradation and 
disruption of tight junction proteins were observed at the time when the 
induction of cell signalling was examined (chapter 4 section 4.5.3.-4.5.5.).  
We propose a paradigm of initial activation of the airway epithelium in 
response to P. aeruginosa infection from our results in conjunction with 
previous established knowledge can be tailored as the following sequence of 
events: (1) apical protrusions in response to P. aeruginosa aggregates (Engel 
and Eran, 2011, Tran et al., 2014) followed by (2) the recruitment of 
basolateral proteins PIP3 to the apical side with localised activation of NF-țB 
signalling and the subsequent (3) alterations of cellular integrity through actin 
degradation, disruption of tight junctions and disturbance of gap junctions that 
lead to apoptosis (Engel and Balachandran, 2009, Losa et al., 2014). The above 
three steps could be mediated by P. aeruginosa effectors (1) type IV pili that 
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bind to N-glycans at the apical surface; (2) the subversion of polarity facilitated 
by the binding of flagellum to heparan sulfate proteoglycans that are enriched 
at the basolateral compartment in the epithelium (Bucior et al., 2010, Bucior et 
al., 2012); (3) disruption of actin cytoskeleton and tight junctions by the T3SS 
apparatus and the secreted effector proteins ExoS and ExoT that target Rho 
family proteins Rho, Rac, and Cdc42, etc. via their N-terminal GTPase activity 
and C-terminal ADP-ribosyltransferase (ADPRT) domain (Engel and 
Balachandran, 2009).  
In contrast to previous studies indicating immunomodulatory properties of AQ 
QS molecules on PBMCs and airway epithelial cells via inhibition of pro-
inflammatory signallings HIP-1Į and NF-țǺ in vitro through the use of AQ 
pure compounds or AQs extracts from bacterial culture supernatants (Kim et al., 
2010a, Kim et al., 2010b, Legendre et al., 2012), we demonstrated that the 
activation of pro-inflammatory responses and the cytotoxicity effect in 
differentiated human airway epithelial cells during P. aeruginosa infection are 
independent of AQs. We postulate that P. aeruginosa pathogenesis on airway 
epithelial cells is initially driven by the flagellum and T3SS (discussed above), 
thus the impact of PQS to P. aeruginosa pathogenesis at early times could be 
relatively minor in this setting. Interestingly, ǻpqsAL infection on the murine 
model was cleared the next day post infection whereas PAO1-L wild-type kept 
persisting on the site of infection for 5 days until the end of the experiment, 
indicating the AQs deficient mutant ǻpqsAL was indeed attenuated compared 
to the PAO1-L Wt (In collaboration with Dr. James Lazenby, personal 
communication). This was performed by the infection of lux-labelled PAO1-L 
and ǻpqsAL (PAO1attB::[PKm]-luxCDABE and ǻpqsALattB::[PKm]-luxCDABE) 
 283 
 
injected subcutaneously on the back neck of BALB/c mice. This is considered 
an acute in vivo infection model (Personal communication, Dr. Jeni Lockett). 
Although the above findings seemed to be contradictory, we propose that the 
AQs deficiency that deprives ǻpqsAL from establishing biofilms for persistence 
could be the reason why ǻpqsAL was quickly cleared with the aid of 
professional immune cells that the initial neutrophil recruitment could be of 
importance in bacterial clearance in the mouse model. In addition, toxins 
pyocyanin and rhamnolipid, both positively regulated by AQ QS, produced at 
higher bacterial cell density such as biofilms, were shown to induce neutrophil 
apoptosis and necrosis in vitro (Prince et al., 2008) and in vivo (Allen et al., 
2005, Van Gennip et al., 2009) which also support our hypothesis that AQ QS 
could be the positive modulator of virulence in P. aeruginosa at later stages 
with biofilm-like growth predominates. A recent study addressed the 
importance of timing in neutrophil infiltration in relation to the role of PQS in 
interfering with neutrophil chemotaxis (Hansch et al., 2014). It was shown that 
low levels of PQS stimulate the chemotaxis of neutrophils via the MAPK and 
p38 signalling pathways, whereas high levels of PQS, most likely produced by 
biofilm-like P. aeruginosa, do not interfere with neutrophils phagocytic 
capability and viability (Hansch et al., 2014). The data indirectly supported our 
hypothesis that PQS enables P. aeruginosa to establish prolonged life-style 
growth by interfering with the ability of neutrophils to clear bacteria; thus the 
PQS deficient mutant ǻpqsAL would have lost the advantage for persistence. 
Neutrophils play a vital role in lung defence by facilitating bacteria clearance. 
The CF airways are characterised by massive neutrophil accumulation that 
dominates inflammatory process on the respiratory epithelial surface, and 
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levels of neutrophil elastase are correlated with poor pulmonary functions 
(Downey et al., 2009, Gifford and Chalmers, 2014). Neutrophil transmigration 
is facilitated by the cleavage of epithelial junctional proteins, E-cadherin and 
occludin for instance, that is mediated by calpains (Ca2+-dependent cysteine 
proteases that target cytoskeletal proteins) via the induction of Ca2+ flux 
generated by the activation TLR2 in airway epithelial cells upon P. aeruginosa 
PAO1 infection (Chun and Prince, 2009).  The sequential events comprising 
junctional protein degradation, endocytosis, actin re-distribution and the 
engagement of neutrophils to eradicate bacterial pathogens in the epithelium 
are suggested to be essential for maintaining membrane homeostasis (Mege et 
al., 2006, Chun and Prince, 2009). Our results suggest that the impact of PQS 
on P. aeruginosa pathogenicity might be missed in the context of our single 
cell culture. To build on our preliminary observation that the reactive oxygen 
species (ROS) production by neutrophils seemed to be altered upon P. 
aeruginosa stimulation in the presence of exogenous PQS molecules despite 
the donor variations and the side effect from the PQS diluent need further 
validation. We propose that AQs might interfere with neutrophil migration 
across bronchial epithelial monolayer. This could be demonstrated in a 
multicellular model as follows: bronchial epithelial cells (Calu-3 cells) are to 
be plated on the underside of 3 ȝM transwells to adhere, flipped over and 
inserted into 24-well plates. 500 ȝl of culture media will be added to the lower 
chamber (apical surface of the cell in this condition) and 100 ȝl of media to the 
transwell (basolateral side of the cells). The lower chamber media will be 
removed when the cells become confluent, therefore cells will be polarised and 
differentiated at air-liquid interface. Migration assay is to be performed by 
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inoculating P. aeruginosa PAO1-L Wt or ǻpqsAL at the apical surface (lower 
chamber) for 3 h (suitable time course experiment could be performed) and 
neutrophils will be added to the basolateral surface for 2 h (Chun and Prince, 
2009). The migration can be observed with immunofluorescent staining 
focusing at bacteria, neutrophils and calpain junctional protein. Alternatively, 
neutrophils transmigrated to the apical chamber will be collected, centrifuged, 
and resuspended in PBS for myeloperoxidase (MPO) assay (Chun and Prince, 
2009). The number of neutrophils across the epithelial monolayer will be 
determined accordingly by the MPO activity generated by a standard curve. 
Meanwhile, the migration assay of neutrophils can be performed toward P. 
aeruginosa and the chemoattractant fMLP (formyl-Methionyl-Leucyl-
Phenylalanine, f-Met-Leu-Phe) as positive control in the absence of an 
epithelial monolayer. The neutrophil migration assay can be modified by 
replacing Calu-3 cells with Calu-3 CFTR knock-down cells and CF bronchial 
epithelial cell line with its correspondent CFTR corrected counterpart (for 
instance IB3-1 and c38 cell lines) to further evaluate the impact of AQs on P. 
aeruginosa pathogenesis in the condition probably happens in the CF lung. 
The lack of differences between Wt and ǻpqsAL raised concerns about the 
efficacy of the diffCalu-3 epithelial infection model, we therefore infected 
diffCalu-3 cells with a CF highly transmissible isolate LESB58. Unexpectedly, 
we demonstrated that the CF clinical strain LESB58 causes less cell damage in 
actin degradation and junction proteins disruption on airway epithelium 
compared to that of PAO1-L. This finding was in line with the in vivo data 
showed that LESB58, although overproduced QS molecules, did not develop 
biofilms and was cleared in the lung demonstrated by an acute murine 
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respiratory infection (Carter et al., 2010). Interestingly, this paper also showed 
that the virulence of the QS-overproducer LESB58 and QS deficient isolate 
LES400 did not differ suggesting that QS does not influence the virulence of 
CF isolates in this acute infection setting (Carter et al., 2010). Moreover, 
another type of P. aeruginosa LES isolate LESB65 was examined for its 
persistence via nasopharyngeal inoculation was successfully demonstrated a 
clinically relevant in vivo chronic infection model up to 28 days (Fothergill et 
al., 2014). It was presented for the first time that the long-term adaption of P. 
aeruginosa in the upper respiratory tract was the key leads to the persistence in 
the lung later on. It was found that LESB65 developed its phenotypes including 
increased resistance to antibiotics and upregulated expression of genes that 
relevant to biofilm formation in the nasopharynx that will advance to its 
persistence and migration to the lower respiratory tract (Fothergill et al., 2014). 
The re-challenge of evolved isolates after persistence also displayed a more 
rapid colonisation than the initial inoculated strain (Fothergill et al., 2014). We 
propose that the attenuated phenotype of LESB58 shown in our in vitro model 
will also exert a privileged adaptation capability thus caused a long-term 
virulence if it was inoculated in the environment with chronic infection setting. 
In addition to targeting actin and tight junction proteins, a study indicated that 
PAO1 also induces airway epithelial apoptosis via binding to the gap junctional 
protein connexin43 (Cx43) which is involved in the paracellular transfer of 
small molecules (Losa et al., 2014). Interestingly, decreased Cx43 expression 
and reduced apoptosis were observed upon CFTR inhibition in Calu-3 cells 
(Losa et al., 2014) suggesting that the CFTR dysfunction in the CF lung 
reduces the efficacy of gap junctional proteins to recognise P. aeruginosa 
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resulting in impaired clearance of infected epithelial cells. The pathogenesis 
mechanism of LESB58 which characterised by minimal actin and junctional 
protein disruptions on Calu-3 cells requires further investigation by infecting 
LESB58 on CF epithelial cell lines to be compared with those performed using 
the PAO1 strain as well as performing LESB58 infections in the chronic 
murine model described above.  
In summary, we demonstrated that PQS is not beneficial for the initial innate 
recognition of P. aeruginosa by in vitro human bronchial epithelial cells based 
on bacterial growth, cytotoxicity, and activation of pro-inflammatory responses 
but could facilitate P. aeruginosa persistence in vivo. CF clinical strain 
LESB58, given the high production of AQs and pyocyanin detected in vitro, 
and its relatively mild infectivity on the human airway epithelium does not 
induce drastic airway inflammation but rather persist after initial colonisation. 
The second project 
Previous studies have focused on the function of myofibroblasts and fibroblasts 
DV SULPDU\ µHIIHFWRU FHOOV¶ GHULYHG IURP G\VUHJXODWHG DSRSWRVLV RI DLUZD\
epithelial cells in tissue remodelling and fibrosis in IPF. However, recent 
studies showed that Th2, Th17 cells, macrophages, and other myeloid cell 
populations are of no less importance in regulating disease progression in IPF 
(Duffield et al., 2013, Wilson et al., 2010). A considerable knowledge in the 
pathogenesis of IPF was built using the bleomycin-induced pulmonary fibrosis 
murine model; however, the mouse model has its limitations as it cannot fully 
recapitulate the complicated heterogeneous disease pattern in IPF. Despite the 
fact that potential serum and BAL biomarkers have been reported, the 
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inconsistent correlations with disease severity and variations among studies 
stress the need for further validation (van den Blink et al., 2010, Richards et al., 
2012, Vij and Noth, 2012). The purpose of the current study was to conduct a 
comprehensive investigation of systemic immune responses in IPF to 1) 
identify the profile of cytokine production by PBMCs in response to unbiased 
stimulation and 2) determine potential cytokine biomarkers in relation to 
disease severity. We hypothesised that the regulation of immune system in IPF 
is fundamentally altered and the pulmonary fibrogenesis might be attributed to 
the action of alternatively activated macrophages induced by a Th2-biased 
environment. Our study revealed for the first time that PBMCs of patient with 
IPF were less responsive to a broad panel of antigen stimulation than healthy 
controls, suggesting that IPF patients are not biased to a particular canonical 
immune status but immunosuppressed. Lower production of cytokines IFN-Ȗ, 
IL-17A and IL-13 by PBMCs in patients with IPF strongly correlated with 
reduced survival.  
The role of T cells in pulmonary fibrosis has been controversial with reports 
suggesting that could be promoting fibrosis, anti-fibrotic or have no significant 
impact per se (Luzina et al., 2008). Pro-inflammatory cytokine IL-17A has 
been considered pro-fibrotic based on the bleomycin-induced fibrotic mice 
model and enhanced levels of IL-17A were also found in the BAL of patients 
with IPF (Wilson et al., 2010). A mechanistic study showed that bleomycin-
induced IL-17A production by Th17 cells is co-dependent on TGF-ȕ1 
signalling, thereby resulting in the promotion of epithelial-mesenchymal 
transition (EMT) (Wilson et al., 2010). These findings seem to contradict our 
result showing that PBMCs in patients with IPF were up to 86% less likely to 
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produce IL-17A than healthy controls (chapter 6, section 6.5.3.). A recent study 
mapped the distribution of immunomodulatory cells and inflammation-related 
markers in the lung biopsy of patients with IPF and tissues were grouped by 
patterns of severity in disease pathology (Nuovo et al., 2012). IL-17 was shown 
to be produced by macrophages, CD3+ T cells and epithelial cells based on the 
co-expression of markers specific to each cell type. However, the pro-
inflammatory cytokines, including IL-17, CCR6, retinoid orphan receptor-Į, ȕ, 
Ȗ (ROR-Į, ȕ, Ȗ) were predominantly expressed by epithelial cells, suggesting 
that the amounts of IL-17A detected in the BAL of patients with IPF could be 
mostly secreted from epithelial cells but not recruited CD3+ T cells, although 
which IL-17 isotype was not specified in the above study and the fact that IL-
17C isotype being predominantly produced by epithelial cells also needs to be 
considered (Ramirez-Carrozzi et al., 2011). In addition, CD4+ Th1-associated 
cytokine IFN-Ȗ and Th2-associated cytokines IL-4, IL-5 and IL-13 have been 
shown to display contrasting activities regarding the promotion of fibrogenesis 
(refer to Fig. 1.6).  
IL-10 was thought to be produced specifically by CD4+ Th2 cells, but later 
studies showed that it was secreted by both Th1 and Th2 cells (Moore et al., 
2001). IL-10 is also made by CD4+CD25+Foxp3+ regulatory T cells (Tregs) 
and IL-10-induced CD4+ Tregs (Tr1 cells) (Moore et al., 2001). An imbalance 
between protective and detrimental subgroups of Tregs in patients with IPF 
was shown previously (Kotsianidis et al., 2009). The uncontrolled airway 
inflammation could be caused by a downregulation of suppressor Tregs and a 
significant correlation between local and systemic Tregs with lung function 
was found. The numerical and functional deficiency of Treg as well as the fact 
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that corticosteroids had no effect in increasing the number of Tregs in patients 
with IPF also indicated that the regulatory Tregs are defective and unable to 
counterbalance the airway inflammation (Kotsianidis et al., 2009). In 
accordance with above findings, our data demonstrating that PBMCs from 
patients with IPF were less likely to secrete IL-10 could be partly due to a 
reduced number of peripheral Tregs. Further to the dysregulation found in 
Tregs population, peripheral blood T-cell anergy due to CD4+CD28null cell 
populations that exhibit a downregulation of T-cell co-stimulatory signalling 
was also reported (Gilani et al., 2010, Herazo-Maya et al., 2013).  
In addition to the immunomodulatory effects from T cells in the peripheral 
blood, we proposed that defective antigen-presenting cells are also involved in 
the regulation of pulmonary fibrosis (Gabrilovich and Nagaraj, 2009, Wynn 
and Barron, 2010). The plasticity of macrophage activation plays a pivotal role 
in the pathophysiology in pulmonary fibrosis (Wynn, 2011, Wynn et al., 2013). 
It has been demonstrated that the depletion of macrophages during early 
inflammation in CD11b-DTR (diphtheria toxin receptor) mice partly relieved 
the fibrosis, whereas scarring persisted if macrophages were removed during 
the tissue remodelling stage (Duffield et al., 2005). This study indicated that 
macrophages adjust their functions for wound healing or fibrosis between the 
inflammatory and remodelling phases. Additionally, a subset of Th2-activated 
macrophages that express arginase-1 are anti-fibrotic by promoting 
myofibroblast apoptosis (Pesce et al., 2009), whereas the Th2 cytokines IL-4 
and IL-13 induce another macrophage subpopulations to secrete pro-fibrotic 
cytokine TGF-ȕ1 (Ingram et al., 2004, Wilson et al., 2010). The above 
evidence showed that macrophages can adopt different activation states 
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depending on the stimulation and can be anti-fibrotic or pro-fibrotic. As such, 
the macrophage activation stage could be indicative of the state of disease 
progression in patients with IPF. To determine the macrophage activation 
status of patients with IPF compared with healthy controls, experiments will 
soon be conducted in our laboratory to analyse the profile of 
cytokine/chemokine secreted by LPS stimulated CD14+ monocytes derived 
from PBMCs of cases and controls. Furthermore, to understand the clinical 
meaning of the state of macrophage activation, the correlation between the 
macrophage activation profile and clinical data including lung functions, 
survival will also be conducted.  
In this study, the association between cytokine production and the disease was 
analysed individually. From the discussion above, it is unlikely for one single 
factor to regulate the disease progression in IPF. For biomarkers to become 
valuable in clinical practice, we proposed that it would be of great interest to 
analyse the profile of cytokine production by PBMCs of each individual (a 
combination of cytokine signature including IFN-Ȗ, IL-17A, IL-10, and IL-13 
of each individual) together with their medical records and disease outcomes. 
Advanced statistical analyses such as multivariate clustering will be required. 
The combination with lung samples, such as biomarkers in BAL and 
histological patterns will also help to elucidate the underlying mechanism of 
IPF.  
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